Studies in the chemistry of fungal natural products by van der Sar, Sonia
Studies in the Chemistry of Fungal 
Natural Products 
 
 
A Thesis  
submitted in partial fulfilment 
of the requirements for the degree 
of 
Doctor of Philosophy in Chemistry 
at the  
University of Canterbury 
by 
Sonia van der Sar 
 
 
 
University of Canterbury 
Christchurch, New Zealand 
 
September 2006 
Acknowledgements 
 
 
 
First and foremost I would like to thank my supervisors, Professors Murray Munro and 
John Blunt for giving me the opportunity to carry out this research.  Despite being on half 
time for most of my time here, you never seemed to stray far from your offices. Your 
support and encouragement has been an asset. 
 
Secondly, A big thanks goes to Gill Ellis for all the assays you have run over the years, 
and recently for your extended role as the general marine group technician.  Trying to 
keep up with everyone’s often disorganised and/or chaotic work habits I know has been a 
challenge. 
 
Of course thanks goes out to the entire technical support staff of the Department of 
Chemistry.  We are very lucky as a department to have such great in-house technical 
expertise.  Especially to Rob McGregor, what would the department do without you? 
Thanks heaps for the personalised glass stoppers!!  Thanks also to Wayne MacKay you 
have always been a smiley, cheery face round the department.  Not to mention the many 
mechanical “emergencies” that you always responded to immediately (and with a smile).  
And of course Bruce Clark, thanks for the countless numbers of EIMS you ran without 
complaint. 
 
To everyone past and present in X-ray crystallography who have either taken part in the 
data acquisiton or processing, thank you.  Special thanks must go to Ward Robinson for 
having to put up with "poor quality natural product crystals"; Ramin for always being 
there with a smile to process all the data for those "poor quality crystals". 
 
A huge thank you must also go to Blair Stuart for his expertise in molecular modelling; 
taking time out from his own work to provide the seemingly endless amounts of data for 
the appendix. 
 
For financial assistance during my time here, I would like to thank the Chemistry 
Department for your assistance in the form of a Teaching Assistant scholarship.  Also to 
the Canterbury Branch of the New Zealand Federation of Graduate Woman, the Royal 
Society, Canterbury Branch of the Royal Society and Rotary for your much needed travel 
grants for conference attendance. 
 
A huge thank you to the marine group (past and present), I don’t think you could find a 
friendlier group of people anywhere.  I am absolutely indebted to you guys; I have to 
name you all because you have all played such an important part in my life; André 
Pinkert, Annabel Murphy, Cherry Chen (+Tony), Christian Narkowicz, David Overy 
(+Berta), Gerhard Lang, Jenni Gadd, Maya Mitova, Petur Dalsgaard, Philipp Kügler, 
Sarah Hickford, Sean Devenish, Stephan Busche, and Warren MacLean what a 
supportive and fantastic group to work in!  Without you all, I may have finished 
sooner…but certainly not with the same happy memories.  A special thanks must go to 
Gerhard, for honestly, being the best postdoc in the world, your knowledge of pretty 
much everything has been invaluable!  And Philipp, what would I have done without you 
these last few months?! Thanks so much for your friendship and the distractions you (and 
your many aliases!!) have provided through some very difficult times. 
 
Thanks to my Dad, you always did have a passion for chemistry, thanks for passing it 
on… Well here it is…the PhD, I know you would have been proud… 
To Mum and Davinia, even though you never entirely understood exactly what my work 
was all about, I know you understood and appreciated why I was doing it.   
 
Finally, to Aaron, thanks for your continued love and support through some frustrating 
and trying times; knowing I would get there in the end, even if I wasn’t able to see “the 
light at the end of the tunnel”. 
 Abstract 
 
 
 
Natural products as sources of novel therapeutic agents experienced a steady increase 
from around the turn of the twentieth century until it peaked in the 1970s and 1980s. 
However since this time pharmaceutical research in natural products has experienced a 
decline.  Despite this trend the natural products industry now seems to be experiencing a 
revival of sorts. 
 
This thesis represents a continuation of the work on the isolation and structure elucidation 
of potential drug leads from terrestrial fungal sources that the natural products group at 
the University of Canterbury is engaged in. 
 
The known compound, pseurotin A (2.7) and two novel diastereomers, pseurotin A2 (2.8) 
and pseurotin A3 (2.9) were isolated from the extract of a Penicillium sp. of fungus 
collected from the foreshore of a beach in Vancouver, Canada.  The absolute 
stereochemistry of pseurotin A2 and proposed absolute stereochemistry for A3 were 
elucidated using a combination of X-ray crystallography (A2 only), circular dichrosim, 
oxidative cleavage reactions, and J2-resoved 2D NMR experiments. 
 
The extract of an as yet unidentified endophytic fungus has yielded eight novel 
compounds related to the spirobisnaphthalene class of compounds.  These eight 
compounds fall into to distinct groupings.  The spiro-mamakones, distinguished by a 
structurally unprecedented oxygenated spiro-nonene skeleton, comprise five compounds, 
spiro-mamakones A-E (3.11, 3.15-3.18).  In addition to these naturally occurring 
compounds, the semi-synthetic compounds, 4-oxo-spiro-mamakone A (3.12) and O-
acetyl-spiro-mamakone A (3.21), were also synthesised.  spiro-Mamakone A was found 
 to be racemic, while X-ray crystallography and optical rotation revealed spiro-mamakone 
C (3.15) to be present as an enantiomeric mixture (4S*, 5S*, 9R*).  Unfortunately the 
enantiomeric excess was unable to be elucidated.  NOE experiments revealed spiro-
mamakone B (3.16) to have the relative stereochemistry 4S*, 5S*, 9S*.  The relative 
stereochemistry of spiro-mamakones D (3.17) (4S*, 5S*, 8S*, 9S*) and E (3.18) (4S*, 
5S*, 8S*, 9R*) was proposed from comparison of coupling constant calculations from 
energy-minimised models with those of the experimentally determined values. The 
second group, comprising three novel compounds named the mamakunoic acids, 
mamakunoic acid A–C (3.8, 3.7, 3.10), are characterised by their acid substituted dihydro 
benzofuran system.  The low yield obtained of these compounds, unfortunately prevented 
their stereochemical elucidation. 
 
In addition to structure elucidation, biosynthetic studies on spiro-mamakone A and 
mamakunoic acid B were also carried out.  Analysis of the NMR spectra derived from 
spiro-mamakone A, labelled with isotopic acetate, revealed a situation complicated by the 
presence of isotopomers and racemisation, resulting in NMR spectra that were somewhat 
anomalous in appearance.  These irregularities however, were resolved leading to the 
proposal that spiro-mamakone A was derived from a dihydroxynaphthalene (DHN) 
intermediate, which proceeds through to spiro-mamakone via an epoxide intermediate.  
Despite problems with purity and low yields of isotopically labelled mamakunoic acid B, 
it was proposed that like spiro-mamakone A, it proceeded via a DHN intermediate. 
 
The extract derived from a Malaysian Scleroderma sp. was found to contain a new 
dichlorinated pulvinic acid derivative, methyl-3',5'-dichloro-4,4'-di-O-methylatromentate 
(4.14), the structure of which was confirmed by X-ray crystallography.  In addition three 
previously reported compounds, 4,4'-dimethoxyvulpinic acid (4.11), methyl-3'-chloro-
4,4'-di-O-methylatromentate (4.12) and methyl-4,4'-dimethoxyvulpinate (4.13), were also 
isolated. 
 
The extract of another, as yet unidentified endophytic fungus was found to contain the 
new acetogenin, 1,5-dihydroxy-6-(2-hydroxyethyl)-3-methoxyacetophenone (5.7), 
 differing from the known compound, 2,4-dihydroxy-6-(2-hydroxyethyl)-3-
methoxyacetophenone (5.8) only by virtue of the substitution pattern.  The structure of 
5.7 was confirmed by X-ray crystallography. 
The implementation of efficient dereplication procedures is paramount for those working 
in the field of natural products.  The recent advances that have been made in the 
dereplication process in the natural products group at the University of Canterbury are 
given using examples from this research and where necessary from other group members. 
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Introduction 
 
 
 
1.1  Evolution of Natural Products  
 
A natural product is generally referred to as a secondary metabolite, in other words a 
metabolite that is not essential for the normal growth, development or reproducibility of 
an organism.  Secondary metabolites usually have no effect on the producing organism, 
though in an indirect way a number of examples have proven to be essential for the 
survival of some organisms in that they have deterrent effects on predators, or 
competitors.1  In the biosynthesis of secondary metabolites there exist four principle 
building blocks: acetate, mevalonate, shikimate and amino acids.  However, most of these 
intermediates are also used for the production of primary metabolites such as the fatty 
acids, nucleosides, and polypeptides.  A theory therefore has been put forward that 
suggests that the secondary metabolism arose as a way of using the acetate, shikimate and 
amino acids that were excess to requirements (‘shunt metabolites’).  It was proposed that 
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changes in genetic make up of an organism (mutations), whether they be natural chemical 
mistakes or exposure to chemicals, viruses or radiation, have lead to the increased 
production of the key intermediates.  When these compounds are able to provide useful 
biological activities that increase the chances of survival for an organism, they are more 
likely to be passed on through the generations, hence, Darwin’s famous theory on 
evolution through ‘survival of the fittest’ comes into play.  This is particularly evident 
when comparing higher organisms such as humans and lower organisms that live in 
extreme ecological niches.  Humans produce few secondary metabolites since our 
survival is determined by physical means.  In contrast, the lower organisms such as fungi 
and bacteria, which generally live in highly competitive environments, are considered as 
major producers of secondary metabolites. 
 
1.2  Natural Products Through History 
 
“The Indians killed another companion of ours… and in truth the arrow did not penetrate 
half a finger, but as it had poison on it, he gave up his soul to our Lord.”  Written by 
Spaniard Francisco de Orellano, who accompanied the conquistadors on their murderous 
campaign to South America in the sixteenth century.1 The poison referred to, was most 
probably that of curare, a name that was given to the extracts of the plant Chondodendron 
tomentosum and some Strychnos sp.2  This muscle relaxant poison exerts its effect by 
antagonising the effect of acetylcholine at the neuromuscular junction.  Investigations 
into the South American arrow poison has lead to the development and use of muscle 
relaxants, such as atracurium (1.1) to allow a reduction in anaesthesia during surgery.3 
 
N
OCH3
H3CO
H3CO
H3CO
CH3
CH2CH2COO(CH2)5OCOCH2CH2 N
H3C
OCH3
OCH3
OCH3
OCH3
2 PhSO3-
1.1  
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For thousands of years medicine and natural products have been linked through the use of 
traditional medicines and natural poisons.  The first records were written on clay tablets 
from Mesopotamia and date from about 2600 BC. The best-known Egyptian 
pharmaceutical record, is the Ebers papyrus dating from 1500 BC, a document that 
describes around 700 drugs (mostly from plants).  It includes formulas for gargles, snuffs, 
poultices, infusions, pills and ointments.4 The Chinese Materia Medica and Indian 
Ayurvedic systems have records dating back to 1100 BC and 1000 BC respectively.4  
These traditional medicines, which derive mostly from plants, after clinical, 
pharmacological, and chemical studies, formed the basis of most of the early medicines.5 
Famous examples include the antimalarial drug quinine (1.2) from the bark of the 
Cinchona species, asprin or acetylsalicylic (1.3), derived from salicylic acid, which 
comes from the bark of the willow tree (Salix alba), and morphine (1.4), named after 
Morpheus, the Greek god of sleep and dreams.6 Morphine comes from the opium poppy, 
Papaver somniferum. 
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1.3  The Rise and Fall of the Natural Product Era  
 
The discovery by Fleming in 1928 of penicillin (see Section 3.1.3.1), re-isolation and 
clinical studies by Chain, Florey, and co-workers in the early 1940s, and 
commercialisation of synthetic penicillins revolutionised drug discovery research.7  The 
huge success of penicillin prompted a worldwide effort by drug companies and research 
groups to assemble large collections of microorganisms in order to try and discover new 
antibiotics.5  The effort paid off, and in fact the early years were extremely prolific, and 
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included the discovery of streptomycin (1.5), chloramphenicol (1.6), chlortetracycline 
(1.7), cephalosporin C (1.8), erythromycin (1.9), and vancomycin (1.10).  All of these 
compounds, or derivatives thereof are still in use as drugs to this day.7,8 
Chapter 1 Introduction 5 
NH
O2N
OH CH2OH
O CHCl2
1.6
O
OHHO
HN
HO N
H
O
H3C
O
OHOHC
O
H
N
OH
OHHOH2C
NH
HN2
NH2
NH
CH3
1.5
Cl
OH O OH O
CONH2
OH
N(CH3)2H
OH
HO CH3
1.7
N
S
O
O
CH3
HO O
O
H
N H
ONH2
O
HO
1.8
O O
O
O
CH3
H3C
OH
HO
O CH3
OHH3C
CH3
OCH3
N
CH3H3C
OH
O
CH3
H3C
H3CH2C
O
OH
CH3
H3C
1.9
OO
O
O
OH
OH OH
OO
OH
NH2
O
H
N
O
N
H
N
H
O
H
NHCH3
H
OH
O
H2N
H
ClCl
N
H
O H
N
O
H
HHN
O
HO2C
HO OHOH
H
HO
1.10
 
Chapter 1 Introduction 6 
Natural products as sources of novel therapeutics peaked in the Western pharmaceutical 
industry in the 1970s and 1980s.9  This was likely due to the breakthrough in the 1970’s 
of mechanism-based screening for bioassay-guided fractionation.  Some of the first 
compounds identified in the early 1970s using this method included the β-lactamase 
inhibitor, clavulanic acid (1.11), from Streptomyces clavuligerus and the HMG-CoA 
reductase inhibitor mevastatin (see Section 3.1.3.2) from Penicillium citrinum.  A 
mixture of clavulanic acid and amoxicillin (1.12), known as Augmentin is still in use 
today as a front-line antibiotic. 
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Of the 877 small-molecule new chemical entities (NCEs) introduced between 1981-2002, 
about half were natural products, semi-synthetic natural product analogues or synthetic 
compounds based on natural product pharmacophores*.10  Despite this success, 
pharmaceutical research into natural products has experienced a slow decline during the 
past two decades.  Several reasons have been blamed for the decline:9 
1. The introduction of High-Throughput Screening (HTS) against defined molecular 
targets has prompted many companies to move away from natural product extract 
libraries towards ‘screen friendly’ synthetic chemical libraries. 
2. Combinatorial chemistry, which offered the promise of simpler, more drug-like 
screening libraries with wide chemical diversity. 
3. Advances in molecular biology, cellular biology and genomics increased the 
number of molecular targets and prompted shorter drug discovery timelines. 
4. A decline in the focus of major pharmaceutical companies on therapy for 
infectious diseases, which has been a traditional area of strength for natural 
products. 
                                                 
* An ensemble of steric and electronic features that is necessary to ensure optimal interactions with a specific biological target 
structure and to trigger (or block) its biological response. 
Chapter 1 Introduction 7 
5. Possible uncertainties regarding the collection of biological materials as a result 
of the 1992 Rio Convention on biological diversity. 
6. Most promising lead compounds have traditionally been available in very small 
quantities, especially those from marine organisms such as sponges.  Due to the 
perceived supply problem, many drug companies are reluctant to pursue these 
sources.  This leaves organic synthesis as the only option for sourcing the drug 
candidates for pre-clinical and clinical trials.  However, due to the often lengthy 
synthetic routes that result from the often highly complicated architecture, long 
development times, low yields and impracticality of scale-up, these compounds 
are even more disfavoured.11 
Drug discovery today requires rapid screening, hit identification, and hit-lead 
development.  Unfortunately, the traditional resource intensive natural product 
programmes based on extract-library screening, bioassay guided isolation, structure 
elucidation followed by product scale-up face a huge disadvantage when compared to the 
defined synthetic chemical libraries.9 
 
1.4  A Natural Products Revival? 
 
Despite the trend in the pharmaceutical industry to downscale its natural product research 
in recent years, there could be change on the wind………. 
The problems with natural products (vide infra) that resulted in these initial decisions are 
being addressed with technological advances, such as increasing the throughput of 
methods for compound purification and identification.12 A problem also lies with the 
unrealised expectations from combinatorial chemistry.  For a molecular screening library 
it is imperative that it covers a significant portion of chemical diversity, but at the same 
time be biased toward ‘biological friendliness’ and ‘drug-likeness’.13  Some of the first 
large combinatorial libraries, in some cases contained in excess of one million 
compounds that were synthesised, only to find very few, or no hits.  This was the first 
mistake of some synthetic chemists, to design the libraries based on chemical 
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accessibility and maximum achievable size rather than on biologically-relevant chemical 
diversity or properties.  This was nicely summed up by Danishefsky “ a small collection 
of smart compounds may be more valuable than a much larger hodgepodge collection 
mindlessly assembled”14  The potential for undesired side effects due to the often less 
specific binding characteristics of many of the simple combinatorial generated molecules 
was also soon realised.11  This has prompted a renewed interest in natural products as a 
source of chemical diversity and lead compound generation. 
So why is it that natural products win the specificity and potency race compared to 
artificially designed molecules?  A recent article in Science11 answered this question 
nicely “…evolutionary selection – natures own high throughput screening process for the 
optimisation of biologically active compounds.”  Natural products tend to have well-
defined three-dimensional structures carrying a plethora of functional groups, which 
provide H-bond acceptor/donors etc.  These have been fine tuned into a precise spatial 
orientation.  The structures of the biological targets of natural products (e.g protein 
binding sites) are often well conserved among proteins even having different genetic 
sequences.  This is such that the secondary metabolites that have evolved for a certain 
purpose and mode of action may display different, yet just as potent effects in other 
situations. 
“There are more things between heaven and earth….”15 Shakespeare’s words still, after 
so many years, continue to ring true.  The ‘catalogue’ of natural products is still far from 
complete.  Discoveries of new structures and functions are likely to continue as 
unexplored sources of natural products are evaluated.  The functional group diversity and 
design introduced into natural products during biosynthesis continues to provide lessons 
for chemists in how to construct biologically active mimics and provide selective ligands 
for cellular targets.12 
 
1.4.1  New Frontiers in the Discovery of Novel Bioactives 
 
Currently, the most interesting natural products have come from recently discovered 
biota.  One such example was the realisation that there was a large and largely 
Chapter 1 Introduction 9 
unexplored group of fungi (Endophytes) living inside higher plants (For more on this 
group of fungi see Section 1.6).  This has led to foccussed discovery efforts by both 
industrial and academic labs. 
The marine environment has also received somewhat of a revival in interest, through the 
discovery of sponge-bacterial symbiosis, and the realisation that many metabolites once 
thought to be sponge metabolites, are most probably produced by symbiotic bacteria.  A 
ground breaking study on an uncultivated bacterial symbiont of the sponge Theonella 
swinhoei has confirmed that the antitumor compounds, the theopederins and onnamides 
(Figure 1.1) are most likely produced by a bacterial symbiont.16  
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Figure 1.1: Structures of theopederin A and onnamide A, two representative compounds from the 
pederin family. 
 
Uncultivated bacterial symbionts offer a goldmine of novel structural possibilities.  
Heterologous gene expression* of natural product biosynthetic pathways provides a 
technique whereby these potentially novel structures can be accessed.  It enables the 
(over)-production of structurally complex substances, can provide a basis to generate 
novel analogues through biosynthetic engineering, and also provide a way of transferring 
‘silent’ (not expressed under standard laboratory conditions) secondary metabolite 
pathways into surrogate host strains.17  This account barely scratches the surface of this 
interesting new field; a full account however, is unfortunately beyond the scope of this 
chapter. 
                                                 
*
The transfer of genes of a secondary metabolite biosynthetic pathway from the original microbial producer into a heterologous host 
(a host of a different species, in this case one that is easily cultivated). 
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1.5  Fungal Secondary Metabolites 
 
There has been a recent and growing understanding of microbial abundance and 
diversity, in particular that of fungi.  It has shown that the fungal world has until now, 
just been superficially scratched.  There is in existence, a huge, still unknown and 
untapped microbial pool, which promises the discovery of novel, useful and 
economically profitable compounds. 
As alluded to, fungi have historically been a gold mine of lead compounds for the 
pharmaceutical industry.  Post 1960s, after the excitement that the discovery of penicillin 
had made, the attention of pharmaceutical companies and academic labs drifted away 
from fungi as a source of lead compounds.  Efforts were instead focussed on 
Actinomycetes.  Despite this, it was again a fungus that was responsible for the next big 
break through in medicine.  In the 1980s, from the filamentous fungus, Tolypocladium 
inflatum, the immunosuppressive agent cyclosporin A (1.13) was discovered.  The 1980s 
turned out to be the decade natural products research saw a resurgence in the discovery of 
useful compounds from fungal sources, not only for antibiotics but also other therapeutic 
areas.  Success stories include, the cholesterol-lowering agent, mevinolin (1.14)18, one of 
the so-called statins, isolated from Aspergillus terreus, and asperlicin (1.15)19, a 
cholecystokinin (CCK)* antagonist from Aspergillus alliaceus. Structure manipulation of 
this compound has led to the discovery of the benzodiazepines (Figure 1.2)20 used for the 
treatment of severe anxiety or insomnia. 
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Figure 1.2: The benzodiazepine core, the R-groups can be varied widely. 
 
                                                 
*CCK is a regulatory peptide hormone found mainly in the gastrointestinal tract, but is also a 
neurotransmitter present throughout the nervous system. 
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1.6  Endophytic Fungi 
 
Endophytic fungi had previously been overlooked as potential sources of bioactive 
metabolites.  This was most likely due to the absence of any sign of fungal colonisation 
in the host plant.21 In the past few decades however, it has been realised that plants may 
contain countless, previously undetected, unrealised numbers of these microorganisms 
known as endophytes.  This has prompted a worldwide scientific effort to isolate 
endophytes and to study their natural products.  Scientists have since discovered that 
endophytes may represent an important area for discovery of new secondary metabolites.  
Of the approximately 300,000 higher plant species that exist on earth, each individual 
plant is thought to play host to one or more endophytes.22 
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The most widely accepted definition of an endophyte is given by that of Bacon et al; 
“microbes that colonise living, internal tissues of plants without causing any immediate, 
overt negative effects.”23 
The majority of endophytic species have been identified as belonging to the ascomycete 
and deuteromycete classes of fungi.24 
 
1.6.1  The Endophyte-Host Interaction 
 
It is thought that endophytism may have evolved from the time that higher plants first 
appeared on the earth millions of years ago.25  This is supported by the fact that plant-
associated microbes have been discovered in the fossilised tissues of stems and leaves.26 
It is plausible therefore, that due to these long-held associations, that some endophytes 
may have developed genetic systems allowing for transfer of information between 
themselves and the higher plants and vice versa. 
In an endophyte-host interaction, the minimum contribution that the plant provides is one 
of nutrition.25  There are other possibilities for these interactions.  These could include, 
the possibility that the plant provides compounds necessary for the completion of the life 
cycle of the microorganism.27  It is also possible that in some cases the endophyte could 
be responsible for the degradation of the dead or dying host plant, beginning the process 
of nutrient re-cycling.  An even more important mechanism could exist.  If it is likely that 
mechanisms exist for the exchange of nucleic acids, then it could also be possible that 
some of the rare molecules made by higher plants could also be produced by endophytes, 
for example taxol. 
 
1.6.1.1  Taxol-a Case Study 
 
Taxol (1.16) is a highly functionalised diterpenoid which is found in all the worlds 
species of Yew (Taxus) tree, although it was first isolated from the Pacific yew, Taxus 
brevifolia.28 
Chapter 1 Introduction 13 
O
O
O
ONH
O
OH
O
O
OHO
O
OH
O
O
H
1.16  
 
It was the world’s first billion dollar anti-cancer drug, and is particularly effective against 
refractory breast and ovarian cancers.21  The yew is a slow growing tree, and the inner 
bark of the tree yields only 0.01% to 0.03% of its dried weight of taxol.  However, a full 
regimen of anti-tumour treatment requires 2g of purified taxol.29  For this reason the cost 
of the drug is phenomenal, making it out of reach for many people. 
A search for an endophyte, that was able to produce taxol was conducted on the basis that 
plant-associated microbes had been found to produce “plant” compounds such as 
gibberellins.  Testing of hundreds of microbes by Stierle and co-workers, resulted in the 
discovery that one, a fungal endophyte, Taxomyces andreanae was capable of producing 
taxol.29  Although the yields of taxol produced by T. andreanae were low (24-50 ng/L) 
this represented a break through in solving the supply problem, which could only lead to 
a decrease in the cost of this important drug to patients.  Since this initial study, taxol has 
been found from other endophytic fungi isolated from a number of different sources other 
than Yew trees.  These include Pestalotiopsis microspora from the bald cypress,30 P. 
guepini from the Wollemi Pine (Wollemia nobilis),31 and a novel fungus, 
Seimatoantlerium tepuiense, isolated from the plant, Maguireothamnus speciosus,32 
which belongs to the same family as blackberry and raspberry. 
 
1.6.2  Metabolites from Endophytic Fungi 
 
The diverse chemistry and bioactivity displayed by natural products isolated from 
endophytic fungi most likely stems from the fact that there are so many endophytes that 
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occupy literally millions of unique biological niches (higher plants) growing in so many 
unusual environments.22  A selection of some of the more interesting metabolites 
produced by endophytic fungi are presented below.  These are grouped according to their 
biological activity. 
 
1.6.2.1  Antiviral Compounds 
 
The endophytic fungus, Cytonaema sp. has yielded two human cytomegalovirus (hCMV) 
protease inhibitors, cytonic acids A (1.17) and B (1.18).33  hCMV is a ubiquitous 
opportunistic pathogen that causes disease in those that are congenitally immune-
deficient. 
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1.6.2.2  Antimicrobial Compounds 
 
Cryptosporiopsis quercina isolated from Tripterigeum wilfordii, a medicinal plant native 
to Eurasia,34 was found to show antifungal activity against some important human fungal 
pathogens, including Candida albicans, and Trycophyton mentagrophytes.  The bioactive 
principle was found to be a novel peptide termed cryptocandin (1.19).34 Cryptocandin is 
currently being considered for use against fungal diseases of the skin and nails.24 
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An investigation of an unidentified endophytic fungus from Costa Rica for antibiotic 
activity yielded Guanacastepene A (1.20).35 It was shown to display antibiotic activity 
against methicillin-sensitive and -resistant Staphylococcus aureus and vancomycin-
resistant Enterococcus faecalis.  Studies have suggested that the primary mode of 
bactericidal action is membrane damage.  It was also found that 1.20 lysed human red 
blood cells and caused leakage of intracellular potassium.36 
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1.6.2.3  Antitumoural Compounds 
 
Aspergillus parasiticus, an endophyte of the coastal redwood (Sequoia sempervirens), 
was found to produce the sequoiatones A (1.21) and B (1.22).  These compounds showed 
moderate and selective inhibition of human tumour cells, with the greatest activity 
against breast cancer cell lines.37 
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1.6.2.4 Immunosuppressive Metabolites  
 
The study of Fusarium subglutinans, an endophyte of the twining vine, Tripterygium 
wilfordii, yielded two non-cytotoxic, but immunosuppressive compounds.  The diterpene 
pyrones, subglutinol A (1.23) and B (1.24) displayed identical immunosuppressive 
activities in the mixed lymphocyte reaction (MLR) assay and thymocyte proliferation 
(TP) assay.38  
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The currently approved immunosuppressive agent, cyclosporin A (1.13), displayed equal 
potency in the MLR assay but was 104 more potent in the TP assay.38  The fact however, 
that 1.23 and 1.24 display no cytotoxicity suggests that further exploration into these 
compounds is required. 
 
1.7  Work Carried Out at UoC 
 
As part of the continuing effort to identify new bioactive natural products with 
pharmaceutical potential, the Marine group at the University of Canterbury has explored 
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various habitats.  Mostly around New Zealand, but also Antarctica and other locations. 
Since 1998, more than 10,000 marine invertebrate and fungal specimens have been 
screened for cytotoxic, antifungal, antimicrobial and antiviral activity, where it has been 
established that ~10% of all isolates show activity in the assays. 
Although much of the research carried out by the group has traditionally been marine 
orientated, first with marine invertebrates, and then with marine fungi, the focus has 
changed in recent years, in that the group is now almost entirely concentrated on the 
isolation of biologically active natural products from terrestrial fungi.  These include such 
diverse groups as endophytes (fungi living inside of higher plants), entomopathogenic 
(insect pathogens) fungi, and biological niches such as Malaysian tropical rainforests.  
Coupled with the development of an HPLC UV library database used in the dereplication 
(see Chapter 2) of crude extracts, this “path” has quickly proven to be a rewarding one.  
 
1.8  Aim of this Research 
 
The primary aim of this study was to characterise the compounds responsible for the 
biological activity of a wide range of terrestrial fungi, collected from a variety of habitats 
around the world, including Canada, Malaysia and New Zealand.   
Fungal extracts were selected based on the biological activity displayed in the anti-
cancer, antimicrobial, and antiviral in-house assays.  Extracts chosen for the structural 
elucidation of the active components were based on a “no hit”* criterion that had to be 
met following dereplication.  The structure elucidation of purified compounds would be 
carried out using various NMR spectroscopy, and mass spectrometry techniques.  Where 
necessary confirmation of correct structural/stereochemical assignment would be 
confirmed by X-ray crystallography, and/or semi-synthetic modifications. 
 
                                                 
* Not found to match any known compounds in the UV and AntiMarin databases. 
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Chapter 2 
 
 
A Canadian Penicillium sp.  
(F2028) 
 
 
 
2.1  General Introduction 
 
The genus Penicillium is probably the most well known of the filamentous fungi, thanks 
to its frequent colonisation of bread and other foodstuffs and the antibiotic properties of 
some species.  Although spoiled food is the most common instance in which they are 
observed, penicillia have a wide variety of habitats, including plants, animals, and in 
some cases other fungi.   
 
2.1.1  Interaction with Plants 
 
Penicillium sp. are primarily known as saprophytes growing on organic substrates 
including dead plant material, however a few species have evolved for growth on living 
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tissue.39  One such species is P. expansum, which causes the soft brown rot on apples, 
and also cherries and grapes.  Important in its infection is the degradation of 
hemicelluloses resulting in plant cell wall breakdown, causing cell wall loosening and 
increased porosity of the wall, as well as allowing the colonisation of the plant tissue.40  It 
is also this species of fungus that is responsible for the production of patulin (2.1) in 
unfermented apple juice produced from poor quality fruit.39,41  
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Another two species, P. digitatum and P. italicum, are responsible for the green and blue 
moulds of citrus fruits, where they produce a soft rot.  The soft rot has been shown to be 
marked by a decrease in pectic substances in the fruit, which has been found to result 
from production of pectin methylesterase, polygalacturonase and macerating enzyme in 
the fungus when cultured.42 
 
2.1.2  Interaction with Animals 
 
Most species of Penicillium are considered quite benign with respect to causing human 
disease.  However, one species of dimorphic fungus, P. marneffei can cause disease 
(penicilliosis) both in immunocompetent and immunocompromised people.  It is 
especially a problem among those persons living in Southeast Asia, where it is 
endemic.43-45 Over the years infection due to this pathogen has increased markedly, which 
is exclusively due to the increasing number of patients infected with the human 
immunodeficiency virus (HIV).43  Symptoms of penicilliosis are non-specific and are 
similar, whether the patient has AIDS, or not.  The main signs of infection include chills, 
fever, cough, anaemia, skin lesions, leukocytosis, and acne-like pustules and nodules on 
the face, trunk and extremities.45  Without treatment, infection from P. marneffei is fatal. 
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2.1.3  Important Drugs Derived from Penicillium sp. 
 
Despite the degradative processes that Penicillium sp. are involved in, they are also a 
highly useful source of medicinal drugs.  Some of the most important drugs of the 
twentieth century have originated from Penicillium sp. of fungi.  These include the 
antibiotic penicillin G, the cholesterol-lowering statins, and the antifungal agent, 
griseofulvin. 
 
2.1.3.1  The 20th Century Wonder Drug: Penicillin. 
 
The penicillins were the first natural product antibiotics discovered and came from a 
Penicillium sp.  The initial discovery was made by Sir Alexander Fleming in 1928, when 
he noticed zones of inhibition on Staphylococcus aureus cultures contaminated with P. 
notatum.46 
Despite this important discovery the clinical potential of the active agents produced by 
Penicillium sp. were not exploited fully.  It was not until WWII that an international 
research effort was conducted.  The object was to produce penicillin (Penicillin G) on a 
large scale.  The effort resulted in enough penicillin to supply all the allied forces by the 
end of the war.  The joint industrial and academic collaboration was second only in 
manpower and cost to the Manhattan Project.  The research found that all the penicillins 
have a common nucleus based on a fused β-lactam-thiazolidine system.39 
Penicillin G (2.2) was found to have many flaws including being active against gram-
positive bacteria only.  The other shortcomings included being broken down in the 
stomach by gastric acid and poor absorption in the blood stream.  It was also found that 
many species of Staphylococcus were able to enzymatically inactivate Penicillin G.47  For 
this reason several semi-synthetic derivatives were produced.  These include ampicillin 
(2.3) and methicillin (2.4).  In the case of ampicillin (2.3), the increased polarity gave 
greater activity against gram positive bacteria.  In the case of methicillin (2.4), the bulky 
group attached to the amino acid side chain provides steric hindrance, which interferes 
with the attachment of the Staphylococcus enzyme.47 
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All penicillins have the same mode of action, inhibition of bacterial cell wall synthesis.  
More specifically, penicillins prevent the cross-linking of peptides on the mucosaccharide 
chains.47 
 
2.1.3.2  The Statins 
 
Discovery of the first statin resulted from the research of Akira Endo.  For the answer to 
lowering cholesterol, he looked toward microbes, as he believed that some microbes 
would produce metabolites that inhibited HMG-CoA reductase (the first committed step 
in cholesterol biosynthesis), most likely as a defence mechanism against other microbes 
that needed sterols or other mevalonate-derived isoprenoids for growth.48 Focussing on 
fungi and mushrooms as sources of suitable compounds, a search of over 6000 fungi was 
conducted over a 2 year period.  The result was the discovery that a metabolite produced 
by the fungus P. citrinum inhibited lipid synthesis.  The inhibiting compound became 
known as mevastatin (2.5). 
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Clinical trials in 1978 went ahead, and by the mid 1980s it was found that mevastatin 
(2.5) lowered total plasma cholesterol and LDL-cholesterol by 20-40% with no serious 
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side effects.48 This important discovery sparked intensive development of other 
cholesterol-lowering drugs, and since then a number of statins have been established as 
effective and safe cholesterol-lowering agents, and have been used by tens of millions of 
patients.48 
 
2.1.3.3  Griseofulvin 
 
The antifungal drug, griseofulvin (2.6) was first isolated in 1939 from P. griseofulvum.49 
The drug is used to treat skin infections such as jock itch, athlete’s foot, ringworm and 
fungal infections of the scalp, fingernails and toenails.50  
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The mode of action is inhibition of fungal mitosis, where the mitotic spindle is disrupted 
through interaction with polymerised microtubules.51 
 
2.2  Introduction 
 
The species of Penicillium fungus in this study was isolated from driftwood on the 
foreshore of a beach in Vancouver, B.C, Canada.  Mr Matthew Walters from the School 
of Biological Sciences purified, cultured on a small scale, and extracted this fungus a 
number of years ago.  Since this time the extract remained frozen at -80°C. 
 
2.3  Preliminary Investigations 
 
The crude extract was submitted for biological testing using the in-house assay system. 
The extract showed no P388 activity, nor did it show antimicrobial activity.  Remarkably, 
however it showed an antiviral activity of 4+, specific only to Herpes simplex virus 
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(HSV) (Section 7.1.6).  For this reason alone the extract was pursued further.  An aliquot 
of the crude extract was chromatographed on reverse phase C18 HPLC, using the 
standard gradient (Section 7.1.4).  This showed the extract to have a fairly simple 
composition, whereby a group of three, clearly related compounds, eluting between 12-13 
minutes were shown to represent the majority of the mass of the extract (Figure 2.1). 
 
 
Figure 2.1: HPLC chromatogram of F2028 showing overlay of ELSD detection (Blue). 
 
These three compounds were shown to have virtually identical UV chromophores, 
suggesting that they were very closely related in structure (Figure 2.2). 
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Figure 2.2: UV profile overlay for SAS-5-19.13(2.72.9). 
 
The antiviral activity shown by the crude extract was proposed to be due to at least one of 
the compounds eluting between 12-13 minutes in the HPLC.  The reason for this is that 
another extract (F2029) was also shown to contain only the compound eluting at 12.2 
minutes, and it displayed identical HSV specific activity (Figure 2.3).  
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Figure 2.3: HPLC chromatogram of F2029, with inset of the UV profile for the peak at 12.2 
minutes  
 
2.4  Chromatography of F2028 
 
Method development using analytical HPLC, was followed by semi-preparative HPLC 
(see Experimental, Section 7.3.1) and resulted in the three compounds, SAS-5-19.1–3 
being isolated.  
 
2.5  Structural Elucidation 
 
2.5.1  Structural Elucidation of SAS-5-19.1 (2.7) 
 
SAS-5-19.1 (2.7) was the major compound isolated from the extract of the Penicillium 
sp.  ESIMS of an aliquot of SAS-5-19.1, collected from the HPLC gave the mass of the 
compound as 432 [M+H]+.  The 1H NMR spectrum (Figure 2.4) showed three methyl 
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signals, at δH 0.90, 1.65, and 3.26, the latter as a methoxyl.  Also present were three 
signals showing oxymethine-like chemical shifts at δH 4.38, 4.42, and 4.47. 
 
ppm2345678910
Solvent
ppm4.324.344.364.384.404.424.444.464.484.504.524.54
 
Figure 2.4: 1H NMR spectrum of pseurotin A (2.7)in d6-DMSO. 
 
Characteristic aromatic signals were shown between δH 7.50–8.30, the multiplicity and 
integrals indicating the aromatic system as a monosubstituted benzene ring.  This was 
indicated by the 2:1:2 integral ratio of the doublet, triplet, triplet arrangement of the 
aromatic protons respectively (Figure 2.5).  The three remaining signals were two 
multiplets at δH 5.40 and 2.05, and a singlet at 9.94.  The integral and chemical shift of 
the signal at δH 5.40, indicated that it represented two protons. These were probably part 
of a double bond moiety.  Given the chemical shift and the complex multiplicity the 
signal at δH 2.05 was proposed to be a methylene adjacent to at least a methyl group.  The 
chemical shift of the singlet at δH 9.94 indicated it as an exchangeable proton on either an 
oxygen or nitrogen.  Because 2.7 was of odd mass, it was proposed that this was a proton 
attached to nitrogen.  
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Figure 2.5: Aromatic region of the 1H NMR spectrum of 2.7 showing multiplicity and integrals. 
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Figure 2.6: COSY NMR spectrum of 2.7 in d6-DMSO showing the aromatic and aliphatic spin 
systems. 
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Figure 2.7: HSQC-DEPT NMR spectrum in d6-DMSO of 2.7, highlighting the oxymethine 
signals. 
 
The COSY and HSQC NMR spectra (Figure 2.6 and Figure 2.7 respectively) confirmed 
the existence of two spin systems, a monosubstituted benzene (Figure 2.8a), and an 
aliphatic chain containing diol and double bond functionalities (Figure 2.8b). 
 
H3C
H
H
H
H
H 8.27
7.55
7.70
7.55
8.27
23
22
21
20
19
18
15
14
13
12
11
10
a b
H
H
5.44
5.402.05
68.7
72.4
0.90
HO
OH H
H
4.38
4.47
H H
 
Figure 2.8: Spin systems a and b for 2.7 
 
The benzene unit showed coupling of the triplet protons at δH 7.55 (H-20, H-22) to a 
triplet proton at δH 7.70 (H-21) and doublet protons at δH 8.27 (H-19, H-23).  These 
protons showed 1JCH correlations to carbons at δC 129.0 (C-20, C-22), 134.5 (C-21), and 
130.8 (C-19, C-23) respectively.  The second system was characterised by a terminal 
methyl group at δH 0.90 (H-15) coupled to the methylene protons at δH 2.05 (H-14).  Both 
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these groups of protons each showed 1JCH correlations to carbons at δC 14.6 and 21.1 
respectively.  The methylene protons also showed coupling to the overlapping proton at 
δH 5.44 (H-13), which in turn was coupled to the other double bond proton at δH 5.40 (H-
12).  These olefinic protons had 1JCH correlations to carbons at δC 129.5 and 134.3 
respectively, thus confirming the olefinic nature of these protons and carbons.  H-12 was 
also coupled to one of the oxymethine protons at δH 4.47 (H-11), which in turn showed 
coupling to another oxymethine proton at δH 4.38 (H-10).  The oxymethine protons were 
confirmed, as such by 1JCH correlations to carbons at δC 68.7 (C-11) and 72.4 (C-10) 
respectively.  Although no OH proton resonances were identifiable in the 1H NMR 
spectrum, the chemical shifts of the oxymethine protons and carbons were consistent with 
a diol functionality.  A vicinal diol, rather than epoxide was proposed based on chemical 
shift arguments.  The protons and their respective carbons in an epoxide, would have had 
substantially higher field chemical shifts. 
Apart from the proton signals of the methyl at δH 1.65 (δC 6.1), the methoxyl at δH 3.26 
(δC 52.2), the remaining oxymethine at δH 4.42 (δC 75.4), there were no further HSQC 
correlations.  This indicated that the balance of the carbons seen in the CIGAR spectrum 
(δC 91.6, 93.0, 112.0, 133.7, 167.1, 187.4, 196.9, and 197.3), were all quaternary.  From 
the chemical shifts of the latter four carbons, it was presumed they were all carbonyl 
groups.  It was unclear however, the identity of the former three carbons, as their 
chemical shifts were suggestive of olefinic, acetal or some other oxygen-shifted non-
aromatic functionality.  The carbon at δC 133.7, because of its chemical shift, was 
presumed to be the aromatic carbon at the point of substitution. 
At this point a search of the AntiMarin database was conducted.  A partial structure 
search was carried out using the mass and the two spin systems presented in Figure 2.8a 
and b as parameters.  This revealed a match with a compound known as pseurotin A 
(2.7).52  The 1H NMR spectrum of 2.7 was compared to that of pseurotin A in the 
literature and was found to be identical. 
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Figure 2.9: CIGAR NMR spectrum of 2.7 in d6-DMSO, showing the couplings that confirm the 
assignments for carbons at C-6 and C-2. 
 
The data from the CIGAR NMR spectrum was used as a final confirmation, that 2.7 was 
pseurotin A (Figures 2.9 and 2.10).  The 2,3JCH correlations displayed by the methyl at δH 
1.65 (H-16) to carbons at 112.0 (C-3), 187.4 (C-2), and 197.3 (C-4), confirmed the 
furanone portion of the molecule, while CIGAR correlations from H-10 to the carbons at 
C-2 and C-3 confirmed the attachment of the aliphatic side chain to the furanone.  There 
was however one discrepancy, the chemical shift of C-2 was ~20 ppm higher than the 
equivalent carbon in the literature. 
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Figure 2.10: CIGAR NMR correlations confirming 2.7 as pseurotin A. 
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The pyrrolidinone was confirmed through the CIGAR correlations from both the 
oxymethine proton at δH 4.42 (H-9) and the NH proton at δH 9.94 (H-7).  In the case of 
H-9 this was to a carbon at δC 91.6 (C-5), and for H-7 to carbons at δC 93.0 (C-8), and 
167.1 (C-6).  A correlation from H-9 to the carbonyl at C-4 confirmed the proximity of 
the furanone to the pyrrolidinone.  Once again, however, there was a discrepancy in 
chemical shifts of 2.7 compared to those recorded in the literature.  This time it involved 
the chemical shift of C-6, which according to our data was ~20 ppm less than that for the 
equivalent carbon in the literature.  It was then realised that the literature chemical shifts 
were wrong, in that the carbons at C-2 and C-6 had been missassigned by inadvertently 
swapping the chemical shifts.  Given that the structures were first reported in the late 
seventies, this was not surprising as 2D NMR techniques were not available.  In the more 
recent literature this mistake had been acknowledged and corrected.53  CIGAR 
correlations from the aromatic protons at H-19 and H-23 to the carbonyl carbon at δC 
196.9 (C-17), showed the attachment of the benzene ring to a ketone, of which was 
shown to be connected to the rest of the molecule by a 3JCH CIGAR correlation from the 
methoxyl protons at δH 3.26.  The methoxyl itself, was shown to be connected to C-8 
through a 3JCH correlation.  Comparison of literature and experimental NMR data is 
presented in Table 2.1. 
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 Table 2.1: Literature and Experimental NMR data for 2.7. 
position Literature δC, ppma 
Literature δ 1H, 
multiplicity  
(JHH Hz) b 
δCc, ppmd δ 1H, multiplicity (JHH Hz) COSY CIGAR  
2 166.6  187.4(C)    
3 111.6  112.0(C)    
4 196.7  197.3(C)    
5 92.4  93.0 (C)    
6 186.8  167.1(C)    
7-NH  9.90, s   9.97, s  C-9, C-5, C-6 
8 91.1  91.6 (C)    
9 75.3 4.41, s 75.4 (CH) 4.42, s  C-8, C-4 
10 72.8 4.2-4.6, m 72.4 (CH) 4.38, d (5.5) H-11 C-2, C-12, C-3, C-11 
11 68.3 4.2-4.6, m 68.7 (CH) 4.47, t (6.7, 6.7) H-12, H-10 C-10, C-13, C-2 
12 128.4 5.1-5.7, m 129.5(CH) 5.40, m  H-11 C-14 
13 134.0 5.1-5.7, m 134.3(CH) 5.44, m H-14 C-14, C-11 
14 20.6 2.10, m 21.1 (CH2) 2.05, m H-15, H-13 C-15, C-13 
15 14.1 0.90, t (7.0, 7.0) 14.6 (CH3) 0.90, t (7.6, 7.6) H-14 C-13, C-14 
16 5.6 1.65, s 6.1 (CH3) 1.65, s  C-4, C-3, C-2 
17 196.4  196.9(C)    
18 133.6  133.7(C)    
19 130.2 8.2-8.4, m 130.8(CH) 8.27, d (7.3) H-20 C-17, C-21, C-23 
20 128.4 7.4-7.8, m 129.0(CH) 7.55, t (7.3, 7.3) H-19, H-21 C-21, C-19, C-22 
21 133.6 7.4-7.8, m 134.5(CH) 7.70, t (7.3) H-20, H-22 C-19, C-23 
22 128.4 7.4-7.8, m 129.0(CH) 7.55, t (7.3) H-21, H-23  C-21, C-23, C-20 
23 130.2 8.2-8.4, m 130.8(CH) 8.27, d (7.3) H-22 C-17, C-21, C-19 
OCH3 51.7 3.26, s 52.2 (CH3) 3.26, s  C-8 
   a 13C NMR data obtained at 22.63 MHz in d6-DMSO54,55 
    
b Data obtained at 100 MHz in d6-DMSO55    
   c  13C multiplicity determined from HSQC-DEPT experiments 
   d Chemical shifts determined from HSQC and CIGAR experiments. 
   1H and 2D NMR data obtained at 500 MHz in d6-DMSO. 
 
The stereochemistry of 2.7, was also confirmed as identical to pseurotin A, as an optical 
rotation (-10 °), revealed a similar value, within experimental error, as that given in the 
literature, [α]20D -5±1° (c 0.5, MeOH).55  The compound, 2.7, was therefore confirmed as 
the known compound, pseurotin A.   
 
2.5.2  Structural Elucidation of SAS-5-19.2 (2.8) 
 
ESIMS on compound SAS-5-19.2 (2.8) gave an identical mass to that of 2.7, 432 
([M+H]+).  Because of this, and the identical UV chromophore displayed by both 2.7 and 
2.8, it was proposed that 2.8 was a stereoisomer of 2.7.  Initially, the 1H NMR spectrum 
(Figure 2.11) was taken to indicate that these compounds were in fact not isomeric.  This 
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was due to the presence of three extra signals that were not seen in the 1H NMR spectrum 
of pseurotin A (2.7). 
 
ppm2345678910
Solvent
ppm4.304.354.404.454.504.554.604.654.704.75
 
Figure 2.11: 1H NMR spectrum of pseurotin A2 (2.8) in d6-DMSO. 
 
The HSQC NMR experiment established that the three extra protons were the 
exchangeable protons of hydroxyl groups, as no 1JCH correlations to any carbons were 
seen.  Excluding these hydroxyl proton signals, the 1H NMR spectrum was more or less 
identical to that of 2.7, with the exception of slight variations in chemical shifts.  
Additional 2D NMR experiments, including COSY and CIGAR, determined that 
structurally 2.8, was identical to 2.7.  The difference therefore, as noted must lie with the 
stereochemistry.  As there have been no stereoisomers of pseurotin A reported in the 
literature, 2.8, qualifies as a new diastereomer of pseurotin A.  On this basis the 
compound was named pseurotin A2.  Full NMR assignments for 2.8 are presented in 
Table 2.2. 
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 Table 2.2: NMR data for 2.8 
position δCa, ppmb δ 1H, multiplicity (JHH Hz) COSY CIGAR  
2 188.0 (C)    
3 111.7 (C)    
4 200.5 (C)    
5 88.6 (C)    
6 167.7 (C)    
7-NH   9.94, s  C-8, C-5, C-9 
8 97.4 (C)    
9 76.1 (CH) 4.64, d (5.9) OH-9 C-8, C-4, C-6 
10 73.0 (CH) 4.38, t (5.3, 5.3) OH-10, H-11 C-2, C-12, C-3, C-11 
11 68.8 (CH) 4.47, m H-13, OH-11, H-10 NA 
12 129.5 (CH) 5.40, m  H-11 C-10, C-14 
13 134.2 (CH) 5.41, m H-14 C-14,  
14 21.0 (CH2) 2.01, m H-15, H-13 NA 
15 14.0 (CH3) 0.88, t (7.4, 7.4) H-14 C-13, C-14 
16 5.5 (CH3) 1.68, s  C-4, C-3, C-2 
17 194.0 (C)    
18 135.1 (C)    
19 130.0 (CH) 8.12, d (7.7) H-20 C-17, C-21, C-23 
20 128.8 (CH) 7.54, t (7.7, 7.) H-19, H-21 C-18, C-19, C-22 
21 133.7 (CH) 7.65, t (7.7) H-20, H-22 C-19, C-23 
22 128.8 (CH) 7.54, t (7.7) H-21, H-23  C-18, C-23, C-20 
23 130.0 (CH) 8.12, d (7.7) H-22 C-17, C-21, C-19 
OCH3 51.3 (CH3) 3.14, s  C-8 
9-OH   6.07, d (6.4) H-9 C-8, C-9 
10-OH   5.75, d (5.4) H-10 C-2, C-11, C-10 
11-OH   4.96, d (5.5) H-11 C-12 
 
a 13C multiplicity determined from HSQC-DEPT experiment 
 b
 Chemical shifts determined from HSQC and CIGAR experiments  
  1H and 2D NMR carried out at 500 MHz in d6-DMSO. 
  NA-signals not observed 
 
2.5.3  Structural Elucidation of SAS-5-19.3 (2.9) 
 
Like the previous two compounds, 2.7, and 2.8, SAS-5-19.3 (2.9) was shown by ESIMS 
to have a mass of 432 [M+H]+.  Once again it was proposed that 2.9 was a stereoisomer 
of the known compound pseurotin A (2.7). 
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ppm2345678910
Solvent
 
Figure 2.12: 1H NMR spectrum of pseurotin A3 (2.9) in d6-DMSO. 
 
The 1H NMR spectrum (Figure 2.12) and HSQC spectrum showed that as in the case of 
pseurotin A2 (2.8), the hydroxyl protons were visible.  Once again exclusion of the 
hydroxyl protons, resulted in a 1H NMR spectrum that was almost identical to that for 
2.7. The remaining 2D NMR data were very similar and hence consistent with the 
structural aspects of the pseurotin A skeleton.  This confirmed that 2.9 was yet another 
stereoisomer of 2.7.  The new diastereomer was assigned the name pseurotin A3 (2.9).  
1D and 2D NMR assignments are presented in Table 2.3. 
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Table 2.3: NMR data for 2.9 
position δCa, ppm b δ 
1H, multiplicity 
(JHH Hz) 
COSY CIGAR  
2 188.6 (C)    
3 112.8 (C)    
4 201.8 (C)    
5 87.6 (C)    
6 167.8 (C)    
7-NH   9.99, s  C-6, C-8, C-5, C-9 
8 95.2 (C)    
9 74.8 (CH) 4.20, d (9.8) OH-9 C-4, C-17 
10 72.3 (CH) 4.52, t (5.1, 5.1) OH-10, H-11 NA 
11 68.4 (CH) 4.59, m H-12, OH-11, H-10 NA 
12 129.1 (CH) 5.43, m  H-11 NA 
13 134.5 (CH) 5.47, m H-14 C-14, C-15 
14 21.1 (CH2) 2.10, m H-15, H-13 C-6 
15 14.6 (CH3) 0.95, t (7.4, 7.4) H-14 C-13, C-14 
16 6.0 (CH3) 1.67, s  C-4, C-2, C-3 
17 196.4 (C)    
18 134.2 (C)    
19 130.7 (CH) 8.28, d (7.7) H-20 C-17, C-21, C-23 
20 128.9 (CH) 7.56, t (7.7, 7.) H-19, H-21 C-18 
21 134.5 (CH) 7.71, t (7.7) H-20, H-22 C-20, C-22 
22 128.9 (CH) 7.56, t (7.7) H-21, H-23  C-18  
23 130.7 (CH) 8.28, d (7.7) H-22 C-17, C-21, C-19 
OCH3 52.0 (CH3) 3.23, s  C-8 
9-OH   6.35, d (9.8) H-9 C-8, C-9 
10-OH   5.88, d (5.3) H-10 NA 
11-OH   5.09, d (4.7) H-11 NA 
          a  multiplicity determined by HSQC-DEPT experiments 
              b 13C shifts determined from HSQC and CIGAR experiments  
               1H and 2D NMR carried out at 500 MHz in DMSO-d6  
                NA-signals not observed 
 
2.5.4  Stereochemical Elucidation of Pseurotins A2 and A3 
 
As the pseurotins contain five chiral centres, a systematic approach was taken to define 
the chirality at each centre. 
 
2.5.4.1  Stereochemical Elucidation of Pseurotin A2 (2.8) 
 
An attempt at crystallisation in MeOH was successful, and produced very small crystals 
of low quality.  Despite this, the crystals were found to diffract reasonably well and for 
this reason, were able to be used for X-ray crystallography.  The solution of the X-ray 
data showed two molecules were present in an asymmetric unit, resulting in eight 
molecules per cell.  Although the R-factor was high (15.8%), the assignment of the 
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relative stereochemistry of 2.8 was possible and given as 5S*, 8S*, 9S*, 10S*, 11S* 
(Figure 2.13). For X-ray crystal data tables see appendix 1. 
 
Figure 2.13: Crystal structure drawing of 2.8. 
 
More tentative conclusions were made as to the absolute stereochemistry of 2.8.  This 
involved the use of circular dichroism (CD) spectroscopy.  This technique measures the 
difference in absorption of left-handed versus right-handed circularly polarised light, 
which arises due to the structural asymmetry of a molecule.  
It was determined that the stereocentre at C8 could definitely be identified by this method 
due to the presence of the adjacent strong phenyl ketone chromophore.  Although there is 
also a strong chromophore adjacent to C5, it is of a shorter wavelength, which was unable 
to be measured on the elderly spectropolarimeter available in the Department of 
Chemistry. 
The identical nature of the traces shown by all three of the stereoisomers, A, A2 and A3, 
indicated that the stereocentre at C8 in pseurotin A2 was the same as that in pseurotin A 
and A3 (see Figure 2.14).   
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Figure 2.14: CD spectra of pseurotins A-A3 (2.7-2.9). 
 
The chirality of all stereocentres for the known isomer, pseurotin A had previously been 
established as 5S, 8S, 9R, 10S, 11S by X-ray crystallography of a brominated 
derivative.56 This meant that the relative stereochemistry provided by X-ray 
crystallography could be converted to an overall absolute stereochemistry, which was 5S, 
8S, 9S, 10S, 11S (Figure 2.15). 
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Figure 2.15: Proposed absolute stereochemistry of pseurotin A2 (2.8) 
 
2.5.4.2 Stereochemical Elucidation of Pseurotin A3 (2.9) 
 
The stereochemical elucidation of 2.9 was not as straight forward as that for 2.8, 
primarily because it could not be successfully crystallised.  Through X-ray 
crystallography it had been established that the isomers 2.7 and 2.8 had the same chirality 
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at the C-10 and C-11 stereocentres.  The 1H and 13C NMR data for the area around 
C10/C-11 for 2.7 and 2.8 were identical, as was expected, and the data for 2.9 was very 
similar. 
In order for the stereochemical differences between 2.9 and 2.7/2.8 to be explored, the 
vicinal-diol was cleaved with sodium periodate under acidic conditions (Scheme 2.1).  
The idea was to remove the C-10 and C-11 stereocentres and so eliminate the possibility 
that the differences in the stereochemistry of 2.9 compared to 2.7/2.8 lay at the vicinal-
diol. 
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Scheme 2.1: Oxidative cleavage using sodium periodate. 
 
HPLC (Figure 2.16) and ESIMS were used to analyse the resulting products of the 
reaction.  The cleavage product of 2.9 showed a different retention time from both those 
of 2.7 and 2.8.  
 
 
Figure 2.16: HPLC chromatogram showing reaction products (red) of NaIO4 cleavage. 
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The difference in retention time for the cleavage products from 2.7 and 2.8 (9.75 and 
10.25 minutes respectively) was expected as they have a diastereomeric relationship 
(Figure 2.17).  
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Figure 2.17: Diasteromeric cleavage products of pseurotin A (2.10) and A2 (2.11). 
 
This indicated that if there was a difference in stereochemistry at the diol of 2.9, this was 
not the only difference when compared to 2.7/2.8.  If the vicinal-diol had been the only 
centre in the molecule with a different stereochemistry, the cleavage product of 2.9 would 
have shown the same retention time as either 2.7 or 2.8, but it did not.  As the cleavage 
products remained diastereomeric it was deduced that the C-5 chirality of pseurotin A3 
must be R- as an S-configuration would have led to the HPLC retention time of 2.12 
being identical to either 2.10 or 2.11, depending on the chirality at C-9. 
An NMR approach was used to probe the stereochemistry of the remaining chiral centre, 
C-9.  As there was a paucity of protons in the ring system in the vicinity of C-9, 1H-1H 
coupling constants, or NOE measurements were not suitable in this situation.  The 
method used was measurement of long-range 1H-13C coupling constants.  To measure this 
coupling constant, a more sensitive NMR technique was employed.  This was a narrow-
window CIGAR experiment with a higher resolution in J2 (carbon axis), and 3JCH 
couplings between H-9 and C-4 were measured for the three diastereomers. 
The 3JCH for 2.7 and 2.9 were found to be <2 Hz each, whereas the measured value for 
2.8 was found to be 2.8 Hz.  The magnitude of 3JCH has a strong angular dependence on 
the dihedral angle φ (Figure 2.18).  
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Figure 2.18: Energy minimised (MM2) conformations for 2.7 and 2.8 as well as the two 
alternative MM2 conformations for 2.9; each showing the H-9–H-4 dihedral angles (φ). 
 
For this reason it was concluded that the relative orientation of H-9 and C-4 were the 
same in 2.7 and 2.9.  Because the C-5 chirality of 2.9 had been assigned as R, the 
opposite configuration of C-5 in 2.7, the angular dependence could only be met by 
assigning the C-9 chirality of 2.9 as S.  The proposed stereochemistry for 2.9 therefore is 
5R, 8S, 9S, 10S, 11S (Figure 2.19).  The assignment of chirality at C-10 and C-11 is 
tentative and cannot be stated unambiguously and followed from the highly correlated 1H 
and 13C shifts for these diasteromers (see Table 2.4).  That of 2.7 and 2.8 had been 
established by X-ray crystallography. 
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Figure 2.19: Proposed stereochemistry for pseurotin A3 (2.9). 
 
Table 2.4: 1H- and 13C NMR chemical shifts for the three pseurotins (2.7-2.9).   
δC δH 
position 2.7 2.8 2.9 2.7 2.8 2.9 
2 187.4 188.0 188.6    
10 72.4 73.0 72.3 4.38, d (5.5) 4.38, t (5.3, 5.3) 4.52, t (5.1, 5.1) 
11 68.7 68.8 68.4 4.47, t (6.7, 6.7) 4.47, m 4.59, m 
12 129.5 129.5 129.1 5.40, m 5.40, m 5.43, m 
13 134.3 134.2 134.5 5.44, m 5.41, m 5.47, m 
14 21.1 21.0 21.1 2.05, m 2.01, m 2.10, m 
15 14.6 14.0 14.6 0.90, t (7.6, 7.6) 0.88, t (7.4, 7.4) 0.95, t (7.4, 7.4) 
 
All three purified compounds were subjected to the in-house antiviral assay.  2.7 was 
found to display antiviral activity against HSV of 4+, the diastereomers, 2.8 and 2.9 were 
found to be inactive against the virus.  It was concluded therefore that the original 
antiviral activity displayed by the crude extract was the result of pseurotin A (2.7) only. 
 
2.6  Discussion 
 
Purification of the extract from a Penicillium sp. of fungus lead to the isolation of three 
pseurotins.  These compounds, elucidated with 1D and 2D NMR techniques, included the 
known compound pseurotin A (2.7), and two previously unreported diastereomers of 
pseurotin A, pseurotin A2 (2.8) and pseurotin A3 (2.9). 
The relative stereochemistry of 2.8 was provided by X-ray Crystallography as 5S*, 8S*, 
9S*, 10S*, 11S*.  By comparison with that of the known compound 2.7, CD spectroscopy 
was used to assign the absolute stereochemistry at C-8 as the S-configuration, leading to 
the proposal that the absolute stereochemistry of 2.8 was 5S, 8S, 9S, 10S, 11S.  On the 
basis of CD spectroscopy, sodium periodate cleavage and J-resolved 2D NMR, 2.9 was 
assigned the absolute stereochemistry, 5R, 8S, 9S, 10S, 11S. 
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The specific HSV antiviral activity shown by the original extract did not translate to the 
new diastereomers, which were found to be inactive in the assay.  It was concluded that 
the activity shown came from pseurotin A only.  Upon purification pseurotin A was 
found to display potent antiviral activity of 4+.  This would seem to indicate that in the 
case of these compounds, stereochemistry plays an important role in the in vitro activity. 
The pseurotin class of compounds, of which there are now nine members, were originally 
isolated from Pseudeurotium ovalis (pseurotin’s A-E), however more recently 2.7 has 
also been isolated from many other fungi, including Aspergillus fumigatus,57 Pochonia 
chlamydosporia,58 Diheterospora chalmydosporia,59 Pseudallescheria boydii,60 and a 
Ulocladium sp.61  The observed biological activity ranged from inhibition of chitin 
synthase57 to induction of differentiation of PC12 cells.59  The isolation reported here, 
however, is the first instance in which pseurotins have been isolated from a Penicillium 
sp. 
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Chapter 3 
 
Unique Compounds Related to the 
Spirobisnaphthalenes, from a New 
Zealand Fungal Endophyte  
(F5062 and F5584) 
 
 
 
3.1  General Introduction 
 
3.1.1  Spirobisnapthalenes 
 
In the last fifteen years, this new class of natural product has been isolated from fungi. 
Metabolites of this class possess two naphthalene units that are fused together via 
oxidative coupling.  In these structures, the naphthalene units are linked together by two 
or three oxygen atoms, and in most cases the naphthalene core is partially saturated or 
oxidised.  Because the oxygen atoms linking the two halves of the molecule are usually 
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involved in a spiroketal bridge system, these compounds are generally referred to as the 
“spirobisnaphthalenes”.  This class of molecule can generally be divided into three sub 
classes, those with two oxygen bridges, such as palmarumycin CP1 (3.1),62 the 
spirobisnaphthalenes with three oxygen bridges, like that of preussomerin A (3.2),63 and 
spiroxin A (3.3),64 which is representative of those with two oxygen bridges and one C-C 
bridge. 
 
OO
O OH
O O
O
O
Cl
OHO
OH O
O O O
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OH
OHOH
3.1 3.2 3.3  
 
The biosynthesis of this class of compounds has been studied by several groups.  Zeeck et 
al.65 studied the biosynthesis of cladospirone bisepoxide (3.4), and from his studies, 
proposed that 1,8-dihydroxynaphthalene (DHN) (3.5) is a probable precursor of the 
spirobisnaphthalenes.  This can also be concluded from the production of brown/black, 
DHN-derived melanin compounds that is seen to accompany the production of the 
spirobisnaphthalenes.  
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The spirobisnaphthalenes have been isolated exclusively from fungi, with the exception 
of work from two research groups, Kouam et al.,66 and more recently Ravindranath et 
al.,67 who have reportedly isolated the compounds from plants.  However, as all other 
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spirobisnaphthalenes have been isolated from fungi it is most likely that these compounds 
were in fact produced by endophytic fungi, living within the plant host.  This is supported 
by Prajoubklang et al.,68 who have recently reported spirobisnaphthalenes from the fruits 
of Diospyros ehretioides, but found later that the compounds were only isolated from the 
dried fruits and weren’t able to be isolated from the fresh fruit at all.  This led them to 
propose that the spirobisnaphthalenes were produced by fungal epiphytes or endophytes. 
 
The biological activity of this class of compounds is diverse and has been widely reported 
as antifungal, antibacterial and antitumoral.  One such compound, Sch 49209 (3.6) 
progressed to in vivo testing in mice.69  
 
3.6
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The authors found growth inhibition of lung epidermoid carcinoma and also, that the 
compound decreased the formation of spontaneous lung metastasis in the same model.  It 
was also found to inhibit the growth of human tumor xenografts in athymic nude mice.  
However, at accumulated doses of 40 mg/kg it was found to be toxic to the animals.  At 
the cessation of drug administration, the tumors started to regrow, which led the authors 
to propose that 3.6 may act in inhibiting tumor expansion by preventing cell invasion.  
Several enzymes have also been reported to be inhibited by this class of compounds, 
including phospholipase D,70-72 DNA gyrase,73 Ras farnesyl-protein transferase,74 and 
thioredoxin reductase.75 
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Part 1  New Spirobisnaphthalenes from 
F5062 
 
 
3.2  Introduction 
 
The sterile endophytic fungus, E484, was isolated from the surface-sterilised leaves of 
rewarewa (Knightia excelsa), which had been collected in a mixed broadleaf-podocarp 
forest in the Kaimai-Mamaku Forest Park, Bay of Plenty, New Zealand.  The fungus was 
grown on a MYE agar slope for small-scale biological and chemical screening. 
 
3.3  Preliminary Investigations 
 
The extract of the small-scale agar culture (F5062) showed excellent cytotoxicity in the 
P388 assay (116 ng/mL).  An aliquot of this crude extract was chromatographed on 
reverse phase C18 HPLC (Figure 3.1), using the standard elution gradient (Section 7.1.4). 
The chromatogram showed a number of compounds with similar UV spectra eluting 
between 10 and 15 minutes.  A compound eluting at 14.2 minutes was shown by ELSD to 
be associated with a large proportion of the mass of the extract (Figure 3.1).  A search of 
the UV database76 revealed that none of the peaks shown in the HPLC trace matched any 
common, highly cytotoxic known compounds.  For this reason, as well as the toxicity 
displayed, the fungus was re-grown on a large scale (see Section 7.4.1 of Experimental) 
to enable a full chemical investigation. 
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Figure 3.1: HPLC chromatogram of the crude extract of F5062 with ELSD comparison (blue). 
 
3.4  Chromatography of Extract from F5062 Culture 
 
The EtOAc extract of the large-scale culture (Section 7.4.1) was loaded on to a C18 
bench column for fractionation (Section 7.4.2).  The two fractions that eluted with 100% 
MeOH (SAS-5-64.10–11) showed the highest cytotoxicities (231 and 166 ng/mL 
respectively).  Injection of a small amount of each of the two fractions on the analytical 
C18 HPLC column showed that both fractions, SAS-5-64.10 and SAS-5-64.11 contained 
the major compound that had eluted at 14.2 minutes.  Fraction SAS-5-64.10, however, 
also contained three other, more polar compounds that, according to the ELSD trace, also 
contributed significant mass to the extract (Figure 3.2).  These showed almost identical 
UV chromophores to the major component (Figure 3.3).  Semi-preparative HPLC was 
carried out on SAS-5-64.10 (18.0 mg) using the method given in Section 7.3.2 of the 
Experimental section, to obtain the four compounds, SAS-5-64.10.1–4, with yields of 4.8, 
1.9, 1.1, and 5.7 mg respectively. 
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Figure 3.2: HPLC chromatogram of fraction 10. 
 
 
Figure 3.3: UV profiles of important compounds from fraction 10. 
Chapter 3 Spirobisnaphthalenes from a New Zealand Fungal Endophyte 50 
3.5  Structural Elucidation of SAS-5-64.10.1–4 
 
3.5.1  Structural Elucidation of SAS-5-64.10.2 (3.7) 
 
ESIMS determined the mass of SAS-5-64.10.2 (3.7) to be 351 ([M+H]+), while HREIMS 
gave a molecular formula of C20H14O6, (14 double bond equivalents).  The large number 
of double bond equivalents indicated a high degree of unsaturation in the molecule, 
probably in the form of aromatic rings, but due to the absorbance only just falling in the 
yellow region of the UV-visible spectrum, it was likely that the rest of the double bond 
equivalents arose from non-aromatic ring systems, double bonds or carbonyl 
functionalities with little or no conjugation.   
The 1H NMR spectrum (Figure 3.4) showed one methylene, one oxymethine and five 
olefinic/aromatic signals. The 13C NMR spectrum (Figure 3.5) showed a total of 20 
signals, indicating no elements of symmetry were present in the molecule.  Examination 
of the HSQC-DEPT spectrum revealed that these carbon signals were comprised of one 
CH2, ten CH and nine non-protonated carbon signals.  Additional 2D NMR experiments 
allowed the rest of the structure to be defined.  The COSY spectrum showed the presence 
of two separated aromatic systems in the molecule.  The first consisted of a 1,2,3-
trisubstituted benzene ring (ring B).  The protons at δH 6.80 (H-3), 6.92 (H-4), and 6.801 
(H-5) were assigned as three adjacent protons.  
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Figure 3.4: 1H NMR spectrum of SAS-5-64.10.2 (3.7) in CD3OD. 
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Figure 3.5: 13C NMR spectrum of SAS-5-64.10.2 (3.7) in CD3OD 
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The proposed order of the protons on the ring is given in Figure 3.6.  The proton at δH 
6.92 is placed at H-3, while the two overlapping protons at δH 6.80 are in positions H-4 
and H-5.  In support of this arrangement are the 2,3JCH CIGAR correlations from δH 6.92 
to carbons at δC 138.2 (C-7), 126.8 (C-2), 118.4 (C-5).  In addition, H-4 showed a 
CIGAR correlation to a non-protonated carbon at δC 147.7 (C-6).  The chemical shift of 
C-6 and possibly C-7, suggested oxygenation.  
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Figure 3.6: Proposed order of protons on ring B indicated by CIGAR correlations. 
 
However, the proton at δH 6.92 appears as a triplet in the 1H NMR spectrum.  If this 
proton were situated at H-3, it would be expected to give rise to a doublet, perhaps a 
doublet of doublets if strong meta coupling were present to the proton at H-5.  A 1H 
NMR spectrum simulation of the ABC system presented in Figure 3.6 was carried out.  
The chemical shifts were defined from the experimental values, while the coupling 
constants were assumed initially as 7.0, 2.0, and 7.0 Hz for J34, J35, and J45 respectively. 
The results, which are shown in Figure 3.7, reveal that the proposed arrangement is 
probably correct, as the simulated spectrum is identical to the experimental spectrum.  
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Figure 3.7: 1H NMR spectrum simulation of the ABC system in 3.7. 
 
The unusual multiplicities observed are the result of second order coupling effects.  This 
occurs when chemical shifts of all the protons in the spin system are similar in value.  
This situation results in increased intensity of the peak of the signal that is closest to the 
peaks of its coupled neighbour, whereas for those further away, the intensity is decreased, 
thus leading to patterns not explained by first order coupling.  
Preliminary findings from biosynthetic studies also revealed that the arrangement of 
protons on ring B of 3.7 was most probably the correct one (see Section 3.11.6).  
A second more complex aromatic system (6-H) was indicated by the proton signals at δH 
6.98-7.43.  One component of this system was a triplet proton at δH 7.38 (H-17) coupled 
to two doublet protons at δH 6.98 (H-18) and δH 7.43 (H-16).  The HSQC-DEPT 
spectrum showed these protons to have 1JCH correlations to carbons at δC 127.0 (C-17), 
108.9 (C-18), and 120.7 (C-16) respectively.  Within this aromatic system, a second spin 
system showed an identical arrangement to that of the first.  This was shown by the 
coupling of the triplet proton at δH 7.41 (H-13) to the doublet protons of δH 7.09 (H-12) 
and 7.42 (H-14).  1JCH correlations from these protons were shown to carbons at δC 127.1 
(C-13), 109.1 (C-12), and 120.6 (C-14) respectively.  CIGAR correlations from the 
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protons at H-14 and H-16 to the non-protonated carbons at δC 134.3 (C-15) and 113.9 (C-
20), indicated the nature of the aromatic entity as a naphthalene system.  The naphthalene 
was shown to be a 1,8 dioxynaphthalene from the chemical shifts (δC 147.4 and 147.1) of 
the two non-protonated carbons in the 1 and 8 positions of the naphthalene, (C-11) and 
(C-19).  CIGAR correlations from H-12 and H-13 to C-11 as well as H-17 and H-18 to C-
19, confirmed C-11 and C-19 as being in the 1 and 8 positions respectively of the 
naphthalene (Figure 3.8).  Most importantly, the CIGAR data also suggested that the 
naphthalene was separated from the other aromatic ring, as there were no other 
correlations from H-12 or H-18 to any carbon in ring B. 
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Figure 3.8: 1,8 dioxynaphthalene fragment showing COSY and CIGAR correlations 
 
The balance of the signals in the 1H NMR spectrum consisted of a one proton doublet of 
doublets at δH 4.65 (H-8) coupled to both a one proton doublet of doublets at δH 2.57, and 
another one proton doublet of doublets at δH 3.02.  HSQC-DEPT data revealed these two 
protons to be a diastereotopic methylene moiety (H-9a, H-9b). 
The 13C NMR spectrum also suggested the presence of an acid or ester carbonyl signal 
(C-10), at 168.4 ppm.  The CIGAR spectrum showed correlations from the H-8, H-9a and 
H-9b protons to the carbonyl at C-10 as well as to the carbon at δC 101.5 (C-1).  The 
former indicated the connectivity of the oxymethine and methylene containing spin 
system through to the carbonyl, and the latter to the oxygenated aromatic ring (Figure 
3.9). 
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Figure 3.9: COSY and CIGAR correlations showing connectivity of side chain and ring B. 
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At this point, the substituent on C-6 was assumed to be an hydroxyl.  No such assumption 
was made for C-7 however.  The chemical shift of C-7 (138.2 ppm) was a little high-field 
to be substituted with a free hydroxyl, the chemical shift was more reminiscent of a 
junction carbon shifted by oxygen.  
A search of the AntiMarin database77 using the 1,8 dioxygenated naphthalene fragment as 
a search parameter, indicated a reasonably large group of spirobisnaphthalene 
compounds, all bearing a spiroketal linked 1,8 bisnaphthalene moiety in common.  NMR 
data of the spiroketal-linked naphthalene of a spirobisnaphthalene from the literature78 
were compared to those for 3.7, and was revealed to show very good correlations.  The 
spiroketal (ring C) system also explained why the two halves of the molecule were unable 
to be linked by CIGAR data.  A thorough search of AntiMarin and SciFinder Scholar 
revealed no compounds that matched all of the NMR data for 3.7, indicating possibly a 
new type of spirobisnaphthalene. 
From the CIGAR correlations (H-8, H-9a, and H-9b to C-1) mentioned previously, as 
well as a 4JCH CIGAR correlation from H-4 to C-1, it was obvious that the dioxygenated 
aromatic ring and the fragment bearing the oxymethine were connected to the 
naphthalene through the spiroketal moiety.  Assuming that C-10 was a carboxylic acid, 
the molecular formula revealed that only one oxygen was to be accounted for in the 
structure.  It was therefore proposed that C-8 and C-7 were substituted with a common 
oxygen, forming a furan ring (ring A).  A further check of the literature revealed no 
compounds that showed any similarity to the uppermost portion of 3.7.  The compound 
has been assigned the trivial name, mamakunoic acid B (3.7). A full list of NMR data is 
presented in Table 3.1. 
A P388 assay revealed 3.7 to be inactive (>12500 ng/mL). 
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Table 3.1: NMR data for 3.7 
position δC, ppm δ 
1H, multiplicity  
(JHH Hz) 
COSY CIGAR 
1 101.5 (C)    
2 126.8 (C)    
3 124.8 (CH) 6.92 t (6.6, 6.6) H-4 C-7, C-6, C-2, C-4 
4 119.6 (CH) 6.80 d (4.7)  H-3, H-5 C-7, C-6, C-2, C-5, C-1 
5 118.4 (CH) 6.80 d (4.7) H-4 C-6, C-2, C-4 
6 147.7 (C)    
7 138.2 (C)    
8 74.6 (CH) 4.65 dd (6.6, 7.7) H-9a, H-9b C-10, C-2, C-1, C-9 
9 37.9 (CH2) a: 2.57 dd (6.6, 13.0) H-8, H-9b C-10, C-1, C-8 
   b: 3.02 dd (13.0, 7.7) H-8, H-9a C-10, C-1, C-8 
10 168.4 (C)    
11 147.4 (C)    
12 109.1 (CH) 7.09 d (7.1) H-13 C-11, C-15, C-14, C-20 
13 127.1 (CH) 7.41 m H-12, H-14 C-11, C-15, C-12 
14 120.6 (CH) 7.42 m H-13 C-16, C-11, C-19, C-15, C-20, C-12
15 134.3 (C)    
16 120.7 (CH) 7.43 m H-17 C-14, C-20, C-19, C-18, C-11, C-15
17 127.0 (CH) 7.38 m H-16, H-18 C-19, C-15, C-18 
18 108.9 (CH) 6.98 d (7.1) H-17 C-19, C-16, C-20 
19 147.1 (C)    
20 113.9 (C)    
1H  and 2D experiments carried out at 500 MHz in CD3OD. 13C data obtained at 75 MHz in CD3OD. 
 
3.5.2  Structural Elucidation of SAS-5-64.10.1 (3.8) 
 
Compound SAS-5-64.10.1 (3.8) was purified as one of the minor components of fraction 
SAS-5-64.10.  ESIMS indicated this compound had a mass of 369 ([M+H]+). Also 
present in the +ve ion MS was a [M-H2O]+ fragment peak at 351, indicating the presence 
of an hydroxyl moiety in the molecule.  The mass of 3.8, 18 mass units more than that of 
3.7, suggested the addition of H2O.  The hydration of 3.7 to form 3.8 could only occur 
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between the oxymethine and the hydroxyl at C-7, thus opening the furan ring (see Figure 
3.10).  
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Figure 3.10: Proposed structure for 3.8 
 
The 13C NMR spectrum of 3.8 (Figure 3.11) showed a total of 16 carbons signals, four 
less than that given by the molecular formula, suggesting that the molecule contained 
either an element of symmetry, or that some of the signals are coincidentally overlapped.  
Comparison of the spectrum with that of 3.7 (Figure 3.5) revealed the two to be very 
similar.  The major differences were that the some of the signals representative of the 
naphthalene system appeared as overlapping signals, whereas in the 13C NMR spectrum 
of 3.7, they had been clearly separated.  Also a small downfield shift was seen for the 
resonance of the carbons at C-7 and C-8.  In order to confirm the proposed structure of 
3.8 (Figure 3.10), the 1D and 2D NMR spectra were analysed. 
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Figure 3.11: 13C NMR spectrum of SAS-5-64.10.1 (3.8) in CD3OD. 
 
The 1H NMR spectrum (Figure 3.12) indicated only small differences in chemical shifts 
between the spectra of 3.7 and 3.8.  Despite the differences in the chemical shifts of the 
naphthalene signals between 3.7 and 3.8, COSY, HSQC-DEPT and CIGAR NMR spectra 
confirmed that the lower portion of the molecule was also a naphthalene unit (rings D and 
E). 
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Figure 3.12: 1H NMR spectrum of SAS-5-64.10.1(3.8) in CD3OD. 
 
An overlapping triplet proton at δH 7.35 (H-17) was shown to be coupled to an 
overlapping triplet proton at δH 7.02 (H-18) and an overlapping doublet proton at δH 7.37 
(H-16).  Examination of the overlapping triplet at δH 7.02 revealed that it was in fact two 
overlapping doublets, integrating for two protons, one of them (H-12) part of the other 
spin system.  This arrangement was repeated with identical proton chemical shifts for the 
carbons of the other spin system (H-12–H-14), together forming rings D and E of the 
naphthalene moiety.  CIGAR correlations from the protons at H-14 and H-16 to the non-
protonated carbons at δC 134.2 (C-15) and 114.2 (C-20), showed these carbons to be the 
point of fusion between rings D and E, to form the naphthalene moiety.  The carbons at 
δC 126.8 (C-13 and C-17), 120.2 (C-14 and C-16), and 108.9 (C-12 and C-18) were, as 
noted (vide infra), seen in the 13C NMR spectrum to have twice the intensity of other 
protonated carbons.  Because the carbons at δC 147.3 (C-11) and 147.5 (C-19) did not 
show the same chemical shift, symmetry of this system was impossible, therefore the 
overlap of C-12–C-18 is best explained as coincidental overlap. 
The spiroketal system (ring C) was also indicated by the presence of the oxygenated 
carbons of the naphthalene moiety at δC 147.5 and 147.3 (C-19 and C-11 respectively) 
and also the spiroketal carbon at δC 103.8 (C-1).  The 3-hydroxy-butyric acid moiety was 
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confirmed through the COSY correlations from the methylene protons at δH 2.59 (H-9a) 
and 2.90 (H-9b) to the oxymethine proton at δH 4.81 (H-8).  CIGAR correlations from 
these same protons to the carbonyl carbon at δC 173.8 (C-10), confirmed the placement of 
the acid moiety at C-10. 
As for 3.7, ring B of 3.8 was confirmed to be a 1,2,3-trisubstituted aromatic ring.  The 
protons at δH 6.81 (H-3), 6.42 (H-4), and 6.59 (H-5) were assigned as three adjacent 
protons from the COSY spectrum.  CIGAR correlations observed from these protons to 
the two carbons at δC 146.0 (C-6) and 143.8 (C-7) confirmed the oxygenation at these 
carbons.  The connection of the butyric acid spin system through to that of the aromatic 
spin system was shown from the CIGAR correlations of the protons at H-8–H-9b to the 
spiroketal carbon at C-1.  In turn protons H-3 and H-4 from ring B, showed CIGAR 
correlations also to C-1. 
As with mamakunoic acid B (3.7), no matches were found in the literature, it was 
therefore considered to be a new compound and given the trivial name, mamakunoic acid 
A (see Figure 3.10). 
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Table 3.2: 1D and 2D NMR data for 3.8 
position δC, ppm δ 
1H, multiplicity  
(JHH Hz) 
COSY CIGAR 
1 103.8 (C)    
2 122.2 (C)    
3 120.3 (CH) 6.81 dd (8.0, 1.6) H-4 C-7, C-6, C-4, C-5, C-1 
4 118.5 (CH) 6.42 t (8.0, 8.0) H-3, H-5 C-7, C-6, C-2, C-3, C-5, C-1 
5 115.7 (CH) 6.59 dd (8.0, 1.6) H-4 C-7, C-6, C-2, C-3, C-4 
6 146.0 (C)    
7 143.8 (C)    
8 72.7 (CH) 4.81 dd (10.2, 2.9) H-9a, H-9b C-10, C-2, C-1, C-9 
9 36.5 (CH2) a: 2.59 dd (10.2, 15.6) H-8, H-9b C-10, C-1, C-8 
   b: 2.90 dd (15.6, 2.9) H-8, H-9a C-10, C-1, C-8 
10 173.8 (C)    
11 147.3 (C)    
12 108.9 (CH) 7.02 t ol H-13 C-11, C-15, C-14, C-20 
13 126.8 (CH) 7.35 t ol H-12, H-14 C-11, C-15, C-12 
14 120.2 (CH) 7.37 d ol H-13 C-16, C-20, C-12, C-19, C-15 
15 134.2 (C)    
16 120.2 (CH) 7.37 d ol H-17 C-14, C-20, C-18, C-11, C-15 
17 126.8 (CH) 7.35 t ol H-16, H-18 C-19, C-15, C-18 
18 108.9 (CH) 7.02 t ol H-17 C-19, C-15, C-16, C-20 
19 147.5 (C)    
20 114.2 (C)    
1H and 2D experiments carried out at 500 MHz in CD3OD. 13C data collected at 75 MHz in CD3OD. 
ol - overlapping 
 
Further work, including elucidation of the stereocentre at C-8, and obtaining biological 
activity data and HREIMS data was reluctantly abandoned due to the 
degradation/transformation of this compound very soon after isolation.  The form of 
transformation of 3.8, was found to be methylation of the carboxylic acid by CD3OD, 
forming a deuterated methyl ester (3.9), while in the NMR sample tube.  This compound 
was characterised by both ESIMS and NMR (see experimental), and the P388 assay 
revealed that 3.9 was not biologically active (>32.5 μM). 
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Following purification of the CD3O ester, very little pure compound was left (0.6 mg).  If 
a greater amount of compound had been obtained there might have been a way to 
elucidate the stereochemistry.  This could have involved hydrolysing the CD3O ester 
followed by re-esterification in order to protect the acid group, and then derivatisation 
with Mosher’s ester at 8-OH.  The problem with this approach lies is that Mosher’s 
esterification is not selective, hence esterification of both the 6-OH and 7-OH would 
almost certainly result.  Esterification at these positions would likely have an effect on 
the same protons affected by esterification at 8-OH, leading to ambiguous results. 
 
3.5.3  Structural Elucidation of SAS-5-64.10.3 (3.10) 
 
The compound, SAS-5-64.10.3 (3.10) was isolated as another minor component from the 
column fraction, SAS-5-64.10.  ESIMS showed that the compound had a mass of 379 
([M-H]-) while HREIMS fitted the molecular formula C21H16O7, corresponding to 14 
double bond equivalents. 
The 1H NMR spectrum of 3.10 (Figure 3.13) showed the presence of the naphthalene 
system with δH 6.98 (H-12, H-18), 7.48 (H-13, H-17), 7.56 (H-14, H-16).  Also present 
were methylene protons at δH 2.44 (H-9) and 2.59 (H-9a) and an oxymethine proton at δH 
4.97 (H-8), as seen in the previous compounds, 3.7 and 3.8.  The major difference 
observed for 3.10 was a large methoxyl singlet signal at δH 3.81. 
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Figure 3.13: 1H NMR spectrum of SAS-5-64.10.3 (3.10) in CD3OD. Crosses indicate impurities. 
 
Comparison of the 1D and 2D NMR spectra of 3.10 with 3.7 indicated that rings A, C, D 
and E were identical to those in 3.7.  Ring B in 3.7 was therefore a 1,2,3,4 tetra-
substituted aromatic ring with the two adjacent aromatic protons appearing as doublets at 
δH 6.91 and 6.34.  The additional methoxyl group was placed on ring B.  The order of the 
substituents around ring B was elucidated with the assistance of CIGAR correlations 
(Figure 3.14). 
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Figure 3.14: Elucidation of the order of substituents on ring B through CIGAR correlations  
 
The two quaternary carbons, δC 149.7 (C-7) and 111.9 (C-2) were placed at the two 
junction points between the furan and aromatic rings.  A strong 3JCH CIGAR correlation 
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was observed between the proton at δH 4.97 (H-8) and C-7.  A lack of correlations from 
the proton at δH 6.91 to C-2 and from δH 6.34 to C-7 suggested the placement of these 
protons as H-5 and H-4 respectively.  The positions of the methoxyl and hydroxyl 
substituents were established by 1D NOE correlations (Figure 3.15). 
 
ppm2345678
ppm2345678
H-5 ( 6.91)δH
H-4 ( 6.34)δH
H-21 ( 3.81)δH
H-4 ( 6.34)δH
H-5 ( 6.91)δH
 
Figure 3.15: 1D NOE spectrum of 3.10 in CD3OD showing irradiation of H-5 (bottom) and H-4 
(top). 
 
When H-5 was irradiated, both H-4 and the methoxyl proton signals were enhanced.  
When H-4 was irradiated only the H-5 proton signal was enhanced.  There were no 
enhancements of any proton signals when the methoxyl proton was irradiated.  These 
results confirm the placement of the H-5 proton as between those of H-4 and the 
methoxyl substituent, which means that only the C-6 position can carry the methoxyl 
substituent.  The hydroxyl was placed in the only remaining position, C-3.   
The resulting structure (3.10) also gave no matches to any compounds in the literature.  
The compound was therefore considered new and given the name mamakunoic acid C 
(3.10).  A full NMR data table is presented in Table 3.3.  
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Table 3.3: 1D and 2D NMR data for 3.10 
position δC, ppm δ 
1H, multiplicity 
 (JHH Hz) 
COSY CIGAR 
1 108.4 (C)    
2 111.9 (C)    
3 149.2 (C)    
4 107.9 (CH) 6.34 d (8.8) H-5 C-4, C-6, C-2 
5 118.3 (CH) 6.91 d (8.8) H-4 C-7, C-6 
6 138.3 (C)    
7 149.7 (C)    
8 85.9 (CH) 4.97 dd (10.7, 3.6) H-9a, H-9b C-10, C-7, C-2, C-1, C-9 
9 35.3 (CH2) a: 2.59 dd (10.7, 16.2) H-8, H-9b C-10, C-1, C-8 
   b: 2.44 dd (16.2, 3.6) H-8, H-9a C-10, C-1, C-8 
10 171.8 (C)    
11 148.1 (C)    
12 108.8 (CH) 6.98 d (7.7) H-13 C-11, C-14, C-20 
13 127.2 (CH) 7.48 dd (7.7, 1.8) H-12, H-14 C-11, C-15 
14 120.6 (CH) 7.56 d (8.5) H-13 C-19, C-20, C-16, C-11, C-15 
15 134.4 (C)    
16 120.6 (CH) 7.56 d (8.5) H-17 C-19, C-20, C-14, C-11, C-15 
17 127.2 (CH) 7.48 dd (7.7, 1.8) H-16, H-18 C-19, C-15 
18 108.8 (CH) 6.98 d (7.7) H-17 C-19, C-16, C-20 
19 148.1 (C)    
20 113.3 (C)    
21 56.6 (CH3) 3.81 s  C-6 
1H and 2D data obtained at 500 MHz in CD3OD.  
13C chemical shifts were determined from HSQC and CIGAR NMR experiments. 
 
Although compound 3.10 was not obtained 100% pure and in sufficient quantity to 
readily purify, the biological activity was determined.  In the P388 assay 3.10 was found 
to have an IC50 of 2335 ng/mL.  However, considering that neither of the other 
mamakunoic acids showed any activity, this moderate activity is likely the result of an 
impurity.  A re-culture of the E484 fungus to obtain more of these compounds (3.7, 3.8 
and 3.10) was carried out, but did not produce the desired metabolites (see Section 3.7).  
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3.5.4  Structure Elucidation of SAS-5-64.10.4 (3.11) 
 
The remaining compound purified from the C18 column fraction, SAS-5-64.10 was the 
major compound of the extract, SAS-5-64.10.4 (3.11).  ESIMS indicated a mass of 321 
([M+H]+), while HREIMS provided a molecular formula of C19H12O5, corresponding to 
14 degrees of unsaturation.   
Comparison of the 1H and 13C NMR spectra of 3.11 (see Table 3.4 and Figures 3.16 and 
3.17 respectively) with those of the mamakunoic acids showed that 3.11 also contained 
the spirobisnaphthalene substructure.  Other than this 3.11 was a very different molecule 
to the mamakunoic acids.  The most notable differences were the absence of the acid 
carbonyl and the methylene carbon.  Instead, 3.11 showed two ketone resonances at δC 
201.1 and 198.6 and a quaternary carbon at δC 68.9. 
Using COSY and HSQC correlations, the protons not involved in the spirobisnaphthalene 
were classified as belonging to two different spin systems.  The first was a three proton 
spin system comprising of one proton at δH 5.93 (J = 5.8, 2.0 Hz) (H-2) correlated to a 
broad singlet proton at δH 5.30 (H-4) and a proton at δH 6.40, also a doublet of doublets (J 
= 5.8, 1.9 Hz) (H-3). 
 
ppm5.45.65.86.06.26.46.66.87.07.27.47.6  
Figure 3.16: 1H NMR spectrum of SAS-5-64.10.4 (3.11) in CD3OD. 
 
Chapter 3 Spirobisnaphthalenes from a New Zealand Fungal Endophyte 67 
ppm8090100110120130140150160170180190200  
Figure 3.17: 13C NMR spectrum of SAS-5-64.10.4 (3.11) in CD3OD. 
 
The proton at H-4 had a 1JCH correlation to the carbon at δC 79.1 (C-4), suggesting that H-
4 was an oxymethine proton.  The protons H-2 and H-3 showed 1JCH correlations to 
carbons at δC 129.9 (C-2) and 142.7 (C-3) respectively.  From these data the spin system 
was proposed to be an allylic alcohol or ether.  In the CIGAR spectrum the proton at H-2 
showed 2,3JCH correlations to C-3 and C-4, to the spiroketal carbon C-1, and the 
quaternary carbon at δC 68.9 (C-5).  The H-3 proton also showed a 3JCH correlation to C-
5, hence a five-membered ring (ring A), attached to the 1,8 bisnaphthalene via the 
spiroketal was constructed (Figure 3.18). 
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Figure 3.18: Important COSY and CIGAR correlations observed for ring A 
 
The second spin system was a two-proton system and showed a doublet proton at δH 7.09 
(J = 5.7 Hz) (H-7) coupled to another doublet proton at δH 7.22 (J = 5.7 Hz) (H-8).  The 
HSQC spectrum showed that these protons had 1JCH correlations to carbons at δC 151.9 
(C-7) and 152.2 (C-8) respectively.  In the CIGAR NMR spectrum the protons at H-7 and 
H-8 both showed 2,3JCH correlations to the two carbonyls at δC 198.6 (C-6) and 201.1(C-
9).  CIGAR correlations from the protons at H-7 and H-8 to the quaternary carbon at C-5 
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enabled the closure of a cyclopentadione ring (ring B), and simultaneously revealed that 
the point of attachment of the two five-membered rings was a spirocentre (Figure 3.19). 
 
O
O
H
H
7.09
7.22
6 7
89
5 B
COSY
CIGAR
 
Figure 3.19: COSY and CIGAR NMR correlations for ring B. 
 
The alternative isomer (Figure 3.20) in which the ketones are placed adjacent to each 
other would also fit the observed CIGAR correlations, but this was not considered a 
possibility because the chemical shifts of the two olefinic carbons would be quite 
different from those actually observed. 
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Figure 3.20: Alternative substitution pattern of ring B including ACD Labs chemical shift 
calculations. 
 
Taking account of the structural components elaborated, just 1 Da was unaccounted for, 
suggesting that the oxygen substituent attached at C-4 was an hydroxyl and not part of an 
ether. 
The structure of 3.11 was found to have no matches in the literature, confirming it as a 
new natural product.  The top half of the molecule comprising rings A and B was in fact 
so unusual it was found to be structurally unprecedented, not just in the 
spirobisnaphthalene class of compounds, but also in the natural product and synthetic 
compound literature.  In light of the new carbon skeleton, the compound was given the 
name spiro-mamakone A (3.11). A complete list of NMR data is presented in Table 3.4. 
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Table 3.4: NMR data for 3.11 
position δ 13Ca, ppm δ 1H ppm, multiplicity, (JHH Hz) COSY CIGAR 
1 111.7 (C)    
2 129.9 (CH) 5.93 dd (5.8, 2.0) H-3, H-4 C-5, C-4, C-1, C-3 
3 142.7 (CH) 6.40 dd (5.8, 1.9)  H-2, H-4  C-5, C-4, C-2  
4 79.1 (CH) 5.30 brs  H-3, H-2 C-2, C-3, C-6, C-9 
5 68.9 (C)    
6 198.6 (C)    
7 152.2 (CH) 7.09 d (5.7) H-8 C-5, C-8, C-6, C-9 
8 151.9 (CH) 7.22 d (5.7) H-7 C-5, C-7, C-6, C-9 
9 201.1 (C)    
10 149.4 (C)    
11 111.0 (CH) 6.83 d (7.3) H-12 C-19, C-13, C-14, C-10 
12 129.0 (CH) 7.40 t (7.8, 7.8) H-13, H-11 C-10, C-14, C-19, C-11  
13 122.0 (CH) 7.45 d (8.8) H-12 C-18, C-14, C-15, C-19, C-11 
14 136.1 (C)    
15 122.5 (CH) 7.47 d (8.8) H-16 C-10, C-14, C-13, C-19, C-17 
16 128.7 (CH) 7.36 t (7.8, 7.8) H-15, H-17 C-18, C-14, C-19, C-17 
17 110.6 (CH) 6.76 d (7.3) H-16 C-19, C-15, C-14, C-18 
18 148.8 (C)    
19 114.8 (C)    
                                    a  No. of attached protons determined by HSQC-DEPT experiments. 
                                    1H  and 2D NMR experiments carried out at 500 MHz in  CD3OD . 13C data obtained at 75 MHz. 
       Carbon assignments for C-2 and C-3 based on the results of CIGAR NMR data for  
  spiro-mamakone C (3.16). 
 
spiro-Mamakone A (3.11) showed potent activity in the P388 (IC50 0.33 μM) and was a 
strong inhibitor against Bacillus subtilis (12 mm), Trichophyton mentagrophytes (10 mm) 
and Cladosporium resinae (6 mm) in the antimicrobial assays. 
 
 
 
3.5.4.1  Confirmation of spiro-Mamakone A (3.11) – The Hemi-Synthesis 
of 4-oxo-spiro-Mamakone A (3.12) 
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In an attempt to obtain confirmation of this unusual structure by X-ray crystallography, 
efforts were made to obtain suitable crystals of 3.11.  These attempts were unsuccessful.  
However, a simple modification, through oxidation of the allylic alcohol at C-4, was 
made to produce a more symmetrical compound. It was predicted that removal of the 
stereocentre at C-4, would render H-7 and H-8 magnetically equivalent. 
Oxidation with freshly prepared manganese oxide (see Scheme 3.1 and Experimental) 
proceeded smoothly to give the expected triketone, in which the H-7 and H-8 protons 
were indeed found to be equivalent in the 1H NMR spectrum (Figure 3.21).  
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Scheme 3.1: Oxidation of spiro-mamakone A (3.11) 
 
Another consequence of the oxidation is the symmetrisation of the intact naphthalene 
unit.  This is a consequence of the newly introduced mirror plane, which passes through 
both centres, making rings D and E symmetrically equivalent.  This change from C1 to Cs 
symmetry is also reflected in the simplified 1H and 13C NMR spectra. 
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Figure 3.21: 1H NMR spectrum of 4-oxo-spiro-mamakone A (3.12) in CDCl3. 
 
The CIGAR spectrum confirmed that a ketone had replaced the hydroxyl at C-4.  This 
was seen from the correlations from the two doublet protons at δH 7.77 (H-3) and 6.69 
(H-2) to an α,β-unsaturated ketone at δC 196.0 (C-4).  The IR spectrum also showed the 
conversion was successful, indicated by an additional carbonyl stretch at 1763 cm-1.  The 
remaining 2D NMR data were in agreement with the structure of 3.12 (see Experimental 
for 1H and 13C NMR data).  EIMS confirmed the mass as 318 ([M]+).  The new 
compound was given the name 4-oxo-spiro-mamakone A (3.12).  
As expected, 3.12, like that of the parent compound, 3.11, displayed similar potent 
biological activity.  In the P388 assay the IC50 of 3.12 was determined to be 1.13 μM, 
while in the antimicrobial assay it was shown to display moderate inhibition (3 mm) of B. 
subtilis, T. mentagrophytes, and C. resinae. 
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3.5.4.2 Oxidative Removal of the Spiroketal 
 
An investigation into the relationship between the structure and bioactivity of spiro-
mamakone A, prompted the modification of 3.11 using a deprotection strategy.  It was 
proposed that the spiro-nonadiene portion of the molecule probably contributed most to 
the observed activity.  This theory was borne out from the observation that the 
mamakunoic acids, although bearing the 1,8-dihydroxynaphthalene and spiroketal 
subunits, were not bioactive in the P388 assay. 
Oxidative removal of the spiroketal with cerium ammonium nitrate (CAN) (see Scheme 
3.2 and Experimental for this chapter), proceded to give the expected spiro-nonadiene 
triketone (3.13). 
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Scheme 3.2: Oxidative deprotection of spiro-mamakone A (3.11). 
 
The 1H NMR spectrum (Figure 3.22) showed the expected, 5 unique proton environments 
assumed for the deprotected molecule.  Confirmation that the product was indeed that of 
the triketone followed from interpretation of the HSQC-DEPT and CIGAR NMR spectra.  
The CIGAR spectrum showed the presence of three magnetically non-equivalent ketone 
resonances (δC 201.4, 199.2 and 196.4), while the HSQC-DEPT spectrum confirmed the 
continued presence of the allylic alcohol at C-4.  This was indicated from the 1JCH 
corelation observed from the proton at δH 5.15 (H-4) to the carbon at δC 75.0 (C-4) 
In the P388 assay the IC50 of 3.13 was determined to be 22.7 μM.  Due to the impure 
nature of the reaction product these results can not be considered particularly accurate 
Attempts at scaling up and purification of this reaction failed to generate greater amounts 
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or material of greater purity.  3.13 seemed to very unstable as shortly after generation 
and/or purification degradation took place.  
 
ppm5.45.65.86.06.26.46.66.87.07.27.47.67.88.0  
Figure 3.22: 1H NMR spectrum of 3.13 in CD3OD. 
 
3.5.4.3 Stereochemistry of spiro-Mamakone A (3.11) 
 
The structure of 3.11 contains a single stereocentre at C-4, but the absence of any optical 
rotation suggested that 3.11 existed as a racemic mixture.  This could be verified by 
esterification of 3.11 with both (S)- and (R)-α-methoxy-α-(trifluoromethyl)phenylacetic 
acid (MTPACl) (Mosher acid chlorides).  If 3.11 were a racemic mixture then each of 
these derivatisations would produce the same pair of diastereomers.  Esterification of 
3.11 was carried out by addition of the (S)- and (R)-Mosher acid chlorides to a mixture of 
3.11 and dimethylaminopyridine (DMAP) in pyridine (see Scheme 3.3 and Experimental) 
according to the method of Ward et al.79 
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Scheme 3.3: Esterification of 3.11 with Mosher’s acid chloride (MTPACl) 
 
The resulting HPLC chromatogram (Figure 3.23) provided confirmation that 4.11 was a 
racemic mixture. 
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Figure 3.23: HPLC chromatogram showing reaction products of Mosher esterification.  
 
For each of the derivatised products, two peaks of equal intensity were observed at 
identical retention times.  These peaks represent the two diastereomers, which are formed 
when a chiral derivatisation occurs at a racemic centre.  To confirm that the peaks at 
around 20 minutes were the desired ester products, the peaks were individually collected 
from the HPLC and submitted for direct inject ESIMS.  All four peaks showed identical 
mass peaks at 559 ([M+Na]+), confirming them as esterification products of 3.11 (Figure 
3.24). 
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Figure 3.24: ESIMS showing the characteristic [M+Na]+ adducts (559 Da) of the esterification 
products of 3.11. 
 
3.6  Discussion 
 
Purification of an extract from an unidentified endophytic fungus (F5062) has resulted in 
the isolation of four new compounds of the spirobisnaphthalene class.  This rather large 
class, which include the palmarumycins, cladospirones, diepoxins and preussomerins, all 
contain a common spiroketal-linked 1,8 bisnaphthalene moiety.  The first three 
compounds have been named mamakunoic acid A, B and C.  
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Mamakunoic acid B and C differ from the already known spirobisnaphthalenes by virtue 
of an acid functionality attached to a furan ring.  In terms of the spirobisnaphthalene class 
of compounds they most resemble palmarumycin C6 (3.14),80 but only in that they both 
contain an indan system, connected to the 1,8-dihydroxy naphthalene via a spiroketal 
bridge.  Mamakunoic acid B was identified as the ring-closed dehydration product from 
mamakunoic acid A.  
The fourth compound was identified as a spirobisnaphthalene of an unprecedented 
structural type, featuring an oxygenated spirononadiene ring system, and was named 
spiro-mamakone A.  The spirononadiene and spioketal of 3.11 give the molecule an 
unusual spatial orientation (Figure 3.25).  
 
Figure 3.25: Energy minimised model (MM2) of 3.11, showing unusual spatial orientation. 
 
Fredericamycin A, an antitumour antibiotic produced by Streptomyces griseus81 (Figure 
3.26), was found to contain the closest partial carbon skeleton containing a spirocentre 
comparable to that of 3.11.  
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Figure 3.26: Structure of fredericamycin A, showing the spiro ring system (green) similar to that 
of 3.11 
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Due to the almost symmetrical nature and lack of CIGAR correlations linking the two 
halves of the molecule, the assignment of the chemical shifts (except in the ring junction 
positions) for the 1,8-dioxynaphthalene portion of the molecule in all four of these new 
molecules is arbitrary.  For example the chemical shift assignments given for positions C-
11 (δC 111.0, δH 6.83) can be interchanged with those on the opposite side, C-17, of the 
adjacent ring (δC 110.6, δH 6.76). 
Chapter 3 Spirobisnaphthalenes from a New Zealand Fungal Endophyte 78 
Part 2  New Spirobisnaphthalenes from 
F5584 
 
 
3.7  Preliminary Investigations of F5584 
 
The fungus E484 (renamed F5584) was re-grown in order to obtain more of the 
mamakunoic acids A, B, and C (3.7, 3.9, and 3.10).  It was envisioned that a full 
characterisation, including stereochemistry, could be obtained with more material. 
The solid agar culture of F5584 was grown under the same conditions as the original 
F5062 culture (see Experimental).  A total of 24 Plates gave some 249 mg of crude 
extract. HPLC analysis of an aliquot of the crude extract using an RP C18 column 
showed that the extract was very different to that of F5062 (Figure 3.27). 
 
 
Figure 3.27: Comparison of the HPLC chromatograms of F5062 and F5584. 
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There was only one peak in common between the two extracts.  This was the major peak 
eluting at 14.2 minutes, representing spiro-mamakone A (3.11).  Despite the extract not 
containing compounds 3.7, 3.9, and 3.10, the UV chromophores of the other peaks were 
almost identical to that of 3.11 (Figure 3.28).  In the hope of finding compounds related 
to the structurally unprecedented spiro compound, 3.11, the extract was pursued further. 
 
 
Figure 3.28: UV spectra overlay of the major peaks in the HPLC of F5584. 
 
3.8  Chromatography of F5584 
 
The crude extract of F5584 was subjected to reverse phase (C18) flash chromatography 
using a stepped gradient for elution (see Experimental).  Two sequential fractions (SAS-
5-103.9 and SAS-5-103.10) that eluted with MeOH/H2O (9:1), contained the compounds 
related to 3.11 (Figure 3.29).  The fraction, SAS-5-103.11 that eluted at 100% MeOH 
contained 3.11.  At this stage fractions SAS-5-103.9 and SAS-5-103.10 were considered 
sufficiently pure for purification by semi-preparative HPLC.  Details of the two gradient 
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methods that were used to elute the compounds of interest are detailed in the 
Experimental section. 
 
 
Figure 3.29: HPLC chromatograms of fractions 9 and 10, indicating those compounds purified. 
 
Purification of SAS-5-103.9 yielded two compounds, SAS-5-103.9.1 (10.8 mg) and SAS-
5-103.9.2 (4.9 mg).  The purification of SAS-5-103.10 yielded three compounds, SAS-5-
103.10.1 (2.1 mg), SAS-5-103.10.2 (11.8 mg) and spiro-mamakone A (3.11) (3.6 mg).  
 
3.9  Structure Elucidation 
 
3.9.1  Structural Elucidation of SAS-5-103.10.2 (3.15) 
 
SAS-5-103.10.2 (3.15) was one of the other major components of the crude extract.  
ESIMS indicated the mass to be 323 ([M+H]+).  An [M-H2O]+ ion peak at m/z 305 
suggested the presence of an hydroxyl entity in the molecule.  The difference of two mass 
units between 3.11 and 3.15 could be accounted for by the reduction of one of the 
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carbonyls in 3.15 to an hydroxyl group.  This was supported by HREIMS, which gave a 
molecular formula of C19H14O5, indicating the molecule had 13 degrees of unsaturation, 
one less than for 3.11. The 1H NMR spectrum (Figure 3.30) was very similar to that of 
3.11. 
 
ppm5.56.06.57.07.58.0  
Figure 3.30: 1H NMR spectrum of SAS-5-103.10.2 (3.15) in DMSO-d6. 
 
The aromatic signals between 6.90-7.60 ppm indicated that 3.15 also contained the 1,8 
bisnaphthalene system.  Other than this, the notable differences in the spectrum were the 
presence of a down-field one proton doublet at δH 7.80, and rather than just one proton 
signal in the oxymethine region of the spectrum (as in 3.11), there were now two, (an 
overlapping proton signal at δH 5.38 and a broad singlet at δH 5.44).  This was further 
evidence in favour of the reduction of one of the ketones.  The 13C NMR spectrum 
(Figure 3.31) showed the carbon signals of the 1,8 bisnaphthalene moiety at δC 147.8 (C-
18), 147.7 (C-10), 134.0 (C-14), 127.6 (C-16), 127.6 (C-12), 120.7 (C-13), 120.4 (C-15), 
113.4 (C-19), 109.0 (C-17) and 109.1 (C-11). 
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Figure 3.31: 13C NMR spectrum of SAS-5-103.10.2 (3.15) in DMSO-d6.  
 
The connectivities of the aromatic protons at 6.90-7.60 ppm to these carbons, forming the 
naphthalene system, were confirmed by COSY, HSQC and CIGAR experiments.  Also 
present in the 13C NMR spectrum was a quaternary carbon at δC 110.4 representing the 
spiroketal carbon.  A quaternary carbon at δC 69.9 was assumed to be the spirocentre 
carbon, thus 3.15 appeared to be part of the spiro-mamakone series, rather than the 
mamakunoic acid series.  Also present in the spectrum were two oxymethine carbons at 
δC 74.4 and 71.0 and only one α,β-unsaturated ketone carbon (at δC 200.6).  2D NMR 
correlations provided the remaining connections to form the upper portion of the 
molecule.  
COSY correlations from a one proton doublet at δH 5.83 (H-2) to another proton doublet 
at δH 6.28 (H-3) and a broad singlet proton at δH 5.44 (H-4) suggested that the structure 
of ring A in 3.11 was retained in ring A of 3.15.  Interestingly, the H-4 proton showed 
three COSY correlations rather than two.  The third correlation was to a proton at δH 5.37.  
This proton showed no correlations to any carbons in the HSQC experiment, and was 
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therefore assigned the C-4 hydroxyl proton.  Another proton signal at δH 5.88 showed 
COSY correlations to the H-9 proton on ring B, but showed no correlations in the HSQC 
spectrum.  Thus, this was presumed to be the C-9 hydroxyl proton.  The HSQC and 
CIGAR correlations confirmed this (Table 3.5).  This meant that the point of difference 
between 3.11 and 3.15 was located in ring B. 
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Figure 3.32: COSY and CIGAR correlations for ring B. 
 
In ring B, COSY correlations were observed from the one proton doublet of doublets at 
δH 7.80 (H-8) to a one-proton doublet at δH 6.32 (H-7) and an overlapping proton signal 
at δH 5.38 (H-9) (Figure 3.32).  The pattern was immediately suggestive of the allylic 
alcohol moiety seen in ring A.  The HSQC spectrum confirmed that the H-9 proton was 
part of a second oxymethine, as was shown by the observed 1JCH correlation to the carbon 
at δC 71.0 (C-9).  The protons at H-7 and H-8 showed 1JCH correlations to carbons at δC 
133.8 and 164.0 respectively.  CIGAR correlations from the protons at H-7, H-8 and H-9 
to a carbonyl carbon at δC 200.6 confirmed that C-6 was the location of the α,β-
unsaturated ketone.  Correlations from H-7 and H-8 to C-5, showed that like 3.11, the 
connection of the two rings, A and B, was via the spiro centre.  The CIGAR correlation 
from the hydroxyl proton at δH 5.37 was to the carbon at δC 142.4, rather than δC 125.7.  
This confirmed that C-3 had a chemical shift of 142.4 ppm rather than C-2.  This was 
interesting as the ACD Labs© software, as well as the literature predicted that the more 
downfield chemical shift (142.4 ppm) would be C-2, and the more upfield chemical shift 
(125.7 ppm) to be C-3. These assignments were subsequently confirmed by the 
biosynthetic studies (see Section 3.14.1). 
The reduction of a carbonyl on ring B means that unlike 3.11, 3.15, contains three 
stereocentres, C-4, C-9 and the spirocentre, C-5.  Because the spirocentre is chiral it 
means that the placement of the ketone or hydroxyl at either C-6 or C-9 is valid as it is 
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not a structural issue, but rather a stereochemical one.  The stereochemistry of 3.15 is 
discussed below in Section 3.9.1.1. 
All 1D and 2D NMR data (see Table 3.5) were in excellent agreement with the structure 
proposed (3.15).  The upper portion of the molecule contains the same novel carbon 
backbone as compound 3.11.  The new compound was given the name spiro-mamakone 
C (3.15). 
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Table 3.5: NMR data of 3.15  
position δ 13Ca, ppm δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
1 110.4 (C)    
2 125.7 (CH) 5.83 d (5.9) H-3 C-3, C-1, C-4, C-5 
3 142.4  (CH) 6.28 d (5.9) H-4, H-2 C-2, C-1, C-4, C-5  
4 74.4 (CH) 5.44 brs 4-OH C-6, C-2, C-3, C-1, C-9, C-5 
5 69.9 (C)    
6 200.6 (C)    
7 133.8 (CH) 6.32 d (5.7) H-9 C-6, C-8, C-9, C-5 
8 164.0 (CH) 7.80 d (5.7) H-7, H-9 C-6, C-7, C-9, C-5 
9 71.0 (CH) 5.38 ol 9-OH C-8, C-7, C-1 
10 147.7 (C)    
11 109.1 (CH) 6.93 d (8.0) H-12 C-10, C-14, C-12, C-13, C-19 
12 127.6 (CH) 7.53 ol H-13, H-11 C-10, C-14, C-13, C-19, C-11 
13 120.7 (CH) 7.64 ol H-12 C-18, C-14, C-15, C-19, C-11 
14 134.0 (C)    
15 120.4 (CH) 7.62 ol H-16 C-10, C-14, C13, C-19, C-17 
16 127.6 (CH) 7.53 ol H-15, H-17 C-18, C-14, C-15, C-19, C-17 
17 109.0 (CH) 6.99 d (8.0) H-16 C-18, C-14, C-16, C-15, C-19 
18 147.8 (C)    
19 113.4 (C)    
4-OH 74.4  5.37 ol H-4 C-3, C-4, C-5 
9-OH 71.0  5.88 d (6.8) H-9 C-8, C-9, C-5 
                                          a No. of attached protons determined by HSQC-DEPT experiments. 
                                          1H and 2D NMR data obtained at 500 MHz in DMSO-d6. 13C NMR carried out at 75 Mhz. 
                          ol- overlap. 
 
3.15 was assessed for biological activity and found to be very active.  The IC50 of 0.95 
μM was of the same order as that of the parent compound 3.11 (0.33 μM).  In the 
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antimicrobial assays, 3.15 strongly inhibited the growth of B. subtilis (7 mm) and T. 
mentagrophytes (5 mm), but unlike 3.11 had no activity against C. resinae. 
 
3.9.1.1  Stereochemistry of spiro-Mamakone C (3.15) 
 
Fortunately, after the slow evaporation of MeOH at 4°C, suitable crystals of 3.15 were 
obtained.  Not only did X-ray crystallography confirm the structure of this new class of 
compound, but it also gave the relative stereochemistry as 4S*, 5S*, 9R* (Figure 3.33). 
 
Figure 3.33: Crystal structure drawing of 3.15. 
 
It was surprising, however, to find that the enantiomer (4R, 5R, 9S), was also present in 
the crystal.  This would usually be indicative of a racemic mixture.  This however was 
not the case, as an optical rotation measurement had shown 3.15 to have optical activity.  
The only possible explanation for this observation was that 3.15 existed as an 
enantiomeric excess, and the crystal that was analysed coincidently contained both 
enantiomers. 
Chapter 3 Spirobisnaphthalenes from a New Zealand Fungal Endophyte 86 
This meant that appropriate derivatisation of 3.15 with a group carrying a heavy atom 
followed by crystallisation to obtain the absolute stereochemistry was now, no longer 
necessary. 
In order to confirm the presence of an enantiomeric excess, derivatisation of 3.15 with 
Mosher acid chlorides was carried out following the methods used for the derivatisation 
of 3.11 (see Experimental, Section 7.3.6).  Unfortunately, the esterification products were 
not able to be detected by HPLC or ESIMS.  Due to limited material available, 
esterification was not attempted a second time.  It is envisioned that this work will be 
carried out at a later date. 
 
3.9.2  Structure Elucidation of SAS-5-103.9.2 (3.16) 
 
Another of the major compounds from the C18 column fraction, SAS-5-103.10 was 
purified.  This was SAS-5-103.9.2 (3.16).  ESIMS revealed the compound to also have a 
mass of 323 ([M+H]+), identical to that of 3.15.  As was also seen in the ESIMS of 3.15, 
there were peaks at 305 ([M-H2O]+) and 355 ([M+Na]+).  HREIMS also gave a molecular 
formula identical to that of 3.15 (C19H14O5), hence the number of double bond 
equivalents were also the same as for 3.15.  From these data it was obvious that 3.16, was 
an isomer of 3.15.  The 13C NMR spectrum (Figure 3.34) indicated that it was probably a 
stereoisomer, as the spectrum showed chemical shifts that were very similar to those of 
3.15.  The 1H NMR spectrum (Figure 3.35) of 3.16 contained two less proton signals than 
that of 3.15, however apart from the extra signals, the spectrum appeared to be very 
similar to that of 3.15. 
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Figure 3.34: 13C NMR spectrum of SAS-5-103.9.2 (3.16) in DMSO-d6. Crosses indicate 
impurities. 
 
 
ppm5.45.65.86.06.26.46.66.87.07.27.47.67.8  
Figure 3.35: 1H NMR spectrum of SAS-5-103.9.2 (3.16) in DMSO-d6. 
 
COSY and HSQC NMR spectra revealed that the spin systems for both the 1,8-
dioxynaphthalene and the upper portion of 3.16 were identical to those of 3.15.  Ring A 
was confirmed as identical to ring A in 3.15.  Unlike for 3.15, no hydroxyl proton signals 
were observed.  Appearance of signals for exchangeable protons is expected in DMSO-
d6, and it is therefore unusual that the exchangeable protons were not seen in this 
spectrum. 
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All other 1D and 2D NMR data (Table 3.6) were found to be in excellent agreement with 
3.16 being a diastereomer of 3.15. 
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Table 3.6: NMR data for 3.16 
position δ 13Ca, ppm δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
1 110.1 (C)    
2 129.0 (CH) 5.95 dd (6.4, 2.0) H-3, H-4 C-3, C-1, C-4, C-5 
3 140.5 (CH) 6.15 dd (6.2, 1.4)  H-3, H-4 C-2, C-1, C-4, C-5 
4 78.7 (CH) 5.06 brs H-3, H-2 C-6, C-3, C-2, C-9 
5 68.0 (C)    
6 201.9 (C)    
7 134.5 (CH) 6.30 d (5.9) H-8 C-6, C-8, C-9, C-5 
8 161.6 (CH) 7.77 dd (5.9, 3.0) H-7, H-9 C-6, C-7, C-9, C-5 
9 75.2 (CH) 5.25 d (3.0) H-8 C-6, C-8, C-7, C-4 
10 147.7 (C)    
11 108.8 (CH) 6.90 d (7.2) H-12 C-10, C-13, C-19 
12 127.5 (CH) 7.46 ol  H-13, H-11 C-10, C-14, C-19, C-11  
13 119.9 (CH) 7.56 ol  H-12 C-18, C-14, C-15, C-19, C-11 
14 134.0 (C)    
15 120.3 (CH) 7.59 ol  H-16 C-10, C-14, C-13, C-19, C-17 
16 127.5 (CH) 7.48 ol  H-15, H-17 C-18, C-14, C-19, C-17 
17 108.9 (CH) 6.92 d (7.2) H-16 C-18, C-15, C-19 
18 147.8 (C)    
19 113.3 (C)    
                                          a No. of attached protons determined by HSQC-DEPT experiments. 
                                         1H and 2D NMR experiments carried out at 500 MHz in DMSO-d6. 13C NMR data obtained at  
  75 MHz. 
                          ol- overlap. 
 
The new compound was given the name spiro-mamakone B (3.16).  Like that of its 
isomer (3.15), 3.16, was also found to display strong biological activity.  It showed potent 
cytotoxicity in the P388 assay (1.39 μM) and moderate to high inhibition in the 
antimicrobial assay (7mm and 8 mm for B. subtilis and T. mentagrophytes respectively).  
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3.9.2.1 Stereochemistry of spiro-Mamakone B (3.16) 
 
An NOE spectrum (Figure 3.36) of 3.16 was obtained.  When the proton resonance for H-
4 was irradiated the proton signal for H-9 was enhanced. 
 
ppm5.56.06.57.07.58.0
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Figure 3.36: 1D NOE NMR spectrum of 3.16, showing the results of irradiation at H-9 (bottom) 
and H-4 (top). 
 
In order to deduce the relative stereochemistry of 3.16, energy-minimised (MM2) models 
of the four possible diastereomers were generated.  The models, created using CHEM 3D 
software, gave the distance through space (Å), between H-4 and H-9 for each of the 
diastereoisomers.  As strong NOE correlations are not normally seen beyond a spacing of 
3.0 Å, it can be deduced that the relative stereochemistry of 3.16 therefore, is 4S*, 5S*, 
9S*, as presented in Figure 3.37b. 
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Figure 3.37: The four possible diastereomers for 3.16, showing H-4–H-9 bond distances (Å). 
 
The possibility that 3.16 was a purely racemic mixture was disregarded as it was found to 
be optically active.  Like that of 3.15, it could however exist as a partial racemate.  An 
investigation of this possibility by Mosher derivatisation might have been a possibility 
had the amount of remaining material been sufficient.  The difficulty with working with 
diols is that introduction of the chiral auxiliary will lead to bis-MTPA esters; each of the 
phenyl rings producing a combination of shielding/deshielding not only on the protons 
nearest the chiral centre, but also on the substitiuents of the other chiral centre.82  In a 
recent article by Freire et al., they describe the use of chiral auxiliaries for determining a 
reliable absolute stereochemistry of diols.83  Although this work was applied to linear 
diols, it will be applied to the spiro-mamakone structure at a future date to explore the 
level of stereochemical complexity.  
 
3.9.3  Structure Elucidation of SAS-5-103.9.1 (3.17) 
 
SAS-5-103.10.1 (3.17) was also one of the major compounds purified from the extract of 
F5584.  ESIMS gave the mass as m/z 341 ([M+H]+), however this ion peak was of very 
low intensity.  The base peak was instead at 323 ([M-H2O]+).  A small ion peak at 363 
([M+Na]+) was also observed, confirming m/z 341 as the correct mass.  HREIMS on this 
compound suggested a molecular formula of C19H16O7, indicating 12 degrees of 
unsaturation in the molecule. 
The 1H NMR spectrum (Figure 3.38) showed aromatic signals between δH 6.85-7.49 
representing H-11–H-17 of the 1,8-bisnaphthalene system in the lower portion of the 
molecule.  A broad singlet at δH 5.51 and two protons at δH 5.76 and 6.17 each appearing 
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as a doublet of doublets, were presumed to represent an allylic alcohol moiety, analogous 
to ring A of 3.11, 3.15 and 3.16. 
 
ppm2.53.03.54.04.55.05.56.06.57.07.5
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Figure 3.38: 1H NMR spectrum of SAS-5-103.9.1 (3.17) in CD3OD. 
 
The remainder of the 1H NMR spectrum showed two, one proton doublet of doublets at 
δH 2.29 and 2.68, a one proton doublet of triplets at δH 4.37 and a one proton doublet 
proton at δH 4.65.  This portion of the 1H NMR spectrum did not show any similarity to 
any of the previously isolated spiro-mamakone molecules.  
The 13C NMR spectrum (Figure 3.39) showed a total of eighteen signals, one short of the 
molecular formula, an indication that two of the carbons signals were overlapping. 
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Figure 3.39: 13C NMR spectrum of SAS-5-103.9.1 (3.17) in CD3OD.Crosses indicate impurities. 
 
These carbons were most likely C-12 and C-16 (δC 128.71 and 128.73 respectively) of 
the naphthalene ring, as these carbons had shown near identical chemical shifts in the 
previously isolated spiro-mamakone molecules, 3.11, 3.15 and 3.16.  The presence of the 
spirobisnaphthalene part of the molecule was confirmed by comparison of the carbon 
chemical shifts for C-10–C-19 and C-1 with those for 3.11, 3.15, and 3.16, where they 
were found to be in good agreement.  The major differences between the 13C NMR 
spectrum for 3.17 and those of the other spiro-mamakones, were a high field carbon at δC 
47.8 and an extra carbon in the 70 ppm region, probably indicative of the presence of an 
extra hydroxyl grouping.  Because the A, C, D, and E rings were already proposed to be 
identical to those of the other spiro-mamakones, and confirmed by 2D NMR data (Table 
3.7), the differences observed were the result of structural changes to ring B.  The ring B 
spin system, shown in Figure 3.40, was shown by COSY data to contain a proton at δH 
4.37 correlated to a proton at δH 4.65 and to the two protons at δH 2.29 and 2.68. 
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Figure 3.40: COSY and CIGAR correlations for ring B. 
 
The HSQC NMR spectrum showed that these latter two protons had a 1JCH correlation to 
the same carbon at δC 47.8, thereby confirming these protons as diastereotopic methylene 
protons.  1JCH correlations were also observed from δH 4.37 and 4.65 to carbons at δC 
73.2 and 78.2 respectively, thus confirming a diol moiety.  COSY NMR also determined 
that the methylene protons and the proton at δH 4.65 were adjacent to only one proton and 
therefore the other adjacent position must contain a quaternary carbon.  CIGAR 
correlations from both the methylene protons and the proton at δH 4.37 to a carbonyl at δC 
208.7 indicated the presence of a ketone on ring B.  A CIGAR correlation from H-4 on 
ring A to this same carbonyl meant that the ketone at δC 208.7 was placed at C-6 of ring 
B.  As mentioned previously it was proposed that both the methylene protons and the 
proton at δH 4.65 were adjacent to quaternary carbons.  The methylene protons were 
found to have the very large geminal coupling constant of J = 18.0 Hz.  This large 
coupling constant is very characteristic of a geminal coupling of a methylene adjacent to 
a carbonyl.  For this reason the methylene protons at δH 2.29 and 2.68 were arbitrarily 
assigned to H-7a and H-7b respectively.  Based on the COSY correlations previously 
mentioned the protons at δH 4.37 and 4.65 were assigned to the adjacent positions, H-8 
and H-9 respectively.  A CIGAR correlation from H-7b to the carbon at C-5 (δC 73.8) 
confirmed the attachment of ring B to that of ring A through the spirocentre at C-5.  A 
3JCH CIGAR correlation was also seen from H-9 to C-1, not only confirming the position 
of this proton, but also the proximity of ring B to that of A.  All 1D and 2D data (Table 
3.7) were in excellent agreement to that of the proposed structure, 3.17.  The new 
compound was given the name spiro-mamakone D (3.17). 
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Table 3.7: NMR data for 3.17 
position 13Ca, ppm Experimental 
1H, 
multiplicity, (JHH Hz) 
COSY CIGAR 
1 111.8 (C)    
2 128.73 (CH) 5.76 dd (5.9, 2.0) H-4, H-3 C-3, C-1, C-4, C-5 
3 142.8 (CH) 6.17 dd (5.9, 1.4)  H-2, H-4 C-2, C-1, C-4  
4 74.5 (CH) 5.51 brs H-2, H-3 C-6, C-2, C-3, C-1, C-9, C-5 
5 73.8 (C)    
6 208.7 (C)    
7 47.8 (CH2) a: 2.29 dd (18.0, 10.5) H-8, H-7b C-6, C-1, C-9, C-8 
   b: 2.68 dd (18.0, 7.5) H-8, H-7a C-6, C-5, C-9, C-8 
8 73.2 (CH) 4.37 dt (10.3, 8.2, 8.2) H-9, H-7a, H-7b C-6, C-9, C-7 
9 78.2 (CH) 4.65 d (8.1) H-8 C-1, C-8, C-7 
10 149.6 (C)    
11 110.6 (CH) 6.85 d (7.7) H-12 C-10, C-14, C-13, C-19 
12 128.71 (CH) 7.40 t (7.7) H-13, H-11 C-10, C-14, C-13, C-19, C-11 
13 121.9 (CH) 7.47 d (8.3) H-12 C-18, C-14, C-15, C-19, C-11 
14 136.1 (C)    
15 122.1 (CH) 7.49 d (8.3) H-16 C-10, C-14, C-13, C-19, C-17 
16 128.73 (CH) 7.39 t (7.7) H-15, H-17 C-18, C-14, C-15, C-19, C-17 
17 110.7 (CH) 6.92 d (7.7) H-16 C-18, C-14, C-15, C-19 
18 149.5 (C)    
19 115.4 (C)    
                               a  No. of attached protons determined by HSQC-DEPT experiments. 
                                1H and 2D NMR experiments carried out at 500 MHz in CD3OD. 
 
The introduction of an extra hydroxyl into ring B increased the number of stereocentres 
to four, equating to eight possible diastereomers.  Approaches taken to elucidating the 
stereochemistry are discussed in Section 3.10.5. 
The P388 activity of 3.17 was assessed, and found to have an IC50 of 3.76 μM.  Unlike 
the parent compound (3.11) and the diasteromeric partially reduced derivatives, 3.15 and 
3.16, spiro-mamakone D (3.17) did not show any antimicrobial activity.  
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3.9.4  Structural Elucidation of SAS-5-103.10.1 (3.18) 
 
SAS-5-103.10.1 (3.18) was purified from the F5584 extract as a minor component.  
ESIMS gave the mass as 341 ([M+H]+), identical to that of 3.17.  As seen in the ESIMS 
of 3.17, it was the [M-H2O]+ ion (m/z 323) that was most abundant.  As expected, 
HREIMS suggested the molecular formula C19H16O6, indicating the molecule also had 12 
double bond equivalents.  Because 3.15 and 3.16 had already been elucidated as 
diastereomers, it was proposed that 3.17 and 3.18 were also diastereomers. 
Interpreting the 1H NMR spectrum (Figure 3.41) was unfortunately not as simple as it 
could have been, as the sample of 3.18 was not entirely pure.  Despite this, the desired 
signals were clearly distinguishable from those for the impurity. 
 
ppm3.03.54.04.55.05.56.06.57.07.5
X X XX
X
X
Solvent
 
Figure 3.41: 1H NMR spectrum of SAS-5-103.10.1 (3.18) in CD3OD. Crosses indicate impurities. 
 
It was apparent from the 1H NMR (Figure 3.41) and COSY spectra that 3.18 was an 
isomer of 3.17.  This was shown by the 1,8-bisnaphthalene proton signals between δH 
6.82 and 7.53.  Also present were methylene signals appearing as doublets of doublets at 
δH 2.43 and 2.80.  The large geminal coupling constant of JHH = 18.5 Hz, indicated that 
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the methylene protons were again adjacent to a carbonyl, as was shown for 3.17.  Proton 
signals at δH 6.35, 5.84 and 4.89 were observed for the allylic alcohol moiety on ring A.  
Also present was a proton at δH 4.65, with a doublet of triplets multiplicity, indicating 
coupling to both methylene protons and a neighbouring oxymethine proton. 
The remaining 2D NMR data (Table 3.8) were in excellent agreement with the structure 
proposed (3.18).  This new compound, a diastereomer of the previously isolated spiro-
mamakone D (3.17), was given the name spiro-mamakone E (3.18).  Discussions on 
stereochemistry are given in Section 3.9.5. 
Biological data was not obtained due the impure nature of the sample, and its subsequent 
degradation.  
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Table 3.8: NMR data of 3.18 
position 13Ca, ppmb Experimental 
1H, 
multiplicity, (JHH Hz)
COSY CIGAR 
1 110.5 (C)    
2 129.5  (CH) 5.84 d (6.4, 2.0) H-3 C-3, C-1, C-4, C-5 
3 139.7 (CH) 6.35 dd (5.9, 2.9)  H-2, H-4 C-4  
4 76.1 (CH) 4.89 d (3.0) H-3 C-6, C-2, C-3, C-1 
5 72.2 (C)    
6 211.1 (C)    
7 42.7 (CH2) a: 2.43 dd (18.5, 9.0) H-8, H-7a C-6, C-8 
   b: 2.80 dd (18.5, 8.5) H-8, H-7b C-6, C-8 
8 68.2 (CH) 4.65 dt (8.9, 8.5, 3.5) H-9, H-7a, H-7b C-9 
9 74.1 (CH) 4.97 d (3.5) H-8 C-6, C-7 
10 147.3 (C)    
11 108.9 (CH) 6.82 d (7.6) H-12 C-10, C-13, C-19 
12 127.1 (CH) 7.42 ol H-13, H-11 C-10, C-14 
13 120.6 (CH) 7.53 ol H-12 C-18, C-14, C-13, C-19, C-11
14 134.4 (C)    
15 120.7 (CH) 7.52 ol H-16 C-10, C-14, C-15, C-19, C-17
16 127.1 (CH) 7.44 ol H-15, H-17 C-18, C-14 
17 109.1 (CH) 6.97 d (7.6) H-16 C-18, C-15, C-18 
18 147.6 (C)    
19 113.8 (C)    
                        a   No. of attached protons determined by HSQC-DEPT experiments.  
                        b   Carbon chemical shifts determined from HSQC and CIGAR experiments.  
                          1H and 2D NMR experiments carried out at 500 MHz in CD3OD. 
                 ol- overlap. 
 
3.9.5  Stereochemical Assignment of spiro-Mamakones D 
(3.17) and E (3.18) 
 
A different approach to the stereochemical elucidation was taken with 3.17 and 3.18.  
The approach taken was to calculate all coupling constants for all possible stereoisomers 
and to then compare these values against the experimentally determined coupling 
constants.  This required the input of dihedral angles and spatial orientation 
(stereochemistry) of the adjacent carbons into the computer program, MestReJ.  The 
programme calculates coupling constants based on the modified Karplus equation, known 
as the Haasnoot-de Leeuw-Altona equation.  The calculated coupling constants are then 
compared to the experimentally obtained coupling constants.  A match of experimental 
with calculated coupling constants can thus provide a tentative relative stereochemistry. 
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Minimum energy conformations for each of the eight possible diastereomers for 3.17, and 
3.18 were modelled using CHEM-3D computer software.  The dihedral angles (φ) 
between each of the proton pairs, H-8, H-9; H-8, H7a and H-8, H-7b, were measured 
from the modelled structures.  These dihedral angles, together with the stereochemistry of 
the carbon centres of the adjacent proton pairs, were entered into the Mestre-J program to 
generate the coupling constants (Figure 3.42). 
 
 
Figure 3.42: Screen capture of the Mestre-J program, showing the calculated coupling constant 
of the H-8, H-9 proton pair, resulting from specification of the dihedral angle and carbon 
substituents. 
 
The results of the Mestre-J calculations, as well as the actual experimental coupling 
constants, for the proton pairs of 3.17 and 3.18 are presented in Table 3.9.  Initially the 
results seemed very promising, in that the data allowed a relative stereochemistry for both 
molecules to be proposed.  This can be seen in Table 3.9, where the closest matches to 
the experimental data of 3.17 and 3.18 are 4S, 5S, 8S, 9S and 4S, 5S, 8S, 9R respectively. 
The initial proposal that 3.17 and 3.18 were trans and cis isomers respectively, across the 
diol was confirmed by these calculations, as the coupling constants for the two 
orientations are very distinctive. 
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Table 3.9: Coupling constants calculated by Mestre-J for the possible  
diastereomers, as well as experimental coupling constants for 3.17 and 3.18. 
 
H-8-H-9 H-8-H-7a H-8-H-7b calculated φ (°) JHH (Hz) φ (°) JHH (Hz) φ (°) JHH (Hz) 
4S, 5S, 8S, 9S 156.0 9.48 13.5 10.17 137.0 6.13 
4S, 5S, 8R, 9R 75.0 1.95 96.4 1.17 26.6 7.41 
4R, 5S, 8S, 9S 162.4 9.81 28.3 8.91 152.1 8.88 
4R, 5S, 8R, 9R 94.4 0.56 122.3 4.76 1.4 10.17 
       
4R, 5S, 8S, 9R 39.3 5.15 18.7 9.86 142.3 7.13 
4S, 5S, 8S, 9R 45.0 4.41 27.5 9.01 151.1 8.71 
4S, 5S, 8R, 9S 39.3 4.75 91.0 0.84 30.5 6.78 
4R, 5S, 8R, 9S 36.4 5.15 91.6 0.87 31.2 6.66 
experimental       
3.17  8.1  10.5  7.5 
3.18  3.5  9.0  8.5 
 
To help confirm these proposed stereochemical assignments, NOE experiments were 
carried out on both 3.17 and 3.18.  The cis isomer (3.18) showed only one NOE 
relationship, that between H-8 and H-9 (Figure 3.43). 
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Figure 3.43: 1D NOE NMR spectra for 3.18 showing irradiation of (from bottom to top) H-7b, 
H-7a, H-8, H-9, and H-4. 
 
This relationship was not able to confirm the stereochemical assignment as this was not 
the only diastereomer predicted by Mestre-J to show an NOE relationship for the H-8 to 
H-9 proton pair.  According to the calculated bond distances for the 4S, 5S, 8S, 9R 
diastereomer an NOE would be expected between one of the methylene protons at H-7 
and H-8, however this was not seen.  In the NOE spectrum of the trans diastereomer 
(3.17) (Figure 3.44), the opposite problem was encountered. 
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Figure 3.44: 1D NOE NMR spectra for 3.17 showing enhancements upon irradiation of H-9 
(bottom), H-4 (centre), and H-7a (top). 
 
In Table 3.10, the bond distances for all relevant pairs in the trans diastereomers are 
presented, these reveal that very few NOE’s would be expected for any of them; even the 
4S, 5S, 8S, 9S isomer that Mestre-J calculated as being the closest match to the 
experimental data.  The experimental data, however shows NOE relationships between 
all of the proton pairs (Figure 3.44).  The most interesting/puzzling NOE correlation 
exists between H-4 on ring A and H-8 on ring B.  The long bond distances (>4.0 Å) 
calculated for the H-4, H-8 proton pair makes an NOE correlation very unlikely.  A 
strong NOE correlation is also seen from H-4 to H-9.  According to the calculated bond 
distances (Table 3.10), the only isomer that would display this NOE correlation would be 
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4R, 5S, 8S, 9S, unfortunately the data for this isomer did not match that calculated for 
3.17 by MestRe-J. 
 
Table 3.10: Bond distances of diastereomeric possibilities for 3.17 and 3.18. 
 Bond distance (Å) 
 9-8 9-7a 9-7b 8-7a 8-7b 4-9 4-8 
4S, 5S, 8S, 9S 3.056 3.851 3.036 2.372 3.042 3.632 5.169 
4S, 5S, 8R, 9R 2.685 4.202 4.017 2.832 2.395 3.824 4.943 
4R, 5S, 8S, 9S 3.085 3.843 2.825 2.404 3.081 2.262 4.728 
4R, 5S, 8R, 9R 2.809 3.936 4.222 2.967 2.344 3.274 4.492 
NOE observed? yes yes yes yes yes yes yes 
        
4R, 5S, 8S, 9R 2.470 4.177 4.046 2.379 3.06 3.201 4.821 
4S, 5S, 8S, 9R 2.476 4.226 3.965 2.406 3.087 3.829 4.899 
4S, 5S, 8R, 9S 2.351 3.829 2.840 2.814 2.414 3.596 5.401 
4R, 5S, 8R, 9S 2.386 3.919 2.975 2.81 2.421 2.236 4.459 
NOE observed? yes no no no no no no 
 
Because the structure of the closely related compound, spiro-mamakone C (3.16) was 
confirmed by X-ray crystallography, the chances that the structure elucidation of both 
3.17 and 3.18 had been misinterpreted were very slim.  Instead it was considered that the 
molecules of 3.17 and 3.18 might possibly be undergoing conformational changes in 
solution.  CHEM 3D, which is able to model only energy minimised (MM2) models, may 
not take into account such occurrences during the modelling process.  For this reason, 
both low- and high-energy conformations of the molecule were then modelled using the 
2005 Schrodinger molecular modeling suite (See Experimental, Section 7.3.9). 
Unfortunately, even then the data obtained from this approach (see Appendix 2) was 
unable to clarify the problem.  Even using the highest energy conformations the bond 
distances between H-4 and H-8 were all too large to generate an NOE effect.  
Surprisingly however, the modelled data was in very good agreement with the dihedral 
angles and bond distances obtained from the CHEM 3D modelled compounds. 
 
3.10  Discussion 
 
Purification of the extract from the re-culture of the unidentified endophytic fungus, 
E484, resulted in the isolation of four new compounds, and one that had previously been 
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isolated.  Like the compounds from the first culture (F5062) these were of the 
spirobisnaphthalene class.  The new compounds were named spiro-mamakones B, C, D, 
and E.  The known compound was the novel spirononadiene, spiro-mamakone A (3.11).  
Spiro-mamakones B-E were named as such because they contained the two cyclopentane 
rings connected at a spirocentre, like that of spiro-mamakone A.  Like that of the 
previouly isolated mamakunoic acids and spiro-mamakone A, the 1H and 13C chemical 
shifts of the 1,8-dioxynaphthalene portion of spiro-mamkones B-E are interchangeable 
with those in the opposite position of the ring.  This of course excludes the two junction 
positions between the rings.   
spiro-Mamakones C and B were elucidated as diastereomers that are partially reduced 
derivatives of spiro-mamakone A.  X-ray crystallography found that spiro-mamakone C 
had the relative stereochemistry of 4S, 5S, 9S, but also that it was present as an 
enantiomeric excess.  Spiro-mamakone B was found to have a relative stereochemistry of 
4S, 5S, 9R.  It stands to reason that if spiro-mamakone C was found to contain an 
enantiomeric excess, then quite possibly spiro-mamakone B could also exist like this.   
Spiro-mamakones D and E were found to show not only reduction of the ketone at C-9, 
but also hydroxylation of the ring B alkene, to give an hydroxyl/methylene moiety.  The 
relative stereochemistry of the two diastereoisomers, D and E was tentatively proposed 
on the basis of the calculation of coupling constants by the computer programme, Mestre-
J as 4S, 5S, 8S, 9S, and 4S, 5S, 8S, 9R respectively. 
Spiro-mamakones B-D were potently cytotoxic in the P388 assay, in the same range as 
that of the parent compound, spiro-mamakone A.  The antimicrobial activity, however, 
was somewhat reduced compared to that of spiro-mamakone A.  No meaningful 
biological activity was obtained for spiro-mamakone E, but based on the similarity to 
spiro-mamakone D it is expected to be comparable. 
 
The relationship between the biological activity and the stereochemistry of these 
compounds is also worth speculating on.  Could this be a case like that of thalidomide,84 
where one enantiomer displays significantly different activity to that of the opposite 
enantiomer?  Given that none of the spiro-mamakones were isolated as enantiomerically 
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pure compounds this is a distinct possibility, and hence is worth investigating in future 
work. 
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Part 3 Biosynthetic studies 
 
 
3.11  Introduction 
 
The isolation of the structurally unprecedented spiro-mamakones (3.11, 3.15–3.18) led to 
the formulation of a biogenetic hypothesis for their formation.  Spiro-mamakones are 
clearly related to the general group of 1,8-dihydroxynaphthalene-derived compounds, the 
spirobisnaphthalenes.  The biosynthesis of this general group has been well studied in 
recent years65,85 and had established that both halves (top and bottom) are polyketide-
derived via the intermediacy of 1,8-dihydroxynaphthalene (DHN) (3.5).  The biosynthetic 
pathway leading to DHN (3.5) is shown in Scheme 3.4. 
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Scheme 3.4: DHN (3.5) Biosynthesis 
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It is also worth commenting that the interpretation of the labelling experiments was 
rendered more complex by the presence of isotopomers.*  This is a consequence of the C2 
symmetry of the 1,3,6,8-tetrahydroxynaphthalene (3.20) intermediate, also present in the 
biosynthesis of DHN, as shown in Scheme 3.4.  The “bottom”-half of the spiro-
mamakones is proposed to arise from DHN.  The origin of the “top”-half however, was 
less certain.  Again it was considered most likely that it too arose from DHN.  Two 
mechanisms were proposed (Scheme 3.5a and 3.5b).  The mechanisms were formulated 
on the consideration of some of the known spirobisnaphthalenes, specifically those of the 
diepoxide, cladospirone bisepoxide (3.4) and palmarumycin C6 (3.13), which bear a 
cyclopentane ring attached to a dihydroxybenzene in the “upper” half of the molecule.  
The ring junction epoxide seen in 3.4 was proposed as an intermediate in the biosynthesis 
of 3.11 as this could undergo the rearrangement and subsequent carbon cleavage required 
to form the nonadiene portion of the molecule.  The first biogenetic proposal (Scheme 
3.5a) was loosely based on the mechanism proposed for the formation of the spirocentre 
in fredericamycin A.86,87 This involved an oxidative rearrangement of DHN (3.5) 
followed by two 1,2-shifts.  The second proposal, (Scheme 3.5b), involves the same 
rearrangement of a DHN (3.5) molecule to the same dihydroxynaphthyl epoxide.  In this 
alternative, the oxidation/rearrangement product is oxidatively cleaved leading to a ring 
opened structure containing carboxylic acid and aldehyde functionalities.  Following this 
are decarboxylation and deprotonation steps, forming a symmetric carbanion 
intermediate, which would readily cyclise generating the other cyclopentene ring upon 
attack on the aldehyde. 
                                                 
* Isotopomers (isotopic isomers) are isomers that have the same number of each isotopic atom but differ in their 
positions.  Isotopomers can be either constitutional isomers e.g CH2DCH=O and CH3CD=O or isotopic stereoisomers, 
e.g (R)- and (S)-CH3CHDOH. 
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Scheme 3.5: The two possible mechanisms (a and b) for the formation of spiro-mamakone A 
(3.11). 
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To test these hypotheses, biosynthetic experiments were carried out.  These involved 
administration of 13C-isotopically labelled precursors to the growing fungal culture.  The 
experiments concentrated on the biosynthesis of spiro-mamakone A.  The reason was that 
3.11 was known to be reliably produced, and in high yields, and that any data obtained 
could presumably be applied to the other spiro-mamakones given their structural 
similarity.  Isotopically labelled acetate was used on the presumption that 3.11 was of 
polyketide origin formed via DHN from the condensation of acetyl-SCoA with malonyl-
SCoA. 
 
3.12  Preliminary Investigations 
 
The original culture medium for the fungus E484, was solid agar plates (see 
Experimental), however this was not suited to feeding studies, as it raises the problem of 
how to get uniform application of the labelled precursor molecules to the growing fungus.  
For this reason biosynthetic studies with fungi are typically carried out in liquid media.  
A time-course experiment was carried out to ascertain not only whether 3.11 is produced 
in liquid culture, but also the stage of fungal growth when production of spiro-mamakone 
A is initiated and if the spiro-mamakones are subsequently metabolised.  This 
information was important because if the precursors are added too early in the 
fermentation, it could result in a rate of incorporation that is too high.  Such a situation 
can cause problems in the interpretation of NMR experiments using doubly labelled 
material.  The opposite problem can also arise if the precursors are added too late.  That 
is, that the rate of incorporation could be too low, which could also impede the 
interpretation of the NMR data, as it would then be difficult to distinguish labelled 
carbons from non-labelled. 
Time-course experiments (see Experimental) were carried out using both static and shake 
conditions.  The production of the metabolites was monitored daily by HPLC analysis, 
using the “standard gradient” (see Section 7.1.7.2 in Experimental) in conjunction with 
an ELSD detector.  The shake culture displayed maximum production of spiro-
mamakone A, after just 6 days (Figure 3.45). 
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Figure 3.45: ELSD traces (12.5-16.0 minutes) showing daily variation in metabolite formation 
during time-course experiments in shake conditions. 
 
At this time the culture consisted of almost entirely spiro-mamakone A, along with 
mamakunoic acid B (3.7), found to be present as a minor component.  The static culture 
was much slower growing.  Although production of spiro-mamakone A peaked after 8 
days, the culture took 7 days to show appreciable amounts of 3.11 (Figure 3.46). 
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Figure 3.46: Stacked HPLC chromatograms from the static time-course experiments, clearly 
showing increase in production of 3.11 (*) 
 
Other minor components were also produced in the static culture; more than were seen in 
the shake culture. 
The decision was made to use shake conditions for the biosynthetic experiments.  This 
was based on the shorter time period involved, as well as a less complicated extract that 
the shake culture presented compared to that of the static.  It was also decided that due to 
the almost immediate production of large amounts of 3.11 in the liquid culture, addition 
of the isotopically-labelled precursors would take place just 24 hours after inoculation of 
the growth media with the fungus. 
 
3.13  Fermentation and Isolation 
 
Four separate cultures (each containing 200 mL of liquid media) of the fungus E484 were 
each inoculated with labelled acetate, two with singly-labelled acetate, [1-13C]-, and [2-
13C]-, and the remaining two, with doubly-labelled acetate, one containing full strength 
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[1,2-13C]-acetate (90%), and the other, half strength [1,2-13C]-acetate (45%).  The half 
strength was included as a precaution in case the incorporation of the full strength 
doubly-labelled acetate was too high.  Preparation of the labelled acetate inoculums is 
detailed in the Experimental section for this chapter (Section 7.3.13) .  
Six days after inoculation, the cultures were extracted with EtOAc using the standard 
protocol (Section 7.1.2, Experimental).  Purification of the resultant extract by semi-
preparative HPLC, yielded pure spiro-mamakone A, as well as mamakunoic acid B 
(present as a mixture with an unidentified contaminate) from each of the four cultures. 
 
3.14  Enrichment of 3.11 with [1-13C]- and [2-13C]-
Acetate 
 
The 13C NMR spectrum obtained after purification of natural abundance spiro-mamakone 
A (Figure 3.47a) was compared to spiro-mamakone A enriched from [1-13C]-acetate 
(Figure 3.47b) and [2-13C]-acetate (Figure 3.47c).  A visual comparison of spectrum a 
with that of b and c was enough to show which of the carbons showed incorporation of 
the isotopic labels.  A quantitative measurement of incorporation was not possible as the 
molecule contained no carbon atoms that were not acetate derived, that could be used to 
standardise the carbon signals of the enriched molecule relative to those of the unlabelled 
version.  
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Figure 3.47: Comparison of 13C NMR spectra derived from unlabelled (a), [1-13C]-acetate (b) 
and [2-13C]-acetate enriched (c) spiro-mamakone A (3.11). All obtained in CD3OD. 
 
a 
b 
c 
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3.14.1 Quantitative Measurement of Enrichment 
 
In order to obtain a reference point for determining a quantitative measurement of 
incorporation, acetylation was performed on the unlabelled spiro-mamakone A (3.11), as 
well as spiro-mamakone A enriched with the singly labelled acetates.  The reaction was 
carried out using acetic anhydride and pyridine (Scheme 3.6), to produce O-acetyl-spiro-
mamakone A (3.21) 
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Scheme 3.6: Acetylation of 3.11. 
 
Analysis of the 1H and 13C NMR spectra (Figure 3.48 and 3.49 respectively) confirmed 
the success of the reaction.  An additional methyl signal at δH 1.97, and the expected 
downfield shift of the allylic carbinol proton from δH 5.30 to δH 5.80 were observed in 
the 1H NMR spectra.  In the 13C NMR spectrum, the addition of a methyl signal at δC 
20.7 (C-21), and an ester carbonyl carbon at δC 172.9 (C-20) were observed (see 
Experimental, Section 7.3.13 for a full listing of 1H and 13C chemical shifts).  
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ppm2.53.03.54.04.55.05.56.06.57.07.5
Solvent
 
Figure 3.48: 1H NMR spectrum of O-acetyl-spiro-mamakone A (3.21) in CD3OD. 
 
ppm406080100120140160180200
C-21 ( 20.7)äC
C-20 ( 172.9)äC
 
Figure 3.49: 13C NMR spectrum of O-acetyl-spiro-mamakone A (3.21) in CD3OD. 
solvent 
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Quantitation using 13C NMR spectroscopy is unable to be carried out using the standard 
13C NMR experiment.  This is because the relaxation times of the 13C nuclei are variable.  
In a standard 13C NMR experiment, many 13C nuclei that have long relaxation times often 
are not allowed sufficient time to achieve full relaxation back to the ground state before 
reirradiation.  In the subsequent spectrum these nuclei appear as low intensity signals, 
while those that have faster relaxation times (and hence have adequate time to relax) 
appear more intense.  A further reason for differences in the measured signal intensities 
in 13C NMR spectroscopy is a consequence of NOEs between 1H and 13C nuclei.  For 
these reasons quantitative measurements based on peak area, or intensity are impossible 
due to the broad range of signal intensities and line widths.  In this situation a modified 
13C NMR experiment is used, whereby the delay (d1), acquisition time (at) and decoupler 
mode (dm) are fine-tuned in order to attain a very long relaxation delay time, but at the 
same time maintain decoupling, but minimise NOE enhancement, using inverse-gated 
decoupling (decouples only 1Hs during acquisition) (see Experimental, Section 7.1.13 for 
parameters).  This ensures that all carbons respond in a relatively equivalent manner. 
The resulting “quantitative” 13C NMR spectra for unlabelled as well as [1-13C]-, and [2-
13C]-labelled O-acetyl-spiro-mamakone A are displayed in Figure 3.50 a, b, and c 
respectively.  Enrichment at each carbon (Table 3.11) was calculated by determining the 
peak intensities relative to the intensity of the acetate carbonyl signal at 172.9 ppm, 
which had originated from a natural abundance source, and then dividing these relative 
intensities by the relative intensities of the same peaks in the natural abundance spectrum.  
These calculations enabled the elucidation of the labelling pattern shown in Figure 3.51.  
As expected, the 1,8-dihydroxy naphthalene portion of the molecule displayed a regular 
polyketide folding pattern, as shown by the alternating labelling of the carbons in this 
ring system. 
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ppm406080100120140160180200
ppm406080100120140160180200
ppm406080100120140160180200  
Figure 3.50: Quantitative 13C NMR comparison for O-acetyl-spiro-mamakone A (3.21). From a-c 
respectively, unlabelled, [1-13C]-, and [2-13C]-labelled material.  
a 
b 
c 
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Table 3.11: Quantitative incorporation of labelled precursors  
into spiro-mamakone A (3.11), derivatised to  
O-acetyl-spiro-mamakoneA (3.21) after labelling experiments. 
 
position [1-13C] [2-13C] position [1-13C] [2-13C] 
1 0.92 1.58 12 3.01 1.05 
2 2.09 0.81 13 0.89 1.63 
3 0.95 1.73 14 2.66 1.00 
4 2.27 1.01 15 0.94 1.73 
5 1.74 0.85 16 2.04 0.81 
6 1.34 1.10 17 0.90 1.54 
7 1.52 1.35 18 2.19 0.89 
8 1.58 1.32 19 0.93 1.65 
9 1.50 1.36 20 (C=O) 1.00 1.00 
10 2.03 0.72 21 (Me) 0.81 0.78 
11 0.83 1.50    
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Figure 3.51: Labelling pattern for 3.11. 
 
Interpretation of the data for the nonadiene portion of the molecule, however was not as 
straightforward.  The 13C NMR spectrum derived from the [2-13C]-acetate experiment 
clearly showed that C-1 and C-3 were labelled, whereas C-6–C-9 appeared to be of 
intermediate enrichment (see Table 3.11).  The 13C NMR spectrum derived from the [1-
13C]-acetate experiment showed that not only C-2, C-4, C-5 but also C-6–C-9 were 
labelled, again, appearing to display an intermediate level of enrichment.  First, these 
results confirmed the NMR chemical shift assignments of C-2 and C-3 as that shown in 
Table 3.4.  In addition, this labelling pattern showed C-1 acetate-derived carbons in 
positions C-4 and C-5.  Two C-1 acetate-derived carbons adjacent is impossible, unless 
of course a C-2 acetate-derived carbon has been lost from between them.  This was 
encouraging as this is the scenario required by both Schemes 3.5a and 3.5b.  This data 
also confirmed that the carbon lost was derived from the C-2 of an acetate unit, a feature 
also required by Schemes 3.5a and 3.5b. 
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The other significant finding from the [1-13C]- and [2-13C]-acetate feeding experiments 
was that C-6–C-9 were labelled from each experiment, but at lower calculated 
incorporations than those noted for C-1–C-5 in the appropriate experiment.  This was 
interpreted as supporting Scheme 3.5b, which proceeds via a C2-symmetric enedione.  
This intermediate would lead to the apparent labelling by both [1-13C]- and [2-13C]-
acetate at each of C-6–C-9 (Figure 3.52).  
Other support for Scheme 3.5b comes from the conclusion that in the final step of 
Scheme 3.5b, in the Knoevenagel-type reaction, when the stabilised carbanion attacks the 
aldehyde group (Figure 3.52) there may well be little chiral induction and a racemate 
would result.  Spiro-mamakone A (3.11) is isolated as a racemate. 
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Figure 3.52: Mechanism (Knoevenagel-type reaction) for the labelling observed for 3.11. 
 
3.15  Enrichment of 3.11 with [1,2-13C2]-Acetate 
 
Incorporation experiments using [1,2-13C2]-acetate are used to establish the direction of 
the folding pattern for the polyketide chain.87 In the case of the spiro-mamakones it will 
also be a useful way to establish the cleavage sites of the acetate in the formation of the 
nonadiene ring system.  Coupling constants were determined for all carbons (Table 3.12) 
from the derived 13C NMR spectrum (Figure 3.53 and 3.54), however in some cases the 
low signal-to-noise ratios (most notable for the spiroketal and carbonyl carbons) and 
signal overlap made the J value calculations questionable. 
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Figure 3.53: 13C NMR spectrum derived from 3.11 enriched with [1,2-13C2]-acetate. 
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ppm109.8110.2110.6111.0111.4111.8112.2
C-6 ( 198.6)äC
C-9 ( 201.1)äC
C-1
 
 
Figure 3.54: Examination of the satellite patterns for C-9, C-6 and C-1 from the 13C NMR 
spectrum in Figure 3.53, showing the effect of low signal-to noise. 
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Table 3.12: 13C –13C coupling constants for spiro-mamakone A (3.11). 
position δ 13C ppm [1,2-13C], JCC Hz position δ 13C ppm [1,2-13C], JCC Hz 
1 111.7 53.7, 44.1 11 111.0 55.5, 75.1 
2 129.9 69.9, 53.7 12 129.0 60.4, 55.5 
3 142.7 69.9, 43.5 13 122.0 ND 
4 79.1 43.5 14 136.1 56.5 
5 68.9 44.1 15 122.5 56.5 
6 198.6 47.9, 44.1 16 128.7 60.4, 55.4 
7 151.9 47.9 17 110.6 55.4, 75.1 
8 152.2 47.5 18 148.8 75.1, 61.1 
9 201.1 47.5, 44.1 19 114.8 61.1 
10 149.4 75.1, 61.1    
ND-not determined 
 
The overall incorporation of the labelled acetate was calculated as 1.3%.  This was 
achieved by integration of the natural abundance peak and the satellites.  The integrals of 
the satellites were multiplied by the natural abundance of carbon (1.1%) and then divided 
by the integral of the natural abundance peak.  
The next step in the analysis was to measure and analyse the data from the 
INADEQUATE NMR experiment. 
 
3.15.1  [1,2-13C2]-Acetate INADEQUATE NMR 
 
The INADEQUATE NMR spectrum (Figure 3.55) experiment showed carbon-carbon 
coupling within the same acetate unit, potentially allowing the direction of the polyketide 
to be elucidated.  If the incorporation of the [1,2-13C2] acetate is very high however, 
coupling between adjacent acetate units can sometimes also be seen.  Naturally, this can 
lead to ambiguous results.  This was not of concern in the spiro-mamakone work as the 
incorporation was low.  This level of analysis was necessary due to the complexity 
generated by the isotopomers present.  This is shown in the analysis of the naphthalene 
portion of spiro-mamakone A (3.11). 
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Figure 3.55: 13C INADEQUATE NMR spectrum with inset of overlapping region (bottom). 
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Most of the carbon resonances (Table 3.12) show TWO pairs of satellite signals.  This 
can be interpreted as indicating TWO separately labelled sets of molecules and is 
supported by the INADEQUATE NMR data, which shows all the combinations 
necessary (e.g 1J 10C 19C / 1J 10C 11C; 1J 12C 11C / 1J 12C 13C etc.) in the naphthalene ring.  This 
can be interpreted as that shown in Figure 3.56. 
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Figure 3.56: Labelling of the naphthalene portion of spiro-mamakone A (3.11), indicating the 
effect of isotopomerism. 
 
Although there is some ambiguity in the region C-13–C-15 (Figure 3.57), the appropriate 
correlations in this region are observed in the INADEQUATE NMR experiment (1J 12C 
13
C; 1J 13C 14C; 1J 14C 15C; 1J 15C 16C). 
 
ppm121.2121.6122.0122.4122.8123.2
C-13
C-15
 
Figure 3.57: C-13/C-15 region of the [1,2-13C2]-acetate 13C NMR spectrum of 3.11.  
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In consideration of the reason why two coupling constants were not seen for C-19 and C-
14 in the [1,2-13C2]-acetate NMR it was concluded that the coupling constants for each of 
the two adjacent carbons were so similar, so as not to be visible as two resolved satellite 
peaks.  This is of course a consequence of the near symmetrical nature of the naphthalene 
subunit.  The two possible incorporation patterns that these data suggest have already 
been reported for the related spirobisnaphthalene, cladospirone bisepoxide.65 In this study 
it was reported that both the “top”- and “bottom”-halves of the molecule showed this 
incorporation pattern, hence resulting in four isotopomers. 
For spiro-mamakone A, this however is not the case.  Although 3.11 is also believed to 
start with a DHN intermediate in both halves of the molecule, the labelling pattern on the 
“top” of 3.11 is very different to that on the “bottom”.  For the “top” half of the spiro-
mamakone molecule, the nonadiene portion, the anticipated labelling patterns from the 
[1,2-13C2]-acetate feeding experiment are summarised in Figure 3.58.  Only the outcomes 
from Scheme 3.5b are shown, as Scheme 3.5a does not go through a symmetric 
intermediate that is capable of interchanging the labels in the C-6–C-9 portion of the 
nonadiene, an absolute requirement established from the [1-13C]- and [2-13C]-acetate 
experiments. 
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Figure 3.58: Labelling patterns obtained from the [1,2-13C2]-acetate feeding experiment. 
 
From the analyses of the INADEQUATE NMR experiment, the derived 1JCC values 
(Table 3.12) and the appearance of the 13C-13C satellites in the 13C NMR spectrum of the 
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enriched sample from the [1,2-13C2]-acetate feeding experiment (Figure 3.59), it was 
possible to confirm the biogenetic hypothesis outlined in Scheme 3.5b. 
 
ppm129.5129.7129.9130.1130.3130.5 ppm142.0142.2142.4142.6142.8143.0143.2143.4
ppm78.278.478.678.879.079.279.479.679.8 ppm68.368.468.568.668.768.868.969.069.169.269.3
C-2 ( = 69.9, 53.7 Hz)JCC C-3 ( = 69.9, 43.5 Hz)JCC
C-4 ( = 43.5 Hz)JCC
C-5 ( = 44.1 Hz)JCC
 
 
Figure 3.59: Key satellite patterns from the 13C NMR spectrum of 3.11 enriched with [1,2-13C2]-
acetate. 
 
It was expected that the C-4 carbon on the spirononadiene portion of the ring would not 
show any coupling and therefore no satellites, as it was proposed that the C-2 acetate 
derived carbon from the DHN intermediate was cleaved between that of C-4 and C-5.  
The INADEQUATE NMR spectrum and coupling constants from the 13C NMR spectrum 
showed that this however, was not the case, C-4 showed a J value of 43.7 Hz, since C-3 
also showed a J value of 43.7 Hz, and was seen to show a strong coupling in the 
INADEQUATE NMR spectrum, it indicated an intact acetate unit lay at the C-3–C-4 
position.  Even more unusual was that carbons C-1–C-3 all showed coupling to two 
different carbons each.  As well as coupling to C-4, C-3 also showed coupling to C-2 
with a typical double bond J value of 70.1 Hz.  In turn C-2 also showed a coupling to C-1 
with a J value of 53.8 Hz.  The carbon at C-5 was found to show an even more complex 
coupling pattern.  Although the 13C NMR spectrum showed only one pair of satellites, the 
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INADEQUATE NMR spectrum showed a rather different picture.  Not only was a strong 
coupling from C-5 seen to C-1 at J = 44.1 Hz, two other couplings were observed in the 
INADEQUATE NMR spectrum to the carbons at C-6 and C-9.  Although these couplings 
were certainly weaker than those of C-5–C-1, they were believed to be greater than the 
intensity of natural abundance, as no intensity enhancement (vs2d) was required in 
processing the spectrum to view these correlations (Figure 3.55). 
It was proposed that only one pair of satellites were observed for C-5 because the 
coupling constant from C-5–C-1 was almost identical to those from C-5 to the ketone 
carbons at C-6 and C-9.  The expected strong coupling from C-6 and C-9 to C-7 and C-8 
respectively was also seen.  According to the biogenetic hypothesis proposed in Scheme 
3.5b and the isotopomer effect presented in Figure 3.58, coupling between C-7 and C-8 
should also be observed. At first this was not obvious from either the 13C NMR or 
INADEQUATE NMR spectra.  A thorough analysis of the INADEQUATE NMR 
spectrum however found a correlation.  The 13C NMR data was found to agree with this, 
however due to the near identity of chemical shifts of the two carbons, the pattern of 
signals generated by these labelled carbons was very irregular.  In the 13C NMR 
spectrum, rather than each signal appearing with two satellites, an unexpected satellite 
pattern was observed (Figure 3.60).  This was attributed to the “roof effect” resulting 
from second order coupling effects.88 
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ppm151.5151.7151.9152.1152.3152.5152.7
C-7 C-8
 
Figure 3.60: Unexpected satellite pattern observed for C-7 and C-8. 
 
The most important discovery was that there was no significant coupling observed 
between C-4 and C-5 in the INADEQUATE NMR.  However, when the vertical scale 
was increased, coupling could be seen.  This was attributed to the coupling between C-4 
and C-5 from the 13C carbons of natural abundance origin.  The 13C INADEQUATE 
NMR spectra in Figure 3.61 show that the intensity of the C-4 to C-5 coupling is around 
five times less than that seen for the weak, but real couplings of C-5/C-6 and C-5/C-9.  
This is because the C-4/C-5 coupling can only be viewed at a vertical scale at least twice 
that of the C-5/C-6 and C-5/C-9 coupling. 
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Figure 3.61: 13C INADEQUATE NMR processed using vs2d=50 (A), and vs2d=100 (B). 
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This lack of coupling is crucial to supporting the biogenetic hypothesis presented in 
Scheme 3.5b, as the proposal requires a C-2 carbon to be lost from between these two 
carbons, and hence no coupling would be expected. 
All of the couplings observed in the INADEQUATE/13C NMR spectra are consistent 
with the biogenetic hypothesis presented in Scheme 3.5b with the added complexity of 
isotopomerism.  Figure 3.62 gives a summary of the labelling pattern observed from the 
NMR spectra.  Because of the free rotation about the C2 axis of the carbanion, half of the 
molecules originating from isotopomer b, will show an intact acetate between C-5 and C-
6, while the other half will show the acetate between C-5 and C-9.  Overall only one 
quarter of molecules will show C-5/C-6 coupling, another quarter will show C-5/C-9, the 
other half of molecules, which originate from isotopomer a, show no coupling between 
C-5–C-6/C-9.  This is proposed to be the reason why the intensity of these couplings is 
less than the other couplings. 
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Figure 3.62: Summary of labelling observed from INADEQUATE NMR and 13C NMR spectra. 
 
The most probable explanation for the incorporation pattern therefore, is racemisation. 
Attack of the carbanion at the aldehyde carbonyl equally on both faces would also result 
in the bottom half of the molecule (the naphthalene) showing racemisation.  This would 
be observed in all carbons, as they would appear to show coupling to two different 
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carbons; this is exactly what is seen for this unusual molecule.  This also explains the 
observed racemate of spiro-mamakone A.  It is uncommon for natural products to display 
this property, due to specificity of biosynthetic enzymes.  A racemic molecule however, 
is precisely the type of molecule expected to result from the biogenetic hypothesis 
presented in Scheme 3.5b, where free rotation at the carbanion would statistically, lead to 
half of the population of molecules being a product of attack at one face while the other 
half, a result from attack at the opposite face. 
At this stage, although the direction of the polyketide chain is clear, the starter unit has 
been unable to be determined.  The folding pattern appears to be that of a regular fungal 
polyketide.  This is also supported by the co-production of the natural product, mellein in 
the growing culture.  The biosynthesis of mellein was elucidated by Abell and co-
workers,89,90 and was found to consist of a regular polyketide folding pattern as shown in 
Figure 3.63.  
O
Me
OOH  
Figure 3.63: The regular polyketide folding pattern of mellein. 
 
3.16  Enrichment of Mamakunoic Acid B (3.7) with 
Labelled Acetate 
 
As mentioned in Section 3.13, mamakunoic acid B, isolated from the first culture of E484 
(Section 3.5.2), was also found to be produced in the isotopically labelled fungal culture, 
used for the biosynthetic studies of spiro-mamakone A (3.11).  Although the quantity 
produced was much less than that of spiro-mamakone A, and complicated by the 
presence of a major impurity, it was decided to proceed with the analysis of the labelled 
13C NMR spectrum.  It was originally thought that the mamakunoic acids could be a 
precursor molecule to the spiro-mamakones.  For this reason it was important to obtain as 
much biosynthetic information as possible. 
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Comparison of the [1-13C]- and [2-13C] acetate NMR with that of the natural abundance 
13C NMR (Figure 3.64) showed which carbons were labelled with [1-13C] acetate, and 
which were labelled with [2-13C] acetate. 
Chapter 3 Spirobisnaphthalenes from a New Zealand Fungal Endophyte 133 
ppm5060708090100110120130140150160170
ppm5060708090100110120130140150160170
ppm5060708090100110120130140150160170
 
Figure 3.64: 13C NMR spectra for unlabelled (a), [1-13C]- (b) and [2-13C]-acetate (c) enriched 
mamakunoic acid B (3.7).  
b 
a 
c 
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Although the spectrum of the labelled compounds contained a major impurity, the correct 
13C NMR signals for mamakunoic acid B were extracted by comparison with the natural 
abundance spectrum, which had contained minimal impurities.  This cursory analysis 
resulted in the labelling pattern presented in Figure 3.65. 
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Figure 3.65: Labelling pattern for mamakunoic acid B (3.7). 
 
The carbons of the naphthalene subunit showed a regular polyketide incorporation 
pattern, where every second carbon contained the same isotopic label.  C-11, C-13, C-15, 
C-17, and C-19 were all shown to show incorporation of [1-13C] acetate, whereas C-12, 
C-14, C-16, C-18, and C-20, all showed [2-13C] acetate incorporation.  The upper part of 
the molecule also showed a regular polyketide incorporation pattern.  C-2, C-4, C-6, C-8, 
and C-10 all showed enrichment with [1-13C] acetate, whereas all the odd numbered 
carbons, C-1, C-3, C-5, C-7, and C-9 showed enrichment with [2-13C] acetate (Figure 
3.65).  The relative rate of incorporation for the singly labeled acetates were 
evaluated/estimated by determining the peak intensities relative to the intensity of the 
quaternary carbon signal at 135.9 ppm, and the quaternary carbon at 115.6 ppm for the 
[1-13C]- and [2-13C] acetate respectively, and then dividing these relative intensities by 
the relative intensities of the same peaks in the natural abundance spectrum (Table 3.13).   
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Table 3.13: Incorporation of singly loabelled acetate in  
mamakunoic acid B (3.7). 
 
position [1-13C] [2-13C] position [1-13C] [2-13C] 
1 0.71 1.61 11 2.98 1.21 
2 4.29 1.24 12 0.60 1.81 
3 0.59 1.65 13 1.78 0.76 
4 1.97 0.74 14 0.64 1.81 
5 0.64 1.63 15 2.47 1.00 
6 2.54 0.96 16 0.59 1.85 
7 0.88 2.95 17 1.97 0.68 
8 1.62 0.88 18 0.50 1.34 
9 0.69 2.27 19 3.19 1.59 
10 2.31 1.30 20 1.00 2.28 
 
Unfortunately, these results were very misleading, compared to the visual analysis of the 
heights of the peaks compared with those of the natural abundance spectrum.  The reason 
for this is the differing intensities of the carbons in the natural abundance spectrum (See 
Section 3.14.1).  Unfortunately in this case, acetylation and the use of the modified 13C 
NMR experiment, was not able to be performed.  There were several reasons for this. 
Firstly, very little of the unlabelled mamakunoic acid B was isolated (1.9 mg).  This was 
enough to get a normal 13C NMR spectrum, but most definitely not enough to obtain the 
modified version, as used for spiro-mamakone A.  The second factor is that after 
acetylation and purification of the labelled mamakunoic acid B, it was likely there would 
be even less compound to work with; certainly too little for running the modified 13C 
NMR spectrum. 
The 13C NMR spectrum (Figure 3.66) obtained from [1,2-13C2]-acetate labelled 
mamakunoic acid B, was also of very poor quality.  Like the 13C NMR of the 
equivalently labelled spiro-mamakone A, doublet satellites were observed for some of the 
carbons, these included C-5 and C-8.  However, some carbons were not observed as 
doublets.  These included C-2, C-3, and C-7. The J values of carbons, C-9, C-4, and C-6 
were unable to be determined due to overlap of impurity signals and/or signals of 
overlapping carbons, creating a very complex coupling pattern.  The J-values of C-1, and 
C-10 were also found to be difficult to determine due to the low signal-to-noise ratio.  
This was especially true for C-1, where it was unclear whether it showed two satellites, or 
just one.  The C-10 carbon was expected to show just one coupling as it is terminal, and 
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is adjacent to just one other carbon.  This appeared to be the case, however extraction of 
the exact coupling constant was difficult due to the low signal-to-noise ratio of one of the 
satellites (Figure 3.66-inset).  
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Figure 3.66: 13C INADEQUATE NMR spectrum for 3.7. 
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The J-values of the naphthalene carbons were also unable to be measured due to the low 
signal to noise ratio and overlap of impurity signals (Figure 3.67). Unfortunately, these 
problems could not be resolved as the amount of material that was isolated was 
insufficient for running an INADEQUATE NMR experiment. 
 
ppm146.6147.0147.4147.8148.2148.6
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Figure 3.67: Satellite patterns of some of the naphthalene carbons of 3.7 showing their 
complexity. 
 
From the data obtained from the [1-13C]- and [2-13C]-acetate feedings, it was concluded 
that mamakunoic acid B (3.7), like spiro-mamakone A (3.11), had originated from 
modification of DHN (3.5), rather than a C6-C4 precursor, such as that shown in Figure 
3.68. 
 
O
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Figure 3.68: C6-C4 precursor molecule. 
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If DHN (3.5) is accepted as the biosynthetic precursor for the mamakunoic acids as well 
as the spiro-mamakones, it is possible to extend the biogenetic hypothesis leading to the 
spiro-mamakones to include the mamakunoic acids by a simple modification to the key 
intermediate.  If the epoxy intermediate is reduced rather than rearranged it is possible to 
generate a plausible pathway to the mamakunoic acids (Figure 3.69).  The observed 
labelling pattern for mamakunoic acid B (3.7), as far as it has been observed, fits this 
hypothesis. 
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Figure 3.69: Proposed biogenetic scheme for formation of the mamakunoic acids, compared to 
that for formation of the spiro-mamakones.  Filled circles indicate [1-13C]-acetate labelling. 
 
3.16.1 Future Work 
 
Due to lack of material and time constraints the biosynthetic studies of mamakunoic acid 
B (3.7) were unable to be continued.  This project should however be completed, to 
enable a more complete picture of this interesting group of molecules.  Future work 
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would include the labelled cultures being grown on a significantly larger scale to ensure 
that adequate quantities of the labelled acid were produced.  If the labelled acid was again 
found to co-elute with an impurity then further semi-preparative HPLC purification using 
a different gradient would need to be carried out.  Once the singly labelled material was 
pure, methylation with diazomethane would be used in order to obtain an unlabelled 
internal standard, which would be used subsequently in the modified 13C NMR 
experiments to quantitatively determine the rate of incorporation.  Finally 
INADEQUATE NMR would be carried out on the doubly labelled material to confirm or 
disprove the biogenetic hypothesis proposed for the mamakunoic acids. 
 
3.17  Discussion 
 
The isolation of the structurally unprecedented spiro-mamakones prompted the study of 
their biosynthesis by incorporation experiments using 13C-labelled precursors.  Both 3.11, 
and 3.7 were isolated, but only 3.11 was obtained in a sufficient quantity to obtain a full 
set of data, so that the labelling could be evaluated.  
The 13C NMR spectrum of 3.11, produced after enrichment with [1-13C]-acetate showed 
strong enrichment of 8 carbon signals, and intermediate enrichment of 4 carbon signals.  
The labelling pattern exhibited in the upper half of the molecule, placed two C-1 derived 
acetate carbons adjacent to each other, indicating cleavage of a C-2 derived carbon. 
Those labelled with [2-13C]-acetate also showed strong enrichment of 8 carbon signals, 
and 4 carbons that carried intermediate enrichment.  The four carbons of intermediate 
enrichment were the same as for those from the [1-13C]-acetate labelled material, located 
on the enedione ring in the “upper” half of the molecule. 
Both the 13C and 2D INADEQUATE NMR spectra of 3.11, after the incorporation of 
[1,2-13C2]-acetate (1.3% enrichment) displayed 13C–13C couplings between all 19 pairs of 
carbons, although this technique was supposed to indicate which carbons originated from 
the same acetate unit, this highly unusual phenomenon instead indicated that each carbon 
had two couplings (inter-acetate coupling was disregarded due to the very low 
incorporation).   
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The unusual results obtained from the incorporation experiments, supported the proposed 
biogenetic hypothesis presented in Scheme 3.5b, whereby it proceeds via a C2-symmetric 
enedione intermediate, and the isotopomer effect initiated by the C2-symmetric 1,3,6,8-
tetrahydroxynaphthalene (3.20), an intermediate in the biosynthesis of the proposed 3.11 
precursor molecule, DHN (3.5).  These data are proposed to reveal that the two halves of 
the molecule are formed from two separate polyketide chains, each assembled from 5 
intact C2 units, and connected together by oxidative coupling.  Rearrangement of an 
epoxide intermediate followed by oxidative cleavage, decarboxylation and finally 
cyclisation is proposed to be the basis for the formation of 3.11.  Although the starter unit 
was not defined in this study the polyketide chain appears to follow a regular fungal 
folding pattern. 
 
For mamakunoic acid B (3.7), only minimal data was obtained for the incorporation of 
isotopic labels.  The 13C NMR spectra of 3.7 produced after enrichment with [1-13C]- and 
[2-13C]-acetate showed enrichment of 10 alternate carbon signals each (a regular 
polyketide incorporation pattern).  The 13C NMR spectrum from [1,2-13C2]-acetate 
incorporation was unable to give complete data on the 13C–13C couplings due to 
impurities and low signal to noise ratios.  However it was apparent that some of the 
carbons at least, exhibited the same “double coupling” phenomena displayed by the 
carbons in 3.11.  From the minimal data obtained, it was proposed that like 3.11, 3.7 also 
initially arose from a DHN (3.5) intermediate.  However, rather than rearrangement of the 
epoxide intermediate, as was proposed for 3.11, reduction of the epoxide intermediate is 
instead proposed (Figure 3.69). 
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Chapter 4 
 
 
Malaysian Gasteromycete  
Scleroderma sp. (F5031)  
 
 
 
4.1  General Introduction 
 
The Scleroderma sp. are otherwise known as earthballs or poison puff balls.  They fall in 
to the group of Basidiomycete fungi known as Gasteromycetes.  This group of fungi is 
characterised by the spore bearing structures, which are totally enclosed in a basidiocarp 
(fruiting body) and never exposed.  They occur as ecto-mycorrhizal associates of a wide 
range of trees, including oak and eucalytus91 or as saprotrophs in soil or rotting wood.92 
The fruiting bodies are formed at the surface of the soil or just below and are reminiscent 
of a potato in appearence.  About 25 species of Scleroderma have been described world-
wide,92 and at least four of these are known to be poisonous: Scleroderma albidum, S. 
areolatum, S. cepa and S. citrinum.  Symptoms of poisoning can occur within an hour of 
eating and include the general signs of central nervous system disruption, including loss 
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of consciousness, severe abdominal pains, vomiting, perspiration, generalised tingling 
sensations, spasms, paralysis and anaphylactic shock.91,93 
 
4.1.1  Metabolites from Scleroderma 
 
The chemistry of the earthballs has been reported to be largely unknown.93 In fact so far 
there are only two classes of natural products that have been described that are known to 
come from Scleroderma sp., lanostane type triterpenes and pulvinic acid derivatives. 
 
4.1.1.1  Triterpenoids 
 
Triterpenoids represent a large class of natural products.  The sterols, such as lanosterol 
are C30 compounds that appear to have an essential role as constituents of cell 
membranes, where they help maintain structural integrity and control permeability.  
Other sterols however are metabolised to produce biologically active molecules such as 
vitamin D and the human sex hormones.1 
So far only a handful of triterpenoids have been reported from Scleroderma sp. and all of 
these are lanosterol-type triterpenoids.  Examples of this type, (20S, 22S, 23E)-22-O-
acetyl-25-hydroxylanosta-8,23(E)-dien-3-one (4.1), isolated from S. citrinum,94 and 
lanosta-8,24-diene-3β,23-diol (4.2) isolated from S. aurantium95 are shown below.  The 
former of these (4.1) was found to display strong antiviral activity against Herpes simplex 
type 1 (HSV-1). 94 
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4.1.1.2  Pulvinic acid derivatives 
 
The pulvinic acid derivatives are arylpyruvic acid derived pigments from the shikimate-
chorismate pathway of secondary metabolism.96 The parent structure, vulpinic acid (4.3), 
was first described as a metabolite of lichens (plants living in a symbiotic relationship 
with fungi and algae).  Vulpinic acid is responsible for the yellow colour observed in 
some of these plant-fungi/algae symbionts.97 These days however, it is a common 
metabolite, isolated from certain species of Basidiomycetes.  Compound 4.3 has been 
found to possess antiinflammatory properties, and although the therapeutic ratio is good it 
was found to cause hyperventilation and in many cases was followed by convulsions and 
death of test animals.98 Although these observations were first documented by Soderberg 
in 1952,99 these properties were probably known to Eskimos, who used lichens 
containing vulpinic acid to poison wolves.98   
The pulvinic acids are not only common to Scleroderma sp. but also to other fungi in the 
order Boletales.  This has been suggested to indicate a close relationship between the 
Boletales and gasteroid Sclerodermatales.100 Other than 4.3, a range of natural pulvinic 
acid derivatives exist, including: xerocomic acid101 (4.4), 3,4,4'-tri-O-methylxercomic 
acid methyl ester (4.5)102 and atromentic acid (4.6).103 
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Interestingly, it has been found that the hydroxylated pulvinic acids such as 4.4 and 4.6, 
are responsible for the yellow and red colours of most boletales, and cause a blue 
colouration to develop on the flesh of the fungus when the fruiting bodies are cut or 
bruised.96 The compounds responsible for the blue colouration have been identified as 
xerocomic acid101 (4.4), also isolated from Scleroderma,104 and variegatic acid (4.7).105 
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The blue colour was found to form upon oxidation of these pulvinic acid derivatives by 
oxidases and is due to the formation of delocalised hydroxyquinone methide ions101,105 
(Figure 4.1).  
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Figure 4.1: The blueing reaction of variegatic acid. 
 
Pulvinic acid dimers have also recently been isolated from Scleroderma citrinum, 
including norbadione A (4.8), badione A (4.9) and sclerocitrin (4.10).104 The former two 
of these had previously been isolated only from the Boletus, Xerocomus badius.106  
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After the nuclear reactor accident at Chernobyl, high concentrations of 137Cs were found 
in the fruit bodies of Xerocomus badius.  It was found that this was due to the 
complexation of the 137Cs by the naphthalenoid pulvinic acids, 4.7 and 4.8, that are 
naturally present in the mushroom as their potassium salts.107 This finding has attracted 
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the attention of some European research groups who are hoping to develop bioremedial 
methods for cleaning polluted environments.108 
 
4.2  Introduction 
 
The fruiting bodies of a Scleroderma sp. (F5031) were collected from a forest in Kuala 
Lompat, Pahang in Malaysia in June 2004. This extract was transported to the University 
of Canterbury, New Zealand for chemical investigation. 
 
4.3  Preliminary Investigations 
 
A biological activity profile of the crude extract was obtained before an in-depth 
investigation was carried out.  The crude extract was submitted for P388 (Section 7.1.3), 
antimicrobial and antiviral assays (Section 7.1.5-6).  At a concentration of 10 mg/mL the 
extract showed no activity towards the in-house viral strains, but did show weak P388 
activity (IC50 66640 ng/mL) and particularly strong antimicrobial activity against B. 
subtilis (Sm11).  For this reason it was decided to investigate the extract further. 
To obtain a visual profile of the extract, an aliquot of the extract was chromatographed on 
reverse phase C18 HPLC using the standard gradient (Section 7.1.7.2).  HPLC (Figure 
4.2) revealed the extract to be relatively simple in nature, consisting mainly of what 
seemed to be a four closely related compounds, as judged by the similarity of their UV 
profiles (Figure 4.3).  Based on the HPLC profile the assumption was made that the four 
related compounds each contained a highly conjugated system, consistent with the 
intense orange colour of the extract and absorbance in the yellow region of the UV-
visible spectrum (Figure 4.3). 
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Figure 4.2: HPLC chromatogram showing elution profile of the crude extract of F5031 
 
 
 
Figure 4.3: UV profile overlay of SAS-6-6.1–3, and SAS-6-14 
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4.4  Chromatography of F5031 
 
Before attempting chromatography, the extract was partitioned with MeOH/Pet. ether. 
The MeOH soluble material (474 mg) was found to contain all of the four compounds in 
question.  Due to the simple nature of the MeOH fraction, chromatography was kept to 
the bare minimum, with semi-preparative HPLC being the only form of chromatography 
carried out in order to obtain each of the four compounds in a sufficiently pure form 
(detail of the method used is given in the Experimental-Section 7.5.1). 
 
4.5  Structural Elucidation 
 
4.5.1  Structural Elucidation of SAS-6-6.2 (4.11) 
 
SAS-6-6.2 (4.11) was the major compound isolated from the extract of the Scleroderma 
sp. ESIMS determined the mass of the compound to be 383 Da [M+H]+.  The 1H NMR 
(Figure 4.4) and COSY spectra indicated the presence of two separated aromatic spin 
systems.  The ortho coupling (JHH = 8.9 Hz) displayed by the two sets of protons on each 
ring, A and C (A: δH 8.12; δH 6.95, C: δH 7.19; δH 6.92) suggested two para-disubstituted 
systems. 
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Figure 4.4: 1H NMR spectrum of 4.11 in CDCl3 
 
Correlations in the CIGAR NMR spectrum showed that each ring was substituted with 
one methoxyl group.  This was confirmed with correlations from the proton signals on 
each ring to oxygenated carbons at δC 159.7 and 159.5 on rings A and C respectively. 
Additional CIGAR correlations from the two sets of protons on both rings ortho to the 
methoxyl moiety (A: δH 6.95 and C: δH 6.92) to carbons at δC 121.8 and 124.3 
respectively, completed the definition of the two aromatic rings.  CIGAR correlations 
observed from δH 8.12 and 7.19 to carbons at δC 105.2 and 115.1 respectively, suggested 
that the unidentified part of the molecule that lay between rings A and C was unsaturated. 
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Figure 4.5: COSY and CIGAR correlations for 4.11. 
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Correlations in the CIGAR and HSQC-DEPT NMR spectra allowed a further fragment of 
the molecule to be determined.  A methyl group at δH 3.87 was shown to have a CIGAR 
correlation to a carbon at δC 171.9.  These methyl protons were also seen to have a 1JCH 
correlation to δC 54.4.  These correlations indicated a methyl ester moiety.  
The lack of any other protons in the 1H NMR indicated that the remaining piece of the 
molecule, which lay in between the aromatic rings, was highly functionalised, most 
probably by double bonds, given the highly coloured nature of the purified compound, 
and oxygen.  
The mass of 382 Da assigned to this structure by ESIMS indicated that 85 mass units 
remained to be accounted for.  The 13C NMR (Figure 4.7) indicated that the three carbons 
unaccounted for included a shielded carbonyl carbon at δC 166.2 and two other 
quarternary carbons at δC 158.7 and 154.7.  It was assumed at this point that the 33 
remaining mass units could be accounted for by two oxygen atoms, one of them 
presumably forming a hydroxyl moiety, thus accounting for the uneven number of mass 
units left over.  
 
ppm708090100110120130140150160170  
 
Figure 4.7. 13C NMR spectrum of 4.11 in CDCl3 
 
At this point a search of AntiMarin was conducted using the two 1,4-disubstituted 
benzenes and the methyl ester substructures as search parameters.  A match was found to 
a group of compounds derived from vulpinic acid (4.3).  These compounds contained two 
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six-membered aromatic ring systems separated by a hydroxy- or methoxy- substituted 
furanone ring.  One of these compounds (4.11) had a mass of 382 Da. 
A comparison of the experimental 1H NMR data with the literature data for compound 
4.11 (Table 4.1) unequivocally confirmed a match with the known compound, 4,4'-
dimethoxyvulpinic acid, a vulpinic acid derivative previously isolated from several 
species of Scleroderma.94,102 
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Table 4.1: Literature and experimental (in CDCl3) NMR data for 4.11 
aLiterature 1H ppm, 
multiplicity, (JHH Hz) 
Position δ 13C ppm δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
 1 121.8 (C)    
8.10 d (9.0) 2 129.4 (CH) 8.11 d (8.9) H-3 C-4, C-6, C-2" 
6.91 d (9.0) 3 113.9 (CH) 6.96 d (8.9) H-2 C-4, C-1, C-5 
 4 159.7 (C)    
6.91 d (9.0) 5 113.9 (CH) 6.96 d (8.9) H-6 C-4, C-1, C-3 
8.10 d (9.0) 6 129.4 (CH) 8.11 d (8.9) H-5 C-4, C-2, C-2" 
3.82 s 4-OCH3 55.3 (CH3) 3.83 s  C-4 
 1' 124.3 (C)    
7.18 d (8.6) 2' 131.4 (CH) 7.19 d (8.9) H-3' C-4', C-6', C-5" 
6.94 d (8.6) 3' 113.6 (CH) 6.93 d (8.9) H-2' C-4', C-1', C-5' 
 4' 159.5 (C)    
6.94 d (8.6) 5' 113.6 (CH) 6.93 d (8.9) H-6' C-4', C-1', C-3' 
7.18 d (8.6) 6' 131.4 (CH) 7.19 d (8.9) H-5' C-4', C-2', C-5" 
3.82 s 4'-OCH3 
55.3 (CH3) 3.83 s  C-4' 
 1" 166.2 (C)    
 2" 105.2 (C)    
 3" 158.7 (C)    
 4" 154.7 (C)    
 5" 115.1 (C)    
 6" 171.9 (C)    
3.86 s CO2CH3 54.4 (CH3) 3.87 s  C-6" 
                                        a Carried out at 600 MHz in CDCl3 using TMS as the internal standard.109  
        1H and 2D experiments carried out at 500 MHz in CDCl3. 13C carried out at 75 MHz in CDCl3. 
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4.5.2  Structural Elucidation of SAS-6-6.3 (4.12) 
 
Compound SAS-6-6.3 (4.12) was the second most prevalent compound in the extract.  
ESIMS indicated the compound not only had a mass of 417 [M+H]+ but was also 
contained a single chlorine substituent, indicated by the isotopic peak ratio 
[MH]+/[MH+2] + of 3:1 (Figure 4.8). 
 
 
 
Figure 4.8. Enlarged view of +ve ESIMS showing chlorine isotope pattern displayed by 4.12 
 
The general features of the 1H NMR spectrum of 4.12 (Figure 4.10), very closely 
resembled that of 4.11, except for differences in one of the aromatic rings.  Rather than 
two identically substituted aromatic rings showing only ortho coupling as in 4.11, ring C 
on 4.12 appeared to carry a non-hydrogen substituent ortho to the methoxyl.  The protons 
in the ring appeared as a doublet of doublets at δH 7.13 with meta coupling to a doublet at 
δH 7.26 (JHH= 2.0 Hz), and ortho coupling to a doublet at δH 6.94 (JHH = 8.7 Hz) (see 
Figure 4.9). 
 
 
Chapter 4 F5031, A Malaysian Scleroderma sp. 154 
7.137.26
6.94
8.7 Hz
2.0 Hz
H
X
O
H
H
c
 
Figure 4.9: Proposed substitution pattern for ring C. 
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Figure 4.10. 1H NMR spectrum of 4.12 in CDCl3. 
 
The non-hydrogen substituent on the second ring was proposed as a chlorine atom as 
required by the isotopic pattern in the ESIMS, leading to the proposed structure (4.12).  
The structure was confirmed from COSY, HSQC-DEPT and CIGAR spectra.  A 
literature search revealed that the NMR data (Table 4.2) matched those of a known 
compound, methyl-3'-chloro-4,4'-di-O-methylatromentate, a vulpinic acid derivative 
previously isolated from Pulveroboletus auriflammeus.102  
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Table 4.2: Literature and experimental (in CDCl3) data for 4.12 
aLiterature 1H ppm, 
multiplicity, (JHH Hz) 
Position δ 13C ppmb δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
 1 121.7 (C)    
8.33 2 129.5 (CH) 8.11 d (8.7) H-3 C-4, C-6, C-2" 
6.77 3 114.0 (CH) 6.96 d (8.7) H-2 C-4, C-1, C-5 
 4 159.7 (C)    
6.77 5 114.0 (CH) 6.96 d (8.7) H-6 C-4, C-1, C-3 
8.33 6 129.5 (CH) 8.11 d (8.7) H-5 C-4, C-2, C-2" 
3.74 s 4-OCH3 55.3 (CH3) 3.84 s  C-4 
 1' 122.3 (C)    
7.77 d (2.0) 2' 131.8 (CH) 7.26 d (2.0)  H-6' C-4', C-6, C-1', C-5" 
 3' 125.0 (C)    
 4' 155.3 (C)    
7.12 d (8.8) 5' 111.6 (CH) 6.94 d (8.7) H-6' C-4', C-3', C-1' 
7.56 dd (8.8, 2.0) 6' 129.8 (CH) 7.13 dd (8.7, 2.0) H-2', H-5' C-4', C-2', C-5", C-5'
3.92 s 4’-OCH3 56.2 (CH3) 3.93 s  C-4', C-5' 
 1" ND (C)    
 2" 105.5 (C)    
 3" ND (C)    
 4" ND (C)    
 5" 113.7 (C)    
 6" 171.5 (C)    
3.83 s CO2CH3 54.4 (CH3) 3.88 s  C-6", C-5" 
a Carried out at 400 MHz in acetone-d6 using TMS as an internal standard.102 
b Determined from HSQC-DEPT and CIGAR experiments. 
ND-Not determined. 
 
4.5.3  Structural Elucidation of SAS-6-6.1 (4.13) 
 
Compound SAS-6-6.1 (4.13) was one of two minor components isolated from the extract 
of the Scleroderma sp.  LCMS of the partitioned extract revealed this compound to have 
a mass of 397 [M+H]+.  As with SAS-6-6.3, the 1H NMR spectrum of SAS-6-6.1 (Figure 
4.11) showed a very close resemblance to that of 4,4'-dimethoxyvulpinic acid, the only 
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apparent difference being an extra methoxyl group, giving a total of four rather than 
three.  
 
ppm4.04.55.05.56.06.57.07.5  
 
Figure 4.11. 1H NMR spectrum of 4.12 in CDCl3. NB small impurities at 7.32, 7.56, and ~3.8 pm. 
 
As observed for 4.11, both of the aromatic rings in 4.13 were 1,4-disubstituted with 
methoxyl substitution at the 4 and 4' positions.  This was supported by the ortho coupling 
(JHH = 8.7 Hz) displayed by the two sets of protons on each of the rings, A and C (A: δH 
7.49; δH 6.95, C: δH 7.64; δH 6.92), and also by the CIGAR correlations from the aromatic 
protons and also from the two methyl resonances at δH 3.83, to two oxygen bearing 
carbons (δC 160.1 and 160.5 respectively).  A comparison of HSQC-DEPT and CIGAR 
data of 4.13 with those of 4.11 backed up the initial assumption that the two molecules 
were identical except for the replacement of one hydroxyl moiety with that of a methoxyl 
in 4.13.  Given that there was only one oxygen that could be methylated and still fit the 
NMR and MS data, it was proposed that a methoxyl had replaced the hydroxyl group on 
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C-3" (4.13).  A literature search followed by comparison of 1H and 13C NMR data (Table 
4.3) established that 4.13 was methyl 4,4'-dimethoxyvulpinte, a vulpinic acid derivative 
previously isolated from Scleroderma sp.94,109  
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Table 4.3: Literature and experimental (in CDCl3) NMR data for 4.13 
aLiterature 
13C 
bLiterature 1H ppm, 
multiplicity, (JHH Hz) 
Position δ 13C ppmc δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
120.6  1 120.6 (C)    
131.0 7.59 d (8.8) 2 131.1 (CH) 7.49 d (8.7) H-3 C-4, C-6, C-2" 
114.3 6.87 d (8.8) 3 114.2 (CH) 6.95 d (8.7) H-2 C-4, C-1, C-5 
160.5  4 160.5 (C)    
114.3 6.87 d (8.8) 5 114.2 (CH) 6.95 d (8.7) H-6 C-4, C-1, C-3 
131.0 7.59 d (8.8) 6 131.1 (CH) 7.49 d (8.7) H-5 C-4, C-2, , C-2"
55.3 3.71 s 4-OCH3 55.4 (CH3) 3.83 s  C-4 
123.6  1' 123.7 (C)    
130.8 7.44 d (8.7) 2' 130.8 (CH) 7.64 d (8.7) H-3' C-4', C-5" 
114.0 6.90 d (8.7) 3' 114.2 (CH) 6.92 d (8.7) H-2' C-4', C-1', C-5' 
160.1  4' 160.1 (C)    
114.0 6.90 d (8.7) 5' 114.2 (CH) 6.92 d (8.7) H-6' C-4', C-1', C-3' 
130.8 7.44 d (8.7) 6' 130.8 (CH) 7.64 d (8.7) H-5' C-4', C-5" 
55.3 3.78 s 4’-OCH3 55.4 (CH3) 3.83 s  C-4' 
168.1  1" ND (C)    
108.2  2" 108.3 (C)    
162.2  3" 162.2 (C)    
140.3  4" ND (C)    
115.6  5" 116.1 (C)    
167.4  6" 167.5 (C)    
52.7 3.84 s CO2CH3 52.8 (CH3) 3.89 s  C-6" 
60.9 3.78 s OCH3 61.0 (CH3) 3.76 s  C-3" 
a Carried out at 100.62 MHz in CDCl3 using solvent as the internal standard.  
b Carried out at 600 MHz in CDCl3, using the solvent as the internal standard. 
c Determined from HSQC-DEPT and CIGAR experiments. ND-Not determined 
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4.5.4  Structural Elucidation of SAS-6-14 (4.14) 
 
SAS-6-14 (4.14) was obtained as an intense yellow amorphous solid.  ESIMS determined 
the molecular weight of the compound as 451/453/455 ([M+H]+/[MH+2]+/[MH+4]+).  
These isotopic peak ratios in the vicinity of [M+H]+ indicated the presence of two 
chlorine atoms in the molecule (Figure 4.12).   
 
 
 
Figure 4.12: Negative ion ESIMS showing the isotope effect of two chlorine atoms  
 
The 1H (Figure 4.13) and 13C NMR (Figure 4.14) spectra for 4.14, as with the previous 
two vulpinic acid derivatives (4.12 and 4.13), bore a strong resemblance to those of 4.11.  
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Figure 4.13: 1H NMR spectrum of 4.14 in CDCl3. 
 
As with 4.12, the structural differences appeared to be in ring C only, with just a singlet 
proton resonance at δH 7.19 on this ring.  Integrals revealing that the singlet proton 
represented two protons indicated a symmetrically substituted ring.  It was noted that 
4.14 still retained the methoxy substitution pattern on the aromatic rings that was seen for 
the previous three compounds  (COSY, HSQC and CIGAR NMR spectra).  Comparison 
of the CIGAR and 13C data (Figure 4.15) with those for 4.11 revealed that the pair of 
carbons at δC 113.6 were replaced by a pair of quaternary carbons at δC 129.4 in 4.14.  
The placement of the non-hydrogen substituents in the 3' and 5' positions was shown by 
CIGAR correlations from the proton at δH 7.19 to the carbons at δC 129.4 and 112.1. 
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Figure 4.14. CIGAR NMR correlations for ring C of 4.14. Also shown is the comparison of δC at 
C-3' and C-5' for compounds 4.14 and 4.11. 
 
ppm60708090100110120130140150160170  
 
Figure 4.15. 13C NMR spectrum of 4.14 in CDCl3. 
 
Given the isotope pattern seen in ESIMS, these carbons at δC 129.4 were proposed to be 
chloro substituted (4.14).  As no matches were found in the AntiMarin, SciFinder 
Scholar, Biosis and Web of Science databases, this is a new vulpinic acid derivative.  The 
compound was given the trivial name of methyl-3',5'-dichloro-4,4'-di-O-methyl-
atromentate, which was in keeping with the naming of other similar vulpinic acid 
derivatives.  A full set of experimental NMR data is presented in Table 4.4. 
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Table 4.4: Experimental NMR data for 4.14. 
Position δ 13C ppm δ 
1H ppm, 
multiplicity, (JHH Hz)
COSY CIGAR 
1 121.2 (C)    
2 129.5 (CH) 8.12 d (8.8) H-3 C-4, C-6, C-3, C-2" 
3 114.0 (CH) 6.97 d (8.8) H-2 C-4, C-1, C-5 
4 159.7 (C)    
5 114.0 (CH) 6.97 d (8.8) H-6 C-4, C-1, C-3 
6 129.5 (CH) 8.12 d (8.8) H-5 C-4, C-2, C-5, C-2" 
4-OCH3 55.3 (CH3) 3.85 s  C-4 
1' 129.1 (C)    
2' 130.4 (CH) 7.19 s  C-4', C-2', C-3', C-5" 
3' 129.4 (C)    
4' 152.4 (C)    
5' 129.4 (C)    
6' 130.4 (CH) 7.19 s  C-4', C-2', C-3', C-5" 
4'-OCH3 60.8 (CH3) 3.96 s  C-4' 
1" 165.6 (C)    
2" 105.8 (C)    
3" 158.0 (C) 13.42 (OH)  C-3", C-4", C-2" 
4" 155.8 (C)    
5" 112.1 (C)    
6" 170.7 (C)    
CO2CH3 54.6 (CH3) 3.89 s  C-6", C-5" 
1H and 2D experiments carried out at 500 MHz in CDCl3.  
13C carried out at 75 MHz in CDCl3. 
 
The proposed structure was supported and confirmed, respectively, by EIMS and X-ray 
crystallography.  In EIMS a fragment peak representing a mass of 418/420/422 was seen.  
This was presumed to be a dilactone peracetate derivative (4.15) formed by the loss of 
MeOH from the parent compound.  
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This phenomenon had been seen in the EI spectra of pulvinic derivatives previously.110 
X-ray crystallography confirmed the structure of 4.14 (Figure 4.16). The tables of 
structural coordinates are presented in Appendix 1. 
 
 
Figure 4.16: Crystal structure drawing of 4.14. 
 
4.14 was only weakly cytotoxic (IC50 20.6 μM), but showed moderate activity against B. 
subtilis (4 mm zone of inhibition). The larger zone of inhibition that was initially seen in 
the crude extract (11 mm) was attributed to the two known compounds, 4,4'-
dimethoxyvulpinic acid, and methyl-3'-chloro-4,4'-di-O-methylatromentate, which 
showed inhibition zones of 8 and 7 mm respectively. 
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4.6  Discussion 
 
Purification of an extract from a Scleroderma sp. resulted in the isolation of four pulvinic 
acid derivatives.  Interpretation of spectral data as well as AntiMarin and literature 
searches identified the first three compounds as the previously reported, 4,4'-
dimethoxyvulpinic acid,94,102 methyl 3'-chloro-4,4'-di-O-methylatromentate102 and methyl 
4,4'-dimethoxyvulpinate.94,109 The fourth compound had no matches in the literature and 
was identified as a new dichlorinated pulvinic acid derivative and was named methyl-
3',5'-dichloro-4,4'-di-O-methylatromentate.  Dichlorinated pulvinic acids, as natural 
products, have been previously reported.  These include methyl-2',5'-dichloro-4,4'-di-O-
methyl-atromentate (4.16),109 where ring C is substituted, or where both rings, A and C 
are mono-substituted ortho to the methoxyl, as in dichloro-tri-O-methylxerocomicacid-
methylester (4.17).102 
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Chapter 5 
 
 
An unidentified fungal endophyte  
(E57) 
 
 
 
5.1  General introduction 
 
5.1.1  Acylresorcinols 
 
The acylresorcinols are a sizable class of polyketide compounds, with examples of this 
type of compound having been found in both the marine and terrestrial environment.  
Isolated from the marine environment is secocurvularin (5.1), originating from an 
unidentified fungus found inside the encrusting sponge, Spirastrella vagabunda.111 
Examples from the terrestrial environment are somewhat more plentiful.  These include 
curvulinic acid (5.2), isolated from Curvularia siddiqui,112 and Oidiodendron 
rhodogenum,113 and its various analogues.  Plants have also been found to be prolific 
producers of acylresorcinols.  These differ from those of fungal origin by reason of their 
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long aliphatic side chains.  This is clearly shown in suranone (5.3), isolated from the 
herb, Peperomia sui,114 and also in 5.4, a metabolite isolated from the stem bark of 
Knema austrosiamensis.115 
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5.1.2  Monocyclic Acetogenins 
 
In an interesting biosynthetic variation of the polyacetate pathway leading to the 
acylresorcinols, such as 5.2, the introduction of an additional hydroxyl function, which is 
subsequently methylated, has given rise to a related group of monocyclic acetogenins.  
Curvulic acid (5.5) and curvin (5.6), also isolated from Curvularia siddiqu116,117 and in 
the case of 5.5, also from Penicillium janthinellum,118 are just two examples of this type 
of compound.  The basic skeleton of these compounds is derived from the head-tail 
condensation of one acetate, and four malonate units, whereas the source of the O-methyl 
is from the C-1 unit derived from formic acid or methionine.119 
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Curvulic acid (5.5) displayed antimicrobial activity against Bacillus subtilis, by the 
inhibition of cell wall synthesis.  
 
5.2  Introduction 
 
The non-sporolating endophytic fungus, E57, was isolated from the New Zealand native 
tree, Coprosma sp., located in a bush-pocket near Gebbies Pass on the Port Hills, 
Christchurch, New Zealand.  The purified fungal material was grown on an agar slope 
(10 mL MYE) for small-scale biological and chemical screening. 
 
5.3  Preliminary Investigations 
 
The initial small-scale agar slope culture of E57 was extracted with EtOAc, and 
concentrated to give 1.8 mg of crude extract.  The quick screen P388 assay showed 
excellent activity for this extract (3.6% which equates to 96.4 % inhibition of cell 
growth).  An aliquot of the extract was chromatographed on reverse phase C18 HPLC 
(Figure 5.1) using the standard elution gradient (Section 7.1.4). 
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Figure 5.1: HPLC chromatogram of the agar slope extract of E57. Numbered in bold are the 
four main metabolites and their molecular weights as determined by ESIMS. 
 
The UV profile of each peak (Figure 5.2) suggested that while peak 1 and 2 were similar 
to each other they were probably not related to peaks 3 and 4, which did have very 
similar profiles and thus were probably related compounds.  
For the dereplication process, a 250 μg injection of the crude extract was made on to the 
analytical HPLC column.  For each of the four peaks, the eluent was collected and 
submitted for ESIMS.  This allowed a definitive mass profile to be obtained for each of 
the four major peaks (Figure 5.1).  Although this information was useful, AntiMarin was 
unable to significantly narrow down the search field.  It was clear at this stage that NMR 
spectra were required for identification of these compounds.  Because there was very 
little of the initial extract left, a large-scale culture was grown.   
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Figure 5.2: Overlay of the UV chromophores of each of the four major peaks in the HPLC 
chromatogram shown in Figure 5.1. 
 
The 24 agar plates from the large-scale culture were extracted with EtOAc.  Upon 
concentration, this fungus yielded just 23.5 mg.  Although the fungus was cultured in an 
identical manner (see Experimental) to that of the small-scale culture, the metabolites 
produced in the large scale differed from those produced in the small-scale culture (See 
Figure 5.3).  The large-scale extract showed one major peak, both in terms of PDA and 
ELSD detection. This was not one of the peaks seen previously from the agar slope 
extract, but it did show a UV chromophore which was almost identical to those of peaks 
3 and 4 in the HPLC trace shown in Figure 5.1.  To avoid wasting the extract it was 
decided to purify this major component.  Although the minor compounds at 13.0, 14.0 
and 14.5 minutes (see chromatogram 1 in Figure 5.3) showed identical UV chromophores 
to that of the main peak, 23 mg of a crude extract was proven too small an amount for 
isolation of the minor compounds.  
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Figure 5.3: HPLC chromatogram showing comparison of the small-scale agar slope extract 
(blue) with that of the large-scale extract (red). 
 
5.4  Chromatography of E57 
 
As in the previous chapter, the simple nature of the crude extract allowed semi-
preparative HPLC to be the only form of chromatography necessary to obtain the 
compound in a very pure form (Section 7.5.1, Experimental). 
 
5.5  Structure Elucidation of SAS-5-75 (5.7) 
 
SAS-5-75 (5.7) was isolated as a cream coloured powder.  ESIMS determined the mass to 
be 227 ([M+H]+).  As well as the [M+H] ion peak, a peak at 209 ([M-H2O]+) was also 
seen.  This is indicative of the presence of a hydroxyl functionality in the molecule.  
EIMS gave a molecular formula of C11H14O5. 
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Figure 5.4: 1H NMR spectrum of 5.7 in CD3OD. 
 
The 1H NMR (Figure 5.4) and COSY spectra indicated a pair of triplet methylenes at δH 
2.77 (H-7) and δH 3.57 (H-8) coupled to each other, with the downfield nature of the 
protons at H-8 suggesting its close proximity to oxygen.  This is partially confirmed at 
least by the multiplicity, a triplet, indicating only the one set of protons at H-7 were 
adjacent to this centre.  The triplet nature of the methylene signal at H-7 when considered 
with a chemical shift of 2.77 ppm suggested that the other adjacent centre was most likely 
a quaternary carbon.  Also from the 1H NMR it was clear that the molecule contained one 
singlet methoxyl at δH 3.78 (H-11) and probably an acetyl, which is seen as a singlet at δH 
2.50 (H-10).  In addition, the 13C NMR spectrum (Figure 5.5) showed one carbonyl at δC 
205.4 (C-9), a 2JCH CIGAR correlation from H-10 to C-9 confirmed the acetyl nature of 
this carbon. Also clearly visible in the 13C spectrum were three quaternary carbons at δC 
167.3 (C-1), 165.8 (C-5), and 164.5 (C-3).  In consideration of the molecular formula 
these carbons were proposed to be somewhat deshielded aromatic carbons rather than 
ester or acid carbonyl carbons.  
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Figure 5.5: 13C NMR spectrum of 5.7 in CD3OD. 
 
HSQC and CIGAR NMR spectra confirmed the presence of a 2-hydroxyethyl group.  
This was seen by 1JCH correlation from the proton at H-8 to a carbon at δC 63.2 (C-8) 
confirming the hydroxyl substitution. It was postulated that the 2-hydroxyethyl moiety 
was directly attached to an aromatic ring (Figure 5.6). This was confirmed by CIGAR 
correlations from the H-7 protons to the quaternary carbons at δC 167.3, 165.8 and 106.9 
(C-6).   
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Figure 5.6: Partial structure of 5.7 assumed from COSY and CIGAR correlations. 
 
At this point a search of the AntiMarin database was carried out using mass and the 1H 
NMR data.  A match was found with 2,4-dihydroxy-6-(2-hydroxyethyl)-3-
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methoxyacetophenone (5.8), an acetogenin previously isolated from Ophiosphaerella 
herpotricha, a cause of spring dead spot (SDS) of bermudagrass.120 
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Although 5.8 had exactly the same molecular formula and seemed to contain all the 
necessary substituents, the pattern of the substitution on the aromatic ring did not fit the 
NMR data for the isolated compound.  The prime reason was the lack of observable 
CIGAR correlations from the singlet proton at δH 5.94 (H-4) to C-7 or in the reverse 
direction.  Nor were correlations observed to C-6 from H-4.  Further evidence for an 
alternative substitution pattern was the upfield nature of the quaternary carbon at C-6.  
This suggested the carbon was shielded by the substituent effects of ortho or para 
oxygens.  For this reason the two hydroxyl substituents were allocated to either side of 
the 2-hydroxyethyl group.  This was a preferred arrangement over the methoxyl 
substituent being in one of these flanking positions.  The shielded nature of the carbon at 
δC 92.4 (C-4) as well as that of the quaternary carbon at δC 107.1 (C-2) meant that these 
two carbons were also flanked on both sides by oxygen bearing carbons. A number of 
alternative structures fit this pattern, however only the structure shown in Figure 5.7, fits 
all the CIGAR NMR correlations.  
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Figure 5.7: Important CIGAR correlations for 5.7. 
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In order to confirm the pattern of substitution around the aromatic ring a 1D NOE 
experiment was carried out.  In this experiment the methoxyl protons at δH 3.78 (H-11) 
were irradiated.  If the substitution pattern is as in 5.7 not 5.8, then NOE correlations 
should clearly be seen from the methoxyl protons to both the aromatic proton and the 
acetyl protons.  If the arrangement of the substituents on the ring were the same as for 
5.8, NOE enhancements would be expected for at least the H-7 protons when the 
methoxyl protons were irradiated.  The NOE spectrum (Figure 5.8) confirms the structure 
as 5.7, as upon irradiation, both the acetyl and aromatic protons, but not the H-7 protons 
were enhanced. 
 
ppm2.53.03.54.04.55.05.56.06.5
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Figure 5.8: 1D NOE spectrum of 5.7 in CD3OD, run with a mixing time of 0.5 s.  Irradiation at 
H-11 shows enhancement of H-10 and H-4 resonances. 
 
Extensive literature searches showed no matches, hence this compound was a new 
structural isomer of the known compound, 2,4-dihydroxy-6-(2-hydroxyethyl)-3-
methoxyacetophenone (5.8).  This was subsequently confirmed by X-ray crystallographic 
analysis (X-ray data tables can be found in Appendix 1) of a small crystal (Figure 5.9).  
Although the numbering of the known compound was unusual, to avoid confusion, the 
same numbering system was used for the new isomer. The new compound was named 
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1,5-Dihydroxy-6-(2-hydroxyethyl)-3-methoxyacetophenone (5.7).  The complete set of 
NMR data is presented in Table 5.1. 
 
Figure 5.9: Crystal structure drawing of 5.7. 
 
Table 5.1: Experimental NMR data for 5.7 
Position δ 13C ppm δ 
1H ppm, 
multiplicity, (JHH Hz)
NOE COSY CIGAR 
1 167.3 (C)     
2 107.1 (C)     
3 164.5 (C)     
4 92.4 (CH) 5.94 s   C-9, C-5, C-3, C-2 
5 165.8 (C)     
6 106.9 (C)     
7 27.8 (CH2) 2.77 t (7.6, 7.6)  H-8 C-1, C-5, C-6, C-8 
8 63.2 (CH2) 3.57 t (7.6, 7.6)  H-7 C-6, C-7 
9 205.4 (C)     
10 34.3 (CH3) 2.50 s   C-9, C-2 
11 57.0 (CH3) 3.78 s H-4, H-10  C-3, C-4 
1H and 2D experiments carried out at 500 Mhz in CD3OD. 13C carried out at 75 Mhz in CD3OD. 
 
1,5-dihydroxy-6-(2-hydroxyethyl)-3-methoxyacetophenone (5.7) was found to show only 
weak antimicrobial activity against Bacillus subtilis (2 mm zone of inhibition).  It was 
noted earlier (Section 6.1.2) that the related compound, 5.5, showed antimicrobial activity 
against B. subtilis.  Structural studies showed that the methoxyl substituent played an 
important role in this antimicrobial activity.118  It stands to reason therefore, that the 
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methoxyl group in 5.7 is perhaps the reason for the observed antimicrobial activity. 
Despite the initial small-scale culture showing very good activity in the P388 quick 
screen assay, no P388 activity was detected from the purified compound.  This is not at 
all surprising given the change in composition of the extract following the scale-up 
(Section 5.3). 
 
5.6  Discussion 
 
The purification of an extract from a New Zealand endophytic fungus has resulted in the 
isolation of a new monocyclic acetogenin.  This new compound, 1,5-dihydroxy-6-(2-
hydroxyethyl)-3-methoxyacetophenone (5.7), closely resembles the known compound, 
2,4-dihydroxy-6-(2-hydroxyethyl)-3-methoxyacetophenone (5.8).  The substituents on 
the aromatic ring are identical, but the substitution pattern differs between the two 
compounds.   
Due to the similarity of the new acetogenin, 5.7 to that of the known compound curvulic 
acid (5.5), the structure activity data for 5.5 was applied to that of 5.7.  Therefore it was 
proposed that the activity that 5.7 displayed against B. subtilis is possibly a consequence 
of disruption of cell membrane synthesis in the bacterium, suggesting that the methoxy 
group plays an important part in this inhibition. 
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Dereplication Methods  
 
 
 
6.1  General Introduction 
 
The rapid identification of already known natural products, a process known as 
dereplication, is strategically important for scientists involved in screening crude extracts 
for novel bioactive compounds from natural sources.121  The continued demand to get 
new drugs to the market more quickly and more cheaply, requires that the analytical 
technologies that support this work keep pace with, for example, the rate at which new 
chemical entities (NCEs) are synthesised for high-throughput screening programmes.122 
Relatively new techniques such as hyphenated LC systems and NMR cryoprobes are now 
used routinely by many operating high-throughput screening programmes.   
The most common hyphenated techniques are those of LC-MS, LC-MS-MS and LC-
NMR.  These techniques all suffer, one way or another, from problems.  For example any 
technique involving mass spectrometry will always potentially suffer from problems 
associated with ionisation (or lack thereof), of the compounds being studied.  Adducts in 
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ESIMS can be an especially big problem, e.g [M+NH3]+, [M+CH3CN]+ appear rather 
than the usual [M+H]+ and [M+Na]+.  Despite this, in the pharmaceutical industry these 
are very powerful techniques for the monitoring, characterisation and identification of 
impurities.123  In the case of LC-NMR, there are three main coupling technologies, 
onflow, stopped flow and loop-storage, all of which have their disadvantages.  Onflow 
results in poor S/N ratio for the NMR spectra unless a reduced flow rate is used, however 
reduced flow can then reduce the chromatographic separation.  This method is really only 
suitable for the more intense signals of the major constituents.  Stopped flow has the 
advantage that a number of chromatographic peaks can be studied, but the frequent stops 
then necessary for data acqusition can disturb the quality of separation, and concentrated 
compounds can contaminate the NMR detection cell. As a consequence this approach is 
most suitable for mixtures having only a small number of constituents.  In the loop 
storage mode, the chromatographic run is not interrupted, instead each analyte is stored in 
a separate capillary loop in order for NMR acquisition to be carried out at a later stage.  A 
prerequisite for this technique however, is that analyte must be stable during the long 
NMR analysis time.124 
Another recent advancement in LC-NMR is the use of a cryoprobe.  In NMR cryoprobes, 
the electronic components are cryogenically cooled to ~20 K while the sample remains at 
ambient temperature.125  This has the effect of reducing the electronic noise.125  
Cryoprobes have been found to provide quite significant sensitivity gains, however there 
is sensitivity loss for experiments such as HMBC that contain a long delay as part of their 
pulse sequences.126 
 
6.2  Introduction 
 
The natural products chemistry group at the University of Canterbury is focussed on 
natural products of fungal origin.  In working with fungal natural products one has to 
cope with the large number of already known metabolites from this source.  Thus, 
effective dereplication techniques are essential.  During the course of my PhD studies I 
have been involved in assisting with the development of the groups strategies towards 
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dereplication.  Throughout it has been an integral, but not a focussed part of my research 
effort.  This chapter represents an overview of dereplication undertaken within the group 
as well as contributions that I have made to the overall effort. 
The group's approach to dereplication utilises a combination of HPLC-UV and the 
establishment of UV libraries using HPLC software, MS analysis, screening for 
bioactivity using the in-house assay system and capillary probe NMR.  This is all used in 
conjunction with the combined MarinLit/Antibase database known as AntiMarin.77  
During the first few months of my own research, the combination of AntiMarin, HPLC-
UV and MS analysis was the standard dereplication protocol.  This method worked but in 
order for it to be efficient, there was a heavy reliance on having a good memory for UV 
profiles, when the same compound was seen again in another extract.  Of course sharing 
the knowledge of UV profiles with other group members was next to impossible.  
The purchase of the Dionex HPLC system gave the group the opportunity to construct a 
UV library where anyone could get access to stored UV data for comparison with those 
present in other extracts.  Involvement in this project was a joint one with Dr. Gerhard 
Lang and Dr. Maya Mitova.  This involved setting up the different libraries and running 
standards and other compounds previously identified, through the HPLC in order to store 
the UV data. 
Prior to purchase of a capNMR probe, it was necessary for this method to be assessed in 
terms of its usefulness to the work carried out in our research group.  The crude extracts 
obtained from the Scleroderma sp. of fungus and the New Zealand endophyte, F5584, 
were very useful for this work.  As the crude extract had a simple profile with well 
defined and separated peaks on the HPLC.  F5584 was useful for the oppposite reason; it 
contained many compounds, most of which eluted very close to one another.  This extract 
would test the capabilites of the fraction collector to separate these compounds while still 
retaining reasonable purity so that identification of the compounds through capNMR was 
feasible. 
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6.3  Dereplication Using an HPLC-UV Library 
Database 
 
Normally, UV-libraries are generated from known compounds,127 our approach however, 
has been to generate libraries of both known and unknown compounds.  Using the 
Chromeleon software on the Dionex analytical HPLC system, this has enabled us, in 
conjunction with independently collected bioactivity data, to answer three key questions 
about every significant peak in the crude extract from a fungus or fungal culture. 
 
1. Is the bioactive peak a new compound 
2. Has the bioactive peak been observed in an extract previously 
3. If it has been observed before, is it a known compound 
 
The process begins with extracts that have already successfully passed the in-house 
requirements for bioactivity; that is, the extract must have an IC50 value <10,000 ng/mL 
for it to be considered bioactive enough for further work. 
In the creation of the UV library, each crude extract was analysed by HPLC on a 
Phenomenex RP C18 column using a standard gradient, with simultaneous collection of 
fractions into a microtitre plate (see Experimental, Section 7.1.4).  All significant peaks 
in the chromatogram (> 10% of the base UV peak) were entered into the UV library, 
logging both the retention times and UV spectra (Figure 6.1). 
 
Chapter 6 Dereplication Methods 180 
 
Figure 6.1: Screenshot of UV library contained within the Dionex analytical HPLC system. 
Highlighted in red are the two key descriptors that are logged into the UV library  
 
Two libraries were constructed; “all compounds, unknown and known”; and “known 
compounds”.  Naturally, at first, all peaks were entered into the former.  As standards 
were obtained and compounds identified, these spectra were copied over to the “known 
compounds” library. 
When the numbers in the libraries started to reach significant proportions (>20), the 
microtitre step in the process was delayed until the extract had first been 
chromatographed.  This meant that an extract was first checked to establish if any of the 
significant peaks were a match with any known compounds already contained within the 
database.  If all such peaks resulted in “known hits” in the library further work on that 
extract was discontinued, bypassing the need for the P388 microtitre analysis thus saving 
time and money.  Of course, if a significant peak in an extract was not matched in the 
database, then further dereplicative steps are carried out. 
Chapter 6 Dereplication Methods 181 
Even if a match to a known compound were found in the in-house UV library, MS 
analysis was usually carried out as confirmation.  There are two ways that this can be 
carried out.  The wells of the “master” microtitre plate that correspond to the peak(s) of 
interest are analysed directly by ESIMS.  This creates an effective 3-D profile of mass 
versus well.  Alternatively a small amount of the crude extract is submitted for LCMS.  
The problem with this approach is correlating the total-ion current (TIC) trace with the 
ELSD or UV profile of the HPLC trace as the LCMS is carried out on a different HPLC 
column. 
An example of the dereplication process is presented below using the crude extract from 
the fungus Tricoderma harzianum as an example (Figure 6.2). 
 
 
Figure 6.2: HPLC chromatogram of the crude extract from the fungus Tricoderma harzianum. 
 
A search of the UV database on peaks 3 and 5 (Figure 6.2) showed matches in both UV 
chromophore and retention time to compounds already present in the database. Peaks 3 
and 5 were thus identified has demethylharzianic acid (Figure 6.3)128 and harzianic acid 
(Figure 6.4, bottom)129 respectively. 
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Figure 6.3: UV library hit (red) of peak 3(black) with that of the known compound 
demethylharzianic acid already present in the database.  
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Figure 6.4: Library hit of peak 5 with that of the known compound harzianic acid already present 
in the database. 
 
The input of UV data and retention time of peaks 1 and 2 displayed no hits to any 
compounds contained within the database.  Although peak 4 also dispalyed a UV match 
with the known compound harzianic acid, the retention time differed significantly.  For 
this reason it was considered to be most likely an isomer of harzianic acid.  In light of 
this, peaks 1, 2 and 4 were purified using semi-preparative HPLC (Experimental, Section 
6.7.1).  Following purification, peak 2 was found to be the known compound, 
harzianolide A (6.1).130,131  The NMR and mass data for peak 4 were found to be in 
agreement with this compound being an isomer of harzianic acid.  For this reason it was 
given the name isoharzianic acid (see Figure 6.4 for structure).  The stereochemistry of 
isoharzianic acid was not determined.  This was primarily because of the unsuitability of 
1 2' 
3' 
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the molecule for Mosher's esterfication and the complication of keto-enol tautomerism 
between C-1 and C-2'/C-3'. 
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HO
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6.2  
 
Peak 1, was found to be a new compound and was given the name, trichobutenolide 
(6.2).132 
 
This approach to dereplication is simple and intuitive. An advantage of this system is that 
no file transfers are needed and large libraries can be constructed as the overhead is very 
low. 
 
6.4  Dereplication from an Impure Fungal Extract 
 
Without having to put effort in to the total purification of an extract, partially purified 
extracts can be effectively dereplicated using the power of the AntiMarin database.  
LCMS and a 1H NMR spectrum of the impure compound is often all that is necessary in 
order to work with the database. 
AntiMarin includes NMR-based functional group recognition.  Many types of functional 
groups present in a molecule, such as the various types of methyl groups, olefin and 
aromatic spin systems can usually be recognised in the 1H NMR of partially purified 
compounds.  By entering recognised functionalites in the search profile, the number of 
candidate structures to be considered can be rapidly reduced.  Furthermore, by including 
other descriptors, such as UV maxima or MS data, the search profile can be made even 
more discriminating. 
The power of this database to rapidly dereplicate a compound from an impure terrestrial 
extract is demonstrated using the example of massarinolin C.  This work was carried out 
by a visiting student from the University of Hanover, Mr. Stephan Busche. 
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From the 1H NMR spectrum (Figure 6.5) of a partially purified sample a singlet methyl 
was identified as most likely belonging to the major compound.  By searching AntiMarin 
on one singlet methyl, the number of possible compounds was reduced from a total of 
44,000 to just 1245.  
 
Solvent
CH2O
CH3 (s)
 
Figure 6.5: The 1H NMR spectrum of a partially purified extract from a terrestrial fungus. 
 
By use of both 1H NMR and COSY spectra, a -CH2O- was identified as being present in 
the major compound.  By searching on both these structural features, the field was 
narrowed even further, so that the total number of possible structures was reduced to 270. 
LCMS on the impure extract resulted in a TIC trace showing that the major component 
had a retention time of 12.43 minutes, and a molecular formula of 266 Da (Figure 6.6). 
Addition of the mass data to the AntiMarin search reduced the number of possibilities 
from 270 to 3. 
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Figure 6.6: TIC trace from LCMS showing [M+H]2+ ion of the compound at 12.43 minutes. 
 
The original NMR data was then compared to the three different structures found in 
AntiMarin (Figure 6.7) as well as the calculated 1H NMR spectra (using ACD software). 
From this data it was concluded that the extract contained the compound massarinolin C 
(6.3), that was originally isolated from the aquatic fungus, Massarina tunicata.133 
Luisol B (6.4)134 was excluded due to the presence of three aromatic protons, none of 
which were evident in the 1H NMR spectrum presented in Figure 6.5.  The nucleoside, 6-
methyl-9-β-D-ribofuranosylpurine (6.5)135 was also easily excluded due to the absence of 
any heteroaromatic protons.  These would usually be present in the chemical shift range 
of 8-9 ppm. 
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This is an extremely simple, yet effective method for the rapid dereplication of known 
compounds from impure extracts.  The important thing to note with this method is that 
there had been absolutely no attempt to solve the structure of massarinolin C. 
The efficiency of these dereplication methods at the University of Canterbury has 
recently been taken a step further by the acquisition of a capillary probe for the existing 
500 MHz NMR. 
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Figure 6.7: Screenshots of the AntiMarin database showing the entry of functional groups and 
molecular weight range (top) and the results of this data input (bottom). 
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6.5  Enhanced Dereplication Utilising a capNMR  
          Probe 
 
Many of the natural products with intense biological activity are only produced in 
extremely small quantities; a reflection of perhaps their natural potency.126 The amounts 
able to be isolated of such compounds inevitably falls well below that needed to carry out 
complete structural elucidation using an inverse-detection probe and low-volume tubes 
(shigemi).  This has led the Marine Chemistry group at the University of Canterbury, and 
others around the world126 to investigate capNMR, not only as a method for obtaining 
data on the new, highly potent compounds, but also as a tool for the dereplication of 
natural product extracts. 
 
6.5.1  An Introduction to Capillary Probe NMR (capNMR) 
  
A capillary probe uses a flow cell that typically has a flow rate through the NMR probe 
of 1-50 µL/min and a sample volume in the range of 1-10 µL.136  This is the reason why 
the capillary probe is sometimes known as a capillary microflow probe, although a 
capillary probe can also have a much larger volume capacity.  
Capillary NMR probes were designed to acquire NMR spectra on mass-limited samples.  
It makes it possible to obtain high quality spectra from sample amounts that previously 
wouldn’t have allowed such data acquisition.  Alternatively, a larger amount of material 
can be used to get the same signal-to-noise (S/N) ratio in a shorter period of time.122  
Normal data acquisition typically requires at least 0.5 mg of material, give-or-take, 
depending on the molecular weight of the compound for an adequate S/N ratio to be 
achieved.  Small volume NMR flow probes were first constructed in the laboratories of 
Sweedler and Albert in the 1990s.137-139 These were developed especially for coupling to 
capillary electrophoresis (CE) and capillary HPLC (CapLC) for the detection of the small 
volumes associated with these techniques. 
A diagrammatic view and photo of the Protasis capillary probe NMR system purchased 
by the Department of Chemistry is presented in Figure 6.8. 
Chapter 6 Dereplication Methods 189 
 
 
 
 
 
 
 
 
 
Figure 6.8: Diagram showing the capillary probe set-up126 and photo of the protasis capillary 
probe. 
 
The CapNMR probe has a small flow cell that is connected to two Teflon capillaries, 
called the inlet and outlet capillaries.  For loading of the cell, the sample is dissolved in 6 
µL of deuterated solvent and injected into the inlet capillary via a syringe.  This is then 
followed by injection of 11 µL of deuterated "push" solvent to position the sample in the 
probe (see Figure 6.8).  The sample for injection into the probe is sourced from individual 
or two combined wells from the microtitre plate collection of a crude extract, separated 
into 88 fractions by analytical HPLC.  
 
6.5.2  Dereplication Utilising capNMR 
 
Before the department obtained its own probe, work was conducted using the identical 
capillary probe installed at the Molecular Targets Development Program, NCI (National 
Cancer Institute), Frederick, USA.  From this work, and work carried out since the 
department obtained its own capNMR, there are now many examples that demonstrate 
the power of this technique in the dereplication process.  A selection of these are 
presented below.  
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6.5.2.1  A Malaysian Scleroderma sp. 
 
Identification and dereplication of this extract was initially carried out using the 
conventional NMR system (this work is presented in Chapter 4).  This extract however, 
was one of two that were used to establish the relative usefulness of the capNMR 
technique in the dereplication of fungal natural products.  Figure 6.9, below shows three 
1H NMR spectra of the known compound, 4,4'-dimethoxyvulpinate (4.13), Figure 6.9 
(top) shows the proton spectrum of 4.13 when carried out at 500 MHz on 1.2 mg of 
material in a shegemi tube using the standard inverse-detection probe.  The 1H NMR 
spectra represented in Figure 6.9 (centre and bottom) were obtained from individual wells 
of a microtitre plate following collection from the HPLC.  Calculation of relative amount 
of material present (8.0 µg) was calculated based on published extinction coefficients 
(ε).94  The power of this technique is clearly shown upon comparison of these two NMR 
spectra.  In the centre, is the 1H NMR spectrum of the material taken from a microtitre 
well and subsequently run at 500 MHz using the inverse probe with shigemi tube, and the 
bottom spectrum is the same material analysed with the capillary probe.  The S/N ratio 
shows a marked increase so that the signals are clearly distinguishable, this is especially 
so, in the aromatic region. 
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Figure 6.9: 1H NMR spectra obtained in CDCl3 at 500 MHz on 1.2 mg (top), 8.0 µg from a 
microtitre well (centre), and 8.0 µg using a capillary probe NMR (bottom). 
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This work was carried out subsequent to the actual structure elucidation. Although the 
spectrum shows that the sample is slightly impure, the signals of the major compound are 
easily distinguished, so that a database search using the key NMR features (as described 
in Section 6.4) could have been carried out. This would have resulted in a positive 
identification. 
 
6.5.2.2 Spirobisnaphthalenes from an Unidentified Endophytic Fungal 
Extract (F5584) 
 
The fungal extract, F5584, was the other extract that was used for assessment of the 
capabilities of the capillary probe. This work was also carried out subsequent to structural 
elucidation of the active compounds (This work was originally presented in Chapter 3). 
From the crude extract of F5584, the NMR spectra of spiro-mamakones A and C are 
presented below.  The ability of the capillary probe to generate a full set of NMR spectra 
including 1H, COSY, HSQC, and HMBC on just µg amounts of material is demonstrated 
very well with this extract. 
Elution of the extract into a 96 well microtitre plate provided the way to generate pure 
compounds from the extract. These samples are then eminently suitable for NMR 
analysis without the requirement of further purification. 
According to the ELSD trace (red) in Figure 6.10, the two main compounds present in the 
extract were spiro-mamakones A and C.  Presented in Figures 6.11-14 are the 1H and 2D 
NMR spectra for the combined wells E2-E3 which correspond to spiro-mamkone A.  An 
estimation of the amount of material present in these combined wells was calculated 
based on the extinction coefficient of purified spiro-mamakone A.  This revealed that 
these exceptionally good NMR spectra were obtained from just 20 µg of material. The 
HMBC spectrum was obtained via routine overnight experiments, the same as that for the 
regular inverse probe utilising shigemi tubes. COSY and HSQC-DEPT were also 
obtained in the same time frame of a sample containing mg of material utilising the 
regular inverse probe (30 minutes and 2 hours respectively). 
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Figure 6.10: HPLC chromatogram of the F5584 extract used to generate the microtitre plate for 
capNMR analysis. The ELSD trace is shown in red. 
 
 
 
ppm5.45.65.86.06.26.46.66.87.07.27.47.6  
Figure 6.11: 1H NMR spectrum of spiro-mamakone A obtained in CD3OD using the capNMR 
probe. 
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Figure 6.12: COSY NMR spectrum of spiro-mamakone A obtained in CD3OD using the capNMR 
probe. 
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Figure 6.13: HSQC-DEPT NMR spectrum of spiro-mamakone A obtained in CD3OD using the 
capNMR probe. 
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Figure 6.14: HMBC NMR spectrum of spiro-mamakone A obtained in CD3OD using the capNMR 
probe 
 
Equally good results were obtained for spiro-mamakone C from just one well (D5).  
Using the same methodology as for spiro-mamakone A, it was estimated that well D5 
contained approximately 5 µg of material.  The 1H NMR spectrum for this is presented 
below (Figure 6.15). 
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ppm5.65.86.06.26.46.66.87.07.27.47.67.8  
Figure 6.15: 1H NMR spectrum of spiro-mamakone C obtained in CD3OD from capNMR. 
 
It was assumed that when selecting microtitre wells containing peaks (compounds) of 
interest, that the UV detection would coincide well with that of the elution into the 
microtitre plate from the fraction collector.  This however, was an incorrect assumption. 
For example wells D3 and D4 of the F5584 microtitre plate, containing the spiro-
mamakones were combined.  The resulting 1H NMR spectrum (Figure 6.16) revealed a 
mixture of two compounds.  The major compound, the signals of which are indicated by 
an asterix (*), was identified as spiro-mamakone C.  It was at this point that the ELSD 
trace (Figure 6.10) was compared to the microtitre wells; it matched exactly. 
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Figure 6.16: 1H NMR spectrum of a new unidentified triol spiro-mamakone with contamination 
of spiro-mamakone C (*). 
 
The remaining signals in the 1H NMR spectrum (Figure 6.16) were compared to those of 
the other spiro-mamakones. They most closely resembled those of the triols, spiro-
mamakones D and E.  However, the protons at positions 4 and 9 of the molecule were 
ambiguous.  As can be seen in the spectrum, two broad singlets are present at 
approximately the correct chemical shift (δH 5.55 and 4.85).  These, however, showed no 
coupling in the COSY NMR spectrum, hence the identity remains unconfirmed.  Due to 
the low resolution and therefore lack of observed coupling between the methine proton at 
δH 4.09 (proposed as H-8) and the H-9 proton (proposed as the broad singlet at δH 4.86), 
even the cis or trans nature of the diol could not be proposed.  Unfortunately, only 1H and 
COSY NMR data were collected for this compound, so further work on the elucidation of 
this further member of the spiro-mamakones family can not be advanced until more 
compound is obtained through routine large scale extraction of a re-culture of the fungus. 
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6.6  Discussion 
 
Effective methods for the rapid dereplication of natural products extracts should be 
regarded as of utmost importance to natural products groups.  Here in the Marine 
Chemistry Group at the University of Canterbury, very effective procedures for 
dereplication have been introduced and gradually refined over the last couple of decades.  
The recent combination of the UV library database, P388 microtitre plate analysis, MS, 
AntiMarin and capNMR has enabled the dereplication process to proceed so rapidly so as 
to have in some cases an identification of the biologically active compound in question 
within minutes; either by comparison within the UV library or a combination of 
capNMR/MS/AntiMarin.  Since installation of the Protasis capNMR in the department, 
and the UV database, the amount of extracts that individual group members are able to 
process has increased by at least two-fold. 
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Chapter 7 
 
Experimental 
 
 
 
7.1  General Methods 
 
7.1.1   Sample Extraction-Solid Culture 
 
Fungal cultures on solid agar plates (85 mm diameter) were macerated with EtOAc using 
a stainless steel potato masher.  This extraction process was carried out twice.  The 
ground agar was left sitting in a third aliquot of EtOAc overnight.  The EtOAc was 
filtered off from the macerated agar using a glass funnel plugged with glass wool.  All 
three quantities of EtOAc were combined and taken to dryness on a rotary evaporator.  
The extract was transferred to a pre-weighed vial, the weight determined and assayed for 
antitumour activity. 
 
7.1.2  Sample Extraction-Liquid Culture 
 
Cultures were homogenised with a Waring commercial blender for ~30 sec or until the 
mycelial mat was sufficiently macerated, then filtered through celite under vacuum.  The 
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filtered broth was extracted three times with EtOAc.  The solid mycelial residue was 
suspended in EtOAc and extracted three times.  The first two EtOAc extractions were for 
one hour and the third overnight.  All organic phases were combined and taken to dryness 
on a rotary evaporator.  A small volume (20 mL) of the aqueous phase was also taken to 
dryness on a rotary evaporator.  Both the aqueous and organic phases were then 
transferred to seperate vials, the weight determined and assayed for antitumour activity. 
 
7.1.3  P388 Assay 
 
Before further investigation, crude extracts were assayed for biological activity against 
the murine leukaemia cell line P388 (ATCC CCL 46, P388D1).  This assay consists of a 
serial dilution of the sample of interest followed by incubation for 72 hours with P388 
cells.  Cell viability is determined colorimetrically by the addition of a yellow dye, MTT 
tetrazolium.  Unhealthy or dead cells cannot metabolise this dye, thereby leaving a 
yellow colour.  Healthy cells however are able to reduce the dye to MTT formazan 
resulting in an intense purple colour (Figure 7.1).   
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Figure 7.1: Reduction of the yellow MTT tetrazolium salt to the purple MTT formazan by healthy 
P388 cells. 
 
The concentration of the sample required to reduce cell growth by 50%, when compared 
to a set of controls, is expressed as an IC50 in ng/mL.  For pure compounds this was 
converted to a value in µM.  All samples were dissolved in double distilled MeOH prior 
to assay submission. 
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7.1.4  HPLC Microtitre Plate Screening 
 
As part of the dereplication process all small scale extracts were initially examined in the 
HPLC microtitre plate screen.  An aliquot of the crude extract (250 µg) was analysed by 
reverse phase C18 HPLC using the following standard gradient solvent system: 2 minutes 
of 10% ACN/H2O; a linear gradient to 75% ACN/H2O for 12 minutes; isocratic at 75% 
for another 10 minutes; a linear gradient for 2 minutes to 100% ACN followed by 
isocratic at 100% ACN for 4 minutes then returned to 10% ACN/H2O in 2 minutes and 
re-equilibriated for 8 minutes; with a flow rate of 1 mL/min.  The eluant was collected 
into 96 well polystyrene microtitre plates, from which 50 and 5 µL “daughter plates” 
were made, which were then assayed for cytotoxicity against the P388 cell line. 
 
7.1.5  Antimicrobial Assay 
 
Antimicrobial activity was detected using a zone of inhibition assay.  The bacteria tested 
against were Bacillus subtilis (ATCC 19659), Escherichia coli (ATCC 25922) and 
Pseudomonas aeruginosa (ATCC 27853).  The fungi tested against were Candida 
albicans (ATCC 14053), Trichophyton mentagrophytes (ATCC 28185) and 
Cladosporium resinae (Department of Biological Sciences, University of Canterbury).  
Each bacterium or fungus (at a known concentration) was mixed with Mueller Hinton or 
potato dextrose agar and poured in Petri dishes to produce a ‘lawn’ of bacterium/fungus.  
Samples of interest were then pipetted onto 6 mm diameter filter paper disks.  After 
evaporation of solvent, the disks were placed onto the above prepared seeded agar. 
Antibiotic controls were run for each batch: gentamycin (10 µg/disk) was used for E. coli 
and P. aeruginosa; chloramphenicol (30 µg/disk) was used for B. subtilis; nystatin (100 
units/disk) was used for C. albicans, C. resinae and T. mentagrophytes.  Antimicrobial 
activity was measured in millimetres as the radius of inhibition (mass/disk). 
Suitable solvent controls were used in every assay run.  
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7.1.6  Antiviral Assay 
 
Two viruses, Herpes simplex virus type 1 (Strain F ATCC VR 733) and Polio virus type 
1 (Pfizer vaccine strain) were used to detect antiviral activity.  Herpes simplex virus type 
1 is a non enveloped virus with a single stranded RNA genome and a site of replication in 
the host cell cytoplasm.  Polio virus type 1 is an enveloped virus with a double stranded 
DNA genome and a site of replication in the host cell nucleus.  BSC-1 cells (African 
Green Monkey kidney cell line, ATCC CCL 26) were used as the host cells for the above 
mentioned viruses.  Samples of interest were pipetted onto 6 mm diameter filter paper 
disks, followed by evaporation of solvent.  The disks were then placed directly onto 
infected BSC-1 cells and incubated for 24 hours at 37°C in an atmosphere containing 
1.5% CO2.  The host cells were then examined, using an inverted microscope, for the size 
of antiviral (viral inhibition) and/or cytotoxic zones as well as the type of cytotoxicity.  
 
7.1.7  Chromatography 
 
7.1.7.1  Flash Column Chromatography 
 
Column chromatography was performed with glass columns of stated dimensions or in 
pre-prepared cartridges as indicated.  All solvents used for chromatography were of 
commercial grade and distilled once, except for MeOH, which was double distilled.  
Reversed phase C18 columns were run under pressure (0.5 kPa) with oxygen-free N2 gas.  
Reversed phase chromatography (RP) used Bakerbond (40μm) octadecyl (C18) packing. 
Samples were either dissolved in a minimal volume of solvent and loaded directly on to 
the column, or absorbed to fresh C18 at a ratio of 1:50 using a minimum volume of 
solvent which was removed under vacuum prior to loading onto the column.  
A standard elution profile was used for reversed phase C18 column chromatography 
(10g, 1.5 x 24 cm).  Columns were equilibrated to 10% MeOH/H2O prior to sample 
loading and then eluted with increasing concentrations of MeOH in steps of 10% per 
fraction, until 100% MeOH then 10% DCM/MeOH, 50% DCM/MeOH, and 100% DCM.  
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Any material remaining on the column was washed off using combinations of DCM and 
MeOH (with 0.05% TFA).  
 
7.1.7.2  High Pressure Liquid Chromatography (HPLC) 
 
In most projects the milli-Q H2O was acidified with 0.05% TFA.  All samples were 
filtered through 0.45 µm PTFE membrane filters immediately prior to injection. 
 
Analytical High Pressure Liquid Chromatography (HPLC) was carried out on a Dionex 
liquid chromatograph equipped with a UVD 340U diode array detector, and connected to 
an Alltech ELSD 800.  For reversed phase HPLC, a Phenomenex Prodigy C18 5 µ ODS3 
column (5 μ, 250 x 4.6 mm) was used.  A standard flow rate of 1 mL/min was used with 
variable concentrations of ACN (HPLC grade) in H2O (milli-Q).  The standard gradient 
given in Section 7.1.4 was used unless otherwise stated. 
 
Preparative HPLC was performed on a Shimadzu LC-4A instrument equipped with a UV 
Spectrophotometric Detector SPD-2AS (wavelength λ=210 nm) and a Hewlett Packard 
3390A integrator.  Reversed phase HPLC was performed on a Phenomenex Luna C18, 10 
x 250 mm, 5 µ column run at 5 mL/min.  Variable concentrations of ACN (HPLC grade) 
in H2O (milli-Q) were used for the mobile phase. 
For all chapters, except chapter 2, when TFA was used in the mobile phase, the eluent 
was evaporated until only H2O remained.  The H2O was then partitioned between EtOAc 
to extract the compound(s) of interest. 
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7.1.8  Mass Spectrometry 
 
7.1.8.1  Electron Impact Mass Spectrometry 
 
High Resolution Electron Impact Mass Spectra (HREIMS) were obtained on a Kratos 
MS80RFA spectrometer, operating with a 4kV accelerating potential, 70eV and a source 
temperature of 250°C. 
 
7.1.8.2  Electrospray Ionisation Mass Spectrometry 
 
High Resolution Electrospray Ionisation Mass Spectra (HRESIMS) were recorded on a 
Micromass LCT spectrometer using a probe voltage of 3200V, an operating temperature 
of 150°C and a source temperature of 80°C.  The carrier solvent was 50:50 ACN/H2O at 
20 µL/minute (for direct inject mode).  A 10 µL injection of sample was made from a 10 
µg/mL sample.  
When obtaining positive ESI mass spectra some samples were protonated with 10 µL/mL 
formic acid prior to injection.  When recording negative ESI mass spectra samples were 
deprotonated, as required, with 10 µL/mL DEA prior to injection. 
 
7.1.8.3  Liquid Chromatography Mass Spectrometry 
 
Liquid Chromatography Mass Spectrometry (LCMS) samples were analysed on a Waters 
2790 HPLC system equipped with a Waters photodiode array detector (PDA) coupled to 
a Micromass LCT spectrometer.  
 
7.1.9  Nuclear Magnetic Resonance (NMR) 
 
1H, COSY, 1D NOE, HSQC, CIGAR, J2-resolved CIGAR described in Chapter 2, and 
modified 13C NMR carried out in Chapter 3 were all recorded on a Varian INOVA 500 
spectrometer at 23°C, operating at 500 MHz.  The INOVA was equipped with a variable 
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temperature and inverse-detection 5 mm probe.  The INADEQUATE NMR carried out in 
Chapter 3 was obtained on the Varian INOVA 500 spectrometer at 23°C, operating at 
500 MHz but using a broadband 5mm probe.  The 13C NMR spectra were recorded on a 
Varian UNITY 300 NMR spectrometer, at 23°C, operating at 75 MHz.  The UNITY was 
equipped with a variable temperature direct broadband 5 mm probe.  Chemical shifts are 
expressed in parts per million (ppm) on the δ scale, and were referenced to the 
appropriate solvent peaks: CDCl3 referenced to CHCl3 at δH 7.25 (1H) and CHCl3 at δC 
77.0 (13C), CD3OD referenced to CH3OD at δH 3.3 (1H) and CH3OD at δC 49.3 (13C) and 
DMSO-d6 referenced to CD3(CHD2)SO at δH 2.6 (1H) and (CD3)2SO at 39.6 (13C). 
 
7.1.10 X-ray Crystallography 
 
For Chapters 2, 4, and 5, X-ray crystallographic data was collected on a Siemens P4 four 
circle diffractometer using graphite monochromised Mo Kα (λ=0.71073 Å) radiation at 
temperature indicated in appropriate tables in the Appendix. 
For Chapter 3, X-ray crystallographic data was collected on a Bruker-Nonius APEX II 
area detector system equipped with a nitrogen low-temperature gas-flow device, which 
was used to collect a full sphere of data with Mo Kα radiation. For crystal processing the 
data processing program, SAINT140 was used. 
 
For all crystals, the structure, refinement, and resulting tables and diagrams were all 
produced using the SHELXTL suite of programs.141,142 
 
7.1.11  UV-Vis Spectroscopy 
 
Purified samples were dissolved in MeOH at a concentration dependent on the strength of 
the UV chromophore of the particular sample.  The UV-vis spectra of these samples were 
recorded on a Varian Cary 50 Probe UV-Visible spectrophotometer. 
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7.1.12  Infrared Spectroscopy 
 
Purified samples were dissolved in CHCl3 or acetone and applied to a KBr disc, the 
solvent was evaporated on the disc by exposure to the air.  IR spectra of these samples 
were recorded on a Shimadzu FTIR-8201 PC spectrometer. 
 
7.1.13  Circular Dichroism Spectroscopy 
 
CD spectra were measured in 0.8 mg/mL MeOH using a 10 mm quartz cell on a Jasco J 
20-C spectropolarimeter. 
 
7.1.14  Optical Rotation 
 
Optical Rotation values were obtained on a Perkin Elmer 341 polarimeter at 20°C with a 
wavelength of 589 nm.  The optical rotation was then calculated using the following 
equation: 
[α]D  = α/LC 
Where L is the pathlength (dm) and C is the concentration (g/L). 
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7.2  Experimental for Chapter 2 
 
7.2.1  Chromatography of F2028 
 
The crude extract (60 mg) was obtained from a fungal collection that had been stored at –
80 °C for several years in the School of Biological Sciences.  The simple nature of the 
extract allowed for minimal purification.  Purification was carried out with semi-
preparative HPLC using a linear gradient of 30-50% ACN/H2O with TFA over 20 
minutes to give three compounds.  1D and 2D NMR techniques and mass spectrometry 
determined these compounds to be a known compound, pseurotin A (2.7, 1.9 mg), and 
two previously undescribed diastereomers of pseurotin A, pseurotin A2 (2.8, 0.6 mg) and 
A3 (2.9, 0.8 mg).  
 
7.2.2  X-ray Crystallography of Pseurotin A2 (2.8) 
 
The structure of 2.8 was confirmed by X-ray crystallography.  Compound 2.8 was 
crystallised from MeOH at 4 °C.  A plate crystal with dimensions 0.44 × 0.24 × 0.23 mm3 
was used for data collection.  The data processing yielded 32305 Bragg reflections, of 
which 29% were unique.  The final R factor was 11.3 %.  See Appendix 1 for tables of 
data. 
 
7.2.3  NaIO4 Oxidative Cleavage 
 
Oxidative cleavage was carried out on all three pseurotins.  Pseurotin A (2.7, 100 µg, 
0.23 µmol) was dissolved in MeOH (100 µL) and mixed with 1.28 molar equivalents of 
NaIO4 (63.5 µg, 0.30 µmol) dissolved in MeOH (63.5 µL), and acidified to pH 2 with 
H2SO4.  After 4 h at 8 °C, the reaction mixture was diluted with H2O and then extracted 
with EtOAc.  LCMS was used to confirm the presence of the aldehyde product.  This 
process was repeated for pseurotins A2 and A3.  
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7.2.4  Physical Data for the Pseurotins 
 
Pseurotin A (2.7): colourless amorphous solid; [α]20D -10° (c 0.1, MeOH); 1H and 2D-
NMR data see Table 4.1; ESIMS m/z 454 [M+Na]+. 
 
Pseurotin A2 (2.8): colourless plate crystal; UV (MeOH) λmax (log ε) 210 (3.72), 252 
(3.71), 280 (3.54) nm; IR (KBr disk) νmax 3425, 1697, 1636, 1450, 1373, 1188, 1080 cm-
1; 1H- and 13C-NMR data, see Table 2.2; HRESIMS m/z  454.1492 [M+Na]+ (calcd for 
C22H26NO8Na, 454.1479). 
 
Pseurotin A3 (2.9): colourless amorphous solid; UV (MeOH) λmax (log ε) 210 (3.72), 
252 (3.68), 280 (3.54) nm; IR (KBr disk) νmax 3402, 1736, 1690, 1636, 1458, 1370, cm-1; 
1H- and 13C-NMR data, see Table 2.3; HRESIMS m/z  454.1469 [M+Na]+ (calcd for 
C22H26NO8Na, 454.1479). 
 
7.3  Experimental for Chapter 3 
 
7.3.1  Culturing and Extraction of F5062 and F5584 
 
The culture and extractions for both fungal cultures was identical. The fungus was grown 
on 24 plates (of dimensions stated in Section 7.1.1) of MYE (Malt Yeast Extract) agar for 
24 days at 26°C.  The resulting culture was extracted with EtOAc as given in the protocol 
in Section 7.1.1 to give the crude extract of 207.7 mg (F5062) and 248.7 mg (F5584). 
 
7.3.2  Chromatography of F5062 
 
The crude extract was first partitioned between Pet. ether and MeOH.  The MeOH-
soluble material was concentrated and partitioned between EtOAc and H2O.  The 
resulting EtOAc-souble material (161.0 mg) was absorbed to C18 (100 mg) and 
fractionated on a reverse phase (C18) column (13 g, 1.5 x 25 cm), using the standard 
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stepped gradient (Section 7.1.7.2).  Fifteen fractions were collected.  These were analysed 
by reverse phase HPLC and assayed for cytotoxicity against the P388 cell line.  Fractions 
10 and 11, both eluting with 100 % MeOH, showed excellent cytotoxicity (231 and 166 
ng/mL respectively.  UV visible detection on the HPLC showed that the compounds 
contained within the two fractions were closely related to each other.  Fraction 11 was 
very pure, showing only two major peaks on the HPLC chromatogram, with only one of 
those associated with any relative mass, as shown by ELSD.  
For final purification of fraction 11, semi-preparative HPLC was carried out using a 
linear gradient of 45-60% ACN/H2O over 20 minutes.  The single compound isolated, 
was determined, by a combination of mass spectrometry and 1D and 2D NMR to contain 
a structurally unprecedented type of spirobisnaphthalene (3.11) (2.3 mg).  
Fraction 10, was found to contain, as well as 3.11, three other compounds with similar 
UV chromophores.  Semi-preparative HPLC using the same linear gradient as was used 
for fraction 11, was used to purify these compounds. 
1D and 2D NMR as well as mass spectrometry determined these to be members of a new 
acidic class of spirobisnaphthalenes (3.7, 3.8, and 3.10) (1.9, 4.8, 1.1 mg respectively) 
and 3.11 (5.7 mg).  
 
7.3.3  Physical Data for the Spirobisnaphthalenes 
 
Mamakunoic acid B (3.7): cream amorphous solid; [α]20D 0.0° (c 0.066, MeOH); UV 
(MeOH) λmax (log ε) 212 (sh), 230 (3.99), 288 (3.57), 314 (3.42), 328 (3.32) nm; IR (KBr 
disk) νmax 1610, 1587, 1464, 1412, 1381, 1273, 1194, 1144, 822, 760 cm-1; 1H- and 13C-
NMR data, see Table 3.1; EIMS m/z (%): 350.1 [M]+ (22), 279.1 (100), 160.1 (12), 115.1 
(14); HREIMS m/z 350.0780 [M]+ (calc for C20H14O6 350.0790). 
 
Mamakunoic acid A (3.8): cream amorphous solid; UV (MeOH) λmax 206, 224, 288, 
298, 313, 328 nm; 1H- and 13C-NMR data, see Table 3.2; ESIMS m/z: 369 [M+H]+  
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Mamakunoic acid A-deuterated methyl ester (3.9): cream amorphous solid; [α]20D +15 
° (c 0.026, MeOH); UV (MeOH) λmax (log ε) 234 (3.98), 296 (4.00), 314 (3.88), 328 
(3.74) nm; IR (KBr disk) νmax 1732, 1609, 1589, 1474, 1412, 1381, 1273, 1072, 818, 756 
cm-1; 1H NMR (DMSO-d6, 500 MHz), δ 7.52 (2H, m, H14/H16), 7.51 (2H, m, H13/H17), 
7.10 (2H, m, H12/H18), 6.78 (1H, dd, 1.0, 7.9, H3), 6.66 (1H, dd, 1.0, 7.8, H5), 6.43 (1H, 
t, 7.9, 7.9, H4), 4.83 (1H, dd, 2.7, 10.0, H8), 2.81 (1H, dd, 2.7, 15.0, H9b), 2.64 (1H, dd, 
10.0, 15.0, H9a); 13C shifts determined from HSQC-DEPT and CIGAR NMR 
experiments (DMSO-d6, 500 MHz), δ 172.0 (C10), 148.0 (C11/C19), 146.3 (C6), 145.0 
(C7), 134.0 (C15), 127.9 (C13/C17), 122.6 (C2), 120.5 (C3), 120.4 (C14/C16), 118.1 
(C4), 115.9 (C5), 114.1 (C20), 109.4 (C12/C18), 104.2 (C1), 71.4 (C8), 37.4 (C9); EIMS 
m/z (%) 485.1 [M]+ (6), 383.1 (3), 367.1 (13), 365.1 (2), 304.1 (7), 279.1 (100), 115.1 
(9); HREIMS m/z 385.1241 [M]+ (calc for C21H15O7 D3 385.1241).  
 
Mamakunoic acid C (3.10): orange/red amorphous solid; UV (MeOH) λmax 206 (sh), 
228, 297, 314 (sh), 328 nm; 1H- and 13C-NMR data, see Table 3.3; EIMS m/z (%) 380.1 
[M]+ (64), 334.1 (32), 304.1 (10), 160.1 (100); HREIMS m/z 380.0881 [M]+ (calc for 
C21H16O7 380.0896).  
 
spiro-Mamakone A (3.11): yellow amorphous solid; [α]20D 0.0 ° (c 0.1, MeOH); UV 
(MeOH) λmax (log ε) 230 (3.89), 300 (3.88), 315 (3.73), 330 (3.43) nm; IR (KBr disk) 
νmax 1707, 1609, 1414, 1379, 1275, 1204, 1107, 1082 cm-1; 1H- and 13C-NMR data, see 
Table 3.4; EIMS m/z (%): 320.1 [M]+ (100), 291.1 (52), 265.1 (23), 197.1 (27), 170.0 
(26), 160.1 (27), 133.0 (27), 114.0 (24); HREIMS m/z 320.0677 [M]+ (calc for C19H12O5 
320.0685). 
 
7.3.4  Oxidation of spiro-Mamakone A (3.11) 
 
spiro-Mamakone A (3.11, 2.0 mg, 6.2 µmol) and freshly precipitated MnO2 (20 mg, 0.23 
mmol), prepared following the procedure of Attenburrow et al.,143 and CHCl3 (0.5 mL) 
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were stirred together at room temperature for 2 h.  The reaction mixture was filtered 
through a (0.45 µm) syringe filter to yield pure 4-oxo-spiro-mamakone A (3.12, 1.6 mg, 
80.5%). 
 
4-oxo-spiro-Mamakone A (3.12): pale yellow amorphous solid; UV (MeOH) λmax (log 
ε) 232 (3.89), 295 (4.04), 314 sh, 330 (3.66) nm; IR (KBr disk) νmax 1763, 1701, 1612, 
1413, 1377, 1275, 1257, 1126, 1047 cm-1; 1H NMR (CDCl3, 500 MHz) δ  7.77 (1H, d, 
5.8, H3), 7.49 (2H, d, 8.3, H15/H13), 7.41 (2H, t, 8.3, 8.3, H16/H12), 7.00 (2H, s, 
H7/H8), 6.90 (2H, d, 8.3, H17/H11), 6.69 (1H, d, 5.8, H2); 13C shifts determined from 
HSQC-DEPT and CIGAR experiments (CDCl3, 500 MHz), δ 196.0 (C4), 194.2 (C9/C6), 
157.0 (C3), 150.8 (C8/C7), 146.2 (C10/C18), 137.7 (C2), 134.0 (C14), 127.6 (C16/C12), 
121.6 (C15/C13), 113.4 (C19), 110.7 (C17/C11), 105.8 (C1), 70.5 (C5); EIMS m/z (%): 
318.1 [M]+ (100), 290.1 (7), 262.1 (19), 234.1 (13), 208.1 (14), 168.1 (9), 114.0 (25); 
HREIMS m/z 318.0533 [M]+ (calc for C19H10O5 318.0528). 
 
7.3.5  Spiroketal Deprotection of spiro-Mamakone A (3.11) 
 
To a stirred solution of spiro-mamakone A (3.11, 2.0 mg, 6.2 µmol) in ACN (200 µL) at 
70 °C was added in one portion a solution of cerium ammonium nitrate (CAN, 8.6 mg, 
15.6 µmol) in H2O (400 µL) following the procedure of Ates et al.144,145  After 5 minutes, 
the crude extract was poured in H2O and extracted with EtOAc twice.  The oragnic layer 
was dried over MgSO4 and then taken to dryness under a flow of N2, to yield 9-hydroxy-
spiro[4.4]nona-2,7-diene-1,4,6-trione (3.13, 0.4 mg) 
 
9-hydroxy-spiro[4.4]nona-2,7-diene-1,4,6-trione (3.13): 1H NMR (CD3OD, 500 MHz) 
δ 8.10 (1H, dd, 2.0, 5.4, H3), 7.99 (1H, d, 5.8, H7), 7.94 (1H, d, 5.8, H8), 6.50 (1H, dd, 
1.5, 5.4, H2), 5.15 (1H, br s, H4); 13C shifts determined from HSQC-DEPT and CIGAR 
experiments (CD3OD, 500 MHz) δ 201.4 (C6/C9), 199.2 (C1), 196.4 (C9/C6), 168.9 
(C3), 154.0 (C8/C7), 153.2 (C7/C8), 133.4 (C2), 75.0 (C4), 72.3 (C5). 
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7.3.6  Derivatisation of spiro-Mamakone A (3.11) with Mosher  
  Acids 
 
To spiro-mamakone A (3.11, 2.5 mg, 7.8 µmol), a solution of (S)-MTPA chloride (5.8 
µL, 33.5 μmol) in pyridine (50 µL) and a small crystal of DMAP were added.  After 2 h 
the solvent was evaporated, the residue dissolved in MeOH (0.5 mL), and the solution 
analysed by HPLC (Phenomenex Luna C18, 250 x 4.6, 5µm; solvents: A water + 0.05% 
TFA, B ACN; linear gradient: min 10% B, 2 min 10% B, 14 min 75% B, 24 min 75% B; 
40 °C; 1 mL min-1). To give the (R)-MPTA ester the same experimental procedure for the 
production of the (S)-MPTA ester was followed. 
 
7.3.7  Chromatography of F5584 
 
The large-scale extract (248.7 mg) was absorbed on to C18 (100 mg) and fractionated on 
a reverse phase (C18) column (13 g, 1.5 x 25 cm), using a stepped gradient from 
MeOH/H2O (1:3) over pure MeOH to pure DCM.  Fourteen fractions were collected and 
analysed by reverse phase HPLC and assayed for cytotoxicity against the P388 cell line.  
Three sequential fractions (fractions SAS-5-103.9–11), eluting with 90-100% MeOH, 
showed the highest cytotoxicity.  Analysis of the HPLC chromatograms of these fractions 
revealed a group of related compounds (as seen by the similarity of the UV spectra) 
eluting between 11.5-14.5 minutes.  On comparison of SAS-5-103.10 and SAS-5-103.11 
with that of SAS-5-64.10 from the first extract (F5062) it was revealed that these two 
fractions contained spiro-mamakone A.  Fraction B also contained other related 
compounds apart from spiro-mamakone A.  Based on this, fractions SAS-5-103.9 and 
SAS-5-103.10 were subjected to final purification by semi-preparative HPLC.   
For the purification of SAS-5-103.9, a linear gradient of 30-45% ACN/H2O was used.  
The two compounds purified were identified using mass spectrometry, 1D and 2D NMR 
as two novel compounds closely related to spiro-mamakone A, to which the names spiro-
mamakone D (3.17) and B (3.16) were given. 
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In the separation of SAS-5-103.10, the gradient was changed to 42-55% ACN/H2O over 
20 minutes.  Under these conditions more of spiro-mamakone A as well as two 
diastereoisomers of 3.16 and 3.17 were isolated (3.15 and 3.18).  Both were identified, as 
before, on the basis of mass spectrometry as well as 1D and 2D NMR, and in keeping 
with the other compounds were given the names spiro-mamakone C and E respectively. 
 
7.3.8  X-ray Crystallography of 3.15 
 
The structure of 3.15 was confirmed by X-ray crystallography.  3.15 was crystallised 
from MeOH at 4 °C.  A block crystal with dimensions 0.45 × 0.20 × 0.15 mm3 was used 
for data collection.  The data processing 1652 Bragg reflections, of which 83% were 
unique.  The final R factor was 7.5 %.  See Appendix 1 for tables of data. 
 
7.3.9  Molecular Modelling 
 
The eight possible combinations of the two diastereomers, spiro-mamakone D (3.17) and 
E (3.18) were constructed in silico using the Maestro build function of the 2005 
Schrodinger molecular modeling suite. A Monte Carlo multiple minimum (MCMM) 
conformational search of each structure was carried out with MacroModel 9.0 using the 
OPLS2001 force field with the GB/SA water solvent model. The criteria for convergence 
of each conformational search was the generation of 3000 starting conformations and a 
maximum of 5000 iterations in the energy miminisation routine for each conformer, 
collecting the ensemble of conformers within 12 kJ of the global minima. A Boltzmann 
weighting for the conformers in each of the three ensembles was established using the 
following expression: 
 
exp[-(E /kBT]
exp[-(E  /kBT]
NA
-
=P
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Relevant H/H distances for all conformers within each ensemble was measured. The 
Boltzmann weighting of each conformer, where a H/H distance was within 2.5Å 
(Boltzmann-weighted percentage of  H/H distances < 2.5 Å), was established. The same 
was calculated for H-H distances < 3Å. The Boltzmann average distance was also 
calculated. The Boltzmann weighted r-6 was calculated for each H/H distance within each 
ensemble which gave virtual NOE values. This data was used to compare the modelled 
data with the experimental data in order to determine the correct isomer. 
 
7.3.10 Physical Data for spiro-Mamakones B-E 
 
spiro-Mamakone C (3.15): pale yellow block crystals, (MeOH): m.p. 110-111°C; [α]20D 
+309° (c 0.1, MeOH); IR (KBr disk) νmax 3364, 1717, 1609, 1585, 1410, 1379, 1339, 
1275 cm-1; UV (MeOH) λmax (log ε) 232 (3.88), 300 (3.80), 314 (3.67), 328 (3.50) nm; 
1H- and 13C-NMR, see Table 3.5; EIMS m/z (%): 322.1 [M]+ (100), 304.1 (66), 293.1 
(25), 221.1 (16), 197.1 (34), 160.1 (49).  HREIMS m/z 322.0830 [M]+ (calc for C19H14O5 
322.0841).  
 
spiro-Mamakone B (3.16): pale yellow amorphous solid; [α]20D -215° (c 0.1, MeOH); 
IR (KBr disk) νmax 3385, 1717, 1609, 1585, 1411, 1381, 1339, 1273, 1111 cm-1; UV 
(MeOH) λmax (log ε) 232 (3.88), 300 (3.65), 314 (3.55), 328 (3.40) nm; 1H- and 13C-
NMR, see Table 3.6; EIMS m/z (%): 322.1 [M]+ (60), 304.1 (27), 267.0 (22), 197.1 (31), 
160.1 (100); HREIMS m/z 322.0840 [M]+ (calc for C19H14O5 322.0841).  
 
spiro-Mamakone D (3.17): pale yellow amorphous solid; [α]20D +162° (c 0.033, 
MeOH); IR (KBr disk) νmax 3364, 1749, 1609, 1585, 1412, 1381, 1340, 1273, 1067 cm-1; 
UV (MeOH) λmax (log ε) 232 (3.91), 300 (3.78), 314 (3.68), 328 (3.51) nm; 1H- and 13C-
NMR, see Table 3.7; EIMS m/z (%): 340.1 [M]+ (6), 322.1 (18), 304.1 (9), 252.1 (5), 
197.1 (15), 160.1 (21); HREIMS m/z 340.0947 [M]+ (calc for C19H16O6 340.0947). 
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spiro-Mamakone E (3.18): pale yellow amorphous solid; UV (MeOH) λmax 232, 300, 
314, 328 nm; 1H- and 13C-NMR, see Table 3.8; EIMS m/z (%): 340.1 [M]+ (4), 322.1 
(80), 304.1 (100), 252.1 (5); HREIMS m/z 340.0960 [M]+ (calc for C19H16O6 340.0947).  
 
7.3.11  Time-Course Experiments 
  
Two quantities of sterile MYE broth (250 mL) were inoculated with a growing agar 
culture of the spiro-mamakone producing fungus, E484.  Both cultures were inoculated 
with four plugs from the same agar plate.  One inoculated broth was placed in static 
conditions, the other under shake conditions, at 26 °C. 
The difference in the morphology of the fungus under these conditions was extensive.  
For example after four days incubation, the static culture showed a clear broth with 
formation of some plaques.  The shake culture at the same time period showed a 
darkened broth heavily laden with mycelia, including balls of mycelia. 
Monitoring of the cultures for production of spiro-mamakone A (3.11) began four days 
after inoculation.  At days 4, 6, 7, 8, and 12, a 10 mL aliquot of the shake culture was 
removed and extracted with EtOAc according to the protocol outlined in Section 7.1.2.  
The resulting extract was chromatographed using the standard gradient (Section 7.1.4) on 
the analytical HPLC in conjunction with the ELSD (Section 7.1.7.2).  This same process 
was repeated for the static culture, except that an aliquot of culture was not taken on day 
7.  These results lead to the use of shake conditions for the growth of isotopically-labelled 
cultures. 
 
7.3.12 Biosynthetic 13C labelling 
 
Feeding experiments were performed using [1-13C]-CH3COONa, [2-13C]-CH3COONa, 
and [1,2-13C2]-CH3COONa (99% 13C).  The precursors were added to the E484 cultures 
(200 mL) 24 hours after inoculation of broth.  Each of the labelled acetates (200 mg) 
were added to sterile H2O (10 mL).  A half concentration of [1,2-13C2]-CH3COONa was 
made up using the labelled precursor (100mg) and unlabelled sodium acetate (100mg).  
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The final concentration of the labelled acetates was 1 mg/mL except in the case of the 
half strength doubly labelled precursor, whereby the final concentration was 0.5 mg/mL.  
Under sterile conditions, the precursor solutions were filtered through 0.2 µm filters into 
the growing cultures.  The labelled cultures were put under shake conditions for a further 
five days.  Extraction of the cultures was carried out as before using the protocol given in 
Section 7.1.2.  Analytical HPLC using the standard gradient without TFA ascertained that 
spiro-mamakone A (3.11) was present and in good quantity, in all labelled cultures.  Also 
present was mamakunoic acid B (3.7), but in significantly smaller quantities.  Purification 
of labelled spiro-mamakone A, and mamakunoic acid B was carried out with semi-
preparative HPLC using a linear gradient of 45-60% ACN/H2O without TFA.  This 
resulted in the isolation of labelled spiro-mamakone A (3.11) from [1-13C]-CH3COONa 
(23.5 mg), [2-13C]-CH3COONa (19.9 mg), and [1,2-13C2]-CH3COONa (18.8 mg).  
Isolation of labelled mamakunoic acid B (3.7) from [1-13C]-CH3COONa (7.2 mg), [2-
13C]-CH3COONa (6.6 mg), and [1,2-13C2]-CH3COONa (6.5 mg) material was also 
achieved.  The half strength doubly labelled material was not purified as analysis of the 
full strength indicated this was not necessary due to very low incorporation. 
 
7.3.13 Acetylation of Isotopically Labelled spiro-Mamakone A  
  (3.11) 
 
The acetylation of unlabelled spiro-mamakone A is used as an example.  Spiro-
mamakone A (3.11, 3.0 mg, 9.38 ×10-3 mmol), was dissolved in dry pyridine (200 µL), to 
which was added acetic anhydride (200 µL, 2.12 mmol).  After 15 h the reaction mixture 
was diluted with dH2O to 10% and then eluted through a C18 cartridge (Bakerbond spe, 
1g) conditioned to 100% H2O.  Using the Vac-elute system the column was run to 
dryness, a further column volume of H2O was used in the same way, followed by 100 % 
MeOH to elute the product, O-acetyl-spiro-mamakone A (3.21, 2.7 mg, 79.5%). 
To give acetylated labelled material, the same experimental procedure was used whereby 
for every 1.5 mg of starting material (11.8 and 9.9 mg of [1-13C]- and [2-13C]-acetate 
labelled material respectively) 100 µL each of pyridine and acetic anhydride were used.   
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O-acetyl-spiro-mamakone A (3.21): pale yellow amorphous solid; [α]20D +0.0° (c 0.05, 
MeOH); UV (MeOH) λmax (log ε) 230 (3.95), 298 (3.72), 314 (3.58), 328 (3.43) nm; IR 
(KBr disk) νmax 1736, 1713, 1605, 1412, 1373, 1258, 1227, 1204, 1134,1057 cm-1; 1H 
NMR (CD3OD, 500 MHz) δ 7.51 (1H, d, 8.3, H15/H13), 7.50 (1H, d, 8.3, H13/H15), 
7.41 (2H, t, 7.4, 7.4, H12/H16), 7.18 (1H, d, 6.3, H8), 7.12 (1H, d, 6.3, H7),6.85 (1H, d, 
7.3, H11/H17), 6.83 (1H, d, 7.3, H17/H11), 6.45 (1H, dd, 2.0, 5.6, H3), 6.12 (1H, dd, 1.7, 
5.8, H2), 5.81 (1H, brs, H4), 1.97 (3H, s, H21); 13C NMR (CD3OD, 125 MHz) δ 199.4 
(C9), 197.1 (C6), 172.9 (C20), 151.4 (C8), 150.9 (C7), 148.8 (C10/C18), 148.5 
(C18/C10), 138.2 (C3), 136.0 (C14), 133.2 (C2), 129.0 (C12/C16), 128.9 (C16/C12), 
122.6 (C15/C13), 122.5 (C13/C15), 114.8 (C19), 112.3 (C1), 111.14 (C11/C17), 111.1 
(C17/C11), 80.2 (C4), 65.7 (C5), 20.7 (C21); EIMS m/z (%): 362.1 [M]+ (100), 320.1 
(37), 291.1 (17), 266.1 (15), 237.1 (8), 197.1 (20), 161.0 (24), 133.0 (17), 114.0 (11); 
HREIMS m/z 362.0784 [M]+ (calc for C21H14O6 362.0790). 
 
7.3.14 Quantitative 13C NMR  
 
The ester carbonyl of the acetylated and labelled spiro-mamakone A was used as the 
standard to determine the incorporation of the singly labelled precursors into 3.11. 
The 13C NMR was carried out as usual but with the following changes to the operating 
parameters: 
dm =  ‘nny’ 
at =  0.8 s 
d1 =  12 s 
 
Rather than the standard run time of 2 hours, due to the long delay, these spectra were 
obtained in 12 hours, for the small amount of unlabelled material, this run time was 
increased to 40 hours. 
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7.4  Experimental for Chapter 4 
 
7.4.1  Identification, and Extraction of F5031 
 
Identification of the fungal material was carried out by Professor A. L. J. Cole.  The 
sample was identified by the characteristic tuberous earth ball fruiting body, differing 
from many other known Scleroderma sp. by the yellow colour and thick rooting stalk. 
Fresh fungal material, consisting of three fruiting bodies (12.53 g) were dried and then 
extracted repeatedly with MeOH (100 mL).  The extract was dried under vacuum to yield 
an intense orange solid crude extract (1.479 g).  This was then transported to the 
University of Canterbury, where it was assayed for cytotoxicity, antimicrobial and 
antiviral activity.  
 
7.4.2  Chromatography of F5031 
 
The extract showed only weak cytotoxicity but very strong activity against B. subtilis 
(Sm 11) in the antimicrobial assay.  Based on these results the extract was further 
analysed by analytical HPLC using the standard 10% gradient (Section 7.1.7.2).  The 
HPLC profile revealed the extract to be very simple, seemingly containing a single family 
of four compounds that eluted between 18 and 22 minutes.  The ELSD confirmed these to 
be the major sources of mass in the extract. 
Due to the simplicity of the extract and the clear separation of the four metabolites, flash 
chromatography was deemed unnecessary.  The extract (1.48 g) was first partitioned 
between MeOH and Pet ether.  The resulting MeOH-soluble material (474 mg) was 
analysed by HPLC using the standard 10% gradient and was found to contain the 
metabolites in question.  A portion (50 mg) of the MeOH-soluble fraction was purified 
using semi-preparative HPLC (Section 7.1.7.2) using a linear gradient (ACN/H2O; 60:40-
80:20% with 0.05% TFA over 20 minutes).  This gave four metabolites (SAS-6-6.1–3 
and SAS-6-14).  On the basis of 1D and 2D NMR spectroscopy and mass spectrometry, 
SAS-6-6.1-3 were identified as three known vulpinic acid derivatives (4.12, 4.13, 4.11) 
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(3.1, 1.6, and 1.2 mg respectively), while SAS-6-14 was found to be a novel dichloro-
vulpinic acid derivative (4.14) (2.1 mg).  
 
7.4.3  X-ray Crystallography of 4.14 
 
The structure of 4.14 was confirmed by X-ray crystallography.  4.14 was crystallised 
from MeOH.  A plate crystal with dimensions 0.70 × 0.35 × 0.02 mm3 was used for data 
collection.  The data processing yielded 5260 Bragg reflections, of which 53% were 
unique.  The final R factor was 3.8 %.  See Appendix 1 for tables of data. 
 
7.4.4  Physical Data for the Vulpinic Acid Derivatives 
 
4,4'-dimethoxyvulpinic acid (4.11): orange/yellow powder; 1H and 13C-NMR data see 
Table 4.1; LCMS m/z 383 [M+H]+. 
 
methyl-3'-chloro-4,4'-di-O-methylatromentate (4.12): yellow/green amorphous solid; 
1H and 13C-NMR data see Table 4.2; ESIMS m/z 417/419 [M+H]+. 
 
methyl 4,4'-dimethoxyvulpinate (4.13): yellow amorphous solid; 1H and 13C-NMR 
data, see Table 4.3; LCMS m/z 397 [M+H]+. 
 
Methyl-3',5'-dichloro-4,4'-di-O-methylatromentate (4.14): yellow needles (MeOH): 
m.p. 170-171°C; UV (MeOH) λmax (log ε) 277 (3.84), 399 (3.60) nm; IR (KBr disk) νmax 
1733, 1710, 1600, 1225, 1255, 1188, 1072, 1311 cm-1; 1H- and 13C-NMR data, see Table 
4.4; EIMS m/z (%) 450/452/454 [M]+ (7/5/1), 418/420/422 (100/67/13), 362/364/366 
(35/20/5), 306/308/310 (28/18/4), 175 (19), 147 (57), 119 (41); HREIMS m/z 450.0266 
[M]+ (calc for C21H1635Cl2O7 450.0273).  
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7.5  Experimental for Chapter 5 
 
7.5.1  Extraction and Chromatography of F5202 
 
The second re-grow of F5202 was cultured on 24 MYE agar plates of dimensions stated 
in Section 7.1.1, at 26°C.  After four weeks the plates were extracted with EtOAc 
according to the protocol also given in Section 7.1.1.  This yielded the crude extract (23.5 
mg).  The extract was analysed by analytical HPLC using the standard 10% gradient 
(Section 7.1.7.2) and ELSD.  The resulting chromatogram was not complex, and showed 
just one major compound.  Semi-preparative HPLC using a linear gradient (35-60% 
ACN/H2O with 0.05% TFA over 20 minutes) was used to purify the major compound.  
1D and 2D NMR in conjunction with mass spectrometry confirmed the compound as a 
new acetophenone derivative (5.7) (3.9 mg). 
 
7.5.2  X-ray Crystallography of 5.7 
 
The structure of 5.7 was confirmed by X-ray crystallography.  5.7 was crystallised from 
MeOH by slow evaporation at 4 °C.  A plate crystal with dimensions 0.67 × 0.40 × 0.28 
mm3 was used for data collection.  The data processing yielded 4327 Bragg reflections, of 
which 43% were unique.  The final R factor was 14.1 %.  See Appendix 1 for tables of 
data. 
 
7.5.3  Physical Data for 5.7 
 
2,4 dihydroxy-3-(2-hydroxyethyl)-6-methoxyacetophenone (5.7): cream amorphous 
solid; UV (MeOH) λmax (log ε) 226 (sh), 290 (3.99) nm; IR (KBr disk) νmax 1618, 1294, 
1151, 1111, 1011, 806 cm-1; 1H- and 13C-NMR data, see Table 5.1; EIMS m/z (%) 226 
[M]+ (33), 208 (54), 195 (100); HREIMS m/z 226.0836 [M]+ (calc for C11H14O5 
226.0841).  
 
Chapter 7 Experimental 222 
7.6  Experimental for Chapter 6 
 
7.6.1  Semi-Preparative HPLC Purification of the Trichoderma  
  harzianum extract 
 
A linear gradient of 10-70% ACN/H2O with 0.05% TFA was used for purification this 
yielded the pure compounds, trichobutenolide, harzianolide A, and isoharzinaic acid.  
 
7.6.2  Capillary Probe NMR 
 
All NMR spectra, including the extracts from Scleroderma and the endophyte F5584 that 
were carried out at the Molecular Targets Development Program, National Cancer 
Institute, Fort Detrick, Frederick, Maryland.  These data were recorded on a Varian 
INOVA 500 spectrometer at 23°C, operating at 500 MHz.  The INOVA was equipped 
with with a variable temperature and capillary probe.  Microtitre plates used in the 
analysis were obtained from the analytical HPLC using the standard method given in 
Section 7.1.4. Rather than making daughter plates however, the plates were dried using a 
centrifugal evaporator. 
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Appendix 1 
 
 
X-ray crystallographic data for: 
 
pseurotin A2 (2.8) 
 
spiro-mamakone C (3.15) 
 
methyl-3',5'-dichloro-4,4'-di-O-methylatromentate (4.14) 
 
1,5-dihydroxy-6-(2-hydroxyethyl)-3-methoxyacetophenone (5.7) 
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Table 1.1: Crystal data and structure refinement for 2.8 
 
Empirical formula   C44 H50 N2 O16  
Formula weight 862.86 
Temperature 113(2) K 
Wavelength  0.71073 A  
Crystal system, space group  Tetragonal,  P4(1)  
Unit cell dimensions a = 10.538(10) A  alpha = 90 deg. 
 b = 10.538(19) A  beta = 90 deg. 
 c = 41.99(7) A   gamma = 90 deg. 
Volume 4663(10) A^3  
Z, Calculated density 4,  1.229 Mg/m^3  
Absorption coefficient 0.094 mm^-1 
F(000)  1824 
Crystal size 0.44 x 0.24 x 0.23 mm  
Theta range for data collection  1.94 to 26.43 deg. 
Reflections collected / unique 32305 / 9312 [R(int) = 0.1175]  
Completeness to theta = 26.43 97.9% 
Absorption correction none  
Max. and min. transmission  0.9847 and 0.9551 
Refinement method Full-matrix least-squares on F^2  
Data / restraints / parameters 9312 / 217 / 572  
Goodness-of-fit on F^2 1.531 
Final R indices [I>2sigma(I)] R1 = 0.1575, wR2 = 0.3806 
R indices (all data) R1 = 0.195, wR2 = 0.4038 
Largest diff. peak and hole 3.228 and -0.693 e.A^-3  
 
 
 
Table 1.2: Atomic coordinates (x 10^4) and equivalent isotropic displacement 
Parameters (A^2 x 10^3) for pseurotin A2 (2.8). U(eq) is defined as one  
third of the trace of the orthogonalised Uij tensor. 
 
 x y z U(eq) 
O(1) 1800(14) 8648(13) 1493(3) 19(3) 
C(2) 1810(20) 9895(19) 1598(5) 17(4) 
C(3) 2220(20) 10090(20) 1905(6) 26(5) 
C(4) 2430(20) 8770(20) 2020(5) 24(5) 
C(5) 2100(20) 7850(20) 1783(5) 20(4) 
C(6) 3186(19) 6966(18) 1700(5) 12(4) 
N(7) 2843(17) 5771(17) 1790(4) 19(4) 
C(8) 1586(19) 5702(17) 1937(5) 15(4) 
C(9) 890(30) 6920(20) 1827(7) 37(6) 
C(10) 1549(17) 10833(18) 1321(4) 13(4) 
C(11) 2662(18) 10933(19) 1111(5) 15(4) 
C(12) 2420(20) 11860(20) 844(6) 29(5) 
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C(13) 2140(20) 11650(20) 531(6) 30(5) 
C(14) 2200(30) 10370(30) 376(5) 34(6) 
C(15) 800(30) 9760(30) 378(8) 54(8) 
C(16) 2420(20) 11270(20) 2069(6) 30(5) 
C(17) 848(18) 4509(18) 1826(4) 13(4) 
C(18) -480(20) 4220(20) 1939(5) 22(4) 
C(19) -1090(20) 4940(20) 2168(6) 31(5) 
C(20) -2400(20) 4710(30) 2244(6) 30(6) 
C(21) -2970(50) 3630(40) 2092(9) 71(12) 
C(22) -2460(20) 3090(20) 1861(6) 33(6) 
C(23) -1110(20) 3250(20) 1767(6) 25(5) 
C(24) 2240(20) 4550(20) 2404(5) 26(5) 
O(4) 2718(17) 8508(16) 2321(4) 28(4) 
O(7) 4184(15) 7319(14) 1589(4) 26(4) 
O(8) 1670(14) 5647(13) 2274(4) 23(3) 
O(9) 316(15) 6673(15) 1555(4) 25(3) 
O(10) 417(15) 10488(13) 1186(4) 21(3) 
O(11) 3767(16) 11338(15) 1270(4) 30(4) 
O(17) 1460(20) 3838(16) 1628(4) 39(5) 
O(1') 6699(17) 1198(13) 1055(4) 27(4) 
C(2') 6843(18) -104(19) 961(5) 14(4) 
C(3') 7153(18) -196(18) 651(5) 13(4) 
C(4') 7296(19) 1015(19) 504(5) 15(4) 
C(5') 7010(20) 1965(19) 791(5) 18(4) 
C(6') 8130(30) 2840(20) 847(7) 40(7) 
N(7') 7739(17) 4026(17) 758(4) 18(4) 
C(8') 6528(19) 4158(18) 612(5) 13(4) 
C(9') 5884(17) 2904(16) 703(4) 8(3) 
C(10') 6621(19) -1030(19) 1206(5) 15(4) 
C(11') 7660(20) -1050(20) 1460(5) 22(4) 
C(12') 7440(20) -2040(20) 1731(5) 25(5) 
C(13') 7570(30) -1690(30) 2037(10) 56(10) 
C(14') 7890(40) -340(40) 2150(11) 76(11) 
C(15') 6160(80) 30(50) 2166(17) 173(13) 
C(16') 7380(20) -1480(20) 465(5) 23(5) 
C(17') 5830(20) 5300(20) 768(5) 22(4) 
C(18') 4432(19) 5571(18) 656(5) 15(4) 
C(19') 3870(20) 4990(20) 387(5) 22(5) 
C(20') 2770(30) 5440(30) 308(6) 48(8) 
C(21') 1970(20) 6200(20) 487(5) 17(4) 
C(22') 2640(30) 6790(20) 762(5) 32(6) 
C(23') 3770(20) 6510(20) 816(5) 22(5) 
C(24') 7205(18) 5202(18) 130(5) 14(4) 
O(4') 7541(17) 1308(16) 230(4) 35(4) 
O(6') 9133(18) 2576(15) 980(4) 32(4) 
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O(8') 6564(14) 4145(14) 282(4) 21(3) 
O(9') 5168(16) 3244(16) 1013(3) 25(3) 
O(10') 5441(13) -609(15) 1383(4) 26(4) 
O(11') 8785(14) -1542(14) 1269(4) 21(3) 
O(17') 6341(13) 6055(12) 919(3) 17(3) 
 
 
Table 1.3: Bond lengths [A] and angles [deg] for pseurotin A2 (2.8) 
O(1)-C(2) 1.39(3) C(2)-O(1)-C(5) 105.4(15) 
O(1)-C(5) 1.51(3) O(1)-C(2)-C(3) 116.3(18) 
C(2)-C(3) 1.37(3) O(1)-C(2)-C(10) 111.3(16) 
C(2)-C(10) 1.55(3) C(3)-C(2)-C(10) 131.8(19) 
C(3)-C(16) 1.45(3) C(2)-C(3)-C(16) 128(2) 
C(3)-C(4) 1.48(3) C(2)-C(3)-C(4) 103(2) 
C(4)-O(4) 1.33(3) C(16)-C(3)-C(4) 129(2) 
C(4)-C(5) 1.43(3) O(4)-C(4)-C(5) 125(2) 
C(5)-C(6) 1.52(3) O(4)-C(4)-C(3) 123(2) 
C(5)-C(9) 1.62(3) C(5)-C(4)-C(3) 111.5(19) 
C(6)-O(7) 1.21(3) C(4)-C(5)-O(1) 103.6(17) 
C(6)-N(7) 1.36(3) C(4)-C(5)-C(6) 112.9(18) 
N(7)-C(8) 1.46(3) O(1)-C(5)-C(6) 108.1(16) 
C(8)-O(8) 1.42(2) C(4)-C(5)-C(9) 122(2) 
C(8)-C(9) 1.55(3) O(1)-C(5)-C(9) 105.5(17) 
C(8)-C(17) 1.55(3) C(6)-C(5)-C(9) 104.2(17) 
C(9)-O(9) 1.32(3) O(7)-C(6)-N(7) 128.4(18) 
C(10)-O(10) 1.37(2) O(7)-C(6)-C(5) 123.8(18) 
C(10)-C(11) 1.47(3) N(7)-C(6)-C(5) 107.6(17) 
C(11)-O(11) 1.41(3) C(6)-N(7)-C(8) 113.8(16) 
C(11)-C(12) 1.51(3) O(8)-C(8)-N(7) 111.5(16) 
C(12)-C(13) 1.36(3) O(8)-C(8)-C(9) 111.2(16) 
C(13)-C(14) 1.51(4) N(7)-C(8)-C(9) 105.3(16) 
C(14)-C(15) 1.61(4) O(8)-C(8)-C(17) 107.4(15) 
C(17)-O(17) 1.27(3) N(7)-C(8)-C(17) 111.6(15) 
C(17)-C(18) 1.51(3) C(9)-C(8)-C(17) 110.0(17) 
C(18)-C(23) 1.41(3) O(9)-C(9)-C(8) 108.5(18) 
C(18)-C(19) 1.39(3) O(9)-C(9)-C(5) 112(2) 
C(19)-C(20) 1.43(3) C(8)-C(9)-C(5) 99.5(19) 
C(20)-C(21) 1.43(5) O(10)-C(10)-C(11) 117.5(16) 
C(21)-C(22) 1.24(5) O(10)-C(10)-C(2) 107.4(16) 
C(22)-C(23) 1.49(3) C(11)-C(10)-C(2) 110.6(16) 
C(24)-O(8) 1.41(3) O(11)-C(11)-C(10) 113.2(16) 
O(1')-C(5') 1.41(3) O(11)-C(11)-C(12) 107.2(18) 
O(1')-C(2') 1.44(2) C(10)-C(11)-C(12) 111.0(17) 
C(2')-C(3') 1.34(3) C(13)-C(12)-C(11) 130(2) 
C(2')-C(10') 1.44(3) C(12)-C(13)-C(14) 123(2) 
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C(3')-C(4') 1.43(3) C(13)-C(14)-C(15) 109(2) 
C(3')-C(16') 1.58(3) O(17)-C(17)-C(18) 124.5(19) 
C(4')-O(4') 1.22(3) O(17)-C(17)-C(8) 113.1(17) 
C(4')-C(5') 1.59(3) C(18)-C(17)-C(8) 122.4(16) 
C(5')-C(6') 1.52(3) C(23)-C(18)-C(19) 122(2) 
C(5')-C(9') 1.59(3) C(23)-C(18)-C(17) 114.8(19) 
C(6')-O(6') 1.22(4) C(19)-C(18)-C(17) 123(2) 
C(6')-N(7') 1.37(3) C(18)-C(19)-C(20) 120(2) 
N(7')-C(8') 1.42(3) C(21)-C(20)-C(19) 116(3) 
C(8')-O(8') 1.39(2) C(22)-C(21)-C(20) 122(3) 
C(8')-C(17') 1.56(3) C(21)-C(22)-C(23) 125(3) 
C(8')-C(9') 1.53(3) C(18)-C(23)-C(22) 113(2) 
C(9')-O(9') 1.55(2) C(24)-O(8)-C(8) 116.5(16) 
C(10')-O(10') 1.51(3) C(5')-O(1')-C(2') 107.8(15) 
C(10')-C(11') 1.53(3) C(3')-C(2')-O(1') 111.2(16) 
C(11')-O(11') 1.52(3) C(3')-C(2')-C(10') 133.1(19) 
C(11')-C(12') 1.56(3) O(1')-C(2')-C(10') 115.7(17) 
C(12')-C(13') 1.34(5) C(2')-C(3')-C(4') 112.3(17) 
C(13')-C(14') 1.53(5) C(2')-C(3')-C(16') 125.3(18) 
C(14')-C(15') 1.87(9) C(4')-C(3')-C(16') 122.4(17) 
C(17')-O(17') 1.15(3) O(4')-C(4')-C(3') 131.1(19) 
C(17')-C(18') 1.57(3) O(4')-C(4')-C(5') 126.5(19) 
C(18')-C(23') 1.39(3) C(3')-C(4')-C(5') 102.4(16) 
C(18')-C(19') 1.42(3) O(1')-C(5')-C(6') 114.3(19) 
C(19')-C(20') 1.30(4) O(1')-C(5')-C(9') 111.2(16) 
C(20')-C(21') 1.39(3) C(6')-C(5')-C(9') 103.9(18) 
C(21')-C(22') 1.49(3) O(1')-C(5')-C(4') 106.1(16) 
C(22')-C(23') 1.25(4) C(6')-C(5')-C(4') 110.7(17) 
C(24')-O(8') 1.45(2) C(9')-C(5')-C(4') 110.7(15) 
 
 
 
Table 1.4: Anisotropic displacement parameters (A^2 x 10^3) for pseurotin A2 (2.8). The 
anisotropic displacement factor takes the form: -2pi^2 [h^2 a*^2 U11 + … +2hka*b* U12]. 
 
 U11 U22 U33 U23 U13 U12 
O(1) 16(7) 19(7) 24(8) 9(6) 9(6) 8(6) 
C(2) 17(4) 17(4) 17(4) 0(2) 0(2) 0(2) 
C(3) 26(5) 26(5) 26(5) 0(2) 0(2) 0(2) 
C(4) 24(5) 24(5) 24(5) 1(2) 0(2) 0(2) 
C(5) 20(5) 20(5) 20(5) 0(2) 0(2) 0(2) 
C(6) 13(4) 12(4) 12(4) 0(2) 0(2) 0(2) 
N(7) 19(4) 19(4) 19(4) 0(2) 0(2) 0(2) 
C(8) 19(10) 7(8) 18(9) -2(7) 9(8) 7(7) 
C(9) 46(16) 15(11) 49(16) -7(10) 22(13) -7(10) 
C(10) 13(4) 13(4) 12(4) 1(2) 0(2) 0(2) 
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C(11) 15(4) 15(4) 16(4) 1(2) 0(2) 0(2) 
C(12) 25(12) 33(13) 29(12) 11(10) 9(10) 19(10) 
C(13) 30(5) 30(5) 30(5) 0(2) 0(2) 0(2) 
C(14) 54(16) 40(14) 9(9) -6(10) -7(10) 18(12) 
C(15) 54(8) 53(8) 54(8) 0(3) -2(3) 0(3) 
C(16) 31(6) 29(6) 30(6) 2(3) 1(3) 1(3) 
C(17) 13(4) 12(4) 13(4) 0(2) 0(2) 0(2) 
C(18) 22(5) 22(5) 23(5) 0(2) -1(2) 1(2) 
C(19) 31(6) 31(6) 30(6) 0(2) 1(2) 0(2) 
C(20) 13(10) 49(15) 28(12) -10(12) 14(9) 16(10) 
C(21) 100(30) 60(20) 60(20) 4(18) 20(20) -30(20) 
C(22) 33(6) 33(6) 33(6) 0(2) 1(2) -1(2) 
C(23) 19(11) 13(9) 42(13) -16(10) -6(10) 9(8) 
C(24) 26(6) 27(6) 27(6) 1(3) 1(3) 2(3) 
O(4) 37(9) 30(9) 18(7) -13(7) 4(7) -8(7) 
O(7) 20(8) 11(7) 48(10) 4(7) 9(7) 11(6) 
O(8) 22(7) 11(7) 35(8) -1(6) -4(7) 5(6) 
O(9) 23(8) 18(7) 35(9) 6(7) -16(7) -6(6) 
O(10) 30(9) 9(7) 23(8) 9(6) -7(7) 2(6) 
O(11) 33(9) 25(8) 32(8) -12(7) 8(8) -13(7) 
O(17) 71(14) 24(8) 21(8) -11(7) -3(9) 6(9) 
O(1') 49(10) 4(6) 28(8) 5(6) 13(8) 4(7) 
C(2') 8(8) 19(10) 16(9) 10(8) 2(7) 9(7) 
C(3') 13(4) 13(4) 13(4) 0(2) 0(2) 0(2) 
C(4') 15(4) 15(4) 15(4) -1(2) 1(2) 0(2) 
C(5') 18(4) 18(4) 18(4) 0(2) 1(2) 0(2) 
C(6') 48(16) 33(13) 38(14) -7(11) 25(13) -5(12) 
N(7') 18(4) 18(4) 19(4) 0(2) 0(2) 0(2) 
C(8') 13(4) 14(4) 13(4) -1(2) 0(2) -1(2) 
C(9') 8(4) 8(4) 8(4) -1(2) 1(2) 0(2) 
C(10') 16(4) 15(4) 15(4) 0(2) 0(2) 0(2) 
C(11') 22(5) 22(5) 22(5) 1(2) 0(2) 0(2) 
C(12') 
C(13') 
25(5) 
22(14) 
25(5) 
36(15) 
25(5) 
110(30) 
0(2) 
21(17) 
0(2) 
2(15) 
1(2) 
23(12) 
C(14') 76(11) 76(11) 76(11) 0(2) 0(2) 0(2) 
C(15') 261(14) 83(14) 174(14) 0(3) 194(3) 0(3) 
C(16') 24(5) 22(5) 24(5) 1(3) 1(3) -1(3) 
C(17') 22(5) 22(5) 22(5) 0(2) 1(2) 0(2) 
C(18') 14(4) 15(4) 15(4) 0(2) -1(2) 0(2) 
C(19') 21(5) 22(5) 22(5) 0(2) 0(2) 0(2) 
C(20') 65(19) 70(20) 13(11) 1(13) 3(12) 27(16) 
C(21') 17(4) 17(4) 17(4) 0(2) 0(2) -1(2) 
C(22') 56(16) 23(11) 18(10) -18(10) 2(11) -8(11) 
C(23') 23(5) 22(5) 22(5) 0(2) 1(2) 0(2) 
C(24') 15(5) 12(5) 14(5) 1(3) 1(3) 1(3) 
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O(4') 41(10) 18(8) 46(10) 10(8) 18(8) 1(7) 
O(6') 41(10) 23(8) 33(9) 5(7) -20(8) 17(8) 
O(8') 21(3) 20(3) 21(3) 0(2) 0(2) -1(2) 
O(9') 31(8) 30(8) 14(7) -1(6) 6(6) -14(7) 
O(10') 5(6) 33(9) 39(9) 32(7) -2(6) -8(6) 
O(11') 21(4) 19(4) 24(4) 0(3) 0(3) -2(3) 
O(17') 14(7) 4(6) 32(8) -4(6) -5(6) -1(5) 
 
 
 
Table1.5: Hydrogen coordinates (x10^4) and isotropic displacement parameters 
(A^2x10^3) for pseurotin A2 (2.8). 
 
 x y z U(eq) 
H(7) 3333 5103 1762 23 
H(9) 284 7235 1992 44 
H(10) 1420 11688 1419 15 
H(11) 2830 10079 1015 18 
H(12) 2471 12728 904 35 
H(13) 1899 12361 404 36 
H(14A) 2798 9814 494 41 
H(14B) 2512 10452 154 41 
H(15A) 547 9570 597 80 
H(15B) 801 8970 253 80 
H(15C) 197 10358 284 80 
H(16A) 3100 11748 1961 45 
H(16B) 2671 11106 2290 45 
H(16C) 1640 11776 2066 45 
H(19) -644 5593 2276 37 
H(20) -2856 5235 2386 36 
H(21) -3753 3314 2171 86 
H(22) -2976 2550 1735 40 
H(23) -705 2748 1608 30 
H(24A) 1595 3901 2442 40 
H(24B) 2657 4767 2606 40 
H(24C) 2880 4222 2255 40 
H(9A) -438 6928 1565 38 
H(10A) -163 10962 1254 31 
H(11A) 4187 11819 1150 45 
H(7') 8224 4693 790 22 
H(9') 5315 2565 532 10 
H(10') 6500 -1894 1112 18 
H(11') 7830 -180 1548 26 
H(12') 7218 -2888 1680 30 
H(13') 7452 -2321 2195 67 
H(14C) 8360 164 1991 91 
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H(14D) 8312 -317 2360 91 
H(15D) 5865 299 1955 259 
H(15E) 6009 715 2320 259 
H(15F) 5685 -727 2232 259 
H(16D) 8265 -1741 490 35 
H(16E) 7195 -1350 239 35 
H(16F) 6819 -2137 551 35 
H(19') 4268 4314 273 26 
H(20') 2478 5229 101 58 
H(21') 1096 6335 440 21 
H(22') 2216 7381 896 39 
H(23') 4208 6975 977 27 
H(24D) 6880 6001 217 20 
H(24E) 7050 5175 -100 20 
H(24F) 8119 5143 171 20 
H(9'1) 4523 2780 1030 37 
H(10B) 5197 -1194 1504 38 
H(11B) 9295 -1911 1392 32 
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Table 1.6: Crystal data and structure refinement for 3.15 
 
Empirical formula   C19 H14 O5  
Formula weight 322.3 
Temperature 93(2) K 
Wavelength  0.71073 A  
Crystal system, space group  Monoclinic,  P2(1)/c  
Unit cell dimensions a = 7.0404(19) A  alpha = 90 deg. 
 b = 8.6194(19) A  beta = 91.611(13) deg. 
 c = 24.924(6) A   gamma = 90 deg. 
Volume 1511.9(7) A^3  
Z, Calculated density 4,  1.416 Mg/m^3  
Absorption coefficient 0.103 mm^-1 
F(000)  672 
Crystal size 0.45 x 0.20 x 0.15 mm  
Theta range for data collection  1.63 to 24.99 deg. 
Limiting indices -7<=h<=7, -8<=k<=9, -29<=l<=20  
Reflections collected / unique 1652 / 1369 [R(int) = 0.0758]  
Completeness to theta = 24.99 51.40% 
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission  0.9847 and 0.9551 
Refinement method Full-matrix least-squares on F^2  
Data / restraints / parameters 1369 / 24 / 219  
Goodness-of-fit on F^2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0745, wR2 = 0.2008 
R indices (all data) R1 = 0.0872, wR2 = 0.2151 
Largest diff. peak and hole 0.512 and -0.361 e.A^-3  
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Table 1.7: Atomic coordinates ( x 10^4) and equivalent isotropic  
displacement parameters (A^2 x 10^3) for 3.15. U(eq) is defined  
as one third of the trace of the orthogonalized Uij tensor.  
 
 x y z U(eq) 
C(1) 3085(8) 6051(5) 3982(2) 14(1) 
C(2) 2343(8) 4878(6) 4382(2) 17(1) 
C(3) 2422(8) 5477(5) 4874(2) 18(1) 
C(4) 3211(8) 7110(5) 4884(2) 16(1) 
C(5) 2957(9) 7612(5) 4279(2) 17(1) 
C(6) 983(8) 8400(6) 4218(2) 17(1) 
C(7) 1310(9) 10061(6) 4153(2) 22(1) 
C(8) 3154(9) 10353(6) 4085(2) 21(1) 
C(9) 4344(8) 8900(5) 4089(2) 16(1) 
C(10) 2262(8) 4821(5) 3160(2) 14(1) 
C(11) 877(8) 4468(6) 2773(2) 18(1) 
C(12) 1255(8) 3207(6) 2415(2) 23(1) 
C(13) 2879(9) 2353(6) 2467(2) 21(1) 
C(14) 4305(9) 2687(5) 2870(2) 20(1) 
C(15) 5997(8) 1856(6) 2942(2) 22(1) 
C(16) 7376(8) 2346(6) 3306(2) 23(1) 
C(17) 7070(8) 3692(6) 3633(2) 20(1) 
C(18) 5405(7) 4449(5) 3586(2) 14(1) 
C(19) 3938(8) 3974(5) 3216(2) 16(1) 
O(4) 2189(6) 8088(4) 5239(1) 20(1) 
O(6) -552(6) 7709(4) 4230(1) 22(1) 
O(9) 5985(6) 9133(4) 4430(1) 21(1) 
O(10) 2002(5) 6118(4) 3486(1) 15(1) 
O(18) 5052(5) 5793(4) 3881(1) 16(1) 
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Table 1.8: Bond lengths [A] and angles [deg] for 3.15. 
 
C(1)-O(18) 1.432(7)  O(18)-C(1)-O(10) 110.3(3) C(10)-C(11)-C(12) 117.4(5) 
C(1)-O(10) 1.435(5)  O(18)-C(1)-C(2) 111.3(4) C(10)-C(11)-H(11) 121.3 
C(1)-C(2) 1.523(6)  O(10)-C(1)-C(2) 114.0(4) C(12)-C(11)-H(11) 121.3 
C(1)-C(5) 1.539(6)  O(18)-C(1)-C(5) 106.9(4) C(13)-C(12)-C(11) 121.3(4) 
C(2)-C(3) 1.329(6)  O(10)-C(1)-C(5) 110.0(4) C(13)-C(12)-H(12) 119.4 
C(2)-H(2) 0.93  C(2)-C(1)-C(5) 103.8(3) C(11)-C(12)-H(12) 119.4 
C(3)-C(4) 1.513(7)  C(3)-C(2)-C(1) 109.9(4) C(12)-C(13)-C(14) 121.9(4) 
C(3)-H(3) 0.93  C(3)-C(2)-H(2) 125.1 C(12)-C(13)-H(13) 119 
C(4)-O(4) 1.430(5)  C(1)-C(2)-H(2) 125.1 C(14)-C(13)-H(13) 119 
C(4)-C(5) 1.575(5)  C(2)-C(3)-C(4) 112.5(4) C(15)-C(14)-C(13) 124.6(4) 
C(4)-H(4) 0.98  C(2)-C(3)-H(3) 123.8 C(15)-C(14)-C(19) 119.1(5) 
C(5)-C(6) 1.551(8)  C(4)-C(3)-H(3) 123.8 C(13)-C(14)-C(19) 116.3(5) 
C(5)-C(9) 1.561(7)  O(4)-C(4)-C(3) 111.6(4) C(16)-C(15)-C(14) 120.7(5) 
C(6)-O(6) 1.235(7)  O(4)-C(4)-C(5) 112.6(4) C(16)-C(15)-H(15) 119.6 
C(6)-C(7) 1.460(7)  C(3)-C(4)-C(5) 102.0(3) C(14)-C(15)-H(15) 119.6 
C(7)-C(8) 1.338(8)  O(4)-C(4)-H(4) 110.1 C(15)-C(16)-C(17) 120.5(5) 
C(7)-H(7) 0.93  C(3)-C(4)-H(4) 110.1 C(15)-C(16)-H(16) 119.7 
C(8)-C(9) 1.507(7)  C(5)-C(4)-H(4) 110.1 C(17)-C(16)-H(16) 119.7 
C(8)-H(8) 0.93  C(1)-C(5)-C(6) 113.6(4) C(18)-C(17)-C(16) 119.0(4) 
C(9)-O(9) 1.429(6)  C(1)-C(5)-C(9) 115.5(4) C(18)-C(17)-H(17) 120.5 
C(9)-H(9) 0.98  C(6)-C(5)-C(9) 103.0(4) C(16)-C(17)-H(17) 120.5 
C(10)-C(11) 1.386(7)  C(1)-C(5)-C(4) 102.4(3) C(17)-C(18)-O(18) 121.6(4) 
C(10)-C(19) 1.391(8)  C(6)-C(5)-C(4) 107.0(4) C(17)-C(18)-C(19) 122.1(4) 
C(10)-O(10) 1.397(5)  C(9)-C(5)-C(4) 115.5(4) O(18)-C(18)-C(19) 116.2(4) 
C(11)-C(12) 1.437(6)  O(6)-C(6)-C(7) 128.1(5) C(10)-C(19)-C(18) 120.7(4) 
C(11)-H(11) 0.93  O(6)-C(6)-C(5) 124.6(5) C(10)-C(19)-C(14) 120.9(4) 
C(12)-C(13) 1.362(8)  C(7)-C(6)-C(5) 107.3(5) C(18)-C(19)-C(14) 118.2(5) 
C(12)-H(12) 0.93  C(8)-C(7)-C(6) 110.8(5) C(4)-O(4)-H(4A) 109.5 
C(13)-C(14) 1.430(8)  C(8)-C(7)-H(7) 124.6 C(9)-O(9)-H(9A) 109.5 
C(13)-H(13) 0.93  C(6)-C(7)-H(7) 124.6 C(10)-O(10)-C(1) 113.2(3) 
C(14)-C(15) 1.397(8)  C(7)-C(8)-C(9) 112.6(5)   
C(14)-C(19) 1.433(6)  C(7)-C(8)-H(8) 123.7   
C(15)-C(16) 1.375(8)  C(9)-C(8)-H(8) 123.7   
C(15)-H(15) 0.93  O(9)-C(9)-C(8) 109.1(4)   
C(16)-C(17) 1.438(6)  O(9)-C(9)-C(5) 114.9(3)   
C(16)-H(16) 0.93  C(8)-C(9)-C(5) 104.0(5)   
C(17)-C(18) 1.344(8)  O(9)-C(9)-H(9) 109.5   
C(17)-H(17) 0.93  C(8)-C(9)-H(9) 109.5   
C(18)-O(18) 1.398(5)  C(5)-C(9)-H(9) 109.5   
C(18)-C(19) 1.425(7)  C(11)-C(10)-C(19) 122.2(4)   
O(4)-H(4A) 0.82  C(11)-C(10)-O(10) 118.6(4)   
O(9)-H(9A) 0.82  C(19)-C(10)-O(10) 119.1(4)   
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Table 1.9: Anisotropic displacement parameters (A^2 x 10^3) for 3.15. The anisotropic  
displacement factor exponent takes the form:-2 pi^2 [h^2 a*^2 U11 + 2 h k a* b* U12]  
 
 U11 U22 U33 U23 U13 U12 
C(1) 15(4) 13(3) 15(2) -2(2) 11(2) 2(2) 
C(2) 23(4) 12(3) 17(2) 0(2) 5(2) -1(2) 
C(3) 23(4) 15(3) 17(2) 1(2) 17(2) 5(2) 
C(4) 19(4) 16(3) 11(2) -1(2) 10(2) -2(2) 
C(5) 26(4) 12(3) 13(2) -1(2) 13(2) 1(2) 
C(6) 22(4) 21(3) 10(2) -4(2) 8(2) 3(2) 
C(7) 27(4) 19(3) 20(2) 1(2) 12(3) 9(2) 
C(8) 30(4) 16(3) 17(2) 2(2) 9(2) 0(2) 
C(9) 20(4) 17(3) 13(2) 0(2) 12(2) -4(2) 
C(10) 15(1) 13(1) 14(1) 1(1) 4(1) -1(1) 
C(11) 19(4) 18(3) 18(2) 4(2) 13(2) 0(2) 
C(12) 25(4) 25(3) 19(2) -3(2) 7(2) -9(2) 
C(13) 28(4) 16(3) 21(2) -6(2) 11(2) -3(2) 
C(14) 31(4) 15(3) 16(2) 1(2) 15(2) -1(2) 
C(15) 23(2) 21(1) 21(1) -2(1) 5(1) 1(1) 
C(16) 20(4) 30(3) 18(2) 2(2) 11(2) 11(2) 
C(17) 19(4) 31(3) 9(2) 1(2) 7(2) 0(2) 
C(18) 15(1) 14(1) 14(1) 1(1) 4(1) 0(1) 
C(19) 16(2) 16(1) 15(1) 1(1) 4(1) -2(1) 
O(4) 26(3) 22(2) 13(1) -6(1) 14(2) -2(2) 
O(6) 20(3) 23(2) 23(2) -4(1) 11(2) 2(2) 
O(9) 19(3) 20(2) 26(2) -7(1) 11(2) -1(2) 
O(10) 14(2) 20(2) 13(1) -2(1) 9(1) 2(1) 
O(18) 13(3) 20(2) 15(1) -3(1) 13(2) -1(1) 
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Table 1.10: Hydrogen coordinates ( x 10^4) and isotropic 
displacement parameters (A^2 x 10^3) for 3.15. 
 
 x y z U(eq) 
H(2) 1901 3890 4296 20 
H(3) 2035 4950 5178 22 
H(4) 4562 7093 4990 19 
H(7) 365 10814 4157 26 
H(8) 3647 11344 4040 25 
H(9) 4740 8669 3724 19 
H(11) -253 5025 2747 21 
H(12) 375 2968 2142 27 
H(13) 3065 1530 2233 25 
H(15) 6194 961 2743 26 
H(16) 8514 1804 3340 27 
H(17) 8012 4033 3875 24 
H(4A) 2829 8857 5313 30 
H(9A) 6838 8551 4338 32 
 
 
Table 1.11: Hydrogen bonds for 3.15 [A and deg.]. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
     
O(4)-H(4A)...O(9)#1 0.82 2.02 2.831(5) 170.1 
O(9)-H(9A)...O(6)#2 0.82 2 2.787(5) 160.4 
 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+2,-z+1    #2 x+1,y,z 
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Table 1.12: Torsion angles (deg]) for 3.15 
 
O(18)-C(1)-C(2)-C(3)  95.5(5) C(6)-C(5)-C(9)-C(8) 14.4(4) 
O(10)-C(1)-C(2)-C(3) -138.9(4) C(4)-C(5)-C(9)-C(8) -101.8(5) 
C(5)-C(1)-C(2)-C(3) -19.2(6) C(19)-C(10)-C(11)-C(12) -1.9(7) 
C(1)-C(2)-C(3)-C(4) 0.0(7) O(10)-C(10)-C(11)-C(12) 174.9(4) 
C(2)-C(3)-C(4)-O(4) 139.1(5) C(10)-C(11)-C(12)-C(13) 2.5(7) 
C(2)-C(3)-C(4)-C(5) 18.6(6) C(11)-C(12)-C(13)-C(14) -1.5(9) 
O(18)-C(1)-C(5)-C(6) 156.3(3) C(12)-C(13)-C(14)-C(15) -179.9(5) 
O(10)-C(1)-C(5)-C(6) 36.5(6) C(12)-C(13)-C(14)-C(19) -0.3(8) 
C(2)-C(1)-C(5)-C(6) -85.9(4) C(13)-C(14)-C(15)-C(16) 173.6(5) 
O(18)-C(1)-C(5)-C(9) 37.7(5) C(19)-C(14)-C(15)-C(16) -6.1(8) 
O(10)-C(1)-C(5)-C(9) -82.2(5) C(14)-C(15)-C(16)-C(17) 2.4(8) 
C(2)-C(1)-C(5)-C(9) 155.4(4) C(15)-C(16)-C(17)-C(18) 1.1(8) 
O(18)-C(1)-C(5)-C(4) -88.7(4) C(16)-C(17)-C(18)-O(18) -177.9(4) 
O(10)-C(1)-C(5)-C(4) 151.5(4) C(16)-C(17)-C(18)-C(19) -0.8(8) 
C(2)-C(1)-C(5)-C(4) 29.0(5) C(11)-C(10)-C(19)-C(18) 174.5(4) 
O(4)-C(4)-C(5)-C(1) -148.3(4) O(10)-C(10)-C(19)-C(18) -2.3(7) 
C(3)-C(4)-C(5)-C(1) -28.6(5) C(11)-C(10)-C(19)-C(14) 0.2(8) 
O(4)-C(4)-C(5)-C(6) -28.6(6) O(10)-C(10)-C(19)-C(14) -176.6(4) 
C(3)-C(4)-C(5)-C(6) 91.1(5) C(17)-C(18)-C(19)-C(10) -177.2(5) 
O(4)-C(4)-C(5)-C(9) 85.3(6) O(18)-C(18)-C(19)-C(10) 0.0(7) 
C(3)-C(4)-C(5)-C(9) -154.9(4) C(17)-C(18)-C(19)-C(14) -2.8(7) 
C(1)-C(5)-C(6)-O(6) 40.4(6) O(18)-C(18)-C(19)-C(14) 174.4(4) 
C(9)-C(5)-C(6)-O(6) 166.0(4) C(15)-C(14)-C(19)-C(10) -179.4(5) 
C(4)-C(5)-C(6)-O(6) -71.8(5) C(13)-C(14)-C(19)-C(10) 0.9(7) 
C(1)-C(5)-C(6)-C(7) -140.2(4) C(15)-C(14)-C(19)-C(18) 6.2(7) 
C(9)-C(5)-C(6)-C(7) -14.6(4) C(13)-C(14)-C(19)-C(18) -173.5(4) 
C(4)-C(5)-C(6)-C(7) 107.6(4) C(11)-C(10)-O(10)-C(1) 158.0(4) 
O(6)-C(6)-C(7)-C(8) -171.4(4) C(19)-C(10)-O(10)-C(1) -25.1(6) 
C(5)-C(6)-C(7)-C(8) 9.3(5) O(18)-C(1)-O(10)-C(10) 54.0(5) 
C(6)-C(7)-C(8)-C(9) 0.7(5) C(2)-C(1)-O(10)-C(10) -72.1(5) 
C(7)-C(8)-C(9)-O(9) -133.2(4) C(5)-C(1)-O(10)-C(10) 171.7(4) 
C(7)-C(8)-C(9)-C(5) -10.1(4) C(17)-C(18)-O(18)-C(1) -152.8(4) 
C(1)-C(5)-C(9)-O(9) -102.0(5) C(19)-C(18)-O(18)-C(1) 30.0(5) 
C(6)-C(5)-C(9)-O(9) 133.6(4) O(10)-C(1)-O(18)-C(18) -57.2(4) 
C(4)-C(5)-C(9)-O(9) 17.4(6) C(2)-C(1)-O(18)-C(18) 70.5(4) 
C(1)-C(5)-C(9)-C(8) 138.8(4) C(5)-C(1)-O(18)-C(18) -176.8(3) 
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Table 1.13: Crystal data and structure refinement for SAS-6-14 (4.14) 
 
Empirical formula C21 H16 Cl2 O7  
Formula weight 451.24 
Temperature 113(2) K 
Wavelength 0.71073 A 
Crystal system, space group Monoclinic,  P2(1)/c 
Unit cell dimensions a = 16.216(5) A   alpha = 90  
 b = 17.340(5) A    beta = 92 
 c = 7.0255(19) A   gamma = 90  
Volume 1974.2(10) A^3  
Z, Calculated density 4,  1.518 Mg/m^3  
Absorption coefficient 0.372 mm^-1 
F(000) 928 
Crystal size 0.70 x 0.35 x 0.02 mm  
Theta range for data collection 3.41 to 25.00 deg.  
Limiting indices -17<=h<=16, -19<=k<=19, -3<=l<=8 
Reflections collected / unique 5260 / 2781 [R(int) = 0.0429]  
Completeness to theta = 25.00 79.70% 
Absorption correction None 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 2781 / 0 / 275 
Goodness-of-fit on F^2 1.089 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.0757  
R indices (all data) R1 = 0.0818, wR2 = 0.0860 
Largest diff. peak and hole 0.230 and -0.210 e.A^-3 
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Table 1.14: Atomic coordinates (x 10^4) and equivalent isotropic 
displacement parameters (A^2 x 10^3) for Compound 4.14. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
Cl(1) 1799(1) 1756(1) 541(1) 24(1)  
Cl(2) 1081(1) 4784(1) 1166(1) 37(1)  
C(1') 3145(2) 3660(2) -31(4) 18(1) 
C(2') 2569(2) 4241(2) 273(4) 21(1) 
C(3') 1769(2) 4049(2) 666(4) 22(1) 
C(4') 1507(2) 3279(2) 727(4) 19(1) 
C(5') 2093(2) 2717(2) 437(4) 18(1)  
C(6') 2901(2) 2896(2) 78(4) 18(1)  
C(1") 5114(2) 3215(2) 3639(4) 19(1)  
C(2") 5828(2) 3495(2) 2620(4) 18(1)  
C(3") 5519(2) 3784(2) 952(4) 19(1)  
C(4") 4626(2) 3690(2) 832(4) 18(1) 
C(5") 4012(2) 3867(2) -447(4) 17(1)  
C(6") 4161(2) 4272(2) -2242(4) 20(1)  
C(1) 6676(2) 3471(2) 3410(4) 21(1)  
C(2) 7332(2) 3731(2) 2340(4) 23(1)  
C(3) 8129(2) 3770(2) 3115(4) 24(1)  
C(4) 8293(2) 3548(2) 4965(4) 22(1) 
C(5) 7657(2) 3260(2) 6036(4) 27(1)  
C(6) 6867(2) 3225(2) 5275(4) 27(1)  
O(4) 9054(1) 3579(1) 5889(3) 27(1)  
C(7) 9689(2) 3956(2) 4894(5) 33(1)  
O(4') 722(1) 3091(1) 1192(3) 25(1) 
C(7') 113(2) 3149(2) -343(4) 27(1)  
O(7) 3474(1) 4352(1) -3283(3) 24(1)  
C(7") 3511(2) 4721(2) -5125(4) 27(1) 
O(1) 5037(1) 2932(1) 5167(3) 26(1)  
O(2) 4402(1) 3336(1) 2484(3) 18(1)  
O(3) 5960(1) 4115(1) -388(3) 27(1)  
O(6) 4830(1) 4513(1) -2759(3) 25(1)  
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Table 1.15: Bond lengths [A] and angles [deg] for 4.14. 
 
Cl(1)-C(5') 1.736(3)  C(7")-H(7"1) 0.98 
Cl(2)-C(3') 1.738(3)  C(7")-H(7"2) 0.98 
C(1')-C(6') 1.386(4)  C(7")-H(7"3) 0.98 
C(1')-C(2') 1.395(4)  O(3)-H(3) 0.84 
C(1')-C(5") 1.491(4)  C(6')-C(1')-C(2') 119.2(3) 
C(2')-C(3') 1.376(4)  C(6')-C(1')-C(5") 121.0(3) 
C(2')-H(2') 0.95  C(2')-C(1')-C(5") 119.9(3) 
C(3')-C(4') 1.402(4)  C(3')-C(2')-C(1') 119.8(3) 
C(4')-O(4') 1.365(3)  C(3')-C(2')-H(2') 120.1 
C(4')-C(5') 1.381(4)  C(1')-C(2')-H(2') 120.1 
C(5')-C(6') 1.378(4)  C(2')-C(3')-C(4') 121.7(3) 
C(6')-H(6') 0.95  C(2')-C(3')-Cl(2) 118.6(2) 
C(1")-O(1) 1.191(3)  C(4')-C(3')-Cl(2) 119.6(2) 
C(1")-O(2) 1.402(3)  O(4')-C(4')-C(5') 121.3(3) 
C(1")-C(2") 1.467(4)  O(4')-C(4')-C(3') 121.5(3) 
C(2")-C(3") 1.354(4)  C(5')-C(4')-C(3') 117.1(3) 
C(2")-C(1) 1.464(4)  C(6')-C(5')-C(4') 122.2(3) 
C(3")-O(3) 1.333(3)  C(6')-C(5')-Cl(1) 119.2(2) 
C(3")-C(4") 1.457(4)  C(4')-C(5')-Cl(1) 118.7(2) 
C(4")-C(5") 1.351(4)  C(5')-C(6')-C(1') 120.0(3) 
C(4")-O(2) 1.373(3)  C(5')-C(6')-H(6') 120 
C(5")-C(6") 1.472(4)  C(1')-C(6')-H(6') 120 
C(6")-O(6) 1.228(3)  O(1)-C(1")-O(2) 118.2(3) 
C(6")-O(7) 1.318(4)  O(1)-C(1")-C(2") 133.4(3) 
C(1)-C(2) 1.399(4)  O(2)-C(1")-C(2") 108.4(2) 
C(1)-C(6) 1.403(4)  C(3")-C(2")-C(1") 105.7(3) 
C(2)-C(3) 1.386(4)  C(3")-C(2")-C(1) 130.7(3) 
C(2)-H(2) 0.95  C(1")-C(2")-C(1) 123.6(3) 
C(3)-C(4) 1.373(4)  O(3)-C(3")-C(2") 125.4(3) 
C(3)-H(3A) 0.95  O(3)-C(3")-C(4") 124.4(3) 
C(4)-O(4) 1.374(4)  C(2")-C(3")-C(4") 110.2(3) 
C(4)-C(5) 1.391(4)  C(5")-C(4")-O(2) 116.9(3) 
C(5)-C(6) 1.371(4)  C(5")-C(4")-C(3") 136.0(3) 
C(5)-H(5) 0.95  O(2)-C(4")-C(3") 107.1(2) 
C(6)-H(6) 0.95  C(4")-C(5")-C(6") 122.6(3) 
O(4)-C(7) 1.425(4)  C(4")-C(5")-C(1') 119.5(3) 
C(7)-H(7A) 0.98  C(6")-C(5")-C(1') 117.9(3) 
C(7)-H(7B) 0.98  O(6)-C(6")-O(7) 122.6(3) 
C(7)-H(7C) 0.98  O(6)-C(6")-C(5") 126.1(3) 
O(4')-C(7') 1.439(4)  O(7)-C(6")-C(5") 111.3(3) 
C(7')-H(7'1) 0.98  C(2)-C(1)-C(6) 116.9(3) 
C(7')-H(7'2) 0.98  C(2)-C(1)-C(2") 120.6(3) 
C(7')-H(7'3) 0.98  C(6)-C(1)-C(2") 122.4(3) 
O(7)-C(7") 1.447(3)  O(4)-C(4)-C(5) 115.4(3) 
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C(3)-C(2)-H(2) 119.3  C(6)-C(5)-C(4) 120.4(3) 
C(1)-C(2)-H(2) 119.3  C(6)-C(5)-H(5) 119.8 
C(4)-C(3)-C(2) 120.3(3)  C(4)-C(5)-H(5) 119.8 
C(4)-C(3)-H(3A) 119.8  C(5)-C(6)-C(1) 121.5(3) 
C(2)-C(3)-H(3A) 119.8  C(5)-C(6)-H(6) 119.2 
C(3)-C(4)-O(4) 125.2(3)  C(1)-C(6)-H(6) 119.2 
C(3)-C(4)-C(5) 119.4(3)  C(4)-O(4)-C(7) 116.1(3) 
O(4)-C(4)-C(5) 115.4(3)  O(4)-C(7)-H(7A) 109.5 
C(6)-C(5)-C(4) 120.4(3)  O(4)-C(7)-H(7B) 109.5 
C(6)-C(5)-H(5) 119.8  H(7A)-C(7)-H(7B) 109.5 
C(4)-C(5)-H(5) 119.8  O(4)-C(7)-H(7C) 109.5 
C(5)-C(6)-C(1) 121.5(3)  H(7A)-C(7)-H(7C) 109.5 
C(5)-C(6)-H(6) 119.2  H(7B)-C(7)-H(7C) 109.5 
C(1)-C(6)-H(6) 119.2  C(4')-O(4')-C(7') 115.1(2) 
C(4)-O(4)-C(7) 116.1(3)  O(4')-C(7')-H(7'1) 109.5 
O(4)-C(7)-H(7A) 109.5  O(4')-C(7')-H(7'2) 109.5 
O(4)-C(7)-H(7B) 109.5  H(7'1)-C(7')-H(7'2) 109.5 
H(7A)-C(7)-H(7B) 109.5  O(4')-C(7')-H(7'3) 109.5 
O(4)-C(7)-H(7C) 109.5  H(7'1)-C(7')-H(7'3) 109.5 
H(7A)-C(7)-H(7C) 109.5  H(7'2)-C(7')-H(7'3) 109.5 
H(7B)-C(7)-H(7C) 109.5  C(6")-O(7)-C(7") 118.8(2) 
C(4')-O(4')-C(7') 115.1(2)  O(7)-C(7")-H(7"1) 109.5 
O(4')-C(7')-H(7'1) 109.5  O(7)-C(7")-H(7"2) 109.5 
O(4')-C(7')-H(7'2) 109.5  H(7"1)-C(7")-H(7"2) 109.5 
H(7'1)-C(7')-H(7'2) 109.5  O(7)-C(7")-H(7"3) 109.5 
O(4')-C(7')-H(7'3) 109.5  H(7"1)-C(7")-H(7"3) 109.5 
H(7'1)-C(7')-H(7'3) 109.5  H(7"2)-C(7")-H(7"3) 109.5 
H(7'2)-C(7')-H(7'3) 109.5  C(4")-O(2)-C(1") 108.6(2) 
C(6")-O(7)-C(7") 118.8(2)  C(3")-O(3)-H(3) 109.5 
O(7)-C(7")-H(7"1) 109.5    
O(7)-C(7")-H(7"2) 109.5    
H(7"1)-C(7")-H(7"2) 109.5    
O(7)-C(7")-H(7"3) 109.5    
H(7"1)-C(7")-H(7"3) 109.5    
H(7"2)-C(7")-H(7"3) 109.5    
C(4")-O(2)-C(1") 108.6(2)    
C(3")-O(3)-H(3) 109.5    
C(3)-C(2)-H(2) 119.3    
C(1)-C(2)-H(2) 119.3    
C(4)-C(3)-C(2) 120.3(3)    
C(4)-C(3)-H(3A) 119.8    
C(2)-C(3)-H(3A) 119.8    
C(3)-C(4)-O(4) 125.2(3)    
C(3)-C(4)-C(5) 119.4(3)    
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Table 1.16: Anisotropic displacement parameters (A^2 x 10^3) for 4.14. The  
anisotropic displacement factor exponent takes the form:  
-2 pi^2 [h^2 a*^2 U11 + ... + 2 h k a* b* U12]  
 
 U11 U22 U33 U23 U13 U12 
Cl(1) 25(1) 22(1) 25(1) 1(1) -1(1) -5(1) 
Cl(2) 32(1) 28(1) 52(1) 0(1) 14(1) 9(1) 
C(1') 15(2) 22(2) 17(2) 0(1) 0(1) 0(2) 
C(2') 25(2) 19(2) 20(2) 0(1) 0(1) -2(2) 
C(3') 19(2) 22(2) 24(2) 2(1) 4(1) 6(2) 
C(4') 14(2) 27(2) 17(2) 5(1) 2(1) -2(2) 
C(5') 21(2) 23(2) 10(2) 0(1) -1(1) -2(2) 
C(6') 18(2) 17(2) 18(2) -1(1) -2(1) 2(2) 
C(1") 18(2) 16(2) 23(2) -2(1) -2(1) -1(2) 
C(2") 18(2) 14(2) 23(2) -2(1) 0(1) -2(1) 
C(3") 18(2) 14(2) 25(2) -3(1) 1(1) -2(1) 
C(4") 23(2) 12(2) 18(2) -1(1) 4(1) -2(1) 
C(5") 15(2) 15(2) 20(2) -1(1) 2(1) -1(1) 
C(6") 22(2) 14(2) 23(2) -3(1) 2(1) 2(2) 
C(1) 24(2) 13(2) 26(2) -3(1) -2(1) 2(1) 
C(2) 27(2) 22(2) 21(2) 1(1) 0(1) 2(2) 
C(3) 22(2) 23(2) 28(2) -1(1) 3(1) 0(2) 
C(4) 18(2) 18(2) 30(2) -2(1) -3(1) 2(2) 
C(5) 20(2) 32(2) 28(2) 8(1) -5(1) 1(2) 
C(6) 26(2) 25(2) 29(2) 5(1) 2(1) -3(2) 
O(4) 16(2) 33(1) 33(1) 3(1) -3(1) -2(1) 
C(7) 20(2) 40(2) 38(2) 2(2) -2(2) -2(2) 
O(4') 14(1) 36(2) 24(1) 5(1) 2(1) 0(1) 
C(7') 20(2) 32(2) 27(2) -2(1) -3(1) 2(2) 
O(7) 20(2) 34(1) 18(1) 4(1) -2(1) -3(1) 
C(7") 29(2) 32(2) 20(2) 4(1) 1(1) 3(2) 
O(1) 25(2) 28(1) 25(1) 9(1) 1(1) -2(1) 
O(2) 13(1) 21(1) 21(1) 4(1) 0(1) 1(1) 
O(3) 20(2) 38(2) 23(1) 11(1) 0(1) -4(1) 
O(6) 19(2) 32(1) 26(1) 9(1) 2(1) -2(1) 
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Table 1.17: Hydrogen coordinates ( x 10^4) and isotropic  
displacement parameters (A^2 x 10^3) for 4.14 
 x y z U(eq) 
H(2') 2728 4767 210 25 
H(6') 3290 2495 -94 21 
H(2) 7229 3884 1054 28 
H(3A) 8563 3952 2363 29 
H(5) 7770 3088 7302 32 
H(6) 6440 3028 6029 32 
H(7A) 9806 3664 3741 49 
H(7B) 10189 3987 5716 49 
H(7C) 9508 4478 4541 49 
H(7'1) 42 3691 -707 40 
H(7'2) -413 2941 70 40 
H(7'3) 297 2853 -1439 40 
H(7"1) 3988 5067 -5131 40 
H(7"2) 3005 5018 -5377 40 
H(7"3) 3564 4327 -6113 40 
H(3) 5645 4253 -1300 40 
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Table 1.18: Torsion angles [deg] for 4.14 
 
C(6')-C(1')-C(2')-C(3') -0.4(4) C(6')-C(1')-C(5")-C(4") -66.1(4) 
C(5")-C(1')-C(2')-C(3') -179.7(3) C(2')-C(1')-C(5")-C(4") 113.2(3) 
C(1')-C(2')-C(3')-C(4') -1.5(4) C(6')-C(1')-C(5")-C(6") 114.9(3) 
C(1')-C(2')-C(3')-Cl(2) 176.6(2) C(2')-C(1')-C(5")-C(6") -65.8(3) 
C(2')-C(3')-C(4')-O(4') 177.3(3) C(4")-C(5")-C(6")-O(6) -2.4(5) 
Cl(2)-C(3')-C(4')-O(4') -0.7(4) C(1')-C(5")-C(6")-O(6) 176.6(3) 
C(2')-C(3')-C(4')-C(5') 2.1(4) C(4")-C(5")-C(6")-O(7) 177.4(3) 
Cl(2)-C(3')-C(4')-C(5') -176.0(2) C(1')-C(5")-C(6")-O(7) -3.6(4) 
O(4')-C(4')-C(5')-C(6') -176.0(2) C(3")-C(2")-C(1)-C(2) -4.6(5) 
C(3')-C(4')-C(5')-C(6') -0.8(4) C(1")-C(2")-C(1)-C(2) 178.4(3) 
O(4')-C(4')-C(5')-Cl(1) 3.6(4) C(3")-C(2")-C(1)-C(6) 172.5(3) 
C(3')-C(4')-C(5')-Cl(1) 178.9(2) C(1")-C(2")-C(1)-C(6) -4.6(4) 
C(4')-C(5')-C(6')-C(1') -1.0(4) C(6)-C(1)-C(2)-C(3) -2.4(4) 
Cl(1)-C(5')-C(6')-C(1') 179.3(2) C(2")-C(1)-C(2)-C(3) 174.8(3) 
C(2')-C(1')-C(6')-C(5') 1.6(4) C(1)-C(2)-C(3)-C(4) 0.4(5) 
C(5")-C(1')-C(6')-C(5') -179.1(3) C(2)-C(3)-C(4)-O(4) -178.4(3) 
O(1)-C(1")-C(2")-C(3") -177.6(3) C(2)-C(3)-C(4)-C(5) 2.0(5) 
O(2)-C(1")-C(2")-C(3") 1.4(3) C(3)-C(4)-C(5)-C(6) -2.3(5) 
O(1)-C(1")-C(2")-C(1) 0.1(5) O(4)-C(4)-C(5)-C(6) 178.1(3) 
O(2)-C(1")-C(2")-C(1) 179.1(2) C(4)-C(5)-C(6)-C(1) 0.2(5) 
C(1")-C(2")-C(3")-O(3) 178.4(3) C(2)-C(1)-C(6)-C(5) 2.1(4) 
C(1)-C(2")-C(3")-O(3) 0.9(5) C(2")-C(1)-C(6)-C(5) -175.1(3) 
C(1")-C(2")-C(3")-C(4") -0.9(3) C(3)-C(4)-O(4)-C(7) 7.6(4) 
C(1)-C(2")-C(3")-C(4") -178.4(3) C(5)-C(4)-O(4)-C(7) -172.7(3) 
O(3)-C(3")-C(4")-C(5") 0.2(5) C(5')-C(4')-O(4')-C(7') -103.1(3) 
C(2")-C(3")-C(4")-C(5") 179.5(3) C(3')-C(4')-O(4')-C(7') 81.8(3) 
O(3)-C(3")-C(4")-O(2) -179.2(3) O(6)-C(6")-O(7)-C(7") 1.5(4) 
C(2")-C(3")-C(4")-O(2) 0.1(3) C(5")-C(6")-O(7)-C(7") -178.4(2) 
O(2)-C(4")-C(5")-C(6") 177.7(2) C(5")-C(4")-O(2)-C(1") -178.7(3) 
C(3")-C(4")-C(5")-C(6") -1.6(5) C(3")-C(4")-O(2)-C(1") 0.8(3) 
O(2)-C(4")-C(5")-C(1') -1.3(4) O(1)-C(1")-O(2)-C(4") 177.8(3) 
C(3")-C(4")-C(5")-C(1') 179.4(3) C(2")-C(1")-O(2)-C(4") -1.4(3) 
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Table 1.19: Crystal and structure refinement for 5.7 
 
Empirical formula C11 H14 O5 
Formula weight 226.22 
Temperature 93(2) K 
Wavelength 0.71073 A 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 4.320(8) A   alpha = 90 deg. 
 b = 11.64(2) A    beta = 90 deg. 
 c = 21.33(4) A   gamma = 90 deg 
Volume 1072(4) A^3 
Z, Calculated density 4,  1.402 Mg/m^3 
Absorption coefficient 0.111 mm^-1 
F(000) 480 
Crystal size 0.67 x 0.40 x 0.28 mm 
Theta range for data collection 1.99 to 26.26 deg. 
Limiting indices -4<=h<=4, -13<=k<=14, -2 6<=l<=21 
Reflections collected / unique 4327 / 1879 [R(int) = 0. 2194] 
Completeness to theta = 25.00 91.00% 
Absorption correction None 
Max. and min. transmission 0.9696 and 0.9293 
Refinement method Full-matrix least-square s on F^2 
Data / restraints / parameters 1879 / 0 / 150 
Goodness-of-fit on F^2 1.281 
Final R indices [I>2sigma(I)] R1 = 0.1413, wR2 = 0.3437 
R indices (all data) R1 = 0.2273, wR2 = 0.4317 
Absolute structure parameter 10(7) 
Largest diff. peak and hole 0.629 and -0.556 e.A^-3 
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Table 1.20: Atomic coordinates (x 10^4) and equivalent 
isotropic displacement parameters (A^2 x 10^3) for 5.7. 
U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor.  
 
 x y z U(eq) 
O(10) 12190(20)  4515(5) 6651(4) 44(2)  
O(8)  10920(20) 1700(6) 5364(4) 45(2) 
O(4) 5590(20) -1672(6) 6037(3) 49(3)  
O(2)  8580(20) 359(6) 4577(3) 52(3) 
O(6) 9860(20) 986(6) 7507(3) 42(2) 
C(5) 7640(30) -357(7) 6792(5) 26(3) 
C(4) 7050(30)  -680(8) 6192(5) 34(3) 
C(2) 7360(40) -231(8) 5015(5) 52(4) 
C(9) 12360(30) 2390(8) 6580(5) 42(3) 
C(8) 9790(30) 1008(9) 5819(4) 39(3)  
C(10) 10180(30) 3454(8) 6583(5) 42(3) 
C(7) 10450(30) 1345(8)  6434(5) 33(3) 
C(1) 5170(30) -1130(10) 4819(5) 41(3) 
C(3) 8200(30) 5(9) 5668(5) 35(3) 
C(11) 4630(40) -2402(9) 6550(5) 54(4) 
C(6) 9300(40) 652(9) 6923(5) 42(3) 
 
 
 
 
Table 1.21: Bond lengths [A] and angles [deg] for 5.7 
 
O(10)-C(10) 1.518(13) C(8)-O(8)-H(8) 109.5 C(2)-C(1)-H(1B) 109.5 
O(10)-H(10)  0.84 C(4)-O(4)-C(11) 116.7(8) H(1A)-C(1)-H(1B) 109.5 
O(8)-C(8) 1.353(12) C(6)-O(6)-H(6) 109.5 C(2)-C(1)-H(1C) 109.5 
O(8)-H(8) 0.84 C(4)-C(5)-C(6) 121.0(9) H(1A)-C(1)-H(1C) 109.5 
O(4)-C(4) 1.355(14) C(4)-C(5)-H(5) 119.5 H(1B)-C(1)-H(1C) 109.5 
O(4)-C(11) 1.446(12) C(6)-C(5)-H(5) 119.5 C(8)-C(3)-C(2) 120.0(9) 
O(2)-C(2) 1.272(13)  C(5)-C(4)-O(4) 123.5(9) C(8)-C(3)-C(4) 116.8(9) 
 O(6)-C(6) 1.328(13) C(5)-C(4)-C(3) 120.3(10) C(2)-C(3)-C(4) 122.6(10)
O(6)-H(6) 0.84 O(4)-C(4)-C(3)  116.0(9) O(4)-C(11)-H(11A) 109.5 
C(5)-C(4) 1.359(14) O(2)-C(2)-C(3) 119.5(12) O(4)-C(11)-H(11B) 109.5 
C(5)-C(6) 1.403(16) O(2)-C(2)-C(1) 116.2(10) H(11A)-C(11)-H(11B) 109.5 
C(5)-H(5) 0.95 C(3)-C(2)-C(1) 124.3(10) O(4)-C(11)-H(11C) 109.5 
C(4)-C(3) 1.460(15) C(7)-C(9)-C(10) 108.2(10) H(11A)-C(11)-H(11C) 109.5 
C(2)-C(3) 1.467(15) C(7)-C(9)-H(9A) 110.1 H(11B)-C(11)-H(11C) 109.5 
C(2)-C(1) 1.471(18) C(10)-C(9)-H(9A) 110.1 O(6)-C(6)-C(7) 117.5(10)
C(9)-C(7) 1.502(15) C(7)-C(9)-H(9B) 110.1 O(6)-C(6)-C(5) 121.7(9) 
C(9)-C(10) 1.556(16) C(10)-C(9)-H(9B) 110.1 C(7)-C(6)-C(5)  120.8(9)
C(9)-H(9A) 0.99 H(9A)-C(9)-H(9B) 108.4   
C(9)-H(9B) 0.99 O(8)-C(8)-C(7)  115.6(10)   
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C(8)-C(7) 1.398(14) O(8)-C(8)-C(3) 120.7(9)   
C(8)-C(3)  1.391(15) C(7)-C(8)-C(3) 123.6(9)   
C(10)-H(10A) 0.99 O(10)-C(10)-C(9) 107.5(9)   
C(10)-H(10B) 0.99 O(10)-C(10)-H(10A) 110.2   
C(7)-C(6) 1.409(15) C(9)-C(10)-H(10A) 110.2   
C(1)-H(1A)  0.98 O(10)-C(10)-H(10B) 110.2   
C(1)-H(1B) 0.98 C(9)-C(10)-H(10B) 110.2   
C(1)-H(1C) 0.98 H(10A)-C(10)-H(10B) 108.5   
C(11)-H(11A) 0.98 C(8)-C(7)-C(6)  117.5(10)   
C(11)-H(11B) 0.98 C(8)-C(7)-C(9) 122.3(9)   
C(11)-H(11C) 0.98 C(6)-C(7)-C(9) 120.2(10)   
C(10)-O(10)-H(10) 109.5 C(2)-C(1)-H(1A) 109.5   
Symmetry transformations used to generate equivalent atoms 
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Table 1.22: Anisotropic displacement parameters (A^2 x 10^3) for 5.7. The anisotropic  
displacement factor exponent takes the form: -2 pi^2 [h^2 a*^2 U11 + 2 h k a* b* U12]  
 
 U11 U22 U33 U23 U13 U12 
O(10) 73(7) 34(4) 26(4) -3(3) 2(4) 2(4) 
O(8) 64(7) 42(4) 27(4) 11(3) 7(4) -12(4) 
 O(4) 104(9) 33(4) 12(3) 2(3) 11(4) -10(4) 
O(2) 99(8) 40(4) 16(4) 7(3) 7(4) -5(4) 
O(6) 65(7) 37(4) 23(4) -2(3) 4(4) -5(4) 
C(5) 19(7) 29(4) 30(5) 8(4) 12(4) -4(5) 
C(4)  42(9) 37(5) 22(5) 3(4) 5(5) 14(5)  
C(2) 111(13) 23(5) 21(5) 6(4) 5(7) 7(7) 
C(9) 74(10) 38(5) 13(5) 3(4) -3(6) 8(6) 
C(8) 66(10) 42(5) 10(4) 4(4) 12(6) -7(6) 
C(10) 65(10) 39(5) 22(5) 4(4) 14(6) -11(6) 
C(7) 48(8) 25(5) 28(6) 3(4) 1(5) 0(5) 
C(1) 56(10) 52(6) 16(5) -6(4) 6(6) -5(6) 
C(3) 47(9) 40(5) 19(5) -4(4) 3(5) -8(5) 
C(11) 112(14) 33(5) 18(5) 8(5) -10(7) -15(7) 
C(6) 76(11) 33(5) 17(5) -1(4)  7(6) 8(6) 
 
 
Table 1.23: Hydrogen coordinates ( x 10^4) and isotropic  
displacement parameters (A^2 x 10^3) for 5.7. 
 
 x y z U(eq) 
H(10) 13979 4319 6763 66 
H(8) 12864 1696 5377 67 
 H(6) 11746 888 7589 63 
H(5) 6913 -820 7129 31 
H(9A) 13996 2489 6260 50 
H(9B) 13361 2303 6995 50 
H(10A) 8987 3490 6187 50 
H(10B) 8699 3402 6936 50 
H(1A) 3305 -1090 5080 62 
H(1B) 6139 -1886 4867 62 
H(1C) 4603 -1012 4378 62 
H(11A) 4233 -1930 6922 82 
H(11B) 6276 -2957 6643 82 
H(11C) 2741 -2814 6433 82 
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Appendix 2 
 
Molecular modelling data for the diastereomers, spiro-
mamakones D (3.17) and E (3.18) 
 
 
Tables are to be read across. Shaded areas indicate point of attachment to the table on the 
following page or below. 
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Column title meanings 
 
A Potential energy of each conformer calculated by the OPLS2003 force field. 
  
B, C, D, E Each of these columns calculates part of the Boltzmann weighting of each 
conformer (column A). The overall equation being 
 
 
exp[-(E /kBT]
exp[-(E  /kBT]
NA
-
=P
 
B E/kT, E = negative potential energy (the negative of column A), k = 
Boltzmann constant (8.32441 J · K-1 · mol-1), T = temperature (300K). 
 Formula =(-A2*1000)/(8.31451*300). 
 
C  e-E/kT, e = natural log. Formula =IF(B2=0,0,EXP(B2)). 
 
D Ne-E/kT, N = number of conformers (entries in column A). Formula 
=COUNT($A$2:$A$300)*(C2). 
 
E Boltzmann. Final calculation performed to give the Boltzmann weighting of 
each conformer (entries in column A). Formula 
=(D2)/SUM($C$2:$C$300). 
 
F %. Calculates the Boltzmann weighted % of each conformer. Formula 
=(E2)/SUM($E$2:$E$300)*100 
 
G E*%. Potential energy (column A) x  Boltzmann weighted % (column F). 
Formula =(A2*F2) 
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H Bolt.Ave.E. Calculates the Boltzmann average potential energy of the 
system within 12 kJ of the global minima. Formula =SUM(G2:G300)/100 
 
J, K, L, M, N, O, P These columns are headed with the relevant H atom numbers and 
measures the distance between each of these H atoms in Angstroms 
for each conformer. At the bottom of these columns the smallest H-
H distance in the ensemble is given for each measured H-H.  
 
R, S, T, U, V, W, X These columns are headed with the relevant H atom numbers and 
gives the Boltzmann weighted % for each conformer if less than 3 
Angstroms otherwise zero is displayed. At the bottom of these 
columns is the Boltzmann weighted % of conformers with a H-H 
distance less than 3 Angstroms. Formula example for column R 
=IF(J2>3,0,F2). Note J changes with each column eg K, L, M, N, O, 
P. 
 
Z, AA, AB, AC, AD, AE, AF  These columns are headed with the relevant H atom 
numbers and gives the Boltzmann weighted % for each conformer if 
less than 2.5 Angstroms otherwise zero is displayed. At the bottom 
of these columns is the Boltzmann weighted % of conformers with a 
H-H distance less than 2.5 Angstroms. Formula example for column 
Z =IF(J2>2.5,0,F2). Note J changes with each column eg K, L, M, 
N, O, P 
 
 
AH, AI, AJ, AK, AL, AM, AN These columns are headed with the relevant H atom 
numbers and give the Boltzmann weighted % x the H-H distance for 
each conformer. At the bottom of these columns is the Boltzmann 
weighted average distance for each H-H. Formula example for 
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column AH =(J2*F2). Note J changes with each column eg K, L, M, 
N, O, P 
 
 
AP, AQ, AR, AS, AT, AU, AV These columns are headed with the relevant H atom 
numbers and calculates 1/r^6 (r = H-H distance) for each H-H 
distance. At the bottom of these columns is the sum of each of the 
above columns and calculates a virtual NOE. Formula example for 
column AP =(1/(J2^6))*E2. Note J changes with each column eg K, 
L, M, N, O 
 
AX, AY, AX Dihedral angles. 
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Table 2.1: Calculations for 4S, 5S, 8S, 9S.  
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
340.61 -136.55 4.97E-60 1.44E-58 12.66 43.67 14873.79 344.06 
343.47 -137.70 1.58E-60 4.58E-59 4.02 13.86 4761.74   
344.51 -138.12 1.04E-60 3.01E-59 2.65 9.13 3145.89   
346.13 -138.77 5.43E-61 1.57E-59 1.38 4.77 1649.44   
346.84 -139.05 4.08E-61 1.18E-59 1.04 3.59 1243.56   
346.94 -139.09 3.93E-61 1.14E-59 1.00 3.45 1197.49   
348.14 -139.57 2.42E-61 7.02E-60 0.62 2.13 740.58   
348.26 -139.62 2.32E-61 6.71E-60 0.59 2.03 708.29   
348.99 -139.91 1.73E-61 5.01E-60 0.44 1.52 529.05   
349.09 -139.95 1.66E-61 4.82E-60 0.42 1.46 509.37   
349.22 -140.00 1.57E-61 4.56E-60 0.40 1.38 482.47   
349.26 -140.02 1.55E-61 4.48E-60 0.39 1.36 474.37   
349.74 -140.21 1.28E-61 3.71E-60 0.33 1.12 392.91   
349.79 -140.23 1.25E-61 3.63E-60 0.32 1.10 385.05   
350.07 -140.35 1.12E-61 3.25E-60 0.29 0.98 344.13   
350.26 -140.42 1.04E-61 3.00E-60 0.26 0.91 318.47   
350.70 -140.60 8.70E-62 2.52E-60 0.22 0.76 268.13   
350.73 -140.61 8.60E-62 2.50E-60 0.22 0.76 265.04   
350.73 -140.61 8.58E-62 2.49E-60 0.22 0.75 264.36   
350.74 -140.61 8.56E-62 2.48E-60 0.22 0.75 263.59   
351.16 -140.78 7.24E-62 2.10E-60 0.18 0.64 223.26   
351.39 -140.87 6.59E-62 1.91E-60 0.17 0.58 203.52   
351.67 -140.98 5.90E-62 1.71E-60 0.15 0.52 182.39   
351.70 -141.00 5.81E-62 1.69E-60 0.15 0.51 179.61   
351.74 -141.01 5.74E-62 1.66E-60 0.15 0.50 177.37   
351.76 -141.02 5.69E-62 1.65E-60 0.14 0.50 175.77   
352.14 -141.17 4.88E-62 1.42E-60 0.12 0.43 150.98   
352.15 -141.18 4.87E-62 1.41E-60 0.12 0.43 150.57   
352.24 -141.22 4.69E-62 1.36E-60 0.12 0.41 145.00   
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 H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
 2.94 4.86 2.71 3.98 4.17 2.37 2.76 
 2.95 4.86 2.70 3.98 4.17 2.37 2.77 
 2.94 4.90 2.70 3.98 4.18 2.36 2.77 
 2.97 4.87 2.71 4.00 4.16 2.36 2.77 
 3.03 4.84 2.71 3.98 4.15 2.37 2.76 
 3.01 4.85 2.71 3.97 4.17 2.37 2.75 
 3.63 3.56 3.05 3.88 2.89 2.37 3.04 
 3.00 4.85 2.71 4.00 4.14 2.36 2.77 
 2.97 4.87 2.70 4.00 4.16 2.36 2.78 
 3.60 3.65 3.05 3.89 2.91 2.37 3.03 
 2.95 4.89 2.71 4.00 4.16 2.35 2.78 
 3.57 3.78 3.05 3.92 2.95 2.36 3.03 
 2.97 4.91 2.70 4.00 4.16 2.35 2.78 
 3.01 4.85 2.70 3.96 4.17 2.37 2.76 
 3.60 3.69 3.05 3.91 2.95 2.36 3.03 
 3.01 4.77 2.75 4.00 4.14 2.35 2.76 
 2.99 4.90 2.70 3.97 4.18 2.36 2.76 
 2.98 4.89 2.70 3.97 4.17 2.36 2.76 
 3.03 4.84 2.70 3.97 4.16 2.38 2.76 
 3.60 3.65 3.05 3.90 2.93 2.36 3.03 
 2.96 4.87 2.71 3.99 4.16 2.37 2.77 
 3.61 3.69 3.04 3.90 2.92 2.37 3.03 
 3.56 3.81 3.04 3.92 2.95 2.36 3.03 
 3.53 3.90 3.04 3.94 2.96 2.37 3.03 
 3.61 3.64 3.04 3.88 2.88 2.38 3.04 
 3.64 3.51 3.03 3.85 2.85 2.38 3.04 
 3.54 3.89 3.04 3.95 3.01 2.35 3.02 
 3.00 4.85 2.70 3.99 4.14 2.37 2.78 
 3.57 3.75 3.04 3.90 2.91 2.38 3.04 
        
Shortest 2.94 3.51 2.70 3.85 2.85 2.35 2.75 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  43.67 0.00 43.67 0.00 0.00 43.67 43.67 
  13.86 0.00 13.86 0.00 0.00 13.86 13.86 
  9.13 0.00 9.13 0.00 0.00 9.13 9.13 
  4.77 0.00 4.77 0.00 0.00 4.77 4.77 
  0.00 0.00 3.59 0.00 0.00 3.59 3.59 
  0.00 0.00 3.45 0.00 0.00 3.45 3.45 
  0.00 0.00 0.00 0.00 2.13 2.13 0.00 
  0.00 0.00 2.03 0.00 0.00 2.03 2.03 
  1.52 0.00 1.52 0.00 0.00 1.52 1.52 
  0.00 0.00 0.00 0.00 1.46 1.46 0.00 
  1.38 0.00 1.38 0.00 0.00 1.38 1.38 
  0.00 0.00 0.00 0.00 1.36 1.36 0.00 
  1.12 0.00 1.12 0.00 0.00 1.12 1.12 
  0.00 0.00 1.10 0.00 0.00 1.10 1.10 
  0.00 0.00 0.00 0.00 0.98 0.98 0.00 
  0.00 0.00 0.91 0.00 0.00 0.91 0.91 
  0.76 0.00 0.76 0.00 0.00 0.76 0.76 
  0.76 0.00 0.76 0.00 0.00 0.76 0.76 
  0.00 0.00 0.75 0.00 0.00 0.75 0.75 
  0.00 0.00 0.00 0.00 0.75 0.75 0.00 
  0.64 0.00 0.64 0.00 0.00 0.64 0.64 
  0.00 0.00 0.00 0.00 0.58 0.58 0.00 
  0.00 0.00 0.00 0.00 0.52 0.52 0.00 
  0.00 0.00 0.00 0.00 0.51 0.51 0.00 
  0.00 0.00 0.00 0.00 0.50 0.50 0.00 
  0.00 0.00 0.00 0.00 0.50 0.50 0.00 
  0.00 0.00 0.00 0.00 0.00 0.43 0.00 
  0.00 0.00 0.43 0.00 0.00 0.43 0.43 
  0.00 0.00 0.00 0.00 0.41 0.41 0.00 
                
                
% < 3 Ang 77.61 0.00 89.87 0.00 9.70 100.00 89.87 
Appendix 2 Molecular modelling data 264 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  128.52 212.31 118.32 173.73 182.24 103.28 120.54 
  40.85 67.38 37.45 55.11 57.83 32.84 38.38 
  26.85 44.71 24.64 36.33 38.16 21.52 25.25 
  14.15 23.21 12.92 19.06 19.81 11.23 13.22 
  10.86 17.35 9.72 14.26 14.89 8.50 9.88 
  10.38 16.75 9.35 13.70 14.39 8.17 9.50 
  7.73 7.58 6.48 8.24 6.15 5.05 6.46 
  6.11 9.86 5.52 8.14 8.42 4.81 5.64 
  4.51 7.38 4.10 6.06 6.30 3.58 4.22 
  5.26 5.32 4.44 5.68 4.24 3.46 4.43 
  4.07 6.76 3.74 5.53 5.75 3.25 3.84 
  4.85 5.14 4.14 5.32 4.01 3.21 4.11 
  3.34 5.52 3.04 4.49 4.68 2.64 3.12 
  3.31 5.34 2.97 4.36 4.59 2.61 3.04 
  3.53 3.63 3.00 3.84 2.90 2.32 2.98 
  2.74 4.34 2.50 3.64 3.77 2.13 2.51 
  2.29 3.74 2.06 3.03 3.19 1.80 2.11 
  2.25 3.69 2.04 3.00 3.15 1.79 2.09 
  2.28 3.65 2.04 2.99 3.13 1.79 2.08 
  2.70 2.74 2.29 2.93 2.20 1.77 2.28 
  1.88 3.10 1.72 2.54 2.64 1.51 1.76 
  2.09 2.14 1.76 2.26 1.69 1.37 1.76 
  1.85 1.97 1.58 2.03 1.53 1.23 1.57 
  1.80 1.99 1.55 2.01 1.51 1.21 1.55 
  1.82 1.84 1.53 1.96 1.45 1.20 1.53 
  1.82 1.76 1.52 1.92 1.42 1.19 1.52 
  1.52 1.67 1.30 1.69 1.29 1.01 1.29 
  1.28 2.07 1.16 1.71 1.77 1.01 1.19 
  1.47 1.54 1.25 1.61 1.20 0.98 1.25 
                
                
bolt.Ave.dist 3.02 4.74 2.74 3.97 4.04 2.36 2.79 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b   H8-H9 H8-H7a H8-H7b 
  0.02 0.00 0.03 0.00 0.00 0.07 0.10   -83.86 -30.41 91.33 
  0.01 0.00 0.01 0.00 0.00 0.02 0.03   -83.82 -30.31 91.51 
  0.00 0.00 0.01 0.00 0.00 0.02 0.02   -83.38 -29.45 92.22 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   -84.45 -28.20 93.55 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   -86.31 -31.09 90.62 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   -84.77 -31.66 90.12 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -163.06 32.57 155.54 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -86.42 -28.38 93.26 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.47 -28.15 93.69 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -161.43 32.82 155.89 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.04 -27.33 94.43 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -159.20 32.06 154.96 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.17 -27.36 94.33 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.72 -31.60 90.25 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -160.13 31.74 154.49 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -88.74 -28.64 92.94 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -83.97 -30.65 91.04 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -83.97 -30.56 91.20 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -85.80 -31.42 90.39 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -161.80 33.19 156.24 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.83 -29.64 91.95 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -160.75 32.40 155.31 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -158.14 32.40 155.42 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -156.67 33.05 156.09 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -161.96 33.98 157.06 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -163.23 33.47 156.60 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -155.58 30.90 153.57 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -85.91 -28.69 93.06 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -159.70 34.09 157.30 
                        
1/r^6 0.04 0.00 0.07 0.01 0.01 0.17 0.21         
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Table 2.2: Molecular modelling data for 4S, 5S, 8R, 9R 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
356.68 -143.00 7.91E-63 2.37E-61 10.27 34.24 12214.16 359.43 
357.05 -143.14 6.82E-63 2.05E-61 8.86 29.55 10549.10   
361.59 -144.96 1.10E-63 3.31E-62 1.44 4.79 1730.36   
362.56 -145.35 7.50E-64 2.25E-62 0.97 3.25 1177.79   
362.58 -145.36 7.44E-64 2.23E-62 0.97 3.22 1168.07   
362.58 -145.36 7.43E-64 2.23E-62 0.96 3.22 1166.22   
362.67 -145.40 7.17E-64 2.15E-62 0.93 3.11 1126.11   
363.53 -145.74 5.08E-64 1.52E-62 0.66 2.20 800.39   
364.08 -145.96 4.07E-64 1.22E-62 0.53 1.76 641.87   
364.26 -146.03 3.79E-64 1.14E-62 0.49 1.64 598.63   
364.44 -146.10 3.53E-64 1.06E-62 0.46 1.53 557.07   
364.51 -146.13 3.42E-64 1.03E-62 0.44 1.48 540.59   
364.74 -146.23 3.12E-64 9.36E-63 0.41 1.35 493.08   
365.62 -146.58 2.20E-64 6.60E-63 0.29 0.95 348.33   
365.68 -146.60 2.14E-64 6.43E-63 0.28 0.93 339.53   
366.72 -147.02 1.41E-64 4.24E-63 0.18 0.61 224.60   
366.73 -147.02 1.41E-64 4.22E-63 0.18 0.61 223.55   
366.84 -147.07 1.35E-64 4.04E-63 0.18 0.58 214.19   
366.86 -147.08 1.34E-64 4.01E-63 0.17 0.58 212.19   
367.01 -147.14 1.26E-64 3.77E-63 0.16 0.54 199.92   
367.05 -147.15 1.24E-64 3.71E-63 0.16 0.54 196.73   
367.26 -147.24 1.14E-64 3.41E-63 0.15 0.49 180.96   
367.85 -147.47 8.99E-65 2.70E-63 0.12 0.39 143.30   
367.86 -147.48 8.96E-65 2.69E-63 0.12 0.39 142.71   
367.86 -147.48 8.95E-65 2.69E-63 0.12 0.39 142.65   
367.94 -147.51 8.65E-65 2.59E-63 0.11 0.37 137.83   
367.97 -147.52 8.55E-65 2.57E-63 0.11 0.37 136.32   
368.38 -147.69 7.25E-65 2.18E-63 0.09 0.31 115.76   
368.48 -147.73 6.97E-65 2.09E-63 0.09 0.30 111.31   
368.53 -147.74 6.84E-65 2.05E-63 0.09 0.30 109.27   
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  2.94 4.86 2.71 3.98 4.17 2.37 2.76 
  2.95 4.86 2.70 3.98 4.17 2.37 2.77 
  2.94 4.90 2.70 3.98 4.18 2.36 2.77 
  2.97 4.87 2.71 4.00 4.16 2.36 2.77 
  3.03 4.84 2.71 3.98 4.15 2.37 2.76 
  3.01 4.85 2.71 3.97 4.17 2.37 2.75 
  3.63 3.56 3.05 3.88 2.89 2.37 3.04 
  3.00 4.85 2.71 4.00 4.14 2.36 2.77 
  2.97 4.87 2.70 4.00 4.16 2.36 2.78 
  3.60 3.65 3.05 3.89 2.91 2.37 3.03 
  2.95 4.89 2.71 4.00 4.16 2.35 2.78 
  3.57 3.78 3.05 3.92 2.95 2.36 3.03 
  2.97 4.91 2.70 4.00 4.16 2.35 2.78 
  3.01 4.85 2.70 3.96 4.17 2.37 2.76 
  3.60 3.69 3.05 3.91 2.95 2.36 3.03 
  3.01 4.77 2.75 4.00 4.14 2.35 2.76 
  2.99 4.90 2.70 3.97 4.18 2.36 2.76 
  2.98 4.89 2.70 3.97 4.17 2.36 2.76 
  3.03 4.84 2.70 3.97 4.16 2.38 2.76 
  3.60 3.65 3.05 3.90 2.93 2.36 3.03 
  2.96 4.87 2.71 3.99 4.16 2.37 2.77 
  3.61 3.69 3.04 3.90 2.92 2.37 3.03 
  3.56 3.81 3.04 3.92 2.95 2.36 3.03 
  3.53 3.90 3.04 3.94 2.96 2.37 3.03 
  3.61 3.64 3.04 3.88 2.88 2.38 3.04 
  3.64 3.51 3.03 3.85 2.85 2.38 3.04 
  3.54 3.89 3.04 3.95 3.01 2.35 3.02 
  3.00 4.85 2.70 3.99 4.14 2.37 2.78 
  3.57 3.75 3.04 3.90 2.91 2.38 3.04 
  2.65 4.68 3.04 2.82 3.79 3.04 2.37 
                
Shortest 2.65 3.51 2.70 2.82 2.85 2.35 2.37 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  34.24 0.00 34.24 0.00 0.00 34.24 34.24 
  29.55 0.00 29.55 0.00 0.00 29.55 29.55 
  4.79 0.00 4.79 0.00 0.00 4.79 4.79 
  3.25 0.00 3.25 0.00 0.00 3.25 3.25 
  0.00 0.00 3.22 0.00 0.00 3.22 3.22 
  0.00 0.00 3.22 0.00 0.00 3.22 3.22 
  0.00 0.00 0.00 0.00 3.11 3.11 0.00 
  0.00 0.00 2.20 0.00 0.00 2.20 2.20 
  1.76 0.00 1.76 0.00 0.00 1.76 1.76 
  0.00 0.00 0.00 0.00 1.64 1.64 0.00 
  1.53 0.00 1.53 0.00 0.00 1.53 1.53 
  0.00 0.00 0.00 0.00 1.48 1.48 0.00 
  1.35 0.00 1.35 0.00 0.00 1.35 1.35 
  0.00 0.00 0.95 0.00 0.00 0.95 0.95 
  0.00 0.00 0.00 0.00 0.93 0.93 0.00 
  0.00 0.00 0.61 0.00 0.00 0.61 0.61 
  0.61 0.00 0.61 0.00 0.00 0.61 0.61 
  0.58 0.00 0.58 0.00 0.00 0.58 0.58 
  0.00 0.00 0.58 0.00 0.00 0.58 0.58 
  0.00 0.00 0.00 0.00 0.54 0.54 0.00 
  0.54 0.00 0.54 0.00 0.00 0.54 0.54 
  0.00 0.00 0.00 0.00 0.49 0.49 0.00 
  0.00 0.00 0.00 0.00 0.39 0.39 0.00 
  0.00 0.00 0.00 0.00 0.39 0.39 0.00 
  0.00 0.00 0.00 0.00 0.39 0.39 0.00 
  0.00 0.00 0.00 0.00 0.37 0.37 0.00 
  0.00 0.00 0.00 0.00 0.00 0.37 0.00 
  0.00 0.00 0.31 0.00 0.00 0.31 0.31 
  0.00 0.00 0.00 0.00 0.30 0.30 0.00 
  0.30 0.00 0.00 0.30 0.00 0.00 0.30 
                
                
% < 3 Ang 78.49 0.00 89.29 0.30 10.04 99.70 89.59 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 0.00 0.00 0.00 34.24 0.00 
  0.00 0.00 0.00 0.00 0.00 29.55 0.00 
  0.00 0.00 0.00 0.00 0.00 4.79 0.00 
  0.00 0.00 0.00 0.00 0.00 3.25 0.00 
  0.00 0.00 0.00 0.00 0.00 3.22 0.00 
  0.00 0.00 0.00 0.00 0.00 3.22 0.00 
  0.00 0.00 0.00 0.00 0.00 3.11 0.00 
  0.00 0.00 0.00 0.00 0.00 2.20 0.00 
  0.00 0.00 0.00 0.00 0.00 1.76 0.00 
  0.00 0.00 0.00 0.00 0.00 1.64 0.00 
  0.00 0.00 0.00 0.00 0.00 1.53 0.00 
  0.00 0.00 0.00 0.00 0.00 1.48 0.00 
  0.00 0.00 0.00 0.00 0.00 1.35 0.00 
  0.00 0.00 0.00 0.00 0.00 0.95 0.00 
  0.00 0.00 0.00 0.00 0.00 0.93 0.00 
  0.00 0.00 0.00 0.00 0.00 0.61 0.00 
  0.00 0.00 0.00 0.00 0.00 0.61 0.00 
  0.00 0.00 0.00 0.00 0.00 0.58 0.00 
  0.00 0.00 0.00 0.00 0.00 0.58 0.00 
  0.00 0.00 0.00 0.00 0.00 0.54 0.00 
  0.00 0.00 0.00 0.00 0.00 0.54 0.00 
  0.00 0.00 0.00 0.00 0.00 0.49 0.00 
  0.00 0.00 0.00 0.00 0.00 0.39 0.00 
  0.00 0.00 0.00 0.00 0.00 0.39 0.00 
  0.00 0.00 0.00 0.00 0.00 0.39 0.00 
  0.00 0.00 0.00 0.00 0.00 0.37 0.00 
  0.00 0.00 0.00 0.00 0.00 0.37 0.00 
  0.00 0.00 0.00 0.00 0.00 0.31 0.00 
  0.00 0.00 0.00 0.00 0.00 0.30 0.00 
  0.00 0.00 0.00 0.00 0.00 0.00 0.30 
                
% < 2.5 Ang 0.00 0.00 0.00 0.00 0.00 99.70 0.30 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  100.78 166.49 92.79 136.24 142.91 80.99 94.53 
  87.06 143.59 79.82 117.45 123.24 69.98 81.79 
  14.07 23.43 12.91 19.04 20.00 11.28 13.23 
  9.65 15.82 8.81 12.99 13.51 7.66 9.01 
  9.76 15.59 8.73 12.81 13.38 7.64 8.88 
  9.67 15.61 8.72 12.76 13.41 7.62 8.85 
  11.28 11.06 9.46 12.03 8.98 7.37 9.42 
  6.62 10.67 5.97 8.81 9.11 5.20 6.11 
  5.24 8.58 4.77 7.04 7.33 4.16 4.90 
  5.92 5.99 5.00 6.39 4.78 3.89 4.98 
  4.50 7.48 4.14 6.12 6.36 3.60 4.25 
  5.29 5.61 4.52 5.81 4.37 3.50 4.49 
  4.02 6.64 3.65 5.41 5.63 3.18 3.76 
  2.87 4.62 2.57 3.78 3.97 2.26 2.63 
  3.34 3.43 2.83 3.63 2.74 2.19 2.81 
  1.85 2.92 1.68 2.45 2.54 1.44 1.69 
  1.82 2.98 1.64 2.42 2.55 1.44 1.68 
  1.74 2.85 1.58 2.32 2.44 1.38 1.61 
  1.75 2.80 1.56 2.30 2.40 1.38 1.60 
  1.96 1.99 1.66 2.12 1.59 1.28 1.65 
  1.59 2.61 1.45 2.14 2.23 1.27 1.48 
  1.78 1.82 1.50 1.92 1.44 1.17 1.49 
  1.39 1.48 1.18 1.53 1.15 0.92 1.18 
  1.37 1.51 1.18 1.53 1.15 0.92 1.18 
  1.40 1.41 1.18 1.50 1.12 0.92 1.18 
  1.36 1.32 1.14 1.44 1.07 0.89 1.14 
  1.31 1.44 1.13 1.46 1.12 0.87 1.12 
  0.94 1.52 0.85 1.25 1.30 0.74 0.87 
  1.08 1.13 0.92 1.18 0.88 0.72 0.92 
  0.79 1.39 0.90 0.84 1.12 0.90 0.70 
                
                
bolt.Ave.dist 3.02 4.74 2.74 3.97 4.04 2.37 2.79 
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  H4-H9 H4-H8 H8-H9 H9-H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.02 0.00 0.03 0.00 0.00 0.06 0.08   169.08 -152.29 -29.47 
  0.01 0.00 0.02 0.00 0.00 0.05 0.07   169.45 -154.51 -31.67 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   169.39 -154.10 -31.31 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   168.47 -155.70 -32.74 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   169.22 -153.09 -30.14 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   168.47 -153.24 -30.33 
  0.00 0.00 0.00 0.00 0.00 0.01 0.00   169.48 -155.42 -32.44 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   82.72 -90.18 31.65 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   169.32 -152.29 -29.57 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   169.63 -154.71 -31.97 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   169.56 -155.50 -32.55 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   169.43 -153.27 -30.36 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   82.91 -89.81 32.04 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.24 -148.88 -26.36 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   167.22 -151.45 -28.89 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   167.47 -152.66 -29.91 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   170.62 -153.01 -30.22 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.57 -149.99 -27.28 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   82.42 -90.34 31.47 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   170.96 -155.09 -32.29 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   82.75 -90.09 31.73 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   169.43 -154.98 -32.05 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   167.49 -151.87 -29.36 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   168.31 -155.48 -32.56 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.47 -149.10 -26.64 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   167.26 -152.88 -30.15 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.39 -150.18 -27.50 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   168.22 -151.05 -28.23 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   81.85 -89.68 32.27 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   167.76 -152.83 -30.12 
                        
1/r^6 0.04 0.00 0.07 0.01 0.01 0.17 0.22         
Appendix 2 Molecular modelling data 272 
Table 2.3: Molecular modelling data for 4R, 5S, 8S, 9S. 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
324.99 -130.29 2.60E-57 5.20E-56 5.13 25.66 8340.13 326.79 
325.01 -130.30 2.58E-57 5.16E-56 5.09 25.46 8276.28   
326.08 -130.73 1.68E-57 3.36E-56 3.32 16.59 5408.98   
327.88 -131.45 8.18E-58 1.64E-56 1.61 8.07 2647.11   
328.87 -131.84 5.51E-58 1.10E-56 1.09 5.44 1788.07   
329.16 -131.96 4.89E-58 9.77E-57 0.96 4.82 1588.19   
329.82 -132.23 3.75E-58 7.51E-57 0.74 3.71 1222.48   
330.21 -132.38 3.21E-58 6.43E-57 0.63 3.17 1048.11   
331.17 -132.77 2.18E-58 4.37E-57 0.43 2.16 713.90   
333.26 -133.61 9.45E-59 1.89E-57 0.19 0.93 310.93   
334.09 -133.94 6.79E-59 1.36E-57 0.13 0.67 223.87   
334.26 -134.01 6.32E-59 1.26E-57 0.12 0.62 208.66   
334.56 -134.12 5.63E-59 1.13E-57 0.11 0.56 185.89   
335.27 -134.41 4.22E-59 8.44E-58 0.08 0.42 139.66   
335.61 -134.55 3.68E-59 7.36E-58 0.07 0.36 121.97   
335.65 -134.56 3.63E-59 7.25E-58 0.07 0.36 120.17   
336.25 -134.81 2.85E-59 5.70E-58 0.06 0.28 94.60   
336.48 -134.90 2.60E-59 5.21E-58 0.05 0.26 86.54   
336.65 -134.96 2.43E-59 4.86E-58 0.05 0.24 80.82   
336.93 -135.08 2.17E-59 4.34E-58 0.04 0.21 72.21   
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  3.95 4.85 2.71 3.99 4.16 2.36 2.77 
  3.95 4.84 2.71 3.99 4.16 2.36 2.78 
  3.93 4.82 2.71 3.99 4.16 2.36 2.78 
  3.95 4.85 2.70 3.98 4.16 2.36 2.78 
  3.96 4.85 2.70 3.98 4.16 2.36 2.78 
  3.94 4.87 2.70 3.99 4.17 2.35 2.77 
  3.93 4.83 2.70 3.98 4.16 2.36 2.78 
  3.95 4.87 2.69 3.99 4.17 2.35 2.78 
  3.92 4.86 2.69 3.99 4.17 2.35 2.78 
  3.94 4.84 2.71 4.00 4.14 2.37 2.78 
  3.98 4.68 2.75 4.02 4.12 2.33 2.79 
  4.19 3.18 3.05 3.88 2.88 2.38 3.04 
  3.99 4.68 2.75 4.02 4.12 2.34 2.78 
  3.89 4.88 2.71 4.00 4.16 2.35 2.78 
  4.18 3.32 3.04 3.91 2.92 2.37 3.03 
  3.96 4.67 2.75 4.02 4.12 2.34 2.79 
  3.89 4.89 2.71 4.00 4.16 2.35 2.78 
  4.18 3.40 3.04 3.93 2.97 2.36 3.03 
  4.18 3.02 3.04 3.83 2.82 2.39 3.04 
  3.99 4.69 2.74 4.01 4.12 2.34 2.78 
                
Shortest 3.89 3.02 2.69 3.83 2.82 2.33 2.77 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 25.66 0.00 0.00 25.66 25.66 
  0.00 0.00 25.46 0.00 0.00 25.46 25.46 
  0.00 0.00 16.59 0.00 0.00 16.59 16.59 
  0.00 0.00 8.07 0.00 0.00 8.07 8.07 
  0.00 0.00 5.44 0.00 0.00 5.44 5.44 
  0.00 0.00 4.82 0.00 0.00 4.82 4.82 
  0.00 0.00 3.71 0.00 0.00 3.71 3.71 
  0.00 0.00 3.17 0.00 0.00 3.17 3.17 
  0.00 0.00 2.16 0.00 0.00 2.16 2.16 
  0.00 0.00 0.93 0.00 0.00 0.93 0.93 
  0.00 0.00 0.67 0.00 0.00 0.67 0.67 
  0.00 0.00 0.00 0.00 0.62 0.62 0.00 
  0.00 0.00 0.56 0.00 0.00 0.56 0.56 
  0.00 0.00 0.42 0.00 0.00 0.42 0.42 
  0.00 0.00 0.00 0.00 0.36 0.36 0.00 
  0.00 0.00 0.36 0.00 0.00 0.36 0.36 
  0.00 0.00 0.28 0.00 0.00 0.28 0.28 
  0.00 0.00 0.00 0.00 0.26 0.26 0.00 
  0.00 0.00 0.00 0.00 0.24 0.24 0.00 
  0.00 0.00 0.21 0.00 0.00 0.21 0.21 
                
                
% < 3 Ang 0.00 0.00 98.52 0.00 1.48 100.00 98.52 
Appendix 2 Molecular modelling data 275 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 0.00 0.00 0.00 25.66 0.00 
  0.00 0.00 0.00 0.00 0.00 25.46 0.00 
  0.00 0.00 0.00 0.00 0.00 16.59 0.00 
  0.00 0.00 0.00 0.00 0.00 8.07 0.00 
  0.00 0.00 0.00 0.00 0.00 5.44 0.00 
  0.00 0.00 0.00 0.00 0.00 4.82 0.00 
  0.00 0.00 0.00 0.00 0.00 3.71 0.00 
  0.00 0.00 0.00 0.00 0.00 3.17 0.00 
  0.00 0.00 0.00 0.00 0.00 2.16 0.00 
  0.00 0.00 0.00 0.00 0.00 0.93 0.00 
  0.00 0.00 0.00 0.00 0.00 0.67 0.00 
  0.00 0.00 0.00 0.00 0.00 0.62 0.00 
  0.00 0.00 0.00 0.00 0.00 0.56 0.00 
  0.00 0.00 0.00 0.00 0.00 0.42 0.00 
  0.00 0.00 0.00 0.00 0.00 0.36 0.00 
  0.00 0.00 0.00 0.00 0.00 0.36 0.00 
  0.00 0.00 0.00 0.00 0.00 0.28 0.00 
  0.00 0.00 0.00 0.00 0.00 0.26 0.00 
  0.00 0.00 0.00 0.00 0.00 0.24 0.00 
  0.00 0.00 0.00 0.00 0.00 0.21 0.00 
                
% < 2.5 Ang 0.00 0.00 0.00 0.00 0.00 100.00 0.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  101.36 124.42 69.45 102.30 106.76 60.55 71.07 
  100.70 123.37 68.89 101.62 105.90 60.07 70.70 
  65.20 80.03 44.87 66.22 68.97 39.12 46.07 
  31.90 39.13 21.79 32.16 33.57 19.08 22.42 
  21.50 26.36 14.66 21.66 22.62 12.85 15.13 
  19.03 23.50 13.01 19.23 20.10 11.35 13.38 
  14.57 17.89 9.99 14.77 15.42 8.76 10.32 
  12.53 15.46 8.55 12.65 13.23 7.47 8.82 
  8.46 10.47 5.81 8.60 8.98 5.07 5.99 
  3.68 4.52 2.53 3.73 3.87 2.21 2.59 
  2.67 3.14 1.84 2.70 2.76 1.56 1.87 
  2.62 1.99 1.90 2.42 1.80 1.48 1.90 
  2.21 2.60 1.53 2.23 2.29 1.30 1.54 
  1.62 2.03 1.13 1.67 1.73 0.98 1.16 
  1.52 1.21 1.10 1.42 1.06 0.86 1.10 
  1.42 1.67 0.98 1.44 1.48 0.84 1.00 
  1.09 1.38 0.76 1.13 1.17 0.66 0.78 
  1.07 0.87 0.78 1.01 0.76 0.61 0.78 
  1.00 0.72 0.73 0.92 0.68 0.57 0.73 
  0.85 1.00 0.59 0.86 0.88 0.50 0.60 
                
                
bolt.Ave.dist 3.95 4.82 2.71 3.99 4.14 2.36 2.78 
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  H4-H9 H4-H8 H8-H9 H9-H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 
H8-
H7a 
H8-
H7b 
  0.00 0.00 0.01 0.00 0.00 0.03 0.06   -83.84 -28.89 92.90 
  0.00 0.00 0.01 0.00 0.00 0.03 0.06   -84.11 -28.16 93.61 
  0.00 0.00 0.01 0.00 0.00 0.02 0.04   -84.09 -27.99 93.78 
  0.00 0.00 0.00 0.00 0.00 0.01 0.02   -83.85 -28.76 93.12 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   -83.77 -28.39 93.48 
  0.00 0.00 0.00 0.00 0.00 0.01 0.01   -83.57 -28.00 93.72 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   -83.73 -28.28 93.58 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   -83.59 -27.65 94.07 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -83.56 -27.46 94.25 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -84.83 -27.69 93.92 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -89.88 -24.83 96.72 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -161.79 33.83 156.89 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -89.80 -26.10 95.47 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -83.23 -27.01 94.76 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -158.30 33.92 157.10 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -89.36 -25.00 96.55 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -82.90 -26.89 94.91 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -156.31 32.68 155.53 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -164.08 34.30 157.39 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -89.65 -26.15 95.54 
                        
1/r^6 0.01 0.00 0.05 0.00 0.00 0.12 0.22         
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Table 2.4: Molecular modelling data for 4R, 5S, 8R, 9R 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
343.34 -137.65 1.66E-60 2.16E-59 5.18 39.82 ###### 345.50 
345.09 -138.35 8.25E-61 1.07E-59 2.57 19.76 6820.61   
346.28 -138.83 5.11E-61 6.64E-60 1.59 12.24 4239.23   
346.80 -139.04 4.15E-61 5.39E-60 1.29 9.93 3445.36   
347.15 -139.17 3.61E-61 4.69E-60 1.12 8.64 2999.39   
349.90 -140.28 1.20E-61 1.56E-60 0.37 2.87 1004.88   
350.89 -140.67 8.06E-62 1.05E-60 0.25 1.93 677.78   
351.36 -140.86 6.67E-62 8.68E-61 0.21 1.60 561.71   
351.94 -141.09 5.29E-62 6.88E-61 0.16 1.27 446.03   
353.79 -141.84 2.52E-62 3.27E-61 0.08 0.60 213.15   
353.99 -141.92 2.33E-62 3.02E-61 0.07 0.56 197.16   
354.90 -142.28 1.62E-62 2.10E-61 0.05 0.39 137.46   
354.94 -142.30 1.59E-62 2.07E-61 0.05 0.38 135.28   
 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  2.87 4.88 3.05 2.82 3.79 3.04 2.38 
  2.92 4.89 3.05 2.82 3.79 3.04 2.38 
  2.85 4.87 3.05 2.82 3.79 3.04 2.38 
  2.93 4.89 3.05 2.82 3.80 3.04 2.38 
  2.83 4.90 3.04 2.85 3.79 3.03 2.37 
  2.89 4.88 3.05 2.81 3.79 3.04 2.38 
  2.81 4.89 3.04 2.85 3.79 3.03 2.37 
  2.89 4.89 3.06 2.83 3.80 3.04 2.37 
  2.89 4.88 3.05 2.83 3.80 3.04 2.37 
  2.89 4.92 3.05 2.85 3.80 3.03 2.37 
  2.86 4.91 3.04 2.84 3.79 3.03 2.37 
  2.91 4.88 3.05 2.81 3.79 3.04 2.38 
  2.86 4.92 3.05 2.86 3.80 3.03 2.36 
                
Shortest 2.81 4.87 3.04 2.81 3.79 3.03 2.36 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  39.82 0.00 0.00 39.82 0.00 0.00 39.82 
  19.76 0.00 0.00 19.76 0.00 0.00 19.76 
  12.24 0.00 0.00 12.24 0.00 0.00 12.24 
  9.93 0.00 0.00 9.93 0.00 0.00 9.93 
  8.64 0.00 0.00 8.64 0.00 0.00 8.64 
  2.87 0.00 0.00 2.87 0.00 0.00 2.87 
  1.93 0.00 0.00 1.93 0.00 0.00 1.93 
  1.60 0.00 0.00 1.60 0.00 0.00 1.60 
  1.27 0.00 0.00 1.27 0.00 0.00 1.27 
  0.60 0.00 0.00 0.60 0.00 0.00 0.60 
  0.56 0.00 0.00 0.56 0.00 0.00 0.56 
  0.39 0.00 0.00 0.39 0.00 0.00 0.39 
  0.38 0.00 0.00 0.38 0.00 0.00 0.38 
                
                
% < 3 Ang 100.00 0.00 0.00 100.00 0.00 0.00 100.00 
 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 0.00 0.00 0.00 0.00 39.82 
  0.00 0.00 0.00 0.00 0.00 0.00 19.76 
  0.00 0.00 0.00 0.00 0.00 0.00 12.24 
  0.00 0.00 0.00 0.00 0.00 0.00 9.93 
  0.00 0.00 0.00 0.00 0.00 0.00 8.64 
  0.00 0.00 0.00 0.00 0.00 0.00 2.87 
  0.00 0.00 0.00 0.00 0.00 0.00 1.93 
  0.00 0.00 0.00 0.00 0.00 0.00 1.60 
  0.00 0.00 0.00 0.00 0.00 0.00 1.27 
  0.00 0.00 0.00 0.00 0.00 0.00 0.60 
  0.00 0.00 0.00 0.00 0.00 0.00 0.56 
  0.00 0.00 0.00 0.00 0.00 0.00 0.39 
  0.00 0.00 0.00 0.00 0.00 0.00 0.38 
                
% < 2.5 Ang 0.00 0.00 0.00 0.00 0.00 0.00 100.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  114.17 194.27 121.57 112.25 150.83 121.13 94.73 
  57.70 96.68 60.37 55.75 74.98 60.09 46.98 
  34.95 59.64 37.37 34.52 46.42 37.23 29.11 
  29.14 48.58 30.35 28.03 37.73 30.21 23.62 
  24.44 42.38 26.30 24.63 32.74 26.20 20.48 
  8.30 14.03 8.76 8.06 10.87 8.73 6.83 
  5.43 9.45 5.88 5.50 7.32 5.86 4.58 
  4.61 7.81 4.89 4.52 6.07 4.85 3.79 
  3.66 6.18 3.87 3.59 4.81 3.85 3.00 
  1.74 2.97 1.83 1.72 2.29 1.83 1.43 
  1.60 2.74 1.70 1.58 2.11 1.69 1.32 
  1.13 1.89 1.18 1.09 1.47 1.18 0.92 
  1.09 1.87 1.16 1.09 1.45 1.15 0.90 
                
                
bolt.Ave.dist 2.88 4.88 3.05 2.82 3.79 3.04 2.38 
 
 
 
  H4-H9 
H4-
H8 
H8-
H9 
H9-
H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.01 0.00 0.01 0.01 0.00 0.01 0.22   169.38 -152.63 -29.75 
  0.00 0.00 0.00 0.01 0.00 0.00 0.11   168.82 -152.67 -29.80 
  0.00 0.00 0.00 0.00 0.00 0.00 0.07   169.15 -152.91 -30.00 
  0.00 0.00 0.00 0.00 0.00 0.00 0.06   168.72 -153.04 -30.13 
  0.00 0.00 0.00 0.00 0.00 0.00 0.05   166.71 -149.30 -26.70 
  0.00 0.00 0.00 0.00 0.00 0.00 0.02   169.08 -153.34 -30.37 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   166.74 -149.58 -26.94 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   169.18 -152.49 -29.76 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   169.34 -153.49 -30.55 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.18 -149.20 -26.66 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.55 -150.04 -27.33 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   168.79 -153.92 -30.88 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   166.49 -149.22 -26.75 
                        
1/r^6 0.02 0.00 0.02 0.03 0.00 0.02 0.55         
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Figure 2.5: Molecular modelling data for 4R, 5S, 8S, 9R 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
342.68 -137.38 2.16E-60 3.46E-59 4.75 29.67 ###### 345.13 
344.57 -138.14 1.02E-60 1.62E-59 2.23 13.93 4799.35   
345.05 -138.33 8.38E-61 1.34E-59 1.84 11.49 3966.31   
345.40 -138.47 7.27E-61 1.16E-59 1.60 9.98 3445.51   
345.97 -138.70 5.80E-61 9.28E-60 1.27 7.96 2752.40   
346.34 -138.85 4.99E-61 7.98E-60 1.10 6.85 2371.52   
346.79 -139.03 4.17E-61 6.67E-60 0.91 5.72 1982.50   
347.04 -139.13 3.78E-61 6.04E-60 0.83 5.18 1798.74   
348.23 -139.61 2.34E-61 3.74E-60 0.51 3.21 1117.60   
349.14 -139.97 1.62E-61 2.60E-60 0.36 2.23 777.71   
350.15 -140.38 1.08E-61 1.74E-60 0.24 1.49 520.99   
352.24 -141.22 4.69E-62 7.50E-61 0.10 0.64 226.62   
352.69 -141.40 3.92E-62 6.27E-61 0.09 0.54 189.49   
353.48 -141.71 2.85E-62 4.56E-61 0.06 0.39 138.25   
353.58 -141.75 2.74E-62 4.38E-61 0.06 0.38 132.69   
353.72 -141.81 2.60E-62 4.15E-61 0.06 0.36 125.98   
 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  2.84 4.78 2.35 3.12 3.89 2.35 2.84 
  3.32 3.10 2.40 4.19 3.94 2.39 3.05 
  3.29 3.08 2.40 4.19 3.94 2.39 3.05 
  2.83 4.76 2.35 3.13 3.90 2.35 2.84 
  3.32 3.03 2.39 4.19 3.95 2.39 3.04 
  3.35 3.03 2.40 4.19 3.95 2.39 3.04 
  3.34 2.98 2.42 4.20 3.94 2.38 3.04 
  3.37 2.98 2.42 4.21 3.94 2.39 3.04 
  2.87 4.81 2.37 3.09 3.89 2.34 2.83 
  2.85 4.80 2.37 3.08 3.88 2.36 2.83 
  2.89 4.82 2.34 3.05 3.87 2.34 2.82 
  2.80 4.62 2.29 3.28 3.91 2.33 2.88 
  2.89 4.80 2.37 3.09 3.90 2.34 2.82 
  2.86 4.83 2.34 3.03 3.84 2.34 2.83 
  2.89 4.85 2.37 3.04 3.88 2.34 2.82 
  2.87 4.79 2.37 3.09 3.89 2.35 2.82 
                
Shortest 2.80 2.98 2.29 3.03 3.84 2.33 2.82 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  29.67 0.00 29.67 0.00 0.00 29.67 29.67 
  0.00 0.00 13.93 0.00 0.00 13.93 0.00 
  0.00 0.00 11.49 0.00 0.00 11.49 0.00 
  9.98 0.00 9.98 0.00 0.00 9.98 9.98 
  0.00 0.00 7.96 0.00 0.00 7.96 0.00 
  0.00 0.00 6.85 0.00 0.00 6.85 0.00 
  0.00 5.72 5.72 0.00 0.00 5.72 0.00 
  0.00 5.18 5.18 0.00 0.00 5.18 0.00 
  3.21 0.00 3.21 0.00 0.00 3.21 3.21 
  2.23 0.00 2.23 0.00 0.00 2.23 2.23 
  1.49 0.00 1.49 0.00 0.00 1.49 1.49 
  0.64 0.00 0.64 0.00 0.00 0.64 0.64 
  0.54 0.00 0.54 0.00 0.00 0.54 0.54 
  0.39 0.00 0.39 0.00 0.00 0.39 0.39 
  0.38 0.00 0.38 0.00 0.00 0.38 0.38 
  0.36 0.00 0.36 0.00 0.00 0.36 0.36 
                
                
% < 3 Ang 48.87 10.90 100.00 0.00 0.00 100.00 48.87 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 29.67 0.00 0.00 29.67 0.00 
  0.00 0.00 13.93 0.00 0.00 13.93 0.00 
  0.00 0.00 11.49 0.00 0.00 11.49 0.00 
  0.00 0.00 9.98 0.00 0.00 9.98 0.00 
  0.00 0.00 7.96 0.00 0.00 7.96 0.00 
  0.00 0.00 6.85 0.00 0.00 6.85 0.00 
  0.00 0.00 5.72 0.00 0.00 5.72 0.00 
  0.00 0.00 5.18 0.00 0.00 5.18 0.00 
  0.00 0.00 3.21 0.00 0.00 3.21 0.00 
  0.00 0.00 2.23 0.00 0.00 2.23 0.00 
  0.00 0.00 1.49 0.00 0.00 1.49 0.00 
  0.00 0.00 0.64 0.00 0.00 0.64 0.00 
  0.00 0.00 0.54 0.00 0.00 0.54 0.00 
  0.00 0.00 0.39 0.00 0.00 0.39 0.00 
  0.00 0.00 0.38 0.00 0.00 0.38 0.00 
  0.00 0.00 0.36 0.00 0.00 0.36 0.00 
                
% < 2.5 Ang 0.00 0.00 100.00 0.00 0.00 100.00 0.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  84.30 141.82 69.74 92.68 115.37 69.81 84.36 
  46.25 43.15 33.43 58.36 54.81 33.32 42.43 
  37.85 35.44 27.55 48.13 45.24 27.49 35.01 
  28.22 47.45 23.43 31.25 38.86 23.45 28.35 
  26.40 24.11 19.05 33.33 31.41 19.00 24.21 
  22.96 20.76 16.43 28.71 27.04 16.36 20.85 
  19.07 17.04 13.81 24.02 22.52 13.63 17.39 
  17.46 15.47 12.55 21.80 20.42 12.36 15.77 
  9.21 15.44 7.60 9.92 12.49 7.52 9.08 
  6.36 10.70 5.27 6.86 8.64 5.25 6.30 
  4.30 7.17 3.49 4.54 5.75 3.48 4.20 
  1.80 2.97 1.47 2.11 2.52 1.50 1.86 
  1.55 2.58 1.27 1.66 2.10 1.26 1.52 
  1.12 1.89 0.92 1.19 1.50 0.92 1.11 
  1.08 1.82 0.89 1.14 1.45 0.88 1.06 
  1.02 1.71 0.84 1.10 1.39 0.84 1.01 
                
                
bolt.Ave.dist 3.09 3.90 2.38 3.67 3.92 2.37 2.94 
 
 
 
  H4-H9 
H4-
H8 
H8-
H9 
H9-
H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.01 0.00 0.03 0.01 0.00 0.03 0.06   36.66 -18.12 103.69 
  0.00 0.00 0.01 0.00 0.00 0.01 0.02   -37.75 32.75 155.83 
  0.00 0.00 0.01 0.00 0.00 0.01 0.01   -37.49 32.66 155.73 
  0.00 0.00 0.01 0.00 0.00 0.01 0.02   36.17 -18.18 103.62 
  0.00 0.00 0.01 0.00 0.00 0.01 0.01   -39.80 32.63 155.61 
  0.00 0.00 0.01 0.00 0.00 0.01 0.01   -40.24 32.63 155.62 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   -41.62 33.50 156.40 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   -42.02 33.53 156.44 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   36.29 -19.81 102.04 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.17 -20.63 101.13 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.50 -20.25 101.49 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   29.32 -9.71 112.08 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   36.15 -20.62 101.24 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.47 -19.31 102.44 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.05 -20.93 100.76 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.60 -21.21 100.56 
                        
1/r^6 0.02 0.01 0.09 0.01 0.00 0.09 0.16         
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Table 2.6: Molecular modelling data for 4S, 5S, 8S, 9R 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
354.66 -142.19 1.77E-62 3.37E-61 5.65 29.75 ###### 356.87 
355.22 -142.41 1.42E-62 2.69E-61 4.52 23.76 8441.79   
356.22 -142.81 9.49E-63 1.80E-61 3.02 15.92 5669.91   
358.45 -143.70 3.90E-63 7.40E-62 1.24 6.53 2340.85   
359.26 -144.03 2.81E-63 5.35E-62 0.90 4.72 1695.42   
360.33 -144.46 1.83E-63 3.47E-62 0.58 3.07 1104.43   
360.70 -144.61 1.58E-63 3.00E-62 0.50 2.64 953.70   
361.05 -144.75 1.37E-63 2.60E-62 0.44 2.29 828.62   
361.48 -144.92 1.15E-63 2.19E-62 0.37 1.93 698.78   
361.49 -144.92 1.15E-63 2.18E-62 0.37 1.93 696.10   
361.51 -144.93 1.14E-63 2.17E-62 0.36 1.91 691.42   
362.13 -145.18 8.91E-64 1.69E-62 0.28 1.49 540.95   
362.38 -145.28 8.04E-64 1.53E-62 0.26 1.35 488.19   
362.73 -145.42 6.99E-64 1.33E-62 0.22 1.17 425.14   
365.72 -146.62 2.11E-64 4.01E-63 0.07 0.35 129.34   
365.74 -146.63 2.09E-64 3.98E-63 0.07 0.35 128.38   
366.22 -146.82 1.73E-64 3.28E-63 0.06 0.29 106.07   
366.34 -146.87 1.65E-64 3.13E-63 0.05 0.28 101.13   
366.44 -146.91 1.58E-64 3.00E-63 0.05 0.26 96.91   
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  2.32 3.55 2.39 4.18 3.96 2.38 3.04 
  2.34 3.52 2.39 4.18 3.97 2.38 3.04 
  2.35 3.49 2.41 4.20 3.96 2.38 3.04 
  2.31 3.60 2.39 4.19 3.94 2.39 3.05 
  2.34 3.56 2.39 4.19 3.95 2.39 3.04 
  2.34 3.52 2.41 4.20 3.94 2.38 3.04 
  2.71 4.87 2.37 3.09 3.89 2.35 2.83 
  2.69 4.86 2.35 3.15 3.91 2.35 2.84 
  2.66 4.84 2.35 3.10 3.92 2.36 2.81 
  2.70 4.86 2.37 3.04 3.89 2.35 2.81 
  2.70 4.84 2.34 3.04 3.86 2.34 2.82 
  2.70 4.86 2.37 3.08 3.88 2.36 2.83 
  2.69 4.84 2.34 2.99 3.85 2.35 2.81 
  2.69 4.86 2.37 3.03 3.88 2.36 2.81 
  2.33 3.38 2.41 4.20 3.96 2.39 3.04 
  2.34 3.52 2.39 4.18 3.96 2.38 3.04 
  2.77 4.91 2.37 3.04 3.87 2.34 2.82 
  2.73 4.88 2.37 3.04 3.89 2.35 2.81 
  2.34 3.37 2.43 4.21 3.95 2.38 3.04 
                
Shortest 2.31 3.37 2.34 2.99 3.85 2.34 2.81 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  29.75 0.00 29.75 0.00 0.00 29.75 0.00 
  23.76 0.00 23.76 0.00 0.00 23.76 0.00 
  15.92 0.00 15.92 0.00 0.00 15.92 0.00 
  6.53 0.00 6.53 0.00 0.00 6.53 0.00 
  4.72 0.00 4.72 0.00 0.00 4.72 0.00 
  3.07 0.00 3.07 0.00 0.00 3.07 0.00 
  2.64 0.00 2.64 0.00 0.00 2.64 2.64 
  2.29 0.00 2.29 0.00 0.00 2.29 2.29 
  1.93 0.00 1.93 0.00 0.00 1.93 1.93 
  1.93 0.00 1.93 0.00 0.00 1.93 1.93 
  1.91 0.00 1.91 0.00 0.00 1.91 1.91 
  1.49 0.00 1.49 0.00 0.00 1.49 1.49 
  1.35 0.00 1.35 1.35 0.00 1.35 1.35 
  1.17 0.00 1.17 0.00 0.00 1.17 1.17 
  0.35 0.00 0.35 0.00 0.00 0.35 0.00 
  0.35 0.00 0.35 0.00 0.00 0.35 0.00 
  0.29 0.00 0.29 0.00 0.00 0.29 0.29 
  0.28 0.00 0.28 0.00 0.00 0.28 0.28 
  0.26 0.00 0.26 0.00 0.00 0.26 0.00 
% < 3 Ang 100.00 0.00 100.00 1.35 0.00 100.00 15.29 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  29.75 0.00 29.75 0.00 0.00 29.75 0.00 
  23.76 0.00 23.76 0.00 0.00 23.76 0.00 
  15.92 0.00 15.92 0.00 0.00 15.92 0.00 
  6.53 0.00 6.53 0.00 0.00 6.53 0.00 
  4.72 0.00 4.72 0.00 0.00 4.72 0.00 
  3.07 0.00 3.07 0.00 0.00 3.07 0.00 
  0.00 0.00 2.64 0.00 0.00 2.64 0.00 
  0.00 0.00 2.29 0.00 0.00 2.29 0.00 
  0.00 0.00 1.93 0.00 0.00 1.93 0.00 
  0.00 0.00 1.93 0.00 0.00 1.93 0.00 
  0.00 0.00 1.91 0.00 0.00 1.91 0.00 
  0.00 0.00 1.49 0.00 0.00 1.49 0.00 
  0.00 0.00 1.35 0.00 0.00 1.35 0.00 
  0.00 0.00 1.17 0.00 0.00 1.17 0.00 
  0.35 0.00 0.35 0.00 0.00 0.35 0.00 
  0.35 0.00 0.35 0.00 0.00 0.35 0.00 
  0.00 0.00 0.29 0.00 0.00 0.29 0.00 
  0.00 0.00 0.28 0.00 0.00 0.28 0.00 
  0.26 0.00 0.26 0.00 0.00 0.26 0.00 
                
% < 2.5 Ang 84.71 0.00 100.00 0.00 0.00 100.00 0.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  68.98 105.68 71.22 124.40 117.66 70.90 90.49 
  55.73 83.58 56.82 99.43 94.26 56.58 72.25 
  37.41 55.56 38.38 66.81 62.97 37.83 48.36 
  15.10 23.54 15.62 27.34 25.74 15.62 19.89 
  11.03 16.78 11.28 19.77 18.66 11.27 14.37 
  7.18 10.80 7.39 12.88 12.09 7.31 9.33 
  7.17 12.86 6.26 8.16 10.29 6.20 7.48 
  6.18 11.15 5.39 7.23 8.98 5.39 6.51 
  5.15 9.36 4.54 5.98 7.57 4.55 5.44 
  5.19 9.36 4.56 5.85 7.49 4.52 5.41 
  5.17 9.26 4.48 5.82 7.38 4.48 5.40 
  4.04 7.27 3.53 4.60 5.80 3.52 4.23 
  3.63 6.52 3.16 4.03 5.19 3.17 3.78 
  3.15 5.69 2.77 3.55 4.55 2.77 3.29 
  0.82 1.20 0.85 1.48 1.40 0.84 1.08 
  0.82 1.24 0.84 1.47 1.39 0.84 1.07 
  0.80 1.42 0.69 0.88 1.12 0.68 0.82 
  0.75 1.35 0.65 0.84 1.07 0.65 0.78 
  0.62 0.89 0.64 1.11 1.04 0.63 0.80 
bolt.Ave.dist 2.39 3.73 2.39 4.02 3.95 2.38 3.01 
 
 
  H4-H9 
H4-
H8 
H8-
H9 
H9-
H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.04 0.00 0.03 0.00 0.00 0.03 0.04   -36.18 31.41 154.40 
  0.03 0.00 0.02 0.00 0.00 0.02 0.03   -38.42 31.54 154.46 
  0.02 0.00 0.02 0.00 0.00 0.02 0.02   -40.10 32.51 155.36 
  0.01 0.00 0.01 0.00 0.00 0.01 0.01   -35.80 32.88 156.00 
  0.01 0.00 0.00 0.00 0.00 0.00 0.01   -38.29 32.96 155.99 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -40.08 33.84 156.80 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   36.75 -19.96 101.88 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   35.43 -18.71 103.06 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   35.69 -22.57 99.07 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.13 -22.89 98.82 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.02 -20.09 101.63 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.35 -20.57 101.17 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.63 -23.00 98.61 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.77 -23.61 98.02 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -40.58 31.87 154.84 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -37.23 32.21 155.11 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.38 -20.99 100.70 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.16 -22.41 99.28 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   -41.93 32.54 155.41 
                        
1/r^6 0.11 0.01 0.10 0.01 0.01 0.11 0.14         
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Figure 2.7: Molecular modelling data for 4S, 5S, 8R, 9S 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
327.78 -131.41 8.51E-58 1.79E-56 6.74 32.08 ###### 330.41 
328.80 -131.82 5.66E-58 1.19E-56 4.48 21.36 7021.69   
330.10 -132.34 3.36E-58 7.05E-57 2.66 12.66 4180.29   
331.56 -132.93 1.87E-58 3.92E-57 1.48 7.04 2334.90   
332.87 -133.45 1.11E-58 2.32E-57 0.88 4.17 1389.14   
333.00 -133.50 1.05E-58 2.21E-57 0.83 3.96 1319.12   
333.97 -133.89 7.10E-59 1.49E-57 0.56 2.68 894.54   
333.98 -133.89 7.08E-59 1.49E-57 0.56 2.67 892.13   
334.76 -134.21 5.18E-59 1.09E-57 0.41 1.95 654.33   
335.20 -134.38 4.35E-59 9.14E-58 0.34 1.64 550.20   
335.31 -134.43 4.16E-59 8.74E-58 0.33 1.57 526.19   
335.31 -134.43 4.15E-59 8.72E-58 0.33 1.57 525.18   
335.62 -134.55 3.67E-59 7.71E-58 0.29 1.39 464.96   
335.76 -134.61 3.47E-59 7.28E-58 0.27 1.31 439.15   
336.81 -135.03 2.28E-59 4.79E-58 0.18 0.86 289.59   
337.06 -135.13 2.06E-59 4.33E-58 0.16 0.78 261.82   
337.30 -135.22 1.88E-59 3.94E-58 0.15 0.71 238.51   
337.82 -135.43 1.52E-59 3.20E-58 0.12 0.57 193.82   
338.75 -135.81 1.05E-59 2.20E-58 0.08 0.40 133.81   
339.11 -135.95 9.07E-60 1.91E-58 0.07 0.34 116.02   
339.50 -136.11 7.74E-60 1.62E-58 0.06 0.29 99.06   
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  2.98 4.76 2.39 3.95 4.18 3.04 2.38 
  2.97 4.75 2.41 3.94 4.19 3.04 2.38 
  2.95 4.76 2.41 3.97 4.18 3.04 2.38 
  2.94 4.76 2.43 3.95 4.19 3.03 2.37 
  3.04 4.78 2.37 3.94 4.18 3.04 2.39 
  3.00 4.77 2.38 3.97 4.17 3.04 2.38 
  3.02 4.77 2.40 3.94 4.19 3.04 2.38 
  2.98 4.76 2.40 3.96 4.18 3.04 2.37 
  2.95 4.75 2.41 3.96 4.18 3.04 2.38 
  3.00 4.77 2.39 3.95 4.18 3.04 2.39 
  2.99 4.78 2.40 3.96 4.18 3.04 2.38 
  3.02 4.79 2.39 3.94 4.18 3.04 2.39 
  2.99 4.77 2.41 3.94 4.19 3.05 2.39 
  2.97 4.78 2.40 3.98 4.17 3.03 2.37 
  2.98 4.77 2.42 3.95 4.19 3.04 2.38 
  2.97 4.74 2.39 3.95 4.19 3.04 2.38 
  2.96 4.77 2.42 3.97 4.18 3.03 2.36 
  2.96 4.77 2.41 3.96 4.18 3.04 2.38 
  2.99 4.79 2.41 3.95 4.18 3.04 2.38 
  2.94 4.78 2.42 3.98 4.18 3.03 2.37 
  2.97 4.79 2.42 3.95 4.19 3.04 2.38 
                
Shortest 2.94 4.74 2.37 3.94 4.17 3.03 2.36 
 
Appendix 2 Molecular modelling data 289 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  32.08 0.00 32.08 0.00 0.00 0.00 32.08 
  21.36 0.00 21.36 0.00 0.00 0.00 21.36 
  12.66 0.00 12.66 0.00 0.00 0.00 12.66 
  7.04 0.00 7.04 0.00 0.00 0.00 7.04 
  0.00 0.00 4.17 0.00 0.00 0.00 4.17 
  3.96 0.00 3.96 0.00 0.00 0.00 3.96 
  0.00 0.00 2.68 0.00 0.00 0.00 2.68 
  2.67 0.00 2.67 0.00 0.00 0.00 2.67 
  1.95 0.00 1.95 0.00 0.00 0.00 1.95 
  1.64 0.00 1.64 0.00 0.00 0.00 1.64 
  1.57 0.00 1.57 0.00 0.00 0.00 1.57 
  0.00 0.00 1.57 0.00 0.00 0.00 1.57 
  1.39 0.00 1.39 0.00 0.00 0.00 1.39 
  1.31 0.00 1.31 0.00 0.00 0.00 1.31 
  0.86 0.00 0.86 0.00 0.00 0.00 0.86 
  0.78 0.00 0.78 0.00 0.00 0.00 0.78 
  0.71 0.00 0.71 0.00 0.00 0.00 0.71 
  0.57 0.00 0.57 0.00 0.00 0.00 0.57 
  0.40 0.00 0.40 0.00 0.00 0.00 0.40 
  0.34 0.00 0.34 0.00 0.00 0.00 0.34 
  0.29 0.00 0.29 0.00 0.00 0.00 0.29 
                
% < 3 Ang 91.58 0.00 100.00 0.00 0.00 0.00 100.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  95.67 152.69 76.54 126.88 134.10 97.59 76.50 
  63.35 101.42 51.40 84.25 89.55 64.93 50.84 
  37.35 60.31 30.47 50.22 52.94 38.45 30.11 
  20.69 33.50 17.09 27.85 29.53 21.37 16.71 
  12.69 19.97 9.90 16.46 17.42 12.70 9.96 
  11.87 18.88 9.44 15.73 16.52 12.03 9.41 
  8.09 12.78 6.42 10.54 11.22 8.15 6.38 
  7.97 12.71 6.42 10.58 11.18 8.11 6.34 
  5.77 9.29 4.71 7.75 8.18 5.94 4.65 
  4.92 7.83 3.92 6.48 6.86 5.00 3.92 
  4.70 7.50 3.76 6.21 6.56 4.77 3.74 
  4.74 7.50 3.74 6.17 6.55 4.77 3.74 
  4.14 6.60 3.33 5.45 5.81 4.22 3.31 
  3.89 6.25 3.14 5.21 5.45 3.96 3.10 
  2.57 4.10 2.08 3.39 3.60 2.61 2.04 
  2.30 3.68 1.86 3.07 3.25 2.36 1.85 
  2.09 3.37 1.71 2.81 2.96 2.14 1.67 
  1.70 2.74 1.38 2.27 2.40 1.74 1.37 
  1.18 1.89 0.95 1.56 1.65 1.20 0.94 
  1.01 1.63 0.83 1.36 1.43 1.04 0.81 
  0.87 1.40 0.71 1.15 1.22 0.89 0.70 
                
bolt.Ave.dist 2.98 4.76 2.40 3.95 4.18 3.04 2.38 
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  H4-H9 
H4-
H8 
H8-
H9 
H9-
H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.01 0.00 0.04 0.00 0.00 0.01 0.17   39.47 -154.35 -31.49 
  0.01 0.00 0.02 0.00 0.00 0.01 0.12   41.23 -155.24 -32.47 
  0.00 0.00 0.01 0.00 0.00 0.00 0.07   39.05 -152.44 -29.75 
  0.00 0.00 0.01 0.00 0.00 0.00 0.04   40.65 -153.38 -30.79 
  0.00 0.00 0.00 0.00 0.00 0.00 0.02   38.72 -155.51 -32.56 
  0.00 0.00 0.00 0.00 0.00 0.00 0.02   39.49 -152.52 -29.69 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   40.61 -156.35 -33.48 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   41.19 -153.48 -30.75 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   39.59 -152.02 -29.14 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   38.02 -154.60 -31.64 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   38.54 -153.68 -30.89 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   38.07 -154.80 -31.81 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   39.59 -154.87 -31.88 
  0.00 0.00 0.00 0.00 0.00 0.00 0.01   37.92 -150.36 -27.71 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   40.09 -154.57 -31.88 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   39.77 -155.53 -32.56 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   39.54 -151.49 -28.92 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.90 -152.71 -29.92 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.64 -152.95 -30.14 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   37.39 -149.63 -26.95 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   38.10 -152.97 -30.15 
                        
1/r^6 0.03 0.00 0.11 0.01 0.00 0.03 0.55         
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Figure 2.8: Molecular modelling data for 4R, 5S, 8R, 9S 
 
Potential Energy-
OPLS-AA E/kT e-E/kT Ne-E/kT Boltzmann % E*% Bolt.Ave.E 
311.87 -125.03 5.02E-55 6.52E-54 2.35 18.06 5632.93 312.81 
311.92 -125.05 4.92E-55 6.40E-54 2.30 17.72 5527.95   
312.57 -125.31 3.79E-55 4.92E-54 1.77 13.64 4262.24   
312.83 -125.41 3.42E-55 4.44E-54 1.60 12.30 3848.56   
312.90 -125.44 3.32E-55 4.31E-54 1.55 11.95 3739.93   
312.95 -125.46 3.25E-55 4.22E-54 1.52 11.70 3662.53   
314.04 -125.90 2.10E-55 2.73E-54 0.98 7.58 2379.07   
314.75 -126.19 1.58E-55 2.05E-54 0.74 5.69 1790.37   
321.48 -128.88 1.06E-56 1.38E-55 0.05 0.38 123.11   
322.31 -129.22 7.63E-57 9.92E-56 0.04 0.27 88.54   
322.50 -129.29 7.07E-57 9.19E-56 0.03 0.25 82.13   
322.52 -129.30 7.00E-57 9.10E-56 0.03 0.25 81.34   
323.20 -129.57 5.34E-57 6.95E-56 0.03 0.19 62.18   
 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  3.98 4.90 2.38 3.96 4.17 3.04 2.38 
  3.97 4.92 2.40 3.96 4.17 3.04 2.38 
  3.97 4.92 2.40 3.98 4.16 3.03 2.37 
  3.97 4.90 2.40 3.95 4.18 3.04 2.37 
  3.96 4.94 2.42 3.98 4.17 3.03 2.37 
  3.95 4.92 2.40 3.96 4.17 3.04 2.38 
  3.96 4.91 2.42 3.96 4.18 3.03 2.36 
  3.94 4.93 2.42 3.97 4.17 3.03 2.37 
  3.92 4.92 2.40 3.97 4.18 3.04 2.38 
  3.91 4.91 2.42 3.96 4.19 3.04 2.37 
  3.96 4.89 2.38 3.96 4.17 3.04 2.37 
  3.92 4.92 2.41 3.97 4.18 3.04 2.38 
  3.91 4.91 2.42 3.96 4.19 3.04 2.37 
                
Shortest 3.91 4.89 2.38 3.95 4.16 3.03 2.36 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 18.06 0.00 0.00 0.00 18.06 
  0.00 0.00 17.72 0.00 0.00 0.00 17.72 
  0.00 0.00 13.64 0.00 0.00 0.00 13.64 
  0.00 0.00 12.30 0.00 0.00 0.00 12.30 
  0.00 0.00 11.95 0.00 0.00 0.00 11.95 
  0.00 0.00 11.70 0.00 0.00 0.00 11.70 
  0.00 0.00 7.58 0.00 0.00 0.00 7.58 
  0.00 0.00 5.69 0.00 0.00 0.00 5.69 
  0.00 0.00 0.38 0.00 0.00 0.00 0.38 
  0.00 0.00 0.27 0.00 0.00 0.00 0.27 
  0.00 0.00 0.25 0.00 0.00 0.00 0.25 
  0.00 0.00 0.25 0.00 0.00 0.00 0.25 
  0.00 0.00 0.19 0.00 0.00 0.00 0.19 
                
% < 3 Ang 0.00 0.00 100.00 0.00 0.00 0.00 100.00 
 
 
 
  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  0.00 0.00 18.06 0.00 0.00 0.00 18.06 
  0.00 0.00 17.72 0.00 0.00 0.00 17.72 
  0.00 0.00 13.64 0.00 0.00 0.00 13.64 
  0.00 0.00 12.30 0.00 0.00 0.00 12.30 
  0.00 0.00 11.95 0.00 0.00 0.00 11.95 
  0.00 0.00 11.70 0.00 0.00 0.00 11.70 
  0.00 0.00 7.58 0.00 0.00 0.00 7.58 
  0.00 0.00 5.69 0.00 0.00 0.00 5.69 
  0.00 0.00 0.38 0.00 0.00 0.00 0.38 
  0.00 0.00 0.27 0.00 0.00 0.00 0.27 
  0.00 0.00 0.25 0.00 0.00 0.00 0.25 
  0.00 0.00 0.25 0.00 0.00 0.00 0.25 
  0.00 0.00 0.19 0.00 0.00 0.00 0.19 
                
% < 2.5 Ang 0.00 0.00 100.00 0.00 0.00 0.00 100.00 
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  H4-H9 H4-H8 H8-H9 H9-H7a H9-H7b H8-H7a H8-H7b 
  71.81 88.58 42.98 71.58 75.25 54.85 42.93 
  70.33 87.28 42.53 70.17 73.94 53.86 42.16 
  54.09 67.04 32.71 54.24 56.77 41.32 32.30 
  48.80 60.23 29.54 48.63 51.43 37.35 29.20 
  47.33 59.03 28.90 47.51 49.82 36.23 28.33 
  46.17 57.52 28.09 46.34 48.84 35.57 27.84 
  30.01 37.18 18.33 30.04 31.65 22.94 17.91 
  22.39 28.02 13.76 22.61 23.71 17.25 13.49 
  1.50 1.88 0.92 1.52 1.60 1.16 0.91 
  1.08 1.35 0.66 1.09 1.15 0.83 0.65 
  1.01 1.24 0.61 1.01 1.06 0.77 0.60 
  0.99 1.24 0.61 1.00 1.05 0.77 0.60 
  0.75 0.95 0.47 0.76 0.81 0.58 0.46 
                
                
bolt.Ave.dist 3.96 4.92 2.40 3.96 4.17 3.03 2.37 
 
 
 
  H4-H9 
H4-
H8 
H8-
H9 
H9-
H7a 
H9-
H7b 
H8-
H7a 
H8-
H7b   H8-H9 H8-H7a H8-H7b 
  0.00 0.00 0.01 0.00 0.00 0.00 0.10   39.13 -152.82 -29.99 
  0.00 0.00 0.01 0.00 0.00 0.00 0.10   38.11 -151.96 -29.11 
  0.00 0.00 0.01 0.00 0.00 0.00 0.08   38.21 -150.61 -27.96 
  0.00 0.00 0.01 0.00 0.00 0.00 0.07   40.97 -153.80 -31.05 
  0.00 0.00 0.01 0.00 0.00 0.00 0.07   36.82 -149.56 -26.91 
  0.00 0.00 0.01 0.00 0.00 0.00 0.06   38.28 -151.97 -29.12 
  0.00 0.00 0.00 0.00 0.00 0.00 0.04   39.90 -151.75 -29.20 
  0.00 0.00 0.00 0.00 0.00 0.00 0.03   37.06 -149.60 -26.94 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   41.23 -152.31 -29.45 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   42.72 -153.21 -30.44 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   39.97 -154.53 -31.55 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   41.65 -152.31 -29.42 
  0.00 0.00 0.00 0.00 0.00 0.00 0.00   43.07 -153.10 -30.31 
                        
1/r^6 0.00 0.00 0.07 0.00 0.00 0.02 0.56         
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Appendix 3 
 
Publications (to date) arising from this thesis 
 
 
spiro-Mamakone A: A Unique Relative of the Spirobisnaphthalene Class of Compounds 
 
Bioactivity Profiling Using HPLC/Microtitrer-Plate Analysis: Application to a New 
Zealand Marine Alga-Derived Fungus, Gliocladium sp. 
 
Dichlorinated Pulvinic Acid Derivative from a Malaysian Scleroderma sp.
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